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ABSTRACT 
Anal incontinence symptoms are more prevalent than generally perceived and can 
affect individuals of any age and either gender, with a variety of widespread 
causes. The taboo nature of the loss of bowel control can significantly impair an 
individual's quality of life, due not only to the consequences of symptoms, but 
also to the considerable effort required to conceal their existence. 
Over recent years the importance of quality of life evaluation has evolved. To date, 
published self-report questionnaires for assessment in this area have largely been 
developed without patient collaboration compromising the relevance of the 
measurement items included. Furthermore, available questionnaires largely tend 
to ignore flatus incontinence and lack evidence of prospective psychometric 
validation. 
Both qualitative and quantitative methodologies were employed to develop the 
ICIQ-B, a self-report questionnaire for the comprehensive assessment of anal 
incontinence symptoms and their impact on quality of life. Qualitative studies 
were undertaken with symptomatic patients and clinicians to derive the items for 
inclusion in the questionnaire. This ensure the questionnaire reflected clinically 
important factors and issues of relevance to individuals with symptoms. Parallel 
sub-studies with potential respondents were undertaken to gather data for 
quantitative analysis to evaluate the questionnaire's measurement properties. 
Factor analyses were conducted to evaluate the underlying structure of the 
questionnaire and provide evidence for a scoring system. The twenty one item 
ICIQ-B was developed and shown to exhibit robust evidence of validity, reliability 
and sensitivity to change. The questionnaire provides evaluation of three different 
perspectives: bowel pattern, bowel control and quality of life. The ICIQ-B is a 
widely applicable, condition-specific, self-report instrument for the evaluation of 
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INTRODUCTION TO THE 
THESIS 
This thesis will describe the development and evaluation of a new questionnaire 
to assess symptoms of anal incontinence and their impact on quality of life: the 
ICIQ-B. In order to establish the need for such a questionnaire, the size of the 
problem and methods of available assessment are explored in detail, followed by 
the methodology and results of this study. 
Anal incontinence symptoms can result from a number of causes, suggesting that 
the potential to be affected is greater than generally assumed. Chapter One 
explores the causes and prevalence of anal incontinence to gauge the size of the 
problem and examine the population in which the ICIQ-B will be required for 
use. Chapter Two outlines the rationale for the psychometric validation of self- 
report questionnaires and identifies the importance of evaluating the 
measurement properties of such a questionnaire. This information is used to 
explore the adequacy of currently available questionnaires in Chapter Three. As 
this thesis will highlight, to date, accurate measurement of symptoms of anal 
incontinence and their impact from the patients' perspective has been flawed. 
Failure to capture the patients' points of view and, in most cases, incomplete 
evaluation of measurement capabilities, has rendered the previously available 
questionnaires inadequate for use in anal incontinence specifically, of which 
flatus incontinence is a component. In addition, measurement instruments have 
often been developed for use in specific patient populations resulting in the lack 
of a validated standardised measure. Qualitative studies conducted to explore 
the patients' perspective of anal incontinence are detailed in Chapter Four to 
establish the existing evidence base regarding quality of life impact of these 
symptoms. 
The methods used to develop the ICIQ-B, taking into account the limitations 
identified in the available literature that were addressed in this study, are 
1 
detailed in Chapter Five. Efforts to ensure the ICIQ-B reflected both clinicians' 
and patients' views and needs are described in the qualitative studies 
undertaken to generate the initial questionnaire. The extensive validation studies 
undertaken during the quantitative phase of the study are detailed to provide 
evidence for the robust measurement properties of the questionnaire. 
Chapter Six details the evidence to support the ICIQ-B's claim that it provides a 
self-completion questionnaire, which reflects patients' and clinicians' 
perspectives, and exhibits robust psychometric properties. The ICIQ-B 
demonstrates evidence of validity, reliability and sensitivity to change, making it 
useful in clinical practice and research for baseline assessment, ongoing 
monitoring and evaluation of treatment outcomes, in adult individuals of 
varying ages and gender with anal incontinence. 
The findings of the study and the implications for future practice and research 
are discussed in Chapter Seven. Developing a questionnaire in such detail has 
provided a valuable tool for use in clinical practice and research, which is only 
the first step. Dissemination of the ICIQ-B is of considerable future importance to 
enable the assessment of unmet need and the development of potentially more 
effective management strategies. 
2 
CHAPTER ONE: THE 
PATHOPHYSIOLOGY AND 
EPIDEMIOLOGY OF ANAL OR 
FAECAL INCONTINENCE 
Introduction 
Loss of bowel control is a significant taboo within society and yet the number of 
individuals who are affected is much higher than most of us would expects. 
Effective treatments are available yet, often, symptoms go unreported due to 
their embarrassing nature, and significant life restriction can ensue2. In order to 
understand this symptom complex it is necessary to explore in detail what is 
meant by anal or faecal incontinence in terms of its definition, how it occurs and 
how many people it affects. The aim of this chapter is to examine the 
pathophysiology and epidemiology of these symptoms, to provide the 
background for this study and contextualise the problem. 
1.1 Definitions of anal and faecal incontinence 
There is an absence of standardised terminology in the area of anal and faecal 
incontinence, with various definitions being used. Considerable disparity exists 
within the literature regarding the parameters of a definition of incontinence. 
Thus, faecal incontinence is defined in many diverse ways, ranging from a "loss 
of voluntary control of stool"3, "loss of voluntary control of stool or flatus"4; 
"involuntary or inappropriate passing of liquid or solid stool, including flatus"5; 
to more general and non-specific definitions such as "incontinence of faeces"6 or 
"involuntary loss of rectal contents through the anal canal"1. 
3 
Medical texts have attempted to include the reason for the incontinent episode, 
while retaining the broad parameters that constitute an episode: 
"the uncontrolled passage of stool through the rectum from either 
a lack of awareness of the need to defecate or an inability to to get to 
a lavatory in time"7. 
The Rome III multinational working teams aimed to provide criteria for the 
classification of functional gastrointestinal disorders for research and clinical 
practice, based on clinical expertise and a research evidence base8. The teams 
comprised clinical experts and, in their most recent review the committee for 
functional anorectal disorders put forward a specific definition, to aid diagnosis 
of functional faecal incontinence: 
"uncontrolled passage of fecal material recurring for >3 months in an 
individual with a developmental age of at least 4 years that is associated with 
any or all of abnormal function in normally innervated and structurally intact 
muscle, minor sphincter structure or innervation abnormalities, disordered bowel 
habits such as retention or diarrhoea, and psychological causes "9. 
This definition is complicated and, as intended, only refers to functional 
disorders, which omits those with an identifiable pathology, sphincter damage or 
neuropathy. Overall, these various definitions of faecal incontinence result in 
very different individuals being identified, depending on their symptom 
complex. 
Similarly, the definition of anal incontinence is also variable, sometimes 
including the description of "occasional staining of underwear (soiling)"10, and 
"flatus incontinence", in addition to the descriptions above. The term "anal 
incontinence" notably appears less frequently within the literature, with faecal 
incontinence having emerged as the term of choice. For example, of all related 
publications in the electronic database PubMed, between July 1941 and August 
2008, searches using the term "faecal/fecal incontinence" accounted for 62% 
whereas "anal incontinence" identified 38% of the publications identified. 
The World Health Organisation supported International Consultations on 
Incontinence (ICI) were held to review the state of the knowledge of all aspects of 
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incontinence and translate that to applicable strategies in practice, following the 
principles of evidence-based medicine". At the Second ICI held in 2001 a 
definition was put forward: "[anal or fecal incontinence] that is a social or 
hygienic problem"12, supported by similar definitions at the time, "involuntary 
or inappropriate passing of faeces that has an impact on social functioning or 
hygiene"13 and "involuntary or inappropriate passing of liquid or solid stool, or 
flatus"5. The addition of "inappropriateness" or that which was a "social or 
hygienic problem", implied that actual occurrence of anal or fecal incontinence 
was not sufficient. A further requirement of inappropriateness, or social or 
hygienic impact, was necessary in order to constitute anal or faecal incontinence. 
The relevance of this was not explored further, however, and was removed from 
the final definition recommended by the Third ICI(2004)14.15: 
"Faecal incontinence, any involuntary loss of faecal material. 
Flatus incontinence, any involuntary loss of gas (flatus). 
Anal incontinence, any involuntary loss of faecal material and/or flatus. " 
Table 1 summarises the definitions described above. 
Table 1 Definitions of anal or faecal incontinence 
Anal incontinence Faecal incontinence 
Loss of voluntary control of stool or flatus4,16 Loss of voluntary control of stool3 
Involuntary loss of faecal material and/or Incontinence of faeces6 
flatus14,15 
Occasional staining of underwear (soiling)10 Involuntary loss of rectal contents through 
the anal canal' 
Uncontrolled passage of stool through the 
rectum from either a lack of awareness of the 
need to defecate or an inability to get to a 
lavato in time? 
Uncontrolled passage of faecal material 
recurring for >3 months9 
Societal component 
Anal or faecal incontinence that is a social or hygienic problem12 
Involuntary or inappropriate passing of liquid or solid stool, including flatus5 
The requirement for uniform definitions has been identified most recently at the 
US National Institute for Health's "State of the Science conference for the 
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prevention of fecal and urinary incontinence", held in December 20072. Efforts to 
reach a consensus on how it should be defined generated considerable 
discussion. Despite the diversity that is evident, there appears to be a main 
distinction between the inclusion, or exclusion, of incontinence of flatus. There is 
also some consensus in the concept of "loss of control". Many of the definitions 
refer to "inability to control" or "involuntary leakage/loss" suggesting that this 
is also a fundamental aspect. 
For the purposes of this thesis the definition recommended by the Third ICI14,15 
was adopted: 
"Faecal incontinence, any involuntary loss of faecal material. 
Flatus incontinence, any involuntary loss of gas (flatus). 
Anal incontinence, any involuntary loss of faecal material and/or flatus. " 
This definition was the consensus opinion of international clinical experts, does 
not impose any qualifying factors such as societal components and does not 
exclude individuals based on the cause of their symptoms. It is thus a pragmatic 
definition which will enable a wide range of individuals with these symptoms to 
be included in the study. 
1.2 Physiology of the lower bowel 
In order to understand anal incontinence and dysfunction of the lower bowel it is 
crucial to consider the "normal" physiology of the system and how it functions. 
As displayed in Figure 1 (pp. 7), the large bowel consists of a continuous pipe 
that extends from the small intestine to include the ascending, transverse, 
descending and sigmoid colon, on to the rectum and finally anus, all of which 
have specific roles in storage of stool and enabling defaecationl7"18. 
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Reproduced with permission from Radiotherapy Answers of the American Society for 
Therapeutic Radiology and Oncology1 . 
The ascending colon functions largely as a mixing reservoir where water is 
reabsorbed to increase solidity of faecal matter in conjunction with "ring" 
contractions which serve to mix the faecal content. These ring contractions are 
performed by an inner layer of circular muscle that lies outside the colonic 
mucosa. A second outer layer of longitudinal muscle runs along the length of the 
colon and is primarily responsible for the peristaltic movement of mixed faecal 
matter along the colon, along with the circular muscle contractions, occuring 
mainly in the transverse and descending colon. 
The rectum remains empty most of the time, but provides a reservoir function to 
accommodate faecal matter until it is socially and practically appropriate to 
empty. The inner circular muscle that is present under the colonic mucosa, 
extends to the distal end of the rectum, ending approximately 10mm from the 
7 
anal verge, where it thickens to form the Internal Anal Sphincter (IAS), displayed 
in Figure 2. This smooth muscle layer is able to maintain tonic contraction for 
extended periods of time and is responsible for approximately 70 to 85% of the 
resting anal sphincter pressure20-23. The External Anal Sphincter (EAS) comprises 
striated muscle that extends to the anal verge, surrounding the IAS. This striated 
muscle is under voluntary control from the pudendal nerve, which arises from 
sacral nerve roots and is easily fatiguable23. The EAS provides approximately 
15% of the overall resting anal sphincter pressure. The main responsibility of the 
EAS is to enable voluntary and reflex sphincter contraction] 7,23. 











Reproduced with permission from the University of Illinois24 
Rectal compliance refers to the ability of the rectum to allow increases in volume 
of faeces with only minor changes in pressure until a critical volume, usually 
greater than 200m1, is reached. Distension of the rectum results in reflex 
relaxation of the IAS and progressive contraction of the EAS25. When the critical 
8 
continence 
volume is attained, and it is convenient to empty the bowel, both sphincters relax 
enabling passage of stool through the relaxed anal canal17 
To assist this bowel activity, the puborectalis muscle, (Figure 3), which is 
normally responsible for supporting the rectum, vagina in women and urethra, 
relaxes. 
Figure 3A diagrammatic saggital representation of the pelvic floor at rest 
and during defaecation 
Pubic 








At rest Defaecation 
Reproduced with permission from l ii' msfield Publishers I. tdl' 
This relaxation results in a straightening of the anorectal angle, further assisted 
by taking the position of sitting or squatting, easing the passage of stool without 
anatomical obstruction. A valsalva manoeuvre is performed, whereby pressure 
is exerted against a closed glottis. This serves to produce downward pressure, 
through the abdomen, which is funnelled by tensing of the abdominal wall 
muscles. This, in turn, provokes a mass contraction of the rectum and sigmoid 
colon to evacuate the bowel. This contraction cycle of the rectosigmoid colon 
continues until the rectum is completely emptied'7'26. All of these structures, 
when functioning appropriately and in coordination, ensure faecal evacuation 
without incontinence. 
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1.3. Pathophysiology of the lower bowel 
Abnormal physiology and dysfunction can be categorised by site of occurrence 
and type of disorder. Anal incontinence can be a complication of any of the 
conditions detailed below. A self-completion questionnaire for the assessment of 
anal incontinence needed therefore to be applicable for the following clinical 
presentations. 
1.3.1. Lower bowel diseases 
Diverticular disease is caused by herniation of the colonic mucosa protruding 
through areas of natural weakness in the muscle layer of the intestinal wall, 
thought to be caused by raised pressure in the lumen of the colon as a result of 
chronic constipation, often related to the western diet18-27-28. Diverticulitis refers to 
the inflammation of these protruding pouches29 and patients often present with 
rectal bleeding as a result of the blood vessels in the herniated pouches being 
more exposed to potential trauma from passing faeces. Other common 
associated complaints include diarrhoea, abdominal pain and swelling, and 
flatus, potentially causing anal incontinence27,29. 
Crohn's disease and Ulcerative Colitis, (UC), are conditions characterised by 
chronic inflammation and ulceration of the bowel mucosa29. UC is restricted to 
the large bowel only, while Crohn's disease can affect the entire alimentary canal 
from mouth to anus30. UC sufferers most commonly present initially with 
symptoms of passage of frequent stools that are blood stained and associated 
with mucus. Also reported are lower abdominal pain and some tenesmus, 
(constant feeling of needing to empty the bowel), although systemic upset tends 
to be minimal and weight loss not necessarily marked. However, patients 
experiencing an acute episode of colitis may exhibit symptoms of constant 
bloody diarrhoea occurring up to twenty times a day or greater, colicky lower 
abdominal pain, weight loss and are generally unwell in appearance. 
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Crohn's disease mainly presents itself in the form of diarrhoea and abdominal 
pain with associated weight loss. Abdominal distension is a particularly common 
characteristic due to the nature of the colonic strictures that develop in Crohn's 
disease, in effect forming an obstruction at the site of long-term inflammation. 
These conditions are more frequently diagnosed in younger adults, in particular 
females, although not exclusively31. Variable stool consistency, and the urgency 
of bowel opening associated with the above conditions, can potentially 
predispose individuals with these diseases to anal incontinence. 
Cancer of the large colon usually first develops as lesions in the mucosa of the 
intestinal wall affecting mainly older people. Over half of patients are aged over 
60, and incidence peaks in patients aged 70 to 80. The site of the tumour affects 
the presentation with two thirds of large bowel tumours occurring in the rectum, 
and descending and sigmoid colon32. Cancer of the ascending colon is typified by 
obstructive symptoms such as colic, vomiting, constipation and abdominal 
distention, or with rather more vague symptoms such as anaemia and weight 
loss. These latter symptoms are secondary to occult gastrointestinal bleeding and 
often confused with a possible diagnosis of stomach cancer32. 
Occurrence of cancer within the descending colon is most commonly presented 
as altered bowel habits with increased diarrhoea or constipation, or alteration 
between the two. Blood associated with the stools, lower abdominal pain or 
discomfort and weight loss are also strong indicators. A third of patients 
however, present as an emergency, with the tumour causing a complete 
obstruction of the bowel. Rectal carcinoma is characterised by rectal bleeding, 
tenesmus, frequency of opening bowels, although passing only blood and 
"slime", and altered bowel habits32. There is a strong hereditary element with 
bowel cancer making a diagnosis more likely in a person with a family history. It 
is estimated that 25% of individuals with colorectal cancer present with altered 
stool type which can compromise the ability to remain continent33. Radiotherapy 
for all pelvic cancers and post-operative complications also predispose 
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individuals to anal incontinence, estimated to be as high as 25% following 
treatment for cervical cancer34. 
1.3.2. Functional lower bowel disorder 
Irritable Bowel Syndrome (IBS) is a condition characterised by the exclusion of 
organic disease. According to the ROME III diagnostic criteria of functional 
gastrointestinal disorders, IBS is defined as patients exhibiting at least a three 
month history of constant or recurrent abdominal pain associated with relief by 
defaecation, change in stool frequency and/or stool form35. IBS is characterised 
by relapses and remissions and its irritability, as suggested by the title, means it 
can take the form of diarrhoea, or be constipation predominant. Diarrhoea is the 
primary link between IBS and anal incontinence, as will be discussed further. 
Unpredictability of diarrhoea and altered stool consistency pose problems to 
even uncompromised anatomy. IBS is also associated with upper gastrointestinal 
symptoms, such as nausea and dyspepsia, as well as non-specific lower bowel 
symptoms30. This condition is benign however, and there is thought to be a large 
psychosocial element to this syndrome whereby stress is a major contributing 
factor36. Treatment is aimed at management of symptoms as opposed to cure, 
with dietary triggers being influential and often individual to the sufferer. These 
triggers require identification and manipulation in order to attempt to control the 
condition37. 
1.3.3. Lower bowel symptoms 
Constipation and diarrhoea are two common bowel symptoms that are 
characteristic of all the conditions discussed previously. They are important 
symptoms that need to be considered in more detail as they may cause anal 
incontinence: overflow incontinence in the case of constipation and incontinence 
due to looser stool type with diarrhoea. These symptoms can also occur in people 
without serious lower bowel conditions as described above. They must, 
therefore, be considered in the assessment of anal incontinence. 
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Constipation is a symptom to which everybody is vulnerable and its 
interpretation is largely influenced by individual expectation of "normal" 
frequency of bowel opening. Research to define normal bowel frequency has 
concluded that, "Conventionally normal bowel function (once per day) is 
enjoyed by less than half the population"38. A further study, undertaken solely in 
females, found that only 51 % of "healthy" females reported one daily bowel 
movement, while 30% reported fewer39. The diagnostic criterion for constipation 
suggested by the ROME III group encompassed bowel opening frequency fewer 
than three times per week; needing to strain, lumpy or hard stools, sensation of 
incomplete evacuation or anorectal obstruction and digitation required, at least 
two of which should be present35. 
Constipation can be characterised by the two mechanisms of slow colonic transit 
and evacuation difficulties, which can co-exist within the same patient. Slow 
colonic transit refers to abnormally slow passage of faeces through the large 
colon which may result in a reduced urge to defecate, or the absence of urge 
sensation. However, these symptoms are not exclusively related to slow colonic 
transit. This can be secondary to a number of causes, such as side effects of 
medication, low residue diet, pregnancy, reduced mobility, or may simply be 
idiopathic, or unknown. Evacuation difficulties encompass poor coordination of 
the rectum, anus and pelvic floor, in addition to obstructive causes. They are 
typified by the need to strain, incomplete evacuation and the requirement for 
manual assistance in order to empty the bowel. Evacuation dysfunction can be 
related to systemic illness impairing the nerve supply to the anorectal region, 
physical abnormality at the site such as rectal prolapse, incoordination or, rarely, 
a colonic cause such as tumour obstruction or strictures in the case of Crohn's 
diseasel8.40. 
Diarrhoea is most commonly acute in nature and is due to an infective cause, 
which is short-lived, such as gastroenteritis. It is crucial for clinicians to make 
this distinction in order only to pursue investigation in those whose symptoms 
would not resolve spontaneously30. Chronic diarrhoea has been defined as the 
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passage of unformed stool more than three times a day for a minimum of one 
month41 and, more recently, functional diarrhoea was defined by the ROME III 
criteria as the presence of "loose (mushy) or watery stools without pain occurring 
in at least 75% of stools"35. 
Organic causes of diarrhoea include reduced intestinal absorption, increased 
intestinal secretion, large amounts of non-absorbable material in the large 
intestine and increased intestinal motility. Conditions such as Crohn's or UC and 
problems with reduced absorption can be responsible for these causes in 
addition to dietary factors (food sensitivities or fructose, sorbitol and caffeine 
ingestion for example) and medication use (antibiotics and antacids)30. These 
factors must be considered as potentially reversible in the assessment of anal 
incontinence. 
1.3.4. Anorectal conditions 
There are various anorectal conditions that are not necessarily directly related to 
anal incontinence, but may be associated with it. Pruritis ani is a condition 
characterised by itching, burning and soreness around the anus. The cause is not 
fully understood, but factors implicated are contamination from anal soiling and 
irritation of the perianal skin. Moisture from sweat, friction, trauma to the 
anorectal region and other dermatological conditions are also thought to have 
some effect. It tends to follow a cyclical trend, with the irritation experienced by 
patients leading to increased itching, subsequently resulting in further increased 
irritation and so it continues4Z43. 
Haemorrhoids are highly vascularised anal cushions that have dilated or 
prolapsed from within the anal canal. The "healthy" anal cushions serve as a seal 
and offer a supportive role in maintaining continence and so their removal can 
have implications for continence. Severity of haemorrhoids can range from 
protrusion into the anal lumen internally to continual protrusion from the anus, 
that in extreme cases become strangulated. Fresh, bright red rectal bleeding 
along with itching and pain are particularly characteristic of haemorrhoids4z44. 
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Anal fissures refer to a tear within the lower half of the anal canal often starting 
after an episode of diarrhoea or constipation following which a tear has failed to 
heal adequately. Pain, especially with movement of the bowels, and rectal 
bleeding are primary signs. Treatment is aimed at reducing anal resting pressure, 
in order for the tear to heal and prevent reoccurrence4z45. Occurrence of either of 
these symptoms, and the treatments indicated, can impair continence 
necessitating accurate assessment and monitoring of these symptoms. 
Anal fistula is the term used to describe a track, or cavity, that has formed 
between the anal canal and an external opening near the anus, or in females this 
can also occur near the vagina. In men, the main cause is thought to be the 
occurrence of an infected anal gland that can lead to the formation of an abscess, 
from which pus can track through or between sphincter components. The main 
cause in women is obstetric injury leading to the passage of stool or flatus via the 
fistula track, causing incontinence. Passage of persistent discharge through the 
track is also a key indicator of fistula formation. Treatment is aimed at surgical 
opening of the fistula in order to promote healing, although fistulae can pass 
through part or all of the sphincter complex and post-surgical continence must 
be considered42,45 
Weakness in the pelvic floor musculature and ligamentous support can result in 
an inability to maintain the rectum in its usual position at times of increased 
intra-abdominal pressure, such as defaecation42.45. The resulting rectal prolapse, 
(eversion of the rectum through the anal canal that may appear externally to 
varying degrees) or rectocele (bulge of the front wall of the rectum into the 
vagina) are commonly associated with symptoms of anal incontinence46. Surgical 
repair of the prolapse is the treatment, dependent on severity. 
1.3.5. Anal incontinence 
Anal incontinence can arise as a symptom of the conditions described previously, 
in response to dietary triggers, due to confusion or inability to access a toilet or as 
a result of the normal anatomy of the anorectal region being disrupted in some 
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way. Often it is the result of a combination of factors21.47. The anatomical causes 
of anal incontinence are described here. 
As previously described, the IAS is under autonomic control and is mainly 
responsible for the resting anal tone in the anal canal. Damage to this area can 
cause passive anal incontinence when flatus, mucus, liquid or solid stool passes 
through the inadequate seal. The EAS is under voluntary control, and is 
implicated in the control of passage of flatus, mucus, liquid or solid stool. The 
absence of an intact EAS reduces the ability to delay or prevent incontinent 
episodes that occur urgently or with little warning. 
Sphincter damage is most often the result of obstetric trauma48-52 with forceps 
and vacuum delivery, third or fourth degree tears, episiotomy, prolonged second 
stage of labour and higher infant weight representing increased risk factors for 
incontinence51-60. The influence of epidural analgesia on resulting incontinence is 
not clear with conflicting results from empirical studies53.61. Pelvic or anal 
surgery62-6 and, more rarely, trauma to the sphincteric region47 can also cause 
damage to the sphincter complex. The occurrence of incontinence, however, can 
be exacerbated by the conditions described previously, such as inflammatory 
bowel disease and diarrhoea, or the treatments for them, as in the case of 
preoperative radiotherapy for rectal cancer66. It is also necessary to consider that 
symptoms may not become evident in women until the menopause, despite the 
primary cause occurring some years previously51. 
The pudendal nerve that controls the EAS can also be damaged, reducing the 
extent of voluntary control that a person is able to apply, despite the presence of 
an intact sphincter. This damage is again commonly due to obstetric causes, with 
elongation of the nerve associated with stretching of the birth canal, in addition 
to direct injury during childbirth47"51. Other causes include any neurological 
conditions which directly affect the nerve supply, for example spinal injury, as in 
the case of cauda equina syndrome, multiple scelorsis, stroke and brain injury67- 
73. 
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With regard to nerve supply, in older adults, anorectal sensation can be poor 
with overall degeneration of nerves preventing the ability to detect an 
accumulation of stool, which can lead to faecal impaction and overflow 
incontinence7'21. In patients with neurological conditions such as multiple 
sclerosis, stroke and spinal cord injury, bowel dysfunction is common. The 
intricate balance of neurological control of the intestinal system can be 
compromised by damage to the afferent nerves reducing awareness of the need 
to open the bowels, efferent nerves interrupting innervation of the intestines and 
voluntary control of the pelvic floor, in addition to reduced anorectal sensation. 
The role of the enteric nerves, which mediate finer control of the gastrointestinal 
system, can also be compromised, although symptoms often result as a 
combination of any or all of these factors74. 
Individual factors such as obesity and primiparity can also increase the risk of 
incontinence due to demands placed on the pelvic floor75-77. 
The above conditions were explored to put into context the wide ranging causes 
of anal incontinence and to establish the nature of the population for whom the 
new questionnaire would be required. The conditions implicated are broad, thus 
the potential to be affected by these symptoms is sizeable within the general 
population. The final part of this chapter will explore the evidence regarding the 
prevalence of incontinence symptoms to establish the size of the problem of anal 
incontinence. 
1.4. Epidemiology of anal incontinence 
It is important to evaluate the extent of anal/faecal incontinence symptoms 
within the population in order to gauge the magnitude of this disorder. This 
information can help to determine the requirement for such an instrument as the 
ICIQ-B, in addition to the exploration of available assessment tools that will be 
detailed in Chapter Three. 
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1.4.1. Prevalence studies of anal or faecal 
incontinence 
Prevalence is defined as; 
"the probability of experiencing a symptom or having a condition or a 
disease within a defined population and at a defined time point. "14 
Prevalence estimates are important to quantify the distribution of a condition 
within a given population. This may, in turn, be useful for estimating the need 
for healthcare services within that population14,78. 
The electronic database PubMed was searched for published prevalence studies. 
Searches were limited to adult human studies and studies reported or translated 
into English dating from January 1970 to April 2008, employing the following 
MeSH search terms used in combination: "prevalence", "incidence" and "fecal 
incontinence" (incorporated "faecal incontinence"). While not a MeSH term, 
"anal incontinence" was also included for comprehensiveness. Manual searching 
of manuscripts referenced in articles identified by the searches was also 
undertaken. One hundred and ninety nine manuscripts were identified. 
Following exclusion of those lacking empirical data, studies not related to 
prevalence and studies conducted in highly specific populations (for example, 
morbidly obese women considering weight loss surgery79, women with benign 
joint hypermobility syndrome80 and athletes8l), reviews and editorial comments, 
sixty studies were available for review (Figure 4, pp. 19). 
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Figure 4 Rationale for exclusion of studies from the review of prevalence and 
incidence data for anal or faecal incontinence 
199 studies identified 
48 studies excluded: review or 
comment only, no empirical data 
151 studies remained 
54 studies excluded: lacked 
relevance to prevalence 
97 studies remained 
22 studies excluded: highly 
specific population 
75 studies remained 
5 studies excluded: studies in 
children 
70 studies remained 
10 studies excluded: English 
language translation not available 
60 studies included 
The prevalence of anal incontinence has been examined in a number of different 
populations, using a variety of definitions and approaches. As indicated above, 
the definition of anal incontinence employed can affect the population sampled 
and estimates of those affected. It has been noted that lack of standardised 
definitions and heterogeneity of the studies undertaken has made the prevalence 
of incontinence difficult to determinel"82. Studies can be simply categorised into 
19 
examination of anal or faecal incontinence, according to inclusion or exclusion of 
flatus incontinence. 
A further distinction used to compare the findings was that studies were 
undertaken in community or clinic populations. Community studies were 
defined as those where prevalence was sought among individuals who were not 
known to have symptoms of incontinence, or not known to be experiencing 
symptoms associated with incontinence. Studies of clinic populations were 
identified as those undertaken with individuals who had sought healthcare for 
symptoms associated with anal incontinence, for example, urogynaecology or 
gastroenterology clinics. 
Community prevalence estimates 
Studies conducted in community populations will be explored first to establish 
what is known about the level of symptoms that occur in general adult 
populations. 
Anal incontinence in females and males 
Prevalence studies of anal incontinence, experienced by men and women in the 
community, provided data on the extent of these symptoms within the general 
adult population (Table 2). Prevalence estimates of anal incontinence ranged 
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Lynch et al commented that their study of community-dwelling adults in New 
Zealand was likely to have overestimated the prevalence of anal incontinence as 
there was evidence of bias within their respondents83. Using a self-selected 
population motivated by their bowel dysfunction, was probably responsible for 
the much higher estimate of 64% of individuals reporting flatus incontinence. 
Giebel et al's study evaluated prevalence of anal incontinence in emergency 
patients, patients undergoing arthroscopy, hospital employees and their families 
as an approximation of community prevalence. This methodology may have 
omitted less active patients, for example those with a more restricted lifestyle due 
to incontinence symptoms, and the generalisability of the results is therefore 
questionableT. 
Nelson et al's US community study reported a rate of 2.2%89. The method of data 
collection, however, involved interviewing one member of a household about all 
members residing there, potentially underestimating the rate of symptoms. In 
addition, direct interviewing of participants to elicit data could have potentially 
led to under-estimation when addressing these symptoms of a socially 
undesirable nature90"91. This could also have affected MacLennan et al's study, 
which used interviews to gather relevant data88. 
Excluding the Nelson and Lynch et al studies provided an estimate of 
community prevalence of anal incontinence between 11.8 % and 19.6 % in men 
and women. 
Faecal incontinence in females and males 
Prevalence estimates for faecal incontinence (excluding flatus incontinence) also 
varied, although less widely than those for anal incontinence. In the mixed 
gender studies below, (Table 3) the prevalence of faecal incontinence ranged 
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Although the Thomas et al94 study outcome was not very different from others, 
the authors indicated that their estimated 1.4% prevalence rate may have been 
inaccurate as questions had been misinterpreted by respondents (further details 
were not supplied). 
The definitions used in the studies detailed in Table 3 displayed wider variability 
compared with the anal incontinence studies (Table 2). The anal incontinence 
studies were conducted using definitions similar to the ICI definition14.15, 
including flatus, liquid or solid stool incontinence. The studies of faecal 
incontinence tended to incorporate more elaborate descriptions. Two studies 
described faecal incontinence as loss of faeces that was "involuntary" and 
"inappropriate", which may have altered the sample identified as the 
"incontinent population"92. In addition, their use of time constraints may have 
underestimated the prevalence of faecal incontinence that occurs less 
frequently93' . Inclusion of assessments of the extent of laundry involved were 
potentially problematic in their interpretation, which could also influence 
resulting prevalence estimates93. These issues suggest caution in relying on 
prevalence estimates. 
The lower prevalence rates in studies of faecal incontinence compared to anal 
incontinence may be due to incontinence of flatus being excluded. This is 
important as studies of faecal incontinence alone do not include this symptom. 
Prevalence of different types of incontinence is explored further below (pp. 37 - 
41). 
Incontinence in females only 
Prevalence studies of anal or faecal incontinence have mostly been undertaken 
with females only, most likely due to the known risks of anal incontinence 
associated with childbirth. Published prevalence rates in female community 
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Eva et al's study reported that 47% of respondents experienced flatus 
incontinence but, on further investigation, it was found that respondents had 
interpreted any passing of flatus as flatus incontinence, due to it being socially 
unacceptable in most contexts%. The remaining anal incontinence (4.4% to 38.5%) 
and faecal incontinence (7.2% to 24.3%) estimates, in women only, were double 
the uppermost limits reported in mixed gender studies (19.6% and 11.2% upper 
limits respectively). These are likely to be related to pregnancy and childbirth. 
Women who have given birth represent a large proportion of the community, 
(58.9% of families within the UK had children in 2001105 with a total fertility rate 
of 1.9 children per woman in 2007106), and so their influence on community 
prevalence estimates of anal incontinence will be substantial. 
Fritel and Varma et al's findings of higher prevalence estimates (24.3% and 
38.5%) were in studies of populations of older adults specifically97.101 - 40 years or 
older. The 38.0% reported by secondary school females in Canada was 
comparable to Fritel's findings, however, and had not included any individuals 
older than 19 years98. 
Prevalence estimates in groups at higher risk of anal 
incontinence symptoms 
There are a number of factors that could lead to a higher risk of anal 
incontinence. The prevalence data within these groups will now be examined. 
Faecal incontinence in older adults 
As detailed in Table 5, there were no studies of anal incontinence specifically in 
older adults. Faecal incontinence was reported to range from 3.0% to 26.3% in 
older adults in the community rising to 47.0% in nursing home residents. Given 
the definition used in Nelson et al's107 study, whereby an individual was 
considered incontinent if they were not "always in control of their bowels", it is 
possible that the rate of 47.0% may have been an over-estimation. This sample 
could have included those who have had events due to a transient cause or even 
experienced urgency without actual incontinence, depending on the 
26' 
interpretation of "complete control". This was supported by the 3.1% rate 
reported in Peet et al's'°8 study of nursing home residents, although the 
requirement for weekly incontinence in this study may have underestimated less 
frequent incontinence in residential care. 
Contrary to the published literature regarding increased risk of incontinence 
with age, the remaining community-based prevalence estimates were similar to 
those reported in both the mixed gender and female only studies of faecal 
incontinence, with the majority of studies reporting prevalence lower than 
15%109-113. Bliss, Stenzelius and Kok et al's studies reported prevalence rates 
greater than 15%114-116. The definitions employed in these studies were less 
restrictive with regard to the frequency of incontinence and allowed for more 
infrequent events. However, it is not clear which studies offer the greatest 
accuracy as the objectives of the individual studies often determined the 
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Anal incontinence in clinic populations 
Anal incontinence is related to wider dysfunction of the pelvic floor, including 
urological and gynaecological symptoms, due to the shared musculature and 
innervation. Table 6 details anal incontinence studies conducted in female 
populations attending urodynamic, gynaecology or combined urogynaecology 
clinics. 
Table 6 Prevalence of anal incontinence in women, clinic samples 
Country Population Age of N Prevalence 
clinics sample (%) 
(years) 
UK117 Urodynamics Not reported 465 36.3 
Khullar et al (1998) 
Israel118 Urogynaecology <30->80 283 29.0 
Gordon et al (1999) 
USA119 Gynaecology 18-64 457 28.4 
Boreham et al 
(2005) 
France120 Urodynamic 18-88 409 28.0 
Leroi et al (1999) 
Italy1z1 Urogynaecology 22-86 504 20.2 
Soli go et al (2003) 
Italyi2 Urogynaecology Mean age 881 20.0 
Meschia et al (2002) 58.6 
Taiwanlý Urodynamic Mean age 320 15.9 
N et al (2002) 45.1 
USA124 Gynaecology Mean age 1004 12.8 
McKinnie et al 42.7 
(2005) 
Switzerlandl00 Urogynaecology 25-84 264 15.9 
Faltin et al (2001) Antenatal 16-43 298 6.7 
General 15-93 666 5.6 
Total 15-84 1228 8.1 
Anal incontinence reportedly affected between 15.9% and 36.3% of women who 
attended clinics for urological or gynaecological symptoms. Faltin et al'sl00 
community study described earlier (Table 4) also incorporated recruitment of 
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patients attending clinics (Table 6), which enabled direct comparisons to be made 
between community and clinic samples with the advantage of identical 
methodology. This study showed that faecal incontinence was more than three 
times more likely to occur in women attending a urogynaecology clinic (15.9%, 
Table 6), by comparison with a community population (4.4%, Table 4) in a similar 
age group. Faltin was also able to demonstrate only a slightly greater prevalence in 
the populations who attended antenatal care and general clinics by comparison with 
the community population (6.7 and 5.6 respectively), supporting the suggestion that 
patients with urogynaecological symptoms have an increased risk of anal 
incontinence. Faltin et al used a questionnaire to collect data that had undergone 
some level of validationlz, suggesting some accuracy in the results obtained. 
Similarly to the largest estimate reported in female-only studies conducted in the 
community (38.5%), studies undertaken with females attending clinics 
demonstrated prevalence estimates of nearly double those reported in the 
community studies of mixed gender (36.3% vs. 19.6%). No clear trend was 
demonstrable with age. The study that reported the lowest prevalence rate among 
clinic populations (15.9% reported in Faltin et al's study), included females up to the 
age of 84 years100. 
Faecal incontinence in clinic populations 
Studies of faecal incontinence specifically within clinic populations were fewer in 
number, but included two studies that involved males126'127 (Table 7). 
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Table 7 Prevalence of faecal incontinence in women and men, clinic samples 
Country Population Age of N Prevalence 
clinics sample (%) 
ears 
UK128 Colposcopy, Mean age 180 55.0 
Bano et al (2007) gynaecology 38.0 
and family 
planning clinic 
El Salvador129 Gynaecology Mean age 236 41.0 
Ozel et al (2007) and general 48.0 
medicine 
*Australia127 Gynaecology Median age 435 20.7 
Ho et al (2005) and colorectal 53.0 
USA130 Urogynaecology Mean age 302 19.0 
Jelovsek et al (2005) 60.0 
*USA126 Primary care 18-92 881 18.4 
Johanson et al and 
(1996) gastroenterology 
clinic patients 
USA131 Gynaecology 21-85 247 17.0 
Jackson et al (1997) and 
uro aecolo 
USA132 Stress Mean age 655 16.0 
Markland et al incontinence 51.9 
(2007) surgical trial 
*male patients included 
As expected, the range of prevalence estimates for faecal incontinence in men and 
women, who attended clinics for associated symptoms, were higher overall than for 
community estimates (with studies excluded that were likely to overestimate), 
16.0% to 55.0%. The lower limit was at least double the lowest rates reported in 
previous comparisons: all community studies and studies of older adults. This 
supports the suggestion that presence of associated urological or gynaecological 
symptoms, for example, may present an increased risk of faecal incontinence. 
However, by contrast with the community studies, faecal incontinence is more 
prevalent than anal incontinence, perhaps providing an explanation regarding 
healthcare-seeking behaviour. The upper estimate at 55.0% was larger than all the 
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more reliable estimates provided in the previous studies, which perhaps 
demonstrates that incontinence may affect between a quarter and half of the 
populations attending healthcare services in high risk groups. There was no 
observable trend of increasing levels of incontinence with increasing age, as studies 
that included the oldest participants demonstrated prevalence estimates at the lower 
end of the range of findings (18.4% and 17.0%)126.131. 
Incontinence related to pregnancy and childbirth 
The following studies were conducted to examine the effects of pregnancy (Table 8). 
All studies, except MacArthur et al's133 ten month follow-up after childbirth from 
one UK maternity hospital, focussed on anal incontinence and included flatus 
incontinence. 
Table 8 Prevalence of anal incontinence in women associated with 
pregnancy 
Country Postpartum Age of N Prevalence (%) 
period (months) sample 
ears 
USA134 Third trimester 14-19 58 50.0 Third 
Lewicky-Gaupp et al and 6 weeks trimester 
(2008) postpartum 9.0 Postpartum 
UK135 12 Not reported 482 36.2 
Williams et al 
(2007) 
Canadai36 3 Not reported 949 26.5 
Eason et al (2002) 
Canada137 6 22-32 1291 20.6 
Hatem et al (2005) 
Denmarkl° 16 weeks 15->35 7557 8.6 
Hoiberg et al (2000) gestation 
UK133 10 Not reported 906 6.1* 
MacArthur et al 
(1997) 
"faecal incontinence only (flatus incontinence excluded) 
Anal incontinence was reported to affect between 8.6% and 50.0% (6.1% faecal 
incontinence) of women during or following pregnancy. These rates were similar to 
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those reported in community studies of women with anal incontinence. The rate of 
50.0% reported by Lewicky-Gaupp et al'' may have over-estimated symptoms, as 
the authors note that they did not imply any strict criteria for definition of anal 
incontinence, simply any positive response was included. Overestimation may also 
have been evident in the 36.2% prevalence rate reported by Williams et al, as the 
study involved a self-report questionnaire that was only returned by 23.3% of the 
individuals invited to participate135. This proportion may represent individuals who 
are more likely to respond because they had existing symptomsl38 and therefore 
may not be representative of the cohort. 
There was no observable trend between length of time postpartum, or stage of 
gestation, and the rate of incontinence within the findings. If Williams et al's study 
were excluded due to the potential overestimation of prevalence, there may be a 
trend of decreasing symptoms with increasing length of time following 
childbirth133.136.137, which is supported by Lewicky-Gaupp et al'sl34findings. The 
small number of studies reviewed, however, prevents any firm conclusions being 
drawn. 
Summary of prevalence estimates 
Due to the wide variability in prevalence estimates among the various study 
categories, it is difficult to determine an overall picture of the size of the problem of 
anal or faecal incontinence. Figure 5 is provided to summarise the results and aid 
comparisons. Studies most likely to skew the results, as detailed earlier in this 
section, were omitted from the estimates. 
33 
Figure 5 Prevalence estimate ranges in different populations 
Associated with pregnancy 
Clinic females and males 
Clinic females only 
Community older adults 
Community females only 
Community females only 
Community females and 
males 
Community females and 
males 







With the exception of mixed gender clinic studies, there is a trend for higher 
prevalence rates in anal incontinence studies than comparable studies of faecal 
incontinence. This is most likely because of the inclusion of the extra symptom of 
flatus incontinence. The overall comparison would suggest that at least 1% to 5`%, of 
individuals in the community are affected, rising to perhaps between 35% and 41% 
of individuals at higher risk of anal or faecal incontinence symptoms. 
Variability in prevalence estimates 
The wide variability in estimates produced in the above studies of prevalence was 
caused largely by the different definitions used. The subtle nuances in each of the 
phrases used to define the study sample resulted in different estimates. Small 
sample sizes could also produce skewed findings. If a representative sample of the 
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population was not recruited, significant bias may have been introduced producing 
results that were not generalisable to the population78. Sample sizes in the studies 
reviewed were mostly reasonable. Nearly half of the studies included more than 
1000 participantslo, ss, 87-89,93-97,99-10ZI04,107,108,110, iis, iia, iib, iza, is7, The smallest sample was 
of African-American pregnant teenagersl34 (n=58) and the largest was of nursing 
home residents in the USA107 (n=18224). 
A number of studies recruited individuals until they had reached a predetermined 
sample size or at a point where sufficient data had been captured to analyse, and the 
non-responder rate was not reported84,89,1°l, l°3,117.118,121,122,124,126,129,131. Excellent 
response rates of between 86% and 100% were reported within the clinic samples. 
However, on further exploration, the data were gathered at clinic appointments and 
therefore the impetus to complete was greater10° 119.12°, 123,127,128.130.132. Remaining 
response rates within the community studies ranged from 48% to 90%83,85-88,92- 
100,102,104, With studies achieving the highest rates, indicating improved 
generalisability of the findings85-88,93,94,97,99.1°0. Studies undertaken among older 
adults tended to have higher response rates than other groups, from 62% to 99%. 
The two studies representing highest and lowest prevalence estimates, however, 
(Nelson et al107: 47.0% and Peet et al: 3.1 % 108) involved analysis of a database and 
information taken from a census of older adult residential care completed by care 
staff respectively, which could have influenced the results obtained in comparison 
to self-completed voluntary questionnaires. Studies of women associated with 
pregnancy displayed the widest range of response rates from 23%135 to 93%10. 
A further concern regarding the accuracy of the reported findings in a number of 
studies was the use of interviewing as the data gathering methodology. Symptoms 
of an embarrassing or a taboo nature, such as incontinence, may be difficult to 
disclose and direct interviewing may underestimate symptoms117,139. Eleven studies 
used interview schedules developed for the purposes of the study, which not only 
potentially underestimated symptoms but there was no evidence presented to show 
35 
that the interview questions used were valid, reliable or suitable to capture the 
information of interest88"89,99,103.109.110,118,121,123,129,133. 
Only thirteen of the sixty studies used self-completion questionnaires that had either 
undergone some level of validation or the authors had made an effort to validate in 
some way83,86,92,95,96, ioo, io2, u2, ii9, iz7, i2s, 130, is7. Forty seven studies, therefore, used data 
collection instruments with no evidence of their ability to capture effectively the 
information of interest. Of the thirteen studies, two used instruments not designed 
for self-completion83.137, one modified an existing questionnaire but did not carry 
out any revalidation on the new modification95, and two developed questionnaires 
for the study, with only one describing the initial validation undertaken%-127. The 
other eight studies used questionnaires that had some evidence of their 
measurement properties86'92,1°°, 1°2,112,119,128,13° although the limitations of the 
questionnaires selected will be explored further in Chapter Three, reinforcing the 
need for development of the ICIQ-B. 
Prevalence estimates: conclusion 
It is thus possible to draw only tentative conclusions from the above studies because 
of methodological issues. Studies in clinic samples represented the most complete 
population data, indicated by high response rates, but results were only relevant to 
specific populations and, in some cases, may have been biased by the use of direct 
interviewing. The most generalisable estimates of incontinence among clinic 
populations were between 15.9% and 28.4%. Community studies that reported 
prevalence rates of between 1.7% and 16.8% were the most reliable in terms of their 
response rates, sample size and inclusion of males and females, and consequent 
generalisability. Only one of these studies had used a questionnaire with any 
evidence of its measurement capabilities (Lam et al's community-based study of 
anal incontinence conducted in Australia in 199986). This study was considered to 
provide the most accurate prevalence data within the published literature of 15.0% 
in men and women aged between 20 and 99 years (mean age 55 years). However, 
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the questionnaire had only been validated for use in older adults and its validity for 
use in adults of all ages was not established. The need for prevalence studies using 
accurate measurement instruments is highlighted and the lack of instruments to 
supply that requirement will be detailed further in Chapter Three. 
1.4.2. Detailed prevalence estimates of anal or faecal 
incontinence 
The above studies reported on the overall prevalence of anal or faecal incontinence. 
The second part of this review will explore what is known about the prevalence of 
different types and frequencies of incontinence in order to establish the needs of the 
questionnaire in terms of anal and/or faecal incontinence. Further differences 
between men and women will be explored and also the distribution of symptoms in 
different age groups. 
Anal incontinence by type 
From the above studies, higher prevalence estimates generally emerged with the 
anal incontinence studies, which included the occurrence of flatus incontinence. This 
could be due to more of the symptoms being attributable to flatus incontinence or 
the elevated estimates could simply be due to the inclusion of the extra symptom. 
The distributions of types of incontinence are presented in more detail where 
distinctions have been possible from the study results. Table 9 details community 
studies. 
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Table 9 Prevalence of different types of incontinence, community samples 
Country Flatus Liquid stool Solid stool 
incontinence e/ b) % incontinence 
New Zealand83 64.0 12.7 9.8 
Lynch et al (2001) 
Canada98 35.0 3.0 Not reported 
Alnai et al (2001) 
France97 28.6 17.7 1.7 
Fritel et al (2007) 
Sweden96 19.0 8.0 1.7 
Eva et al (2003) 
UAE103 14.4 5.8 5.5 
Rizk et al (2001) 
Sweden% 9.0 5.0 0.3 
Eva et al (2003) 
Germany84 5.5 6.7 4.8 
Giebel et al (1998) 
USA89 1.3 1.2 0.8 
Nelson et al (1995) 
USA102 Not studied 3.6 3.7 
Bharucha et al 
(2005) 
Australia92 Not studied 9.0 2.0 
Kalantar et al 
(2002) 
Netherlands113 Not studied 1.1 2.0 
Teunissen et al 
(2004) 
Taiwan99 8.6 2.8 
Chen et al (2003) 
Australia86 7.5(F) 8.1(M) 1.1 stool >1/week 
Lam et al (1999) 4.5 stool<1/week(F) 
2.7 stool >1/week 
12.4 stool <1/week(M) 
Australia88 10.9(F) 6.8(M) 3.5(F) 2.3(M) 
MacLennan et al 
(2000) 
France85 16.1 7.1 
Siproudhis et al 
(2005) 
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Flatus incontinence was reported to occur in 1.3% to 35.0% in the community 
populations sampled (Lynch et al's 64.0% prevalence of flatus incontinence was 
excluded from comparison due to the potential overestimation of symptoms that 
may have resulted from the self-selected sample of individuals with bowel 
dysfunction). In contrast, liquid and solid stool affected 1.1% to 17.7%, and 0.3% to 
9.8% respectively. In those studies quantifying prevalence of "stool", where 
distinction was not made between liquid and solid stool, rates ranged from 1.1 % to 
12.4%, including the relatively high frequency of one episode per week as reported 
by Lam et als. Higher rates of flatus incontinence than either liquid or solid stool 
incontinence were reported in ten studies out of twelve. These results suggest that 
flatus incontinence exhibits higher prevalence than incontinence of either liquid or 
solid stool. Prevalence of liquid stool is the second most frequent after flatus, 
accounting for nearly twice as many individuals in the community as those affected 
by incontinence of solid stool. 
Prevalence estimates of anal incontinence in clinic patients ranged from 5.0% to 
25.6% for flatus, 1.3% to 29.2% for liquid stool and 0.2% to 27.0% for solid stool 
(Table 10). Where the more general term of "stool" was used, a range of 3.1 % to 
26.0% was reported. Flatus incontinence was the only type to demonstrate a higher 
overall estimate within community populations than patients within clinic samples 
(Community 35.0%: Clinic patients 25.6%). The higher proportion of individuals 
with liquid stool incontinence in comparison to solid stool incontinence found in the 
community (17.7% vs. 9.8%) was not as evident within clinic samples (29.2% vs. 
27.0%). 
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Table 10 Prevalence of different types of incontinence, clinic samples 
Country Flatus Liquid stool Solid stool 
incontinence % incontinence (%) incontinence ob 
USA119 25.6 12.9 13.1 
Boreham et at 
(2005) 
France120 18.3 9.5 1.0 
Leroi et at (1999) 
Israel118 14.0 6.0 9.0 
Gordon et al (1999) 
El Salvador129 Not studied 29.2 27.0 
Ozel et at (2007) 
USA132 Not studied 10.0 6.0 
Markland et at 
(2007) 
Australia127 Not studied 9.0 5.1 
Ho et al (2005) 
Switzerlandl°° 5.0 3.1 
Faltin et al (2001) 
Canadal36* 25.5 3.1 
Eason et al (2002) 
Canada137* 14.2 1.2 
Hatem et al (2005) 
Denmarkio* 5.9 1.3 0.2 
Heber et al (2000) 
UK117 Not reported 26.0 
Khullar et al (1998) 
*patients were either pregnant or up to 6 months post partum 
Comparing the speciality of the clinic populations, there was no observable 
difference between the rate of flatus incontinence reported in urology/ gynaecology 
or combined clinic samples (5.0% to 25.6%), and individuals within the populations 
related to pregnancy and childbirth (5.9% to 25.5%). A difference was noticeable 
between the general clinic samples and those related to pregnancy for liquid and 
solid stool incontinence, with a trend appearing of increased prevalence in the 
urology/ gynaecology clinic attendees (3.1% to 29.2% vs. 0.2% to 3.1%). 
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Anal incontinence by frequency 
The frequency of anal or faecal incontinence is often used as a proxy indicator of the 
severity of symptoms. It has been assumed that the more often an event occurs the 
more severe the symptoms are perceived to be by the patient. The validity of this 
assumption and the relationship between symptom frequency and severity is 
discussed later in this thesis (pp. 73-75). Table 11 displays the frequency of faecal 
incontinence, with flatus documented where available. Prevalence of the frequency 
of symptoms presented relates to the overall community or clinic sample rather than 
individuals known to have symptoms unless otherwise stated (t). 
Table 11 Prevalence of incontinence by frequency of occurrence 
Study Preva lence 
>Daily > Weekly >Monthl < Monthly 
Australial27t 11.8 24.7 16.5 47.1 
Ho et al (2005) 
USAIO' 
Varma et al (2006) 
Flatus 8.9 14.6 13.9 33.7 
Stool 0.2 1.9 3.4 18.8 
Israel118t 7.0 - 60.0 - 
Gordon et al 
(1999) 
Sweden96 
Eva et al (2003) 
Flatus 5.5 8.5 9.0 24.0 
Liquid stool 1.8 4.5 3.5 21.0 
Solid stool 0.4 0.7 1.5 5.5 
France97 
Fritel et al (2007) 
Flatus 4.4 10.8 13.3 
Liquid stool 0.1 0.4 7.2 
Solid stool 0.0 n=0 0.2 1.5 
USAI26 2.7 4.5 7.1 - 
Johanson et al 
(1996) 
(%) calculated from reported subgroups to aid comparison between similar 
frequency groups 
t% of respondents with Al /Fl 
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Table 11 continued Prevalence of incontinence by frequency of occurrence 
Study Preva lence 
>Daily > Weekly >Monthl < Monthly 
USA102 t 2.0 (21.0) 24.0 55.0 
Bharucha et al 
(2005) 
Denmark'° 
Hejberg et al 
(2000) 
Flatus 1.9 2.3 1.7 - 
Liquid stool 0.1 0.1 1.1 
Solid stool 0.0 (n=3) 0.1 0.1 - 
USA114 1.5 - 11.0 19.0 
Bliss et al (2004) 
New Zealand83 
Lynch et al (2001) 1.4 6.1 27.8 28.7 
Flatus 0.0 (n=3) 0.0 (n=5) 4.2 7.4 
Liquid stool 0.0 (n=3) 1.1 2.8 5.4 
Solid stool 
Canada'36 
Eason et al (2002) 
Flatus 2.7 6.8 16.0 - 
Stool 0.3 0.4 2.3 - 
UK93 0.7 1.3 1.3 2.7 
Perry et al (2002) 
Australia86 - 3.8 16.9 - 
Lam et al (1999) 
(%) calculated from reported subgroups to aid comparison between similar 
frequency groups 
t% of respondents with Al /FI 
Half of these studies assessed levels of anal incontinence while the other half 
evaluated faecal incontinence and overall higher prevalence of infrequent 
incontinence was reported. Hojberg and Ho et al's clinic studies10'127, and Varma et 
al's community study of women over the age of 40 yearsl01, were the only 
exceptions. Ho and Varma's studies reported lower monthly incontinence (16.5% 
and 13.9%) by comparison with weekly (24.7% and 14.6%), although both remained 
more common than daily incontinence (11.8% and 8.9%). Hejberg's study reported 
higher rates of daily (1.9%) and weekly incontinence (2.3%) of flatus by comparison 
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with monthly (1.7%). Overall, however, these findings suggested that frequent anal 
incontinence was less common. 
Anal incontinence by gender 
Evaluating mixed gender studies enables direct comparison of the prevalence of 
symptoms that occur in both men and women. Due to the variation in reporting of 
these studies, direct comparisons were not straightforward between studies. Table 
12 displays results of studies organised into groups with some degree of 
homogeneity: adult community dwellers, older adult populations and finally 
population samples that were considered likely to have higher estimates of the 
prevalence of incontinence due to associated risk factors. A wide range of 
prevalence estimates are displayed. Most studies reported prevalence by gender as a 
proportion of study participants within that gender group, but two studies reported 
estimates as a proportion of participants with symptoms8.107and two further 
studies reported prevalence per total study respondents89,113. Regardless of the 
individual analyses, of the seventeen studies distinguishing prevalence in females 
compared with males, eight reported a higher prevalence in 
females'5, ss, a9,92, im'110'116,127, six reported higher prevalence in males83M6'109,111,113,126, 
while three studies reported no difference between genders93,112,114. Considering anal 
and faecal incontinence separately, three studies of anal incontinence85'-89 and five 
studies of faecal incontinence9zlO7, l10,116.127 supported the suggestion that prevalence 
is higher in females, while two83,86 and four studieslü9. lil"113.126 respectively reported 
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There were no clear observable trends between the different populations sampled to 
explain the distribution of symptoms between the genders. A more detailed 
exploration of prevalence by gender according to type of incontinence aimed to 
evaluate if different types of incontinence were responsible for the variability in 
prevalence estimates between males and females (Table 13). 
Table 13 Prevalence of incontinence type by gender, community samples 
Study Flatus incontinence (%) Stool incontinence 
Female Male Female Male 
Australia88 10.9 6.8 3.5 2.3 
MacLennan 
et al (2000) 
Australia86 7.5 8.1 1.1 >1/week 2.7 >1/week 
Lam et al 4.5 <1/week 12.4 <1/week 
(1999) 
Sweden87 4.9 5.9 10.9 Liquid stool 9.7 Liquid stool 
Walter et al 1.4 Solid stool 0.4 Solid stool 
(2002) 14.5 Soiling 21 Soiling 
Germany8' Soiling of underwear 35.1 (more freq in 
Giebel et al men p<0.001) 
(1998) Liquid stool incontinence 6.7 (more freq 
in women <0.05 
Australia92 Not recorded 8.8 Liquid stool 9.4 Liquid stool 
Kalan tar et 1.1 Solid stool 3.1 Solid stool 
al (2002) 
Only five studies provided this level of data. MacLennan et al's8I study reported a 
higher prevalence in females of flatus and stool incontinence, as supported by 
Giebel's84 findings for liquid stool incontinence alone. Lam's86 study suggests a 
consistently higher rate of both flatus and stool incontinence in men as mirrored in 
Kalantar's92 study of stool incontinence. This finding was also supported by 
Giebel's84 findings with regard to underwear soiling, qualified by the distinctions of 
"often" or "always". Walter et al's87 study reported similar results to Giebel et al 
with higher rates of stool incontinence reported by women, regardless of type of 
stool, yet higher rates of flatus incontinence and soiling reported by men. 
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Overall, it is therefore not clear whether females or males are more affected or by 
which symptoms in particular. The lack of conclusive findings within these studies 
is probably due to variation in definitions and data collection instruments, as 
described throughout this chapter. 
Anal incontinence by age 
Further characterisation of individuals with symptoms was possible across age 
groups (Table 14). 
Table 14 Prevalence of anal or faecal incontinence by age (years) 
Study Overall revalence (0/6) 
20-29 30-39 40-49 50-59 60-69 70-79 80-89 90+ 
Netherlands113 - - - 10 16 10 
Teunissen et al 
(2004) 
Israel"8 11.0 29.0* 28.0* 19.0* 30.0* 36.0* 45.0* 
Gordon et al 
(1999) 
Denmark" (4.0) (5.5) - 
Hejberg et al 
(2000) 
Sweden% - - (26.0) (31.0) - 
Eva et al (2003) 
USA101 - - 17.7 24.2 28.9 32.7 
Varma et al 
(2006) 
USA102 7.3 11.9 17.3 21.7 21.1 21.2 20.1 
Bharucha et a! 
(2005) 
USA126 12.3 - - - 19.4 - - 
Johanson et al 
(1996) 
UKW - - 3.9 5.0 6.4 8.3 11.7 
Perry et al (2002) 
Netherlands"' - - - (3.2) (4.9) (11.3) 15.9 
Kok et al (1992) 
Swedenl16 - - - - 12.3 (17.7) 26.6 
Stenzelius et a! 
(2004) 
(%) calculated from reported subgroups to aid comparison between similar age 
groups 
* best-fit for age range, actual age categories 31-40,41-50, etc. 
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All of the studies listed above showed a general trend towards increased prevalence 
of incontinence with increased age. Bharucha et al's102 study reported an increase 
occurring from the third to sixth decade (20-59 years) with no further rise in 
increasing age thereafter. A number of additional studies did not report detailed 
data but commented on observed trends within their findings. All studies reported a 
positive relationship between anal or faecal incontinence and age, except two 
studies conducted in adults older than 65years110112, which reported findings similar 
to Bharucha et allot. 
Anal incontinence by race 
Only four studies, to date, have looked at the effect of race on prevalence of anal or 
faecal incontinence101.111"13i, 140. Varma et al's101 study compared White, African- 
American, Asian, Latina and Native American participants and Huang et al's140 
study evaluated pelvic floor dysfunction in Asian-American women compared with 
Caucasian women. Both studies reported that Latina and Asian women were less 
likely to report symptoms than white females but, after adjustment for risk factors 
such as irritable bowel syndrome in Huang et al's study, there was no longer an 
association. Markland et al'slll"132 studies of community dwelling older adults and 
women in a surgical trial for urinary stress incontinence also reported no difference 
according to race for anal or faecal incontinence. 
1.5. Incidence of anal or faecal incontinence 
Data regarding the incidence of anal incontinence was particularly lacking, leading 
the National Institute for Health's (NIH) State of the Science conference for urinary 
and fecal incontinence, held in December 2007, to conclude that "the data were too 
sparse to permit estimates that could be generalised to the population"2. A major 
limitation of studies of incidence in this area was a lack of baseline data and 
therefore existing incontinence could have been a confounding factor141. In the few 
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MAIMCAL 
studies identified, continence was assumed prior to the event under examination for 
example, childbirth or neurological event. They were therefore not strictly incidence 
studies but represented the available literature to date. Six studies were undertaken 
in relation to childbirth to explore the incidence of anal incontinence symptoms at 
varying stages postpartum (Table 15). 
Table 15 Incidence of anal or faecal incontinence following childbirth 
Country Post partum time N Incidence 
ela sed oho 
Swedenl42 9 months 242 44.0 of women with 
Pollack et al (2004) tears 
5 years 53.0 of women with 
tears 
9 months 25.0 of women 
without tears 
5 years 32.0 of women 
without tears 
Norway143 Median 25 months 156 women 33.0 
Norderval et al (2004) following 
primary 
sphincter repair 
USA'" 3-6 months 8774 29.0 
Guise et al (2007) 
Finland145 4 months 99 27.0 
Pinta et al (2004) 
The Netherlandsl46 3-4 years 479 22.0 
Schraffordt Koops et al 
(2003) 
UK147 5 days 159 8.7* 
Varma et al (1999) 
*anal sphincter injuries identified on endoanal ultrasound 
Reported incidence of incontinence ranged from 8.7% to 44.0% following childbirth, 
although these findings were unlikely to be accurate as methodological flaws were 
identified, similar to those found in the prevalence studies. Pinta, Guise and 
Norderval et al's studies incorporated direct interviewingl45, a modified 
questionnaire that had not undergone further revalidation of alterationsl« and use 
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of a tool that had not been developed for self-completionl43, to elicit presence of 
symptoms respectively. The remaining studies used measures with no published 
evidence of their measurement propertiesl4"146. 
Two further studies were identified that evaluated the incidence of incontinence 
following stroken (n=1563) and in a cohort of older residents in nursing care 
followed for 10 monthsl48 (n=1186). Incidence of faecal incontinence was found to be 
30.0% in the immediate period following stroke (7-10 days) which then declined 
over time. The influence of other causative factors during follow-up, however were 
not accounted for in the analysis. 
Within the cohort of older adult patients 20.0% developed new onset of incontinence 
symptoms in the 10 months they were followed up, which was primarily associated 
with acute diarrhoea or faecal impaction. The incidence of long lasting faecal 
incontinence was 7.5%14. 
1.6. Conclusion 
The absence of standardised definitions in the field of anal incontinence has resulted 
in considerable variation in estimates of prevalence. The restrictive nature of 
existing studies means that the findings were often not generaliseable beyond the 
sample involved, and pooling of results was not possible because studies differed so 
much in terms of their methodology and definitions. Attempts have been made at 
consensus definitions, including the Third International Consultation on 
Incontinence (2004), which was based on the opinion of clinical experts and 
included all causes of symptoms14,15. Numerous definitions exist in research studies, 
however, with no conformity. 
Within the studies reviewed here, the definition of anal incontinence appeared to be 
much clearer than that of faecal incontinence. The studies of anal incontinence more 
consistently included the presence of flatus incontinence and also more uniformly 
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collected and reported rates of different stool types. In contrast, numerous 
definitions for faecal incontinence were used including simply "stool"101,11Z114,116,126 
or "faeces"94.108.113,115 without specifying whether liquid or solid. In addition, non- 
specific items that addressed "control of bowels"1O9-109-llo or "degree of soiling"93,127, 
were incorporated to evaluate prevalence of faecal incontinence, raising issues of 
variability in interpretation. 
Due to the varied definitions, methods and reporting structures employed in 
epidemiological studies of anal incontinence, it was difficult to make clear 
comparisons of prevalence estimates between different sub-groups of the 
population. Widespread variation in the reported prevalence estimates led the NIH 
state of the science conference (December 2007) to conclude: 
"Because these studies used varying definitions of incontinence and different 
methods of population sampling, the preceding statistics [prevalence estimates] 
should be considered to be fairly crude estimates"2 
Reporting in the studies detailed above varied, with some mixed gender studies that 
presented estimates split by gender and others that reported overall estimates. Some 
studies also detailed overall prevalence of anal or faecal incontinence while others 
demonstrated prevalence of individual types of anal incontinence, making 
conclusions about the rate of symptoms difficult, particularly when attempting to 
characterise prevalence by gender. 
From the above literature, with all the caveats suggested, some tentative conclusions 
can be drawn. It would appear that anal incontinence does increase with age, 
although this may plateau in individuals over 65 years unless admitted to a care 
home. This was reported to be the second most common reason for requesting 
nursing home placement149. It is unclear if anal incontinence is more prevalent in 
men than women. Eight studies of both anal and faecal incontinence, taken 
separately and together, appeared to suggest a higher prevalence of symptoms in 
females compared to males. Nine further studies, however, reported the converse or 
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reported no difference between the genders, and thus no firm conclusions of the 
association between gender and prevalence of incontinence could be drawn. These 
findings were also supported by a systematic review undertaken by Pretlove et ali50 
which evaluated associations between age, gender and anal incontinence. 
It appeared that flatus incontinence was more prevalent than liquid or solid stool 
according to both the evidence of individual types of incontinence and also the 
estimates in which anal incontinence was used by comparison with faecal 
incontinence. As expected, clinic populations reported higher rates of incontinence 
than community samples for liquid and solid stool, at more than double the rate for 
solid stool incontinence in particular. However, rates of flatus incontinence were 
reportedly higher in the community with nearly 10% more individuals affected. 
A significant factor that cannot be overlooked in studies of the prevalence of anal 
incontinence is the taboo nature of the subject. Prevalence estimates may have 
limitations dependent on the methodology employed. Direct interviewing, as used 
in several of the studies discussed above8-89.99"lO3, lO9.11o, 118,121,123,129,133, may have 
under-estimated reported rates, whereas anonymous questionnaires could have 
increased disclosurel17. 
In a systematic review of community-based prevalence studies of faecal 
incontinence conducted in 2004, MacMillan et a182 concluded that the prevalence of 
faecal incontinence ranged between 11% and 15%. Only sixteen studies, however, 
were sufficiently robust for critical appraisal. MacMillan et al commented that no 
standardised definitions were evident within the literature although anal 
incontinence tended to include incontinence of flatus while faecal incontinence 
excluded this. Prevalence estimates were found to have a tenfold variation, leading 
the authors to conclude that: 
"the heterogeneity of the included studies with regard to sample frames and study 
design meant that pooling of prevalence estimates could not sensibly be 
undertaken. " 
51 
Recommendations were made for: 
"a consensus definition of faecal incontinence, including flatus incontinence, that 
accounts for an alteration in quality of life to greatly enhance the validity of future 
estimates of prevalence". 
An important limitation of the above sixty studies was the type of data collection 
tool. Only thirteen studies used self-report questionnaires, and only eight of these 
used an instrument with some evaluation of its measurement capabilities. In essence 
this meant that the remaining studies had used instruments that were potentially 
flawed in various respects, the importance of which is detailed in Chapter Two. A 
further limitation was the use of direct interviewing of individuals as opposed to 
self-report, potentially underestimating the prevalence of these taboo symptoms, 
which will be expored further in Chapter Four (pp. 135-139). 
Evident throughout this chapter has been the need for a standardised definition of 
these symptoms, and also the use of high quality, validated, standardised measures, 
to ensure confidence in the results obtained. In addition, the wide-ranging causes 
and conditions associated with anal incontinence indicated that such measures 
should be applicable to a wide range of patient groups with these symptoms, rather 
than a small subset of the population. Such an instrument would need to enable 
widespread evaluation of anal incontinence regardless of aetiology. This chapter has 
established therefore, the urgent need for a self-completion questionnaire for anal 
incontinence. 
The following chapter will describe methods of evaluating measurement 








Chapter One showed that very few studies of anal incontinence used validated 
questionnaires. For a questionnaire to be useful it must be able to measure 
symptoms and quality of life aspects of patients' experiences in an accurate (valid) 
and consistent (reliable) manner9-151-153. Questionnaire properties need to be 
investigated to provide evidence of the capabilities of an instrument in order for the 
user to judge the confidence they can place in the measurements madei54. 
Psychometric analysis is a scientific method of evaluating these properties. 
2.1. What is psychometric analysis? 
The psychometric analysis relevant here is the branch of testing that is used to 
determine the quality of a survey instrument or questionnairei55. Psychometrics 
evolved from psychology and can be defined as "science applied with the purpose 
of measuring psychological or qualitative phenomena"156. Psychometric tests exist 
to measure the intrinsic mental characteristics of a person which are inherently 
subjective in nature157. In the case of questionnaires, psychometric testing provides 
standardised methods by which to evaluate instruments enabling quantification of 
their measurement capabilities. Essentially this "provides a way to quantify the 
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precision of measurement of qualitative concepts"158, such as quality of life, in an 
objective manner. It is important to evaluate the quality of a measure to enable 
claims arising from the questionnaire's data to be verified independently159. 
Historically, expert peer review was employed to assess an instrument's quality and 
ability to measure a given concept. However, empirical evidence of a 
questionnaire's psychometric robustness has now become a basic requirement to 
ensure that it is appropriate and valid for its intended usel60. This is particularly 
important where such data may be used to inform policy or clinical decisions, 
influence patient management and evaluate outcomes, or as illustrated in Chapter 
One, for accurate studies of epidemiology161. 
2.2. Evaluating psychometric properties 
Each item in a questionnaire is effectively a measure of a particular variable152. 
Unlike measures of "fixed" variables, such as a thermometer measuring 
temperature, concepts such as symptoms are not constant over time and differ 
between individuals. It is therefore particularly important to collect evidence of the 
instrument's psychometric properties to show that each question is accurately 
measuring its designated variable. The three main properties that questionnaires 
should demonstrate are: 
" Validity - indicates that the instrument is an accurate measure of the concept 
in question; 
" Reliability - indicates that the instrument can measure the concept in a 
reproducible manner; 
" Sensitivity to change - indicates that the instrument is able to detect a real 
change in the status of the concept, which is of particular importance in 
health-related outcome measures9"15l-153,162,163 
The process of psychometric testing involves a series of studies to establish basic 
levels of validity and reliability in the first instance, followed by ongoing studies to 
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provide further evidence of the questionnaire's properties. It is particularly 
important to gather further information when the questionnaire is used in different 
settings, different populations and at different time periods from those in which it 
was originally validatedlM, l65. 
2.3. Question item generation 
Prior to evaluating questionnaire items, a list of potential questions needs to be 
developed, forming the foundation of the instrumentl66. The process by which items 
are generated is of importance when evaluating the appropriateness and 
applicability of a questionnaire. It is generally accepted, that for health-related 
questionnaires, clinical health professionals are most often involved to ensure the 
questionnaire is able to measure clinically important factors151.167. Indicators of the 
mechanism of illness and diagnostic items are most likely to be suggested by those 
with clinical experience of the symptom area. Individuals from the population of 
interest, "key informants", are also a valuable source of potential question items, as 
Streiner and Norman point out, 
"Whereas clinicians may be the best observers of the outward manifestations of a trait 
or disorder, only those who have it can report on the more subjective elements. "(pp. 15) 
Exploration among these individuals is an important step in the process of 
questionnaire development, as it enables the developer to identify issues of 
importance to those directly affected by the condition. These issues may not 
otherwise have emerged from consultations with cliniciansl68-470. 
The methods for gathering information from both sources include expert panels, 
focus groups and in-depth interviews. No particular advantage is reported for any 
method and it is ideal to use all three. The most important factor, and indeed an 
ethical responsibility, is to make sure that the items reflect the differing perspectives 
to ensure the questionnaire covers all the pertinent issues for accurate 
assessmentl71,172. Existing literature is also a good source of potential items. In this 
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thesis, existing literature, expert panels and interviews with patients will be 
employed to identify relevant questionnaire items. 
2.4. Validity 
The validity of an instrument is evaluated by examining how well it measures what 
it claims to measurei73 (for example, the concept of pain) and that it does not instead 
measure a closely related, but different, concept (such as anxiety)174. Validity testing 
can be further divided into content validity, criterion validity and construct validity, 
each providing individual, although overlapping, estimates of the overall validity of 
an instrument90,151-153,162,163. 
2.4.1. Content validity 
It is not practically possible to enquire about every aspect of a concept using a 
questionnaire. Such an approach would also impose a significant burden on the 
respondent. The questionnaire therefore contains a selection of items that are 
intended to be generalisable to the concept as a wholeln. Thus, questionnaires 
require a degree of compromise. However, content validity testing is a method of 
ensuring that suggested items adequately represent the content domain and do not 
omit important issues. This process is also used to exclude irrelevant items to 
maximise the specificity of the questionnairel75,176. Opinions can be gathered from 
clinical experts and symptomatic individuals in a manner of ways, from written 
comments on draft items to detailed discussionsl71"177. Alternative approaches to 
evaluating content validity have been suggested to ensure relevance of items to the 
content domain. Experts can be instructed to rate the relevance of each item, 
comparatively, with explicitly described content domains on a four point scale, and 
a subsequent index of relevance is derived'78179. There is no evidence to suggest a 
preferable method. The crucial aspect is that evaluation of content validity is 
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undertaken and efforts made to ensure the items included are of most relevance to 
the issue under examination. 
Face validity 
The term "face validity" is an aspect of content validity that refers more specifically 
to whether the questionnaire appears to measure what it intends to180181. In the case 
of questionnaires designed to assess symptoms, clinical experts are consulted to 
ensure it captures symptoms that are important to clinical assessment and the 
content domain. However, for the assessment of more subjective issues, members of 
the target respondent group can be interviewed to evaluate the acceptability, clarity, 
ambiguity and comprehension of the questionnaire's items and responses90"167, as 
there is little point including all pertinent issues if the question items are not 
understandable' 53. 
Missing data 
Content validity may be further explored by assessing the level of missing data for 
each question item when administered to potential respondents. Items that are 
repeatedly missed may indicate poorly performing, difficult or irrelevant 
questions90.152. These items may represent important areas of assessment and 
therefore removal of the question may not be appropriate but this process can point 
towards items that require further modification in order to achieve higher rates of 
completion. 
Overall response rates can indicate the feasibility of the questionnaire for self- 
completion'75'182. The subject area must be considered, as items addressing sensitive 
issues often have more missing data, which is of particular relevance in this thesisl83. 
2.4.2. Construct validity 
Construct validity relates to the questionnaire's ability to reflect known theories 
(constructs) regarding the concept it is measuring. For example, stress urinary 
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incontinence is known to be more prevalent in women than men14, and so an 
instrument in this area should detect this difference. The relationship between the 
questionnaire and the hypotheses surrounding the construct(s) it is measuring is 
often called "convergent validity". It is important to use well evidenced theories 
when evaluating construct validity, as the apparent inability of a questionnaire to 
reflect theory may, instead, be due to an inadequacy of the theory itself184. 
"Discriminant validity" is the opposite of convergent validity, and refers to the way 
the questionnaire fails to correlate with other concepts or variables that are 
theoretically dissimilar174. For example, a questionnaire should not provide data 
indicating that stress urinary incontinence is more prevalent in men when existing 
evidence suggests the contrary. 
This form of analysis involves testing numerous hypotheses but because there may 
be differences between a questionnaire and other measures of the same or similar 
constructs, strong correlations between the two are unlikely to be observed. 
Typically a number of successive studies exploring different constructs are 
undertaken to gather increasing evidence to demonstrate the questionnaire's 
construct validity161. 
2.4.3. Criterion validity 
Criterion validity refers to the relationship between a questionnaire and an existing 
"gold standard", that is an accepted and well-established measure of# eceneept in-- 
questionl14. This is sometimes termed "concurrent validity" as the new measure is 
compared with an existing measure administered at the same time. The existence of 
a gold standard may pose the question: "Why develop a new questionnaire if there 
is an acceptable existing one? " Most often when a new questionnaire is being 
developed, there is no existing gold standard and, therefore, comparisons are made 
with another established measure in the field. Other reasons include development of 
a new measure that may be more acceptable (less invasive for the patient, for 
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example) or more cost effective than the gold standardl54. Analysis involves the 
calculation of a correlation coefficient for related items, with higher correlations 
between the measures indicating good criterion validity174 
An alternative form of criterion validity is "predictive validity", whereby the 
instrument's ability to detect future changes in the concept being measured is 
examined. However, it is often not possible or appropriate to evaluate predictive 
validity, as this often relies on outcomes that are not available until a later date176. 
2.4.4. Validity: conclusion 
Content, construct and criterion validity represent different aspects of this 
measurement characteristic that can be examined to corroborate a new instrument's 
claim to "measure what it intends to measure". The three elements provide: 
o opinions on the relevance of question items, ability to complete the 
questionnaire and applicability of the questionnaire to the target audience; 
o evidence of the questionnaire's ability to detect known theories; 
o evidence of the convergence of data obtained from the new questionnaire 
with results from existing measures of similar concepts. 
The results of these analyses provide the user of a questionnaire with evidence to 
evaluate the "degree of confidence that can be placed on the inferences drawn from 
the data"1M 
2.5. Reliability 
An instrument's reliability refers to its ability to perform in a stable, reproducible 
and consistent manner9O-15U52. The homogeneity of the questionnaire is also 
important to ensure the same concept is reliably being measured from different 
perspectives176. As with validity testing, absolute tests of reliability in questionnaire 
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development are not achievable and therefore estimates are gathered to provide 
evidence. This can be approached using three methods to be discussed here: test- 
retest (stability), alternate form and internal consisitency. 
2.5.1. Test-retest reliability 
Test-retest analysis is a calculation of the reproducibility of a set of results, as an 
approximation of the stability of the instrument. Assessment is undertaken by 
administering the same questionnaire at different time points to produce paired 
results for comparison90-151, '52. 
Data can be displayed graphically to visually represent item score differences 
between first and second administration with less variation in response categories 
indicating good stabilityl85. Agreement can also be calculated between the data pairs 
to indicate crude agreement, although this approach can overlook the level of 
agreement that might be expected by chancel86. A further evaluation is the weighted 
Kappa statistic that is calculated to analyse the relationship between two sets of 
ordinal data, (where responses are categorised and have a definite order176). This 
approach allows for chance agreements by examining the proportion of responses in 
agreement, in relation to those expected by chancel86. The value of the Kappa 
statistic ranges from 0 to 1, where 1 indicates perfect agreement and 0 indicates no 
agreement better than chance187. Guidelines for interpretation of the Kappa statistic 
are provided below (Table 16), with higher Kappa values indicating more 
favourable agreement and therefore better reliability of the questionnaire results'88. 
Table 16 Interpretation of Kappa values 





0.81-1.0 Very good 
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The Pearson product correlation coefficient is an alternative method to assess test- 
retest reliability for interval data (where the differences between any two response 
items are known to be ordered and equal)176. The use of Pearson's coefficient has 
been criticised, however, as it measures the strength of a linear relationship between 
the two data sets as opposed to the agreementl85. Furthermore, in the case of a 
systematic difference between administrations of the questionnaire, a second data 
set with responses twice as large as the first would produce perfect correlation 
results, despite the reproducibility being very poor 167 and demonstrating weak 
clinical agreementl85. Thus, the weighted Kappa statistic and graphical 
representation are preferred to correlation coefficients alone. 
There are known limitations with the test-retest method. A "practice effect" may 
occur when respondents recall their initial responses, resulting in false inflation of 
reliability estimates175. Alternatively, given the opportunity to consider the concept 
being measured in more detail, respondents may attenuate their responses on the 
second administration, resulting in under-estimation of the instrument's 
reliability189. Consideration should therefore be given to the time interval between 
the two administrations of the measure. This is largely determined by the nature of 
the concept being measured and should allow sufficient time for individuals to be 
unable to recall their initial responses, but not too long so that a change in the 
concept being measured may be expected to occur167,189. The time period should 
also exclude interventions that could be expected to affect the concept under 
examination. A two week interval is typically considered adequate182. Variables that 
have experienced real change, potentially due to time that has elapsed (and an 
improvement in symptoms for example) or the nature of the concept (such as 
spontaneous recovery of symptoms), may be readily detected by a sensitive 
measure, but may be interpreted as reflecting poor reliability, despite the instrument 
performing as intended167.189. 
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2.5.2. Alternate form reliability 
This method of evaluating reliability involves the administration of the same item, 
worded differently, to measure the same concept. The expectation is that the same 
outcome will be reported. Both forms of the question are administered at the same 
time, thereby minimising the practice effect'89. Care must be taken with this 
approach to ensure that the exact aspect of the attribute is measured, to the same 
degree and at the same vocabulary level, in both forms, in order to avoid 
underestimation of reliability. The simplest way to achieve this is to retain the 
original wording of the item but to reverse the response options or to replace the 
response options with alternate equivalents (for example, "four times a day" and 
"every six hours") although, again, care must be taken with interpretation189. 
Other methods of reliability estimation have been devised that include 
administering altered versions of the questionnaire. The split-half method requires 
that items contained within the questionnaire are randomly split into two groups for 
administration at different time points to calculate intercorrelation comparisons. The 
parallel-form method uses two conceptually equivalent forms of the test containing 
different items, for correlation analyseslm. These methods have limitations in their 
design. First the number of items involved in the reliability analysis is reduced 
which can negatively compromise reliability. Secondly, the analyses of the altered 
versions of the questionnaires do not provide indications of which items affect 
reliability, making it more difficult to refine the questionnairel90. 
2.5.3. Internal consistency 
Internal consistency is a measure of the homogeneity of an instrument, or the degree 
to which it is examining similar issues. It measures the extent to which items relate 
to a particular dimension, to the exclusion of other dimensions151. In essence, it looks 
at the questionnaire's ability to measure different aspects of the same concept and 
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indicates how well the different items complement and relate to each other. The use 
of multiple related items is important, in order to provide more reliable data on 
distinct concepts, rather than stand-alone items that may measure only one facet of 
the issue189. Internal consistency can be evaluated by a single administration of the 
instrument, typically using Cronbach's Alpha (a) coefficient151, l52,182,190. Cronbach's a 
ranges between 0 and 1, with a low value indicating that the items have little in 
common with each other191. It should be noted, however, that a low value is more 
common when a measure contains few items. A high a coefficient may indicate 
excellent internal consistency although, when a questionnaire contains a large 
number of items, it can indicate redundancy or overlap between itemsl92"193. It is 
suggested that an a of between 0.7 and 0.9 is acceptable from the statistical 
perspective'82,190. 
2.5.4. Reliability: conclusion 
The concepts described above provide methods for evaluating a questionnaire's 
ability to perform in a reproducible and consistent manner. While not all of the 
methods are required to evaluate reliability, test-retest evaluation and internal 
consistency are the most common methods reported in studies involving the 
development of a new questionnaire. These elements provide information to show: 
o the ability of the questionnaire to measure the same concept, to the same 
degree, when there has been no actual change in the concept under 
examination; 
o that the items contained evaluate differing aspects of the same concept, 
providing more depth of assessment, instead of a superficial assessment of 
unrelated concepts. 
These evaluations are of particular importance in health-related questionnaires 
where assessment of longstanding or chronic conditions is often undertaken, as in 
the case of this thesis. 
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2.6. Error or bias in questionnaire measurement 
As with all measures, questionnaires have a degree of "tolerance" that includes 
errors that cannot be totally eradicated. In the example of the thermometer, at the 
start of this chapter, the nature of the fixed variable being measured remains 
constant or varies by known increments. The thermometer, however, will have a 
degree of inaccuracy that is taken into consideration when interpreting the 
temperature reading but, as this is usually less than 1°C, the effect is negligible. 
Systematic errors threaten the validity of the questionnaire and random errors 
threaten reliability, potentially biasing the results obtained. Therefore, the less error 
the more accurate the instrument'89. Several methods of assessing and reducing bias 
can be used. 
2.6.1. Random error 
Classical test theory, devised by Karl Pearson, is a model for assessing the degree of 
random error and states that any observation comprises two components: a "true" 
score, reflecting the true answer to the question, and "associated error", resulting 
from the questionnaire's designl86"194. This inflicts a permanent unsystematic 
variation in the measurements obtained and consequently affects the accuracy of the 
instrumentiM. Due to the random nature of these errors, observed scores can vary 
between being either higher or lower than the true score. The assumption is that 
these differences will cancel each other out over repeated administration. Thus, the 
results are not thought to produce bias in one direction195. 
As described earlier, the most common technique used to establish reliability in 
questionnaire design and any experimental methodology is by replication157. 
It is important to note that the classical test theory has been criticised for proposing 
the existence of a hypothetical "true" score, but more recent publications have 
concluded that, while new theories have been suggested, the underlying principles 
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of the classical test theory are sufficient and applicable to all measurement 
situations, and that newer approaches have either been fundamentally flawed or are 
merely extensions of this classical approach'86. It is clearly essential to take as many 
steps as possible to reduce bias. 
2.6.2. Systematic error 
Systematic error refers to the consistent over- or under-estimation of the concept 
being measured, resulting in the production of results that are unilaterally biased. 
Unlike non-random error, where repeated observations are expected to negate the 
effect, repeated measurement with an instrument that has systematic errors is 
expected to consistently exaggerate or underrate the issue under examination. 
Systematic error is thought to be due to poor questionnaire design, over- 
representation of one or more concepts by the items included, and measurement of 
multiple unrelated concepts. Efforts taken at the stage of item generation and 
content validity testing can help to reduce inherent design errors'%. 
2.6.3. Error in questionnaire measurement: conclusion 
As with validity and reliability, direct measurement of the level of error is not 
achievable. However, rigorous methods incorporated into the studies designed to 
gather evidence of these properties can help to reduce the occurrence of errors, 
thereby further enhancing the psychometric properties of a questionnaire. 
2.7. Sensitivity to change 
In the context of health research, questionnaires are often developed as outcome 
measures in order to detect improvement or deterioration in a patient's condition 
following treatment. For questionnaires to be used in this manner, it is essential that 
the questionnaire's responsiveness, or sensitivity, to actual changes that occur over 
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time is evaluated167,184,197. It has been argued that sensitivity to change is not a 
distinct concept but a central element of both validity and reliability'97-199. However, 
it has been suggested that sensitivity to change be seen as a distinct concept, a 
separate and equivalent attribute, in recognition of the importance of sensitivity to 
change to health measurement200. 
Sensitivity to change is a measure of the association between changes in observed 
scores and change in the actual construct. These associations are then explored to 
ensure that any changes detected by the questionnaire are not due to measurement 
error' 84. Ideally, these comparisons should be made between a treatment group 
receiving an intervention of known efficacy and a control group receiving no active 
intervention, in order to establish that any changes in outcome scores are genuine 
and not a chance occurrence201"202. However, this approach is not always appropriate 
and may be unethical if individuals are denied effective treatment. Instead, the 
instrument's sensitivity may be explored by examining its ability to detect changes 
in respondents receiving two different, yet established, treatments (patients 
receiving surgery versus conservative management, for example). In this situation, 
the magnitude of improvement may be expected to be greater in the more 
aggressive treatment group, and the questionnaire should reflect this203. This 
assumption, however, must be based on the published literature. Change over time 
can be calculated by use of simple percentage alterations in responses at baseline 
and post-treatment, and the Wilcoxon signed-ranks test for paired ordinal data can 
be used to determine the significance of the calculated change. 
2.8. Factor analysis 
Factor analysis is a statistical technique that is often used to refine a questionnaire 
and develop a scoring system, if applicable. The process is used to select 
particular question items from the entire pool of items to represent a hypothetical 
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trait, for example quality of life205. More specifically, factor analysis can be used to 
identify potential question items for removal and determine: 
o Groupings or clusterings of variables (items); 
o Which items belong to which groups and how strongly they belong; 
o How many dimensions (factors) are needed to explain the relations among 
the items; 
oA frame of reference to describe the relations more conveniently; 
o Scores of individuals in such groupings. 
A questionnaire, therefore, needs to comprise a range of variables that sufficiently 
represents the concept under measurement and provides data from which 
inferences can be made, with regard to every aspect of the concept207 
Caution must be exercised when interpreting the results of factor analyses and 
determining which items should be retained in the final questionnaire. Relying 
solely on the results of this statistical technique may cause items of high clinical 
importance (with considerable relevance to either health professionals or patients 
themselves, for example) to be removed, if an item does not "fit" well with the 
dimension (factor) structure identified by the analysisl84. In a study developing a 
disease-specific questionnaire for asthma assessment, item selection through factor 
analysis was compared with items selected by the target population. While there 
was a certain element of overlap (56-63% same items selected by both sources), 
items would have been omitted had either source of evidence been used in 
isolation208. Therefore, expert opinion should be used when interpreting the results 
of the factor analysis and determining the content of the final questionnaire, in 
combination with the results obtained in the previous studies of validity, reliability 
and sensitivity to change. 
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2.9. Conclusion 
Developing a questionnaire that is psychometrically robust is a detailed and lengthy 
process involving numerous sub-studies, in order to achieve the highest level of 
validation. -The relevance o¬ the various properties, and the value that they lend to 
the resulting data obtained from a health measurement questionnaire, has been 
illustrated. Establishing validity, reliability and sensitivity to change is crucial for a 
questionnaire such as the ICIQ-B because it aims to be used for health measurement 
and to be useful in informing decisions regarding treatment options or outcome 
measurement in the development of new pharmaceuticals or management 
strategies, for example. The psychometric analyses used to evaluate the ICIQ-B will 
be detailed in Chapter Four. Before moving to this, the next chapter will consider 
currently available questionnaires that could be used to assess anal incontinence and 
focus on their psychometric properties. 
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CHAPTER THREE: EVALUATION 
OF EXISTING MEASURES OF 
ANAL OR FAECAL 
INCONTINENCE 
Introduction 
As discussed in Chapter One, anal incontinence is reported to affect one in six 
people of the community adult population, with a wide range of causes for these 
symptoms. Accurate assessment is needed to perform consistent and dependable 
evaluations in clinical patient care and in new treatment and management strategies 
for these symptoms in the research setting. This chapter will describe measures 
currently available to assess incontinence. 
The focus will be particularly on measurement using questionnaires, although other 
methods will be briefly described. The scope of assessment offered, methods of 
questionnaire development and mode of administration will be evaluated. In 
addition, the evidence of psychometric properties for these measures will be 
described and critically evaluated in terms of validity, reliability and sensitivity to 
change. This is important in order to assess their applicability in context and explore 
the reliance that can be placed on information obtained from them, as outlined in 
Chapter Two. A particular aim of this Chapter will be to explain why there is a need 
for the development of a new questionnaire in this area. 
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3.1. Assessment of anal incontinence 
The accurate assessment of anal incontinence symptoms and their impact on quality 
of life is essential for clinicians to identify aetiological factors, diagnose conditions, 
propose treatment strategies and evaluate their effects210. Assessment instruments 
for anal incontinence fall into two main categories: objective physiological measures 
and evaluations based on subjectively reported information. The latter category can 
be further divided into clinician-reported measures and patient-reported measures, 
including severity scores and symptom and impact questionnaires respectively. 
Each group is considered below. 
3.2. Physiological testing in patients with anal 
incontinence 
Physiological measures of anal incontinence are typically employed to provide 
evidence of aetiology following a detailed patient history and the findings on rectal 
examination. Measures include: 
o Anorectal physiology -a series of measurements to assess anal sphincter 
function, rectal sensation, rectoanal reflexes and rectal compliance21i 
o Endoanal ultrasonography - ultrasound imaging that provides 360° cross- 
sectional or three dimensional images of the anal canal and its constituent 
structures212 
o Magnetic resonance imaging - multiplanar imaging of the anal canal and 
associated structures providing more detailed information than cross- 
sections, through ultrasound imaging, and improved tissue differentiation212 
o Electromyography - assessment of the neuromuscular integrity of the anal 
sphincter by recording action potentials generated by the external anal 
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sphincter and puborectalis muscle fibres under differing states, e. g. at rest 
and during voluntary contraction213 
These measures provide objective data to help identify the cause of symptoms and 
to inform treatment decisions211, but their use is not without limitations. These tests 
lack standardised methods214, exhibit poor reproducibility215 and little information is 
available regarding "normal" reference ranges216.217. Intra- and inter-observer 
variability have also been identified218,219. 
A review undertaken for the development of the National Institute for Clinical 
Excellence (NICE) guideline for the management of faecal incontinence in adults22° 
identified a number of studies that compared the value of diagnostic functional 
testing and imaging with routine clinical assessment. The review indicated that 
digital rectal examination may achieve greater sensitivity and specificity but 
reduced accuracy in identifying sphincter function when compared to anal 
manometry221'224. A study by Sultan et al 225 reported the lack of specificity and 
sensitivity of manometry and electromyography in diagnosing anal sphincter 
defects. Further studies by Dobben et al m comparing physiological tests found that 
only larger defects in the external anal sphincter were reliably detectable on digital 
examination, compared with endoanal ultrasonography. Higher proportions of 
smaller defects were found to be missed. Dobben et al went on to report only "fair" 
agreement reported between magnetic resonance imaging and endoanal 
ultrasonography in the depiction of sphincter defects (weighted Kappa = 0.24)226. 
Thus it appears that, although digital examination alone may not be accurate, more 
complex tests are also associated with some limitations. This is particularly 
important when more complex treatment options, such as surgery, are considered. 
In the absence of robust evidence, the consensus is that specialist assessment, as 
detailed above, should be considered only in individuals with continuing 
incontinence following conservative management. NICE guidelines, published in 
2007, recommended that baseline clinical assessment should include taking a 
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relevant medical history from the patient and performing both a general and an 
anorectal examination. More specialist assessment is suggested only when 
considering further treatment options, such as surgery216"220227-zig. 
Despite evidence that many of the available physiological tests are subject to flaws, 
clinicians feel they have a purpose in identifying anatomical defects or abnormal 
results, which may indicate treatment pathways, in particular the use of endoanal 
ultrasonography227-230-232. Clinically objective changes observed in these parameters, 
however, at best only serve as a proxy for patient experiences of symptoms and such 
changes may not concur with patients' reports of improvement in their 
symptoms-. Several studies have shown that symptoms do not correlate with 
physiological findings215.25-237, while other studies have demonstrated associations 
with certain parameters, for example, resting and maximum anal squeeze pressures, 
and maximum tolerable anal volume234"238. Despite inconclusive data regarding 
these associations239.240, it is clear that physiological tests fail to capture the patients' 
perspective of their situation completely. It is also over-simplistic to assume that 
clinical parameters can be used to interpret the degree of restriction caused to an 
individual's life. Many patients greatly modify their lifestyle to avoid episodes of 
incontinence, if at all possible, and an evaluation of the extent of these modifications 
may more accurately reflect disease severity and impact than "objective" 
measuresl53-241. 
3.3. Severity scores for anal incontinence 
Numerous scores have been devised to quantify the severity of incontinence 
symptoms as a method of evaluating anal incontinence. These scores have primarily 
been devised by clinicians for their completion and the scores are broadly divided 
into two categories depending on how severity is defined: increased incontinence 
frequency indicating increased symptom severity, or type of incontinence indicating 
severity, such as solid stool being more severe than flatus (Table 17). 
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Table 17 Published/existing severity scales 
Definition of severity Published measures 
More frequent incontinence equates to Keighley and Fielding (1983)242 
more severe incontinence Broden et al (1988) 243 
Miller et al (1988)244 
Williams et al (1991)245 
Pescatori et al (1992)246 
Jorge and Wexner - Cleveland Clinic 
Continence Grading Scale (1993)3 
Vaizey's adaptation of the Continence 
Grading Scale - St. Mark's 
Score(1999)247 
Rockwood et al - Fecal Incontinence 
Severity Index FISI (1999) 248 
Solid stool incontinence is more severe Parks (1975)249 
than liquid stool incontinence and in Lane (1975) 2N 
turn both are more severe than flatus Rudd (1979)251 
incontinence Keighley and Fielding (1983)242 
Corman (1985)252 
Hiltunen et at (1986) 
Womack et al (1988) 
Miller et at (1988)244 
Rainey et al (1990)255 
Williams et al (1991)245 
Pescatori et al (1992)246 
The majority of measures used just one of the variables as the indicator of increased 
severity. Park's249 scale is an example that graded the type of stool incontinence to 
characterise severity: "normal", "difficult control of flatus and diarrhoea", "no 
control of diarrhoea" and "no control of solid stool". Broden et al243 used increased 
frequency to determine increased severity: "no episodes of incontinence", "episodes 
of incontinence" and "incontinence to stool at all times". Two of the more widely 
used severity measures, the Cleveland Clinic Continence Grading scale3 and the St. 
Mark's score247, did not rely on discrimination between stool type to indicate 
severity and included flatus incontinence. This approach assumed the similar 
importance of all types of incontinence in determining severity and recognised the 
contribution of flatus. 
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Four measures used a combination of increased frequency and type of anal 
incontinence: 
" Keighley and Fielding's evaluation of surgery242, 
" Miller's evaluation of differences between conservative and operative 
management of incontinence244, 
9 Williams' tool for anal sphincter evaluation245 and 
" Pescatori's continence grading scale246 
The Pescatori scale246 for example, scored incontinence of solid stool more severely 
than flatus or mucus leakage and combined that with a score that also increased 
with frequency. The remaining measures in Table 17 followed the patterns 
described for Park's249 and Broden et al's scale243 although different descriptions of 
stool type or incontinence frequency were used. The amount or magnitude of an 
incontinent episode was only considered by one of the instruments, Rudd's score 
developed to evaluate transanal anastomosis251. These assessment tools make crude 
assumptions about the relationship between particular aspects of incontinence and 
severity. However, there seem to be no data to justify these assumptions. 
Rockwood et al (1999)248 took an alternative approach in the development of the 
Fecal Incontinence Severity Index (FISI) rather than pre-assigning scores according 
to the frequency or type of incontinence. The authors explored the differences 
between clinician and patient rankings of severity, in terms of frequency and type of 
incontinence, to determine two scoring systems that reflected the patients' and 
surgeons' perspectives. They found that rather than a simple linear relationship, 
there was a complex interplay between the type, frequency and severity of 
incontinence. High correlations were found between surgeons' and patients' 
rankings of the type and frequency of incontinence (Pearson s correlation coefficient, 
r=0.97). Discrepancies occurred, however, where the surgeons perceived a more 
severe condition status in those experiencing infrequent incontinence of solid stool, 
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as this was more likely to be due to a worse physiological condition. Patients placed 
more emphasis on episodes that affected personal hygiene and caused 
embarrassment, such as mucus or flatus incontinence. 
Importantly, the FISI248 attempted to reflect the patients' perspective and to consider 
severity rather than occurrence of symptoms alone. Similarly, the Cleveland Clinic 
Continence Grading scale3 included two additional items that assessed the 
frequency of pad usage and how often patients adapted their lifestyle to appraise 
the effects of incontinence. Vaizey et al modified this scale into the St. Mark's 
score247. The question regarding pad use was altered to reflect presence or absence 
rather than the frequency of needing to wear pads and two further items were 
added regarding the use of constipating medications and the ability to defer 
defecation for 15 minutes247. These additional variables acknowledged the role of 
behaviour modifications that may be used by patients in an attempt to conceal their 
incontinence, and that may influence patients' perceptions of the severity of their 
condition. The item relating to the use of pads did not, however, specify whether the 
pads were used for anal or urinary incontinence. Consequently, this may have 
systematically overestimated the severity of anal incontinence247. More thorough 
validation involving patients in the development of the questionnaire may have 
improved the phrasing and understanding of these items. 
Baxter's review of measures of faecal incontinence concluded that a significant 
flaw in a number of severity scales was that they did not allow all individuals to be 
categorised24z, m, 25s, 2" Specific definitions were applied to available response 
categories such that an individual's symptoms might not fit into any of the 
categories. This may have been due to limitations in the validity and robustness of 
the scales, as discussed in Chapter Two (pp. 55-56). The inability of a measure to 
categorise all potential respondents is an issue that should be detected through 
thorough testing of a questionnaire. Many of these instruments were developed for 
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individual studies of treatments where perhaps validation of the instruments within 
the studies was not a priorityz4-245'251-255. 
There were only limited data relating to the validation of these scales, as established 
by The Standards Committee of the American Society of Colon and Rectal 
Surgeons257, and only two reported any formal validation247.248. Validation of the St. 
Mark's score was reported by Vaizey et a1247 and evaluated the convergence of 
results with other existing non-validated questionnaires; Pescatori246, the Cleveland 
Clinic Continence grading scale3 and the American Medical Systems Fecal 
Incontinence Scoring System258 (not reviewed here as it is an unpublished scoring 
system used to evaluate a new device). The reliability and responsiveness of these 
instruments were also analysed. As detailed above, Rockwood et a1248 evaluated the 
agreement between severity of symptoms according to clinician and patient reports, 
but no further evidence of reliability or sensitivity to change was provided. 
Vaizey et a1247 reported that the Pescatori2'6 score and Cleveland Clinic Continence 
grading scale' score showed good correlations with clinical impressions, 0.72 and 
0.78 respectively. "Moderate" to "good" reliability was reported for these measures 
when they were repeatedly administered to the same individual. The study found 
that the St. Mark's score exhibited the highest correlation with clinical impression 
(0.79), although this result was very similar to the other scores, and "very good" 
reliability over time247. All measures administered following surgery, (overlapping 
anterior sphincter repair or implantation of artificial bowel sphincter), detected an 
improvement in symptoms identified by decreased scores. All but the AMS score 
indicated statistically significant improvement (P<0.05) providing evidence of their 
sensitivity to change. Score changes also correlated significantly with clinicians' 
impression of improvement (Table 18). 
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Table 18 Comparison of St. Mark's score with non-validated questionnaires - 
sensitivity to change analysis (n=10)247 
Score Sensitivity to change Correlation of score 
Mean score change change with clinical 
% (P-value) impression of 
improvement 
St. Mark's score -53 (0.004) 0.94 
Pescatori -40 (0.03) 0.87 
Cleveland Clinic -46 (0.03) 0.87 
Continence grading scale 
American Medical -29 (0.09) 0.86 
Systems AMS 
Vaizey's study provided some evidence of the convergent validity of the scores with 
clinical impressions and acceptable reliability. Convergence with clinical impression 
might not be sufficiently robust due to the unstandardised nature of clinical history 
taking. Evidence of sensitivity to change was found for all but the AMS severity 
scale. It should be noted, however, that the instruments were tested in a small 
sample of individuals (convergent validity: n=24, test-retest reliability: n=13, 
sensitivity to change, n=10), increasing the risk of bias and raising questions about 
the generalisability of the findings. 
Further evaluation of the St. Mark's score was undertaken in the development of the 
Colorectal Functional Outcome Questionnaire (COREFO), which is described later 
in this Chapter (pp. 109). The authors compared results from self-completion of the 
COREFO with an adapted self-completion version of the St. Mark's score. Higher 
levels of missing data were found for completion of the St. Mark's score, a median 
average of 7.5 missing responses compared to 1 for the COREFO. The authors note 
that the adaptation of the St. Mark's score from its intended clinician-completion 
origin may have increased missing data. Fifteen percent of patients reported finding 
questions confusing and indicated problems with understanding the structure of the 
questionnaire. 
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A more recent study evaluated sensitivity to change of the St. Mark's score and its 
ability to reflect patients' perceptions in larger samples259. Data were gathered using 
the St. Mark's score and a subjective perception of bowel control visual analogue 
scale in 390 patients with faecal incontinence. A moderate correlation was reported 
(Pearson s Correlation coefficient r=0.53) indicating the St. Mark's score's ability to 
reflect patients' perceptions of their bowel control that did not differ by age, gender 
or type of incontinence. Post-conservative treatment data were gathered for 131 of 
the study patients. These demonstrated an improvement in symptoms that 
concurred with patients' subjective reports of improvement in eighty three cases, 
but with only a moderate correlation (r=0.45). As higlighted by the authors, 
however, twenty six patients reported subjective improvement that was detected as 
"no change" or "deterioration" in the St. Mark's score. This indicated that while 
their symptoms had not benefited, their subjective perception was of some 
improvement, which the St. Mark's score was not able to detect. 
3.3.1. Severity scores for anal incontinence: conclusion 
A common fundamental characteristic of the above scales was that they relied on 
clinicians' interpretations of patients' symptom severity as determined by the 
frequency and type of incontinence events. This presents two potential problems for 
the accurate evaluation of symptom severity. Firstly, it implies that a reduction in 
incontinent episodes equates to successful treatment and that "less" is "better". 
Secondly, previous research has shown that there is a tendency for clinicians to 
underestimate the degree of interference in quality of life when evaluating 
symptoms and taking clinical histories2e0a61. 
As it is not known if a reduction in incontinence episodes actually means success, 
the patients' interpretation of improvement is vitally important, as stated by Baxter, 
"Because faecal incontinence is a symptom, the subjective perception of the patient 
must be the foundation of any evaluation of incontinence or the impact of 
incontinence. " 
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Considering the second issue, Rockwood et al made a concerted effort to reflect the 
patients' perspective in the development of the FISI's scoring system. However, the 
conflicting opinions of the surgeons and patients, with respect to determinants of 
severity, raised issues regarding the interpretation and intended use of such an 
instrument. The authors suggested the surgeon's scoring system may be more 
appropriate for a surgical outcome evaluation, due to the underlying anatomical 
and physiological relevance. The patients' scoring system may be more appropriate 
for individual outcome evaluation, as events causing more socially unacceptable 
situations may be perceived to be more important than underlying sphincter 
integrity248. The relevance of both scoring systems requires further research. This 
highlights the issue of clinicians' potentially overlooking quality of life issues, or 
impact from the patients' perspective, which may be exacerbated using severity 
scores where the lack of quality of life question items is evident. 
It was also identified through this review that only one instrument considered the 
amount of leakage. The other instruments imply, therefore, that leakage that cannot 
be controlled by protection and may be evident to others in a social situation is no 
more severe than a small amount of stool leakage contained by underwear. 
Similarly, the implication was that small amounts of "undetectable" flatus were just 
as severe as audible and odorous flatulent events that occurred at the same 
frequency, if magnitude was not considered. These assumptions are debatable. 
A further fundamental flaw with these scales was their lack of validation, meaning 
that there was no evidence of their measurement capabilities. The vast majority of 
scales were developed for individual studies where the validation of the 
measurement tool was not the primary focus of the study. Thus the use of such 
severity scores for accurate evaluation of anal incontinence cannot be recommended. 
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3.4. Self-completion questionnaires for anal 
incontinence 
The Symptom and Quality of Life assessment committee of the Third ICI 
recommended that patient-completed self-report measures be developed to evaluate 
anal incontinence: 
"the only valid way of measuring the patient's perspective of their predicament is 
through the use of psychometrically robust self-completion questionnaires"153. 
Bowel diaries can be considered self-completion instruments, since the patient 
records their bowel events over a period of time. Diaries can be used to offer insight 
into the occurrence of incontinence episodes, as well as providing information on 
broader bowel patterns. Bowel diaries, however, are associated with poor patient 
compliance and lack a validated gold standard233. In addition, diaries of events do 
not capture impact issues. As commented by Moore241, 
"Indeed, people with faecal incontinence may control stool leakage through 
constipation; keeping a stool leakage/defecation diary may show no episodes of soiling 
because of gross constipation. " 
The symptom and quality of life assessment committee of the Third ICI reviewed 
the available evidence of psychometric properties for published self-completion 
questionnaires for assessing anal incontinence, to inform grades of recommendation 
(Table 19)153,262. 
Table 19 Criteria for recommendation of questionnaires for Faecal 
Incontinence at the 3rd International Consultation on Incontinence 
Grade of recommendation Level of evidence 
Grade A Validity, reliability and responsiveness established 
with rigour 
Grade B Validity and reliability established with rigour, or 
validity, reliability and responsiveness indicated 
Grade C Early development - further work required and 
encouraged 
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These questionnaires, along with others not reviewed by the committee, will be 
described below, together with their grades of recommendation, where available. 
The review undertaken for this thesis included questionnaires that were not 
reviewed by the ICI committee, either due to their non-specificity, or because they 
were simply not identified at the time of the Third ICI (Table 20). Questionnaires 
were identified through searches of the electronic database PubMed, in addition to 
manual searching of manuscripts referenced in identified articles. These were 
limited to adult human studies, employing the following MeSH search terms in 
combination: "fecal incontinence" (included "faecal incontinence"), 
"questionnaires" and "quality of life". Over three hundred publications were 
identified dating from January 1979 to April 2008. However, many studies did not 
detail the development of questionnaires. Only papers detailing the development 
and/or validation of questionnaires were retained for this review, resulting in the 
inclusion of nineteen questionnaires. The rest of this chapter will explore the 
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3.4.1. Questionnaires for gastrointestinal assessment 
that include items for anal incontinence 
Four measures had been devised to assess gastrointestinal symptoms, quality of life, 
or both, that included items of some relevance to anal/faecal incontinence, albeit 
few in number. Two of these, the Rome III criteria9 and Talley et al's Bowel Disease 
Questionnaire (BDQ)2 , were symptom-specific measures designed to identify 
functional gastrointestinal symptoms, meaning no detectable organic cause present8. 
The BDQ encompassed domains for gastroduodenal, bowel and abdominal 
symptoms, which were included in the Rome III criteria, along with oesophageal, 
biliary and anorectal dysfunction. 
The Gastrointestinal Quality of Life Index (GIQLI)264and Irritable Bowel Syndrome 
Quality of Life (IBS-QOL)265questionnaires were more specifically concerned with 
the effects of gastrointestinal symptoms. The GIQLI measured symptoms associated 
with disorders of the oesophagus, stomach, gall bladder, pancreas, small intestine, 
colon and rectum, while the IBS-QOL focused on the symptoms included in the 
criteria for IBS diagnosis described by the first Rome criteria groupz79 , including 
abdominal pain or discomfort, and stool form. The IBS-QOL included items related 
to bowel control and issues related to "bowel problems", potentially including 
incontinence, and the GIQLI evaluated excessive passage of gas, diarrheoa, urgent 
and frequent bowel movements and uncontrolled stools. Both instruments 
contained questions or statements relating to the effect of symptoms and asked the 
respondent to quantify the extent of that impact on five-point Likert scales. While 
the IBS-QOL contained no items relating to occurrence of symptoms, the GIQLI 
directly asked about the degree that the individual had been "troubled" by their 
symptoms. 
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Although the diagnostic criteria of the Rome III measure were developed following 
a review of the literature by clinical experts in the field, they have not been validated 
formally. The extent of validation of the other questionnaires was also variable. 
Studies of content validity were conducted in reasonable patient populations (n=30- 
70) to refine the BDQ, GIQLI and IBS-QOL and to improve their acceptability. In 
addition, the items generated for the IBS-QOL to assess perceived quality of life, and 
interference with attainment of personal goals and needs, were generated through 
qualitative interviews with forty affected individuals. 
High levels of reliability were reported for these three questionnaires in studies of 
patients where the questionnaire was administered twice, when symptoms were 
expected to remain stable (Table 21). 
Table 21 Reliability results for gastrointestinal assessment questionnaires 
Questionnaire Test retest reliability statistics 
BDQ263 0.78 (Median Kappa statistic) 
Talley et al (1989) 
GIQLI264 0.92 (Intraclass correlation coefficient) 
E asch et al (1995) 
IBS-QOL265 0.86 (Intraclass correlation coefficient) 
Patrick et al (1998) 
The test-retest results indicated high levels of reliability, although the second 
administration of the questionnaires took place after a short time interval (24 to 48 
hours in some cases) in the BDQ and the GIQLI studies. It is possible that 
individuals may have remembered their initial responses, which could have 
potentially caused false elevation of reliability estimates, as discussed earlier in this 
thesis. 
The responsiveness of the GIQLI was evaluated in 194 patients who underwent 
laparoscopic surgery to remove their gall bladders. While the results did not 
provide evidence for its use in patients undergoing treatment for anal incontinence, 
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improvements in mean scores were detected that reflected the expected pattern of 
recovery (P<0.001). 
A major limitation of each of these four questionnaires, however, and of particular 
relevance to this thesis, was that they did not provide in-depth assessment of 
incontinence specifically. While some issues addressed by all of the questionnaires 
may be pertinent for individuals with anal incontinence, they were developed for 
the assessment of a much broader group of gastrointestinal symptoms and thus 
would provide only very limited and superficial data for patients with anal 
incontinence. 
3.4.2. Questionnaires for anal incontinence assessment 
Six questionnaires have been published for the assessment of anal incontinence in 
the general population: a questionnaire for the assessment of faecal incontinence 
and constipationl25, a bowel function questionnaire266, a fecal incontinence 
questionnaire671 the Birmingham Bowel and Urinary Symptoms Questionnaire 
(BBUSQ)280, the Faecal Incontinence and Constipation Assessment (FICA)271 and the 
Pelvic Floor Distress Inventory (PFDI)2""269, described in detail in Table 22. Four of 
these' , 266,26'. zn are suitable for men and women and two (the BBUSQ and the PFDI) 
are designed for use in women only268'269"280. All of these questionnaires primarily 
focus on the evaluation of symptoms of anal incontinence, but some assess a limited 
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The six questionnaires described in Table 22 were developed using various methods 
including clinical expert opinion, adaptation of existing instruments including 
urinary incontinence questionnaires and evolution through clinical practice. Patient 
interviews were not included in any of these questionnaires as a source of question 
items. Areas of assessment included incontinence, more general bowel symptoms, 
related disease and surgical history, and related comorbidity such as urinary 
symptoms. Three out of these six instruments were consequently lengthy with forty 
sevenl25, sixty three267 and ninety eight271 question items respectively. The others 
contained a less onerous twenty to twenty eight items. All of the "incontinence- 
specific" instruments reviewed dedicated no more than a third of items to the 
assessment of incontinence. This may indicate the belief that it is important to assess 
associated bowel symptoms and "normal" bowel habits in order to contextualise the 
clinical impression of incontinence, but does question their relevance for use in 
conducting focussed assessment of anal incontinence. 
As discussed in Chapter One, flatus incontinence was the most prevalent type of 
anal incontinence. However, only three of the six instruments' 25,266,269 included 
assessment of flatus. Reilly et a1267 who developed the Fecal Incontinence 
Questionnaire reported that they deemed flatus to be, "of lesser importance"267. The 
FICA271 purported to measure flatus incontinence after the use of a filter question; 
"Have you ever had problems with leakage of stool (accidents or soiling)? ". The 
problematic wording of this item, however, would probably preclude those with 
flatus incontinence from reaching subsequent items. 
Quality of life items were included in four of the six questionnaires26 , 267 269.271. None 
of these, however, were generated with patient input and thus the relevance of the 
issues selected is questionable, despite broad coverage of the key quality of life 
domains: physical, social and sexual impact, and wellbeing. Although the PFDI 
addressed symptoms alone, it was designed to be used in conjunction with the 
Pelvic Floor Impact Questionnaire (PFIQ)26.269 (described later in this Chapter), 
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which focused on quality of life impact of each of the symptoms covered by the 
PFDI. 
With the exception of Osterberg's tool for the evaluation of faecal incontinence and 
constipation125 published in 1996, all of these tools had been developed more 
recently than the severity scores, mostly since 2000. Increased understanding of the 
importance of psychometric validation was evident in comparison with the severity 
scores, with these studies conducted to a higher standard and reaching reasonable 
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The validation studies undertaken for each of the questionnaires varied, although 
greater attempts to evaluate criterion validity and reliability, compared to other 
psychometric properties, was evident. Four of the questionnaires evaluated criterion 
validity by analysis of correlations between the questionnaire findings and bowel 
diariesl25.268, anal manometry ° or clinical impression271. Associations ranged from 
"reasonable" to "excellent" and Osterberg's questionnaire demonstrated the 
strongest correlation with bowel diaries (spearman's rho = 0.96 -1.0)125. 
Five questionnaires explored reliability, demonstrating "moderate"125,280 to 
"good"267"271 results using the weighted Kappa statistic, and a high intraclass 
correlation coefficient of 0.87 for the PFD1268. There are some concerns over the 
methodology used to examine the test-retest reliability of the faecal incontinence 
and constipation questionnaire'25, where a variable retest period ranged from one to 
twelve months. Given the inherent variability of incontinence symptoms over time, 
a twelve month period may be too long, and thus the reliability of the instrument 
may have been somewhat under- or over-estimated. 
The BBUSQ280 and Osterberg et al's'25 questionnaire for faecal incontinence and 
constipation were the only measures with published evidence of sensitivity to 
change evaluation. This evaluation for the BBUSQ investigated the relationship 
between an individual key identifier question for incontinence, "Does stool leak 
before you can get to the toilet? ", and an overall domain score that comprised this 
question. The expectation was that a change would be detected in both the question 
item and the overall domain score if the BBUSQ was sensitive to change. No 
external verification of individual improvement in symptoms was sought, and so it 
is not possible to determine accurately whether the questionnaire was able to detect 
change in symptoms reliably. 
Of note among the questionnaires detailed was the general lack of patient input, via 
interviews, to evaluate content validity. Reilly et a1267 were the only authors to 
conduct interviews with ten patients referred with gastrointestinal complaints, and 
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then only to evaluate the understanding and appropriateness of their questionnaire 
rather than carrying out any in-depth exploration of relevant issues. As discussed 
earlier, poor content validity can adversely affect the interpretation and general 
acceptability of these instruments. 
Validation data was lacking in some respect for all of the questionnaires, and in the 
case of HallbÖök and Sjödahl's266 bowel function questionnaire, it was entirely 
absent. 
3.4.3. Questionnaires for quality of life assessment 
specific to anal or faecal incontinence 
Unlike symptom assessment where the observed or reported presence or absence of 
symptoms is recorded, quality of life assessment requires quantification of the 
patient's subjective experience. Chapter Four will review more fully what is known 
about the effects of anal incontinence on quality of life. If designed appropriately, 
self-completion questionnaires enable accurate and objective measurement of 
subjective phenomena, such as quality of life, and provide data to complement 
patient narratives or clinical histories that may largely overlook such issues153. 
Three self-completion questionnaires have been developed for use in the general 
adult population to assess the impact on quality of life or distress caused by anal or 
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The above instruments represent a determined effort to capture the key components 
of impact on quality of life caused by anal incontinence, such as lifestyle, physical 
and social implications, and personal and emotional issues. They are also relatively 
concise self-completion questionnaires with seven269, twenty nine4 and thirty one272 
items each. This brevity may lead to greater acceptability, higher response rates and 
lower levels of missing data than lengthier questionnaires. 
Flatus incontinence was addressed more comprehensively in the Manchester Health 
Questionnaire (MHQ) and PFIQ than the Fecal Incontinence Quality of Life 
questionnaire (FIQL). The MHQ and PFIQ used more general terminology such as 
"bowel" or "bowel problem" by comparison with the phrase "due to accidental 
bowel leakage" employed in each of the FIQL's quality of life impact questions. This 
may have caused respondents some difficulty with interpretation. Incontinence of 
flatus may not necessarily be interpreted as "bowel leakage" and might potentially 
exclude respondents for whom these symptoms may be relevant. The title of the 
questionnaire specifically states "faecal incontinence" and therefore the exclusion of 
individuals with flatus incontinence might have been intentional, although this was 
contradicted by the definition of faecal incontinence used within the publication: 
"inability to control the passage of stool or flatus". As with the earlier 
questionnaires, patient involvement at the design stage may have enabled more 
appropriate phrasing to avoid possible exclusion of respondents. Individuals with 
symptoms were not involved in the generation of any of these questionnaire's items, 
so again it is not clear if the issues of relevance to patients were included. 
As shown in Table 24, the MHQ and PFIQ were informed by a review of existing 
urinary incontinence quality of life questionnaires, in addition to clinical expert 
opinion. This approach, however, assumed that the nature and impact of urinary 
and anal symptoms/incontinence were similar. A study that compared quality of 
life in women with urinary incontinence and women with both urinary and faecal 
incontinence concluded that, "faecal incontinence further reduces the functional 
96 
status and quality of life of women with urinary incontinence"284. While this may be 
related to a cumulative effect of additional symptoms it is possible that it is also due 
to other reasons. Adaptation of urinary incontinence questionnaires therefore does 
not necessarily capture the issues of relevance for anal incontinence. 
Validation studies of the above questionnaires are described in Table 25. Although 
prospective sensitivity to change testing was absent, evidence was published for the 
validity and reliability of each of the questionnaires in appropriate study 
populations in terms of the sample selected and reasonable sample sizes. It was not 
clear whether the content validity of the FIQL was assessed via face-to-face 
interviews or by postal administration, as used for testing of the MHQ. 
Misinterpretation of comments received by post is therefore a possibility and the 
valuable frank face-to-face discussion of questionnaire improvement is forfeited 
when replaced with written comments. However, a significant effort was made by 
the authors of the FIQL and MHQ to ensure that the instruments were 
understandable and able to be completed by potential respondents. 
Convergent validity comparisons with other proxy measures varied for each 
questionnaire. The FIQL and MHQ comparisons were made with generic health 
related quality of life measures with some weak correlations demonstrated (0.28- 
0.65). These poor results were to be expected, as the specific nuances of the 
condition-specific measure may not be detected using these global approaches. 
Bowel diaries were used as comparators for quality of life items in the PFIQ. This 
was not necessarily intuitive as the number of incontinence episodes may not relate 
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Internal consistency for each questionnaire was good, although Cronbach's alpha 
coefficient values of 0.91 and 0.96 for the FIQL and MHQ respectively, indicated a 
degree of overlap between their individual items, some of which could probably be 
removed. 
Exploration of the evidence for the stability of the FIQL was compromised by an 
initial response rate lower than expected for the second administration of the 
questionnaire. Fifty five participants (61 % of those approached) completed their first 
questionnaire when approached directly in clinic and only nine (10%) returned their 
second questionnaire by post within the specified ten to fourteen days. A further 
sample of sixty one individuals were, therefore, selected to repeat stability testing 
over the telephone, which was then analysed and found to have no significant 
difference between administrations. The use of the telephone for the follow-up 
questionnaire completion must be considered as the initial questionnaire, which was 
the comparator for the reliability analysis, was self-completed by symptomatic 
patients. In addition, the instrument was not designed for administration by a 
telephone researcher in the first instance, and the effects of social desirability when 
reporting symptoms of this nature through a mediator are potentially sizeable2 . 
Kwon et al' S286 study of the modification of the FISI for telephone administration 
found lower symptom severity scores reported by telephone than the written form. 
These results can only suggest, therefore, that the FIQL was reliable when self- 
completed at first administration and subsequently completed by a researcher, 
although it was designed for self-completion. 
As highlighted in Chapter Two (pp. 61), the use of correlation coefficients in the 
evaluation of stability for the MHQ and PFIQ could have misrepresented the 
agreement between paired responses reported at different time points. The 
coefficient of 0.81-0.92 reported as "very good" agreement, actually represents "very 
good" correlations between the paired responses even if subsequent responses are 
consistently different. Without analysis of actual agreement between the response 
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pairs, a potential user of the MHQ or PFIQ is unable to conclude whether this 
instrument is sufficiently stable for clinical use. 
Prospective evaluation of the ability to detect a change in quality of life status was 
not undertaken during the initial validation of the FIQL, MHQ or PFIQ. Published 
evidence is therefore not available. Several studies have since been published 
employing the FIQL as an outcome measure that have demonstrated its ability to 
detect change. Examples included surgery for incontinence of obstetric origin287, 
sacral nerve stimulator insertion and the SECCA procedure289, (delivering radio 
frequency energy to the anorectal junction). These were evaluated in populations of 
nine, fourteen and fifty participants respectively. Overall improvements in FIQL 
scores, and also improvements in specific domain scores, were detected in all three 
studies. The two studies that incorporated physiological measures, however, 
reported no significant changes in any of these parameters. This was as expected, 
given the data presented earlier regarding the poor relationship between symptom 
reports and physiological parametersm-289 (pp. 70-72). 
This evidence suggests that the FIQL may be an appropriate self-report measure for 
use in evaluating faecal incontinence. The decision to exclude flatus incontinence, 
however, meant that the FIQL was not applicable for individuals with anal 
incontinence, which was the aim of this study, given the prevalence and widespread 
risks of these symptoms. In addition, there was no certainty that the items included, 
albeit sensitive to change, were the most appropriate measures of the impact of 
these symptoms, due to the lack of patient involvement in the design of the FIQL. 
Holubar and Hyman sm study compared symptoms and quality of life using the 
FISI and FIQL, respectively, in patients after ileal pouch-anal anastomosis with age 
and gender matched controls following laparascopic cholecystectomy. FIQL scores 
for both groups were similar, although incontinence symptoms were more prevalent 
in the group of patients following ileal pouch-anal anastomosis. This may suggest 
that the impact of these incontinence symptoms are negligible, indeed equivalent to 
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the impact expected following laparascopic cholecystectomy. Alternatively, it may 
suggest that the question items included were not sensitive to the issues that cause 
impaired quality of life as a result of incontinence. 
Thus, the FIQL had several attributes required for a questionnaire assessment in this 
area, but it was lacking in several essential areas. 
3.4.4. Questionnaires for anal incontinence in specific 
patient groups 
The following questionnaires are available for the assessment of patients with 
altered bowel symptoms in specific populations: for the evaluation of surgical 
outcome, patients with prostate cancer, postpartum females, patients with a 
neurological cause for their symptoms and the older adults. Table 26 details the 
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These questionnaires were designed for specific patient populations and, with the 
multiple outcomes relevant to these populations, incontinence was not the primary 
concern in some cases273.274. For example, where outcomes relate to prostate cancer 
therapies274, incontinence forms only one of numerous potential side effects of 
interest, which include urinary and hormonal effects. 
Among these questionnaires, however, the Expanded Prostate Index Composite 
(EPIC)274, Post Partum Flatal and Fecal Incontinence Quality of Life scale (PPFI)27' 
and the Colorectal Functional Outcome questionnaire (COREFO)278, represented the 
only questionnaires in this review to have consulted patients in the derivation of 
items for inclusion in the instrument. This approach was more exploratory in nature 
than the content validity interviews that were conducted in studies described 
earlier, as these interviews did not involve commenting on draft questionnaires and 
allowed the individual to report their own feelings without being led in specific 
directions'52. 
The authors of the COREFO instructed individuals to comment on "stool related 
complaints" while Cockell's277 PPFI study involved one hour qualitative interviews 
to explore issues associated with bowel continence following childbirth. The value 
of this method was highlighted by the addition of the item that addressed 
"embarrassment" within the adaptation of the FIQL4 for women following 
childbirth. While the original FIQL reported a domain that addressed 
"embarrassment", the items included were: unawareness of leaking stool, worrying 
about others smelling stool on the individual and feeling ashamed. These issues are 
no doubt associated with embarrassment, yet the issue was not directly evaluated 
and, as identified by Cockell, "the FIQL is relevant to women with postpartum anal 
incontinence, but it did not include all important quality of life factors". This raised 
the question as to whether other important factors may have been overlooked for 
individuals in the general population as their opinions were not sought in the 
development of the original FIQL. 
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Flatus incontinence assessment was one of the primary aims of Cockell's PPFI, 
which required a rephrasing of the lead question. "Accidental leakage of gas and/or 
stool from your bowel" replaced the original question published by Rockwood et al, 
"Accidental bowel leakage". This supported the suggestion identified above that the 
FIQL in its unadapted state probably excluded individuals with flatus incontinence 
as a result of the phrasing used. 
A novel approach to assessment of the impact of faecal incontinence symptoms, 
suggested by Byrne et a1276, was the "Direct Questioning of Objectives" method. This 
involved individuals directly identifying their own objectives for improvement, 
enabling individualised assessment specific to a patient's needs. As recognised by 
the authors themselves, this method only identifies the issues of most importance 
and may omit other aspects of life that are being affected but constitute a lower 
priority276. This may be considered a strength of the approach, as it helps the 
individual to focus on the most important factors. However, it makes comparisons 
between patients and treatment strategies difficult as, although similar objectives 
were identified by different patients, there is no standardisation of the measurable 
outcomes. This method is probably more suitable for individual assessment over 
time153. 
Questionnaires such as the EORTC QLQ-C30293 and EORTC QLQ-CR382 , for the 
evaluation of quality of life in cancer trials and colorectal cancer-specific outcomes 
respectively, are not discussed in detail here as they were designed specifically for 
use in individuals with cancer. Similar issues to those included in the instruments 
described so far relating to incontinence were included, in particular those relating 
to colorectal cancers, such as "bothersome gas" and "unintentional release of 
stools". These instruments, however, were much more focussed on impact in 
relation to the cancer, as opposed to the impact of symptoms of incontinence more 
generally. For this reason many items were included that were unlikely to be of 
relevance to those without cancer. 
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Validation studies were not published for Hull's surgical outcome too1275 or 
Cockell's277 postpartum incontinence tool, although the intention was indicated in 
both publications, with Cockell's adaptation already included in an intervention 
trial, (no further details supplied). Byrne et al compared the "direct questioning of 
objectives" method with the existing St. Mark's score and Pescatori severity scales as 
its only form of validation. The improvement in designated objectives weakly 
correlated with improvement in severity scores (mean Pearson's correlation 
coefficient for all objectives: 0.354 for the St. Mark's score and 0.378 for the Pescatori 
scale)276. Validation studies for the remaining questionnaires were undertaken to 
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The questionnaires for specific patient populations contained in Table 27 have 
relatively high levels of validity and reliability. Missing data for completion of the 
COREFO was low (median average of one missing response) which is a good 
indicator of the acceptability of a questionnaire. In addition, 46% (n=45) of the study 
population that were recruited to compare the COREFO with the St. Mark's score 
and Hallbook's bowel function questionnaire, stated that they preferred this 
questionnaire in terms of reflecting their problems (n=23,24% preferred the bowel 
function questionnaire, n=8,8% preferred the St. Mark's tool and n=20,20% stated 
no preference). 
Content validity of the measures, through patient interviews, was undertaken with 
all the questionnaires except the EPIC274. Validity was further explored by 
examination of convergence with existing instruments or correlation with clinical 
impression. Convergent validity for the COREFO was reasonable (0.5-0.8)278 when 
compared with the bowel function questionnaire266. As the COREFO was derived 
from the bowel function questionnaire this would be expected and the use of this 
comparator is therefore questionable. Weaker results were exhibited for the EPIC 
(0.25-0.49) in convergence evaluations using the SF-12274. This was to be expected 
when using generic quality of life instruments, by comparison with condition- 
specific instruments, as they do not necessarily measure the specific facets of the 
symptoms being considered. The convergence of the EBSQ findings with the 
doctor's impression provided "good" agreement (weighted Kappa, 0.68), as one 
would assume that the clinician might focus on the specific considerations within 
their patient population in a similar manner to a condition-specific questionnaire273. 
Internal consistency was evaluated in both the COREFO and EPIC. Cronbach's 
alpha coefficient values of 0.9 and 0.92, respectively, indicated that the items related 
strongly to each other in measuring similar concepts, but may have indicated some 
redundancy among the items. Reliability was further examined for all the 
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questionnaires described in Table 27 through a test-retest analysis, with the 
COREFO and EPIC exhibiting excellent correlation coefficients between 
administrations of 0.93 and 0.84. The EBSQ demonstrated "moderate" agreement 
using the weighted Kappa statistic (0.65). 
None of these questionnaires for specific patient populations have undergone any 
studies of sensitivity to change and, therefore, their ability to detect change in 
symptom and quality of life status is unknown. As indicated above, these 
questionnaires were not useful in the assessment of anal incontinence because of 
their aims to assess specific clinical conditions. 
3.5. Use of questionnaires in studies of anal or 
faecal incontinence 
The level of use of the questionnaires in studies of anal incontinence was 
investigated in published outcome studies using the electronic database PubMed. 
Searches were limited to adult human studies and studies reported or translated 
into English, using the following MeSH search terms in combination: "fecal 
incontinence" (incorporated "faecal incontinence"), "treatment outcomes" and 
"questionnaires". Seventy three studies were identified, dating from November 1994 
to April 2008. Twenty two studies were excluded from this review (twelve were 
undertaken in children, two were questionnaire validation studies described earlier, 
one focussed on constipation only, one was not an outcome study, and data were 
not available regarding the questionnaires used within six of the studies). A further 
nineteen studies were identified through Cochrane Reviews of "Surgery for fecal 
incontinence in adults"5, "Methods of repair for obstetric anal sphincter injury"2, 
"Drug treatment for faecal incontinence in adults"2w and "Electrical stimulation for 
faecal incontinence in adults"m. These were considered to be of sufficient 
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methodological quality for review (one of which was already included above). Sixty 
nine studies were therefore included in this review (Table 28). 
Table 28 Use of questionnaires in studies of anal or faecal incontinence (n=69) 
Number of studies Number of studies Total studies 
that used that used study- using 
recognised specific or questionnaire 
questionnaires (n) modified evaluation 
questionnaires (n) 
Symptom 39259,290,299-335 18335-352 57 
assessment 
Quality of life 35259,290,3,303,304,306- 2332,351 37 
assessment 309,311-329,334,335,352-356 
Fifty seven of the sixty nine studies included questionnaire evaluation of symptoms. 
Thirty nine studies incorporated use of a recognised symptom assessment, such as 
the Cleveland Clinic Continence Grading scale, FISI or, in earlier studies, Park's 
severity score for example. The authors of eighteen studies had used outcome 
measures that were developed for the study specifically and, modifications of 
severity scales or unstandardised self report methods, therefore, no evidence of the 
measurement capabilities of these instruments was available. 
Looking at these studies in more detail, the use of questionnaires designed for 
individual projects was greater among the earlier studies. From the questionnaire 
design studies detailed above it was clear that the vast majority of available 
measures were developed since 2000. Using the year 2000 as an arbitrary cut-off, 
eleven out of the twenty five studies (44%) that were published during 2000, or 
before, used questionnaires or employed instruments designed specifically for the 
study purposes. In comparison, in the years following 2000, only nine out of sixty 
seven studies (13%) used questionnaires designed for the individual study, 
implying increased use of published questionnaires. This was encouraging, as it 
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indicated that researchers were willing to incorporate recognised instruments in 
preference to developing study specific measures. 
Thirty seven studies reported questionnaire assessment of quality of life, with all but 
two using recognised instruments. On further exploration, however, the 
instruments selected for use in fourteen of the studies were not specific to quality of 
life and offered only limited evaluation of this aspect, namely the Cleveland Clinic 
Continence Grading Scale that incorporated only one item on overall lifestyle 
alterationu9,3°°, 304'306-308,316,320-322,324,32ß, 334,33s. It must be considered that these studies 
span a thirty four year period and the importance of quality of life evaluation has 
only been recognised over more recent years. In total, thirty five studies used 
recognised questionnaires. 
The most frequently used questionnaires are displayed in Table 29. 
Table 29 Questionnaire selection in studies of anal or faecal incontinence 
Questionnaire Number of studies that used 
questionnaire 
Cleveland Clinic Continence Grading Scale 13 
FIQL 10 
St. Mark's Score 8 
SF-36 6 
EORTC modules 5 
FISI 4 
Park's seventy score 4 
Kei hle and Fielding severity score 2 
Pescatori severity score 1 
MHQ 1 
The Cleveland Clinic Continence Grading Scale was the most widely used 
instrument among the research studies reviewed. The studies largely used the FIQL 
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in combination with either the Cleveland Clinic scale or the FISI to provide a 
symptom and quality of life evaluation. The use of both the Cleveland Clinic score 
and the FISI provide the means to assess flatus incontinence, whereas the FIQL 
reflects the impact of faecal incontinence on quality of life (excluding flatus 
incontinence). It is necessary to consider the use of these questionnaires. Published 
results can imply the evaluation of flatus incontinence, although this is beyond the 
scope of the FIQL, by simply reporting individual symptom outcomes and overall 
quality of life outcome results317. That flatus incontinence is often reported from a 
symptomatic perspective suggests the importance of this aspect in evaluation of 
outcome. In the absence of a quality of life instrument that can measure the effect of 
flatus incontinence, the FIQL is used. Further support is therefore provided for a 
robust evaluation of the impact of anal incontinence. Indeed one of the main 
conclusions reported by the Cochrane review for methods of repair for obstetric anal 
sphincter injury was that: 
"outcome measures of future trials need to address quality of life issues that are 
important and meaningful to women... however, at present there are no validated 
questionnaires to assess the quality of life affected by anal incontinence during day-to- 
day activity ". 2% 
3.6. Conclusion 
A number of existing published measures were identified that provided some 
assessment of anal incontinence. These ranged from physiological measures 
providing data on clinical variables, to clinician-completed severity scales used for 
the quantification of incontinence episodes, through to self-completion 
questionnaires that varied in their level of assessment of anal incontinence and 
resultant impact on quality of life. There was no conclusive evidence for the value of 
physiological tests for the assessment of anal incontinence per se but their clinical 
utility was evident with regard to anatomical detail, in particular when considering 
further treatment. 
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The development of measurement tools within this area has grown over recent 
years as has their inclusion in outcome studies. Symptom and quality of life self- 
report questionnaires were available with varying levels of published evidence 
about robustness. Examining the merits of the various questionnaires showed an 
overall lack of psychometric validation, which is necessary to provide the robust 
data needed to place confidence in the instruments. In particular, the lack of 
prospective sensitivity to change data in the incontinence-specific quality of life 
questionnaires was noted as a significant limitation and a priority for this study 
developing the ICIQ-B. However, it should not be assumed that because the 
evidence was not published it did not exist. Complete detailed reporting of the 
properties of questionnaires in either development or intervention studies is 
notoriously poor, yet vital to the interpretation of the outcomes reported153. The ICI 
review highlighted that none of the available instruments had sufficient evidence of 
their psychometric properties to enable recommendation in the highest category, 
grade A. In summarising their findings the committee suggested that, 
"the assessment of anal incontinence is still developing and researchers are 
encouraged to raise the standard of outcome assessment"153,262. 
The NIH state of the science conference for the prevention of urinary and fecal 
incontinence concluded in particular that, "studies of burden were limited by the paucity 
of validated instruments measuring quality of life". 
A limiting factor for many of the available questionnaires was the lack of patient 
input in their generation. This may mean that issues of importance to patients that 
may serve as more sensitive indicators of condition status, particularly with regard 
to quality of life, were missed. Some questionnaires incorporated quality of life 
assessment in very general terms, to encompass impact on physical and social 
activities, while other questionnaires had endeavoured to capture pertinent 
elements that were specific to anal incontinence symptoms, such as awareness of 
toilet location. Only three of the questionnaires that were validated for use in 
114 
specific-populations274,277 278 were based on the individual's perspective of the 
impact that anal incontinence has on their quality of life. 
As ientified by Cocke11277, the FIQL, the most widely used outcome tool for faecal 
incontinence quality of life evaluation, did not capture all elements of importance in 
a population of postpartum females. There may be other pertinent issues that may 
also have been omitted within the original FIQL due to the absence of patient 
contribution in its design. In addition, the FIQL required adaptation to incorporate 
flatus incontinence in Cockell et al's study, and as Norton and Chelvanayagam357 
commented, 
"Incontinence of flatus may appear a trivial symptom, but many people who are 
unable to control the passage of flatus, experience embarrassment in work, social, or 
intimate situations". 
This review also highlighted the importance of understanding the relationship 
between symptoms and impact on quality of life and the need to assess both within 
the proposed new questionnaire. Physiological measures are able to detect 
physiological abnormalities but these do not reflect the patients' experience of 
symptoms or the impact those symptoms impose and therefore cannot indicate 
severity for a given individual, or its improvement or deterioration. Rockwood et 
a1248 looked further at the relationship between symptoms and their perceived 
severity and found that there was also not a linear relationship between frequency 
or type of incontinence episodes and severity. There is inevitably a subjective 
element of interpretation that reflects the perspective of the individual performing 
the evaluation. Further support was evident in Bordeianou et al's study using the 
FISI and FIQL assessments to evaluate symptom correlation with quality of life in 
patients with faecal incontinence. Only weak to moderate negative correlations 
between symptoms and quality of life were detected which led the authors to 
conclude, and the Standards Committee of the American Society of Colon and 
Rectal Surgeons257 to comment, 
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"even though this supports the common assumption that the quality of life in 
patients with faecal incontinence worsens with an increase in disease severity, it also 
stresses the need of measuring both variables to determine the true impact of any 
treatment". 
It can therefore be summarised that a validated questionnaire for the comprehensive 
assessment of anal incontinence symptoms and their impact on quality of life for use 
in men and women was lacking. Modifications, or further validation of existing 
instruments that appeared to have demonstrated encouraging results, was not 
considered feasible, given their major limitations: most had not included the 
patients' perspective and only half had included flatus incontinence. In addition, the 
majority of symptom-specific questionnaires had been developed for use in women 
only. In-depth qualitative studies were required to provide a scientific foundation 
for any suggested modifications to currently available questionnaires and, in doing 
so, it was anticipated that the information generated would identify such changes 
that a new questionnaire would need to be developed, as evidenced in Chapter Six. 
Also, of critical importance, was the fact that the published literature recognised the 
lack of a quality of life instrument in this area. The NICE guideline for managing 
faecal incontinence highlighted that adequate measures did not currently exist220, 
the Third ICI recognised that this was still a developing area for anal 
incontinence153,262 and the NIH state of the science conference concluded that there 
was a paucity of validated instruments measuring quality of life2. 
Some qualitative research and quantitative data using generic quality of life 
evaluation has been reported to indicate the specific impact of symptoms of anal or 
faecal incontinence. These broad areas will be considered in the next chapter, after 
the theoretical issues relating to the concept of quality of life are described. 
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CHAPTER FOUR: QUALITY OF 
LIFE IN ANAL INCONTINENCE 
Introduction 
This Chapter will discuss the concept of quality of life and what it means in general 
terms before exploring the literature with regard to impact for individuals with anal 
incontinence specifically. Exploration of the evidence in this area was expected to 
provide a theoretical framework from which potential question items could be 
considered for inclusion in the ICIQ-B. Although few in number, qualitative studies 
are detailed. These were more likely to indicate the subjective areas of concern that 
studies employing more generic measures of quality of life impact may have missed. 
The quantitative studies that used generic measures are also described, in order to 
give an overview of the impact of these symptoms, to provide broad themes for 
consideration in the ICIQ-B. 
4.1. "Quality of life" and its assessment 
Quality of life assessment has evolved considerably over recent decades359, in part 
due to the recognition of the importance of understanding the impact of healthcare 
interventions on peoples lives' and not just their symptom profile, in chronic 
conditions360. Early estimations of quality of life were initially made by means of 
variables such as the Gross National Product, which was essentially an inference 
made from an economic assessment of whole populations, described as the "state of 
states"170. An opposing perspective encompassed a more individual assessment of 
subjective experiences, providing an index of the "state of persons"170. Although 
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based more on individuals, this "state of persons" incorporated the impact of 
variables not directly related to health status, such as environmental factors and 
subsequent standard of living, and attitudes such as happiness and satisfaction361. It 
therefore remained broad in nature. 
Health-related quality of life (HRQOL) is increasingly incorporated in studies of 
health outcome and is of particular importance when considering anal incontinence, 
due to its symptomatic nature362. A full understanding of the term HRQOL relies on 
an objective definition of quality of life, which is notoriously poorly defined as 
commented by Farquhar (1995), 
"many studies of quality of life have either avoided defining what they purport to 
measure or have limited their definitions to what the authors have seen as large 
components of the whole concept". 363 
Comprehensive detailed objective definitions have developed in recent years to 
acknowledge the multifaceted nature of the concept362, with the World Health 
Organisation (WHO) proposing that quality of life is, 
"an individual's perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, standards 
and concerns. It is a broad ranging concept, incorporating in a complex way 
individuals' physical health, psychological state, level of independence, social 
relationships, personal beliefs and their relationships to salient features of the 
environment. "365 
Whilst it is suggested that "quality of life" in particular is the most inconsistently 
used term in human sciences and confusion remains with this elusive concept367, 
this definition provides some appreciation of the important components. Consensus 
is achieved among authors that quality of life is subjective, giving rise to the 
inconsistencies associated with this conceptl53,359363368. 
HRQOL is more specifically defined as, 
"attributes valued by patients including their resultant comfort or sense of well- 
being; the extent to which they are able to maintain reasonable physical, emotional 
and intellectual function; the degree to which they retain their ability to participate in 
valued activities within the family, workplace and in the community. "369 
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As the above definitions suggest, quality of life is composed of varying elements 
and is further complicated by individual expectations, which are particularly 
important in the context of health-related quality of life. Some have acknowledged a 
"disability paradox" to describe individuals who, despite being very ill, complain 
very little in comparison to those who are not so unwell and yet complain a lot370. 
Similarly, there are difficulties in quantifying quality of life for those experiencing a 
short happy life compared with a long miserable life170. The influence of personal 
expectations is highlighted in these examples and reinforces the fact that quality of 
life is a highly personal construct that can mean very different things to different 
people - "it is whatever it is to a given individual at any given time"170. The 
objective measurement of quality of life is consequently very difficult. 
Different types of self-completion questionnaires have emerged to assess HRQOL, 
each of which possesses its own merits and limitations371: 
o Global measures - These typically incorporate more simple and general 
parameters, and are inadequate for more sophisticated hypothesis testing, 
but are useful in characterising and describing populations, eg. census. 
o Generic measures - These instruments offer a more detailed assessment of 
the various quality of life domains but are still not specific to a particular 
condition or disease area, therefore lack sensitivity to changes in individual 
conditions151. They are useful for comparing different populations or diseases 
eg. SF-36372, EuroQol-5D37 . 
o Disease-specific measures - These measures are designed to address 
condition-specific issues and are subsequently generally more sensitive to the 
changes in the status of a given condition or the effects of its treatment over 
time, eg. Fecal Incontinence Questionnaire267, FIQL4. 
Generic measures are not able to assess condition-specific nuances exhibited by 
patients and, as discovered in Chapter Three, many of the existing questionnaires 
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potentially omit key concepts that are very specific to anal incontinence. The 
development of a disease-specific questionnaire was therefore considered most 
useful for this study in terms of sensitivity of assessment for individuals with anal 
incontinence. 
4.2. The impact of anal incontinence on quality of 
life - the qualitative approach 
As discussed above, quality of life reflects an individual's perception of their life 
situation which is very particular to that person. In order to fully explore the impact 
of anal incontinence on quality of life, some qualitative studies have been 
conducted, albeit few in number. 
Collings and Norton374 conducted semi-structured interviews with 20 female 
patients who presented with faecal incontinence to a specialist tertiary referral 
centre in the UK, to explore the psychosexual and psychosocial effects of faecal 
incontinence. Individuals were interviewed face-to-face (n=14) or over the telephone 
(n=6). Similarly, Wilson3" conducted interviews with twenty two adult males and 
females with faecal incontinence, in order to find out how this affected their lives. 
Interview content underwent thematic analysis and a dynamic continuum was 
identified from Wilson's study that described attitudes, experience and adaptation. 
One pole of the continuum that described "overwhelmed" individuals was 
characterised by increased negativity, stigmatisation and impact on QOL. Taking 
control and adaptation to life with faecal incontinence facilitated movement along 
the continuum to the opposite pole signifying improved mood and QOL, described 
as "approaching mastery "376. Collings and Norton identified aspects that may be 
considered to determine placement on Wilson s continuum. Themes, predominantly 
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negative issues associated with symptoms, were identified and are displayed in 
Figure 6. 
Figure 6 Negative issues reported by individuals with faecal incontinence 
(n=20)374 
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Fear of incontinence, shame and embarrassment appeared to be key areas of concern 
in this group of patients, as supported by Wilson's findings: 
"1'm usually with my muni or my sister, you know, if I do go out into town. 
Probably because if anything does happen you're not as embarrassed if there is 
somebody with you. " 
Inability to control bowels was a distinct difficulty identified through Wilson's 
interviews with participants "personifying" their bowels or faeces as an external 
entity; 
"I can be fine then all of a sudden it just bursts into life. " 
"1 didn't get to the toilet it came from nowhere. " 
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The consequence of lack of control was further described through discussions held 
at a psycho-educational support group initiated for women with faecal incontinence 
of obstetric origin, reporting limited benefit from their previous biofeedback 
programme377. The group of five women met monthly for eight months for an 
educational session facilitated by two nurse specialists, and through group 
conversation described disempowerment and reduced self-esteem as a consequence 
of anal incontinence. Primarily this was due to the unpredictable nature of this 
condition, the lack of control over symptoms and the efforts made by patients to 
hide their condition. This alluded to the coping strategies described by Collings and 
Norton, devised by individuals in an attempt to minimise or take control of their 
symptoms (Table 30). 
Table 30 Coping strategies described by individuals with faecal incontinence 
(n=20)374 
Strategy Number of participants 
Restricting activities 6 
Working as a distraction 6 
Denial 5 
Awareness of toilet location when out 5 
Pads 5 
Counselling 3 
Care of diet/fasting 3 
Using medication 3 
Separate bedrooms 3 
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These coping mechanisms were also reported in the psycho-educational support 
group, in addition to a "safety zone", in which participants claimed they were able 
to travel without fear of experiencing symptoms. The anxiety caused by travelling 
outside of this safety zone, however, tended to precipitate heightened bowel 
activity. Less common strategies such as requiring privacy in the bathroom, moving 
to a new home, careful selection of clothes and carrying spares, controlling 
occurrence of sex, and getting a new job were mentioned by only one or two 
participants374. This illustrated the individuality of the pattern of coping 
mechanisms, dependent on the nature of individual symptoms. All of these 
strategies were considered influential in promoting adaptation to faecal 
incontinence, encouraging positive adjustment and favourable progression along 
Wilson's continuum375. 
Personal support structures were important, particularly when considering 
symptoms of a taboo nature, and subsequent attitudes and adaptation. Collings and 
Norton found that support was predominantly provided by family members. 
Twelve participants reported support from partners and twelve from children, with 
friends and other family members accounting for eight and four respondents 
respectively. The participants in the support group reported considerable relief at 
being able to disclose their symptoms to others in the group in a "safe" environment 
without fear of embarrassment or stigmatisation378, reflected in the following 
comments: 
"It has had a great positive psychological effect". 
"To realise that you are not alone with incontinence is liberating and to discuss 
problems with people who understand totally what you are experiencing is very good 
for your psychological well being". 
Empowering patients through their realisation that they are not the only one 
experiencing these symptoms, and enabling them to place trust in healthcare 
professionals, is central to encouraging patients to reveal their symptoms. This is 
123 
particularly significant when only one participant cited the hospital as a source of 
support in the earlier study374, suggesting that methods of disclosure and 
encouragement of the "safe" environment may require attention in healthcare 
settings. A number of participants commented on having experienced positive 
outcomes (in the form of unexpected support) from partners and friends despite 
their fear of rejection, when individuals had been forced to reveal their symptoms 
due to an incontinent event377. In the same manner, none of the participants in 
Wilson's study mentioned any negative responses from others and described 
strangers showing understanding and attempting to quell embarrassment in the 
event of a public "accident". 
While these were relatively small studies, among self-selecting individuals, the use 
of in-depth interviews enabled the authors to explore patients' experiences of their 
symptoms and thereby identify areas perceived to be of particular importance to the 
individuals themselves. 
Further studies with qualitative elements have been conducted in more specific 
patient populations. As described earlier in the review of available measures, Byrne 
et a1276 recruited 118 participants with faecal incontinence as a result of pudendal 
neuropathy. These patients were asked to identify important aspects of their life 
affected by faecal incontinence that they would like improved. Participants were 
then asked to assign grades of importance (between 0 "least important" and 10 
"most important") to each objective to form the basis of treatment evaluation in a 
randomised controlled trial of biofeedback. The most commonly reported objectives 
related to ability to shop and socialise outside the house, without worrying about 
toilet location (34% of all objectives). Improvement in psychological parameters, 
such as self-esteem, embarrassment and the feeling of loss of self-control, was the 
second most frequent category (15% of all objectives). The categories graded as most 
important were family and relationships (average importance ranking 9.0) and 
job/work (average importance ranking 8.9), which only accounted for 8% and 5% of 
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the overall objectives respectively. "Getting out of the house" and psychological 
objectives followed closely, with average rankings of 8.2 and 8.4 respectively. Of 
least importance was "exercise and walking" (average grade 7.8,9% of objectives). 
Conversely, Rizk et al's103 study of females with faecal incontinence in the United 
Arab Emirates (UAE) described the main inconvenience as interference with 
praying (92%), feeling disgusting and dirty (84%) and feeling self-conscious, 
ashamed and embarrassed (76%). Fewer comments were made about the inability to 
have sex (43%), limited social activities (27%) and difficulties with physical 
activities, housework or job (20%). While there were similar issues identified in 
these studies, the emphasis placed on issues was almost reversed between the study 
populations. More emphasis was placed on the practical restrictions within Byrne's 
study while more emotive inconvenience emerged from Rizk's investigation. This 
highlighted the complicated nature of the impact of anal incontinence in the context 
of societal norms and altered personal expectations. In stark contrast to Colling's 
and Norton's findings, not one of the 500 UAE women had discussed their 
symptoms with their husband, indicating the differences in perceived sources of 
support in these two populations. This is most likely due to cultural differences 
between the populations, but also reflects the complexity of the impact these 
symptoms can impose. 
Rizk et al's study was primarily designed to explore barriers to healthcare seeking 
behaviour among clinic and community adult females (Table 31). Of the 11.3% 
(n=51) of women identified with faecal incontinence in the previous year (random 
selection in the community and consecutive selection in a clinic population), only 
41.2% (n=21) had sought medical advice. 
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Table 31 Barriers to seeking healthcare reported by UAE females with faecal 
incontinence (n=51)103 
Barriers to seeking healthcare Number of females with incontinence 
Embarrassment 32(64.7%) 
Male physician 28(54.9%) 
Prefer to discuss with friends/family 
as may resolve sntaneousl 
24 (47.1%) 
Presumed normal in old age 16(31.3%) 
Belief in self-treatment, as low 
expectation from medical management 
12 (23.5%) 
Continent women reported similar reasons if they considered themselves becoming 
incontinent, in approximately the same proportions to those with incontinence, 
although it is unclear whether these categories were suggested by interviewers or 
emerged spontaneously. 
An unusual appraisal of the impact of anal incontinence can be inferred from 
Norton s379 study of sixty nine self-selected patients (eleven males and fifty eight 
females) who underwent colostomy formation to manage their incontinence. 
Measurement instruments were used and supplementary qualitative data were also 
sought. This study uniquely offered retrospective insight into these experiences of 
faecal incontinence, reflecting individuals' perspectives following treatment success 
or treatment failure. Restriction caused by the stoma was reportedly "quite a lot" or 
"a great deal" for 17% of participants, and the reasons given were similar in nature 
to the restrictions reported in previous studies of those with faecal incontinence: 
being conscious of toilet locations, travel restrictions, feeling self-conscious about 
noise or smells and the possibility of bag or continued anal leakage374,3aß, 276,103. 
When asked to recall restrictions on their lives imposed by their poor bowel control 
prior to the formation of their stoma, many in Nortons study reported that their 
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lives focussed around the toilet and that some were virtually housebound. 
Restrictions to social, personal and work life were also common. Five individuals 
described their lives with faecal incontinence as a "nightmare" and other comments 
included, 
"I absolutely hated myself. 
"Sheer hell ". 
The study found just over half of the participants (66%) would definitely have a 
repeat stoma given the choice and 80% would definitely or probably have a repeat 
stoma, perhaps highlighting the severe nature of the impact caused by faecal 
incontinence. 
Nancy J. Norton0 summarised the impact of living with faecal incontinence from a 
more personal perspective, as a sufferer herself, and the founder of the International 
Foundation for Functional Gastrointestinal Disorders (IFFGD). Norton proposed 
that a supportive environment, such as that offered by the IFFGD, afforded 
individuals the opportunity to unburden themselves of secrecy and shame as put 
forward by Chelvanayagam and Mott377, whilst also being able to learn practical 
strategies to cope with this disorder. Norton remarked, 
"People with faecal incontinence differ widely in backgrounds and other demographic 
factors, but there is a common denominator: the disorder affects nearly every aspect of 
their daily lives. These individuals are attempting to manage bodily processes that 
cannot be controlled. The cost is loss of confidence, self-respect, modesty and 
composure. " 380 
Norton underlined the difficulties of living with these symptoms: 
"For some people with this disorder it is difficult to walk out the front door. " 380 
From the qualitative studies detailed above, common themes can be identified that 
impose a considerable impact on the quality of life of people with faecal 
incontinence. Patients reported substantial emotional burden caused by the fear, 
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shame and embarrassment associated with faecal incontinence. Fear of the reactions 
of others was also important. Individuals with incontinence also frequently 
employed coping mechanisms to enable them to function as "normally" as possible 
in their daily lives, potentially masking the severity of their symptoms. Studies of a 
more quantitative nature provide support for these findings. These will now be 
discussed. 
4.3. Emotional impact 
Embarrassment, low self-esteem and feelings of loss of control were reported in the 
qualitative studies and were a frequent observation in non-research literature, such 
as editorial comments, reviews, and case histories'-6.229-380-388. To explore the 
emotional implications of anal incontinence, several studies have been conducted 
employing generic quality of life measures that evaluated related psychological and 
mental components. While the studies used rather general parameters to elicit the 
presence of faecal incontinence, "incontinence of stool" and "problems controlling 
stool", the existence of effects on the participants' psychological status is evident 
(Table 32). Generic measures are not designed to detect the specific nuances of 
impact caused by certain symptoms. However, the findings below suggest that there 
were emotional and psychological effects incurred through symptoms of anal 
incontinence that were detectable in the most general terms. The studies were not 
without limitations, as most were conducted with patients who had already sought 
healthcare which may be an indication of increased severity of symptoms. 
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Table 32 The emotional impact of anal or faecal incontinence 
Country Population Measures used Findings 
USA 280 consecutive Symptom checklist 90 Reduced quality of life in 
Crowell et al gastroenterology - Revised individuals with incontinence 
(2007)389 outpatients QoL measure - compared to those without. 
Institution standard Increased psychological distress 
assessment in individuals with incontinence 
Unnamed bowel compared to those without. 
symptom 
questionnaire 
USA 502 consecutive SF-36372 Reduced scores for "emotional 
Bordeianou et patients with faecal role", "mental health" and 
al (2007)358 incontinence "social functioning" in 
individuals with incontinence 
compared with age and sex- 
matched US population 
P<0.001 
The 259 consecutive EQ-5D 2 Proportion of patients reporting 
Netherlands patients with faecal anxiety/depression increased 
Deutekom et al incontinence with increasing severity of 
(2005) incontinence (P=0.037) 
Sweden 4277 adults aged 75 SF-12 Reduced scores for "mental role 
Stenzelius eta! years or over living limitation", "social functioning" 
(2004)116 in the community and "vitality" for individuals 
or residential home with both faecal and urinary 
setting incontinence compared with 
those with urinary incontinence 
alone (P<0.0001) 
USA 425 urology and SF-12393 Reduced scores for "mental role 
Fialkow et al urogynaecology limitation", "social functioning" 
(2003)2M outpatients and "vitality" for individuals 
with faecal incontinence 
compared to urinary 
incontinence alone P 0.032 
Two prevalence studies also attempted to ascertain the impact on quality of life in 
UK community-dwelling adults aged 65 years or overl10 and primiparous women in 
Quebec six months after childbirth137. Standardised questions for the assessment of 
psychological wellbeing in the older adults394 were used to compare those with 
incontinence and those without, in the UK older adult study, while the Fecal 
Incontinence Quality of Life Scale (FIQL)4 was employed in Quebec. Psychological 
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impact was noted in both studies with a four-fold increase in anxiety and five-fold 
increase in depression in older individuals with incontinence, compared to those 
without (20% vs. 5% and 15% vs. 3% respectively). Significantly reduced self-esteem 
in women with anal incontinence following childbirth was also noted (P=0.037). The 
findings from the study following childbirth should be interpreted with caution, 
however, as 45% of potential respondents did not reply. 
The emotional impact of anal incontinence must, therefore, be considered in any 
evaluation of these symptoms. 
4.4. Functional impact 
As demonstrated in the qualitative studies above276,374,377, faecal incontinence can 
interrupt the ability to conduct daily activities. Patients devised and employed 
various coping mechanisms in attempts to prevent or manage their symptoms and 
to minimise disruption to their lives, with most individuals reporting restriction of 
activities to reduce the likelihood of an incontinent episode374377. Cavanaugh et al, 
(2002)395, in their study of patients following a fistulotomy procedure, found that 
64% of patients experienced incontinence (n=59), of whom nearly a quarter reported 
restrictions to their life: 14% reported "mild" restrictions, 10% reported "moderate" 
restrictions. 
As with the evaluations of emotional impact, studies that employed generic health 
related quality of life measures were conducted to estimate the effects caused by 
anal incontinence on physical or daily function (Table 33). 
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Table 33 The functional impact of anal or faecal incontinence 
Country Population Measures used Findings 
USA 280 consecutive Symptom checklist 90 Increased interference with 
Crowell et at gastroenterology - Revised390 daily activities in individuals 
(2007)389 outpatients QoL measure - with incontinence compared to 





USA 502 consecutive SF-36372 Reduced scores for "physical 
Bordeianou et patients with faecal functioning" (P<0.05) and 
at (2007) incontinence "physical role" (P<0.0011) in 
individuals with incontinence 
compared with age and sex 
matched US population 
The 259 consecutive EQ-5D392 Proportion of patients reporting 
Netherlands patients with faecal disturbance to usual activities 
Deutekom et al incontinence increased with increasing 
(2005)391 severity of incontinence 
(P<0.001). 
Sweden 4277 adults aged 75 SF-12 Reduced scores for "physical 
Stenzelius et at years or over living role limitation", "physical 
(2004)116 in the community functioning", "bodily pain" and 
or residential home "general health" for individuals 
setting with faecal/ urinary 
incontinence or both compared 
with those without incontinence 
(P<0.0001) 
No difference in impact 
between types of incontinence 
USA 425 urology and SF-12393 Reduced scores for "physical 
Fialkow et at urogynaecology role limitation", "physical 
(2003)04 outpatients functioning", "bodily pain" and 
"general health" for individuals 
with faecal incontinence and 
urinary incontinence (P=0.027) 
No difference in impact 
between urinary or anal 
incontinence 
The impact of anal incontinence on physical activities was clear from the above 
studies. Reduced scores for those affected were reported in domains such as 
"physical function" and "physical role", in studies that compared individuals with 
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and without incontinence116.358.389. Deutekom et al also reported increased 
disturbance of activities with increased incontinence severity391. Fialkow et al found 
that physical component scores did not differ between those with urinary and faecal 
incontinence. Those with both, however, were significantly more affected 
(P=0.027)x. 
As identified in the qualitative literature, the more specific daily functional issues 
that were not identified in the studies using generic quality of life measures were 
preferences to remain near a toilet and 
. always endeavouring to locate the nearest toilet276,374,377,379,380. 
A "length of tether to the toilet"1 has been described whereby individuals ensure 
they are close enough to a toilet to allow them to retain some degree of safety. 
Comments have been made that poor public toilet facilities often restrict people 
with continence problems from venturing further afield137,3%. 
Efforts focused on "dealing with the inevitable" were supplementary to coping 
strategies, devised to minimise the occurrence of incontinence. Containment of 
incontinence with the use of protective pads or nappies was a "management" 
strategy described by 8%395 to 37%103,126 of those with anal incontinence. Frequent 
washing (53%) and regular changing of underwear (49%) was also reported in about 
half of individuals affected, in the study conducted in the United Arab Emirates103. 
4.5. Impact on sexual relationships 
Three studies that evaluated the impact of faecal incontinence on sexual 
relationships were identified; two qualitative investigations and one community- 
based population survey374.103' 39'. Collings and Norton, (2004)374, reported that six 
(30%) of twenty women who were interviewed about their faecal incontinence 
reported a lack of sexual arousal and desire, whilst seven women (35%) stated their 
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symptoms were only a problem if incontinence happened during intercourse. Rizk 
et al (2001)103 similarly reported that 43% of women with faecal incontinence said 
that the inability to have sex was a significant consequence of their faecal 
incontinence. Finally, a survey of community-dwelling adults in Germany reported 
a marked effect on sexuality397, although further detail was not available. Miner 
(2004)381 commented that effects on sexuality occur due to psychological inhibitions 
and the need to manage incontinence during intercourse. These conclusions, 
however, were extrapolated from the experience of patients with urinary 
incontinence. 
4.6. General impact on quality of life 
Parks249 described living with faecal incontinence: 
"The plight of a patient with frank faecal incontinence is a very unhappy one indeed. " 
The above studies put this statement in context, with regard to specific aspects of 
living with faecal incontinence, and several further studies have attempted to 
capture the overall impact of faecal incontinence. Perry et al's93 community-based 
prevalence study of individuals aged over 40 years, reported 51 % of those with 
major incontinence experienced "a lot" of impact on their quality of life. "A lot" of 
impact was also reported by 16% of those with minor incontinence providing 
further evidence of the individualised nature of the effect on quality of life. These 
findings support earlier comments that impact is not necessarily dependent on the 
level of symptoms and require that both variables are assessed to evaluate anal 
incontinence. 
Two studies were conducted to identify a threshold of faecal incontinence severity 
that had an impact on quality of life. Rothbarth et al's study was undertaken in a 
sample of Dutch women undergoing anterior sphincter repair following obstetric 
injury. Damon et al's study included patients who experienced either constipation 
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or faecal incontinence398. Both studies used the Gastrointestinal Quality of Life Index 
(GIQLI)2M with the addition of the SF-20 in the study of women undergoing anterior 
sphincter repair. A response rate of 91 % was achieved in both studies (n=32W and 
n=157398) and reports of losing stool more than once per week was considered to 
impact adversely on quality of life within Rothbarth et al's study. Damon et al were 
unable to discern a symptom cut-off to indicate an increased impact on quality of 
life and recommended instead the need for systematic exploration of quality of life 
impact. Both studies demonstrated lower GIQLI scores in those with faecal 
incontinence by comparison with individuals without symptoms. This indicated 
increased impact on quality of life caused by incontinence (Table 34). 
Table 34 GIQLI mean scores in studies of symptomatic individuals in 
comparison with unaffected individuals 
Population Sample size Mean GIQLI score 
(n) (lower score indicates increased 
impact on QoL 
Unaffected individuals264 168 125.8 
Women following anterior 32 105.0 
sphincter repair for obstetric 
injury386 
Individuals with faecal 157 86.8 
incontinence398 
Sailer et a1399 used the GIQLI to compare quality of life in individuals with differing 
anorectal conditions to establish which caused the greatest impact for the 
individual. Three hundred and twenty five consecutive German patients who 
attended a proctology outpatient clinic (182 male, 143 female, mean age 49 years) 
completed the questionnaire. Lower GIQLI scores indicated greater impact on 
quality of life and faecal incontinence along with severe constipation were found to 
cause the greatest impairment (Table 35). 
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Table 35 GIQLI mean scores for populations with different anorectal 
conditions (n=325)399 
Diagnosis Sample size 
(n) 
Mean GIQLI score 
(lower score indicates increased 
impact on QoL 
Faecal incontinence 35 93 
Severe constipation 14 94 
Anal fissure 38 104 
Symptomatic rectocele 12 112 
Perianal abscess 7 115 
Miscellaneous conditions 
eg. skin tags, rectal 
of s 
94 117 
Fistula in ano 22 119 
Haemorrhoids 96 120 
Perianal thrombosis 7 129 
A comparison was also undertaken between the mean score for those with faecal 
incontinence in Sailer's study and an age-matched sample of healthy volunteers 
involved in development of the original GIQLI. Sailer reported a significantly lower 
mean score in those with faecal incontinence compared to the healthy volunteers (93 
vs. 121, P<0.0001)1. 
4.7. Reluctance to report symptoms 
Given the substantial limitations inflicted on individuals with anal incontinence it is 
perhaps surprising that the literature249''O"3 and findings from the qualitative 
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studies described above indicated a general reluctance among patients to report 
symptoms of faecal incontinence103. In contrast, though, patients demonstrated relief 
when given the opportunity to disclose their symptoms in a supportive 
environment37". The nature of symptom disclosure is explored here to establish 
what is known about encouraging patients to reveal their symptoms, which will be 
crucial in providing a useful and accurate assessment tool. 
Evidence suggests that anywhere between 11% and 54% of the individuals studied 
with faecal incontinence had not discussed their symptoms with a health 
professionalu°'404' 0,119. Johanson and Laffertyl26 found that out of 881 individuals 
attending a primary care clinic or a gastroenterologist, only 34% of those with faecal 
incontinence had discussed their symptoms with a doctor. On further analysis it 
was shown that 48% of individuals had discussed their symptoms with a 
gastroenterologist, compared with 21 % who had talked with a primary care 
clinician. This suggested that patients with faecal incontinence were more likely to 
discuss their symptoms with a specialist in this field. The motivation for this 
disclosure was not explored but could indicate that those attending 
gastroenterologists had more severe symptoms or perhaps were more overt in their 
discussions due to a pre-existing disorder. 
Similarly, Leigh and Turnberg6 found that thirty nine (51 %) of seventy six patients, 
presenting to a gastroenterologist with diarrhoea, were also experiencing problems 
with faecal incontinence. Only 19 (49%) of those individuals spontaneously 
volunteered this information with the remainder requiring more direct probing, 
suggesting that patients may perceive "diarrhoea" to be a more acceptable symptom 
to present to a doctor. 
Boreham et alu9 went on to investigate further the extent to which healthcare 
professionals raised this subject with their patients. Edwards and Jones reported 
that 28% of affected individuals who had not discussed their symptoms with a 
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healthcare professional would like to do so, which perhaps indicates the difficulty 
patients experience initiating disclosure, as opposed to the actual discussionil0. As 
many as 107 (83%) of 130 women with anal incontinence in Boreham's study 
reported that they had not been asked about the presence of anal incontinence 
symptoms during an appointment at a North American general gynaecology 
clinicn9. 
Recommendations have been made for more concerted efforts from healthcare 
professionals to explore the existence of symptoms of faecal incontinence in 
individuals at risk"0.126'401'405. In particular the introduction of the National Institute 
for Clinical Excellence (NICE) guideline for managing faecal incontinence in 
adults2° suggests 
"healthcare professionals should actively yet sensitively enquire about symptoms in 
high risk groups". 
This is of particular importance in primary care as, for affected individuals in the 
UK, the GP is likely to be the first point of contact for accessing healthcare and, as 
reported by Johanson and Lafferty, barriers to discussing these symptoms in 
primary care may already exist126. It has been commented that encouraging 
disclosure of these symptoms is essential to promote early identification and 
subsequent intervention, thereby improving treatment outcomes and improved 
quality of life0"406. 
The method of enquiry must then be considered. Khullar et al's117 study of 465 
women attending a UK urology clinic for urodynamic investigation found that 
women were less likely to admit the presence of faecal incontinence during direct 
questioning, compared with a self-completion questionnaire administered by post 
and completed at home prior to their clinic appointment. Seventy one participants 
(15%) reported incontinence of liquid or solid stool during direct questioning 
compared to 26% (n=121) who revealed this by way of self-report through use of a 
questionnaire. However, in a similar study comparing clinician-completed 
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evaluation with two patient-completed questionnaires, discordance was evident 
with clinicians reporting higher levels of faecal incontinence. Interviews conducted 
with participants who had faecal incontinence, but who had provided different 
responses to the clinician-completed instrument, gave the main reason for disparity 
as misinterpretation, in particular of the term "soiling", and therefore confusion 
over what constituted faecal incontinence. In addition not interpreting their 
symptoms as incontinence and embarrassment were also given as reasons. For those 
who did not have incontinence, but where disagreement was evident between 
evaluations, the main reasons cited were their misinterpretation of the questions 
and poor understanding of faecal incontinence. Among those without incontinence, 
all participants (n=13) reported that they would feel comfortable if their GP initiated 
discussions regarding these symptoms. 
It is important to consider measurement error of both verbal and written assessment 
instruments when evaluating reluctance to reveal symptoms. Misinterpretation is 
easy if definitions are not explicit and may account for some of the perceived 
reluctance to report symptoms. As discussed in Chapter Two, robust measurement 
properties are fundamental. It is possible that the findings from Khullar's study may 
be due to use of an underdeveloped tool resulting in overestimation of self-reported 
symptoms, as this study did not identify the measure being used. 
Patients' perceptions of anal incontinence as a condition worthy of seeking 
health/ medical care also have an effect on help-seeking behaviour. Bharucha102 
found that those with milder symptoms were less likely to seek help from health 
services. A study into urinary incontinence suggested that reluctance to seek help 
was due to symptoms being perceived as "not serious" enough - in the sense that 
they were not life threatening - and that seeing a doctor would not be legitimate, 
which could also be true of anal incontinence. Adverse responses from health 
professionals have been reported, and may further discourage individuals from 
seeking the healthcare they require103,377.378"409. For some patients, a reluctance to 
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seek healthcare is born out of anger and mistrust of healthcare providers due to 
misdiagnosis, provision of incorrect information or incontinence being directly 
caused by medical intervention374.378 . This may not only affect patients' willingness 
to report their symptoms, but may pose a barrier to considering further treatment. 
The importance of societal norms in disclosure of faecal incontinence, and in 
deterring help-seeking, must be considered410. Bowel control is taught at a young 
age and is a basic requirement for social acceptance374"4. Freud commented that 
control of defecation is a crucial aspect in the development of one's concept of self or 
ego411. The loss of this ability, therefore, transgresses society's basic rules, leading 
sufferers to presume that they will not be accepted by society should they disclose 
their symptoms; hence the veil of secrecy. This only serves to perpetuate society's 
perception of anal incontinence as an unacceptable condition and thereby support 
patients' reluctance to seek help. These fears of being different from the norm also 
have roots in the theories of stigmatisation, as suggested by Goffman (1963)412, with 
the assumption that faecal incontinence will be received negatively by society, 
giving rise to discrimination, leading to avoidance and exclusion41z, 413. Living with 
this stigma involves learning to pass as "normal"3, which inevitably involves 
secrecy374 0" Hence there is a reluctance to disclose these symptoms, even to health 
professionalsl03. 
Consideration must, therefore, be given to the most appropriate way of encouraging 
individuals to disclose their symptoms and to access the healthcare services 
required. These societal issues and exploration of the taboo nature of anal 
incontinence are useful in guiding development of the ICIQ-B and understanding 
the issues for symptomatic individuals, in order to provide a useful questionnaire 
that will achieve these aims. 
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4.8. Conclusion 
The evidence provided here by individuals with anal incontinence highlighted the 
significant impact that these symptoms can impose on different aspects of their 
lives. Thus, the importance of patient involvement in questionnaire design was 
illustrated, as highlighted in Chapter Three. Reliance on clinical assumptions alone, 
when generating items for inclusion in questionnaires, could result in these 
important issues being omitted. Embarrassment, shame and low self-esteem were 
found to be key issues for sufferers, which may be partly responsible for the under- 
reporting of symptoms to healthcare professionals. The method of eliciting 
symptoms and attitudes to the treatment of faecal incontinence of both patients and 
healthcare professionals, however, can influence access to healthcare. For this 
reason, issues surrounding the reluctance to disclose these symptoms were also 
explored. 
Coping mechanisms, such as restricting activities, remaining close to toilets and 
wearing protection such as pads, were strategies commonly employed by 
individuals with incontinence in an attempt to minimise disruptions to their lives 
and to thereby enable them to lead "normal" lives as determined by societal norms. 
However, they mainly served to mask or hide the condition from friends, family 
and society in general, thereby maintaining the veil of secrecy that surrounds this 
condition and making evaluation of severity very difficult. Less was known about 
the impact on sexual relationships, although incontinence during intercourse, and 
subsequent restriction of sexual activity, had been reported. 
Anal or faecal incontinence, along with constipation, were found to be the 
symptoms that imposed the largest affect on quality of life when compared with 
other anorectal conditions. Evaluation using generic questionnaires identified 
themes of physical and emotional impact on aspects of everyday life. The inclusion 
140 
of question items to evaluate these broad perspectives was therefore necessary for 
the proposed new questionnaire. 
The quality of life issues identified in this chapter were a useful basis on which to 
consider development of the new questionnaire. Issues regarding the impact on 
physical and emotional aspects of daily life were identified and examples specific to 
anal incontinence highlighted. Qualitative evaluation of the effects on quality of life 
was necessary for the purposes of this study, however, in order to avoid potential 
omissions by extrapolating findings from these previous studies. As discussed in 
Chapters Two and Three, the robust foundations of a new questionnaire are 
paramount. Efforts to ensure relevance to the population and appropriateness for 
the intended use of the ICIQ-B were essential in the study methodology to provide a 
new questionnaire that addressed the limitations of existing questionnaires. Only 
then could extensive psychometric testing of the new questionnaire be undertaken. 
The following chapter will discuss the development of this new measure for 
symptoms of anal incontinence and their impact on quality of life: the ICIQ-B, which 
will supply the need for a psychometrically robust measure that is clinician and 
patient-centred. 
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CHAPTER FIVE: METHODS OF 
DEVELOPING THE ICIQ-B 
Introduction 
As described in Chapter Two, the process of producing a robust self-completion 
questionnaire is lengthy and complex. The justification for doing so in this area is 
the limited number of questionnaires available for the assessment of anal 
incontinence specifically, and the low level of published evidence of the 
psychometric validation of existing instruments, and their lack of patient-input at 
the design stage. The objectives for this questionnaire were: 
o To provide a comprehensive symptom and quality of life, self-completion 
questionnaire for anal incontinence (including flatus incontinence). 
o To include input from patients with symptoms in its design, to ensure 
inclusion of the issues of most relevance to individuals experiencing 
symptoms and quality of life impact. 
o To include clinicians' perspectives in its design, to enable the resulting 
questionnaire to be useful in clinical practice as well as in research. 
o To provide robust prospective evidence of the questionnaire's 
measurement characteristics. 
o To provide a questionnaire with applicability for adult women and men of 
all ages, with anal incontinence of varying causes. 
This Chapter describes the methodology used for the development of the 
International Consultation on Incontinence Questionnaire for anal incontinence: 
the ICIQ-B. 
The ICIQ-B was developed as a module of the ICIQ project414. The ICIQ is an 
international project aiming to standardise assessment of symptoms related to 
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the lower urinary tract, lower bowel and vagina, through the use of 
psychometrically robust questionnaires in order to facilitate comparisons, for 
example between different treatment strategies and in different patient groups. 
The research methods used in this study will be detailed, from the initial 
generation of question items, through to the production of the final version, 
illustrating the stages involved in devising a robust health measurement scale for 
use in clinical practice and research. 
5.1. Question item generation 
There are no absolute rules for the methods of question item generation, but the 
importance of gathering evidence from varied sources is acknowledged171. The 
importance of patient input, evidence from existing literature and the opinions of 
clinical experts to identify key areas for assessment were outlined in Chapter 
Two. The development of the ICIQ-B drew on all these sources, as described 
below. 
5.1.1. Qualitative exploration of free text comments 
made by patients with anal incontinence 
A randomised controlled trial had been previously undertaken to compare 
different methods of biofeedback treatment for anal incontinence and the results 
published415. A pre-treatment questionnaire had been specifically drafted for this 
study about symptom events, and it contained one open-ended question asking 
about the perceived impact of symptoms: 
"If your bowel control does restrict your life, please briefly describe in 
what way(s)". 
The free text responses to this question were felt to highlight aspects of the lived 
experience for individuals with anal incontinence. As space was limited for the 
free text, it was thought that the responses provided would most likely reflect the 
issues that were of main concern. As the principal investigator for the study was 
one of the advisors for this thesis (CN) these free text responses were made 
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available. They were analysed using content analysis methods to reveal patterns 
of impact on quality of life for people with anal incontinence416. A coding frame 
for these responses was devised by the investigator, in response to the content, 
and emerging themes, and all free text was analysed accordingly15' (Appendix 1). 
Care was taken not to "overgroup" at this stage, which could lead to the 
potential loss of more subtle categories. Categories and comments were reviewed 
and themes that had appeared distinct, but that had obvious overlaps, were 
grouped together in a second phase of the analysis. 
5.1.2. Qualitative exploration of patient issues 
Audio-taped patient interviews using qualitative methods were undertaken in 
order to explore symptoms in-depth as perceived by patients, and to ascertain 
the impact on quality of life that they imposed. Ethics approval was granted from 
Harrow and Southmead local research ethics committees. Initially, participant 
recruitment commenced with individuals who had presented to an Inflammatory 
Bowel Disease specialist nurse, or to a urology clinic. This approach aimed to 
include patients without anal incontinence as their presenting condition, but who 
had experience of other bowel problems. The aim was to explore wider bowel 
terminology and possible symptoms in those who were less familiar with the 
field of anal incontinence. Subsequent interviews involved patients with anal 
incontinence to focus more specifically on the area of interest152. 
A convenience sample of patients was recruited from outpatient clinics at St. 
Mark's Hospital, London and Southmead Hospital, Bristol, from November 2004 
until May 2005. Patients over 18 years of age, attending for routine clinic 
appointments for anal incontinence, were invited to take part. The purpose of the 
study was explained by the investigator in a private room within the clinic. 
Individuals were provided with an information sheet, (Appendix 2) describing 
the study objectives162 and informing them that there was no obligation to take 
part. It was emphasised that their care would not be affected in any way if they 
decided to decline151.152. Further assurances were provided that confidentiality 
and anonymity would be maintained throughout. Any further questions that 
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participants had regarding the study were addressed prior to completion of a 
written consent form (Appendix 3). 
The purpose of the study was described as the "development of a bowel 
symptoms questionnaire". Participants were asked to describe the key issues of 
their experiences as an individual with anal incontinence, in order to develop a 
questionnaire that would evaluate matters of importance to patients. The 
interviews were semi-structured, with the areas of the "type of symptoms 
experienced" and "how they affected participants" used as the foci, with 
encouragement given to freely discuss these and other points151"52 (Appendix 4). 
The description of symptoms by individuals with anal incontinence was 
important in order to ensure the greatest understanding of the problems they 
experienced. It was also necessary to ensure that all symptoms that were 
important to patients were included. 
The most appropriate terminology for this area was explored, including terms 
that had already appeared in self-completion questionnaires, along with more 
familiar conversational terms. Interestingly, individuals who had not presented 
with anal incontinence were particularly informative for the terminology 
evaluation as they were less familiar with medical terms used in this field. A 
written list of all known terms was used as a visual prompt during interviews to 
ensure written acceptability rather than verbal acceptability, given the nature of 
the self-completion questionnaire (Appendix 5). Patients were asked to explain 
their understanding of the terms and also to indicate which words would be 
most acceptable. Alternative terms were also sought for inclusion in further 
interviews in an iterative manner151. 
Interview audiotapes were transcribed verbatim using Microsoft Word, and a 
coding frame devised for analysis, according to emerging themes (Appendix 6). 
The coding frame evolved over the course of the analysis and was devised by 
breaking down the transcribed interviews into paragraphs, sentences and words 
to conceptualise the content and identify distinct phenomena, in order to identify 
similar phenomena presented by further participants417. Preliminary analyses 
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were undertaken after the first five interviews in order to inform the subsequent 
interviews418'419. This approach was then repeated with reviews of interview 
findings being conducted after each round. These findings were used to inform 
the focus of subsequent interviews, until saturation was achieved and no new 
themes were identified418'420,421 . Two randomly selected transcripts were coded at 
an early stage by an independent researcher to compare highlighted themes and 
to review the devised coding framel5l, 418. This was important to ensure the 
reliability of the analysis by the primary investigator. Responses regarding 
terminology were analysed using content analysis to evaluate consensus over 
preference and understanding of terms. 
5.1.3. Expert clinical opinion 
A purposively selected sample of multi-disciplinary clinical experts was invited 
to comment on potential items for inclusion in the new questionnaire in a 
modified Delphi techniquelsl. The experts were chosen specifically to encompass 
the range of healthcare professionals responsible for care of individuals with anal 
incontinence (for example, colorectal surgeons, gastroenterologists, specialist 
nurses and physiotherapists). There is no definitive guidance on the number of 
clinical experts required for this process although between three and seven 
individuals has been suggested as reasonable to achieve the aims of this phasel7l. 
This process took place concurrently with the interviews described above. 
All symptom items in the existing questionnaires reviewed in Chapter three3.9'246- 
249,263,264,267,269,271-275,278,280 were collated in an attempt to produce an exhaustive list 
of currently available question items (Appendix 7). The item list was organised 
into domains: upper gastrointestinal assessment items, bowel storage, bowel 
evacuation and anal/faecal incontinence. Similar items within domains were also 
grouped together, to aid clarity when considering which question items should 
feature in the new instrument. 
Clinicians were approached via email and the list of items circulated 
electronically, with instructions to comment on the need to include or exclude 
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items, in order to achieve a comprehensive symptomatic assessment of anal 
incontinence. Clinicians were also encouraged to suggest new items for inclusion 
that would provide the means for a thorough evaluation. A strict Delphi 
technique would have involved an initial open-ended approach to gather broad 
comments from the clinicians prior to rating the importance of items151. Given 
the wide range of symptoms that appeared in the reviewed instruments, and the 
time constraints of the individuals involved, the provision of a guide list of 
assessment items was considered to be the most appropriate method to yield 
opinions and comments. A content analysis of responses was conducted to find 
areas of agreement and disagreement between the clinicians. The list was re- 
circulated for clarification where consensus was not achieved, until a clear set of 
items was identified for inclusion. 
5.1.4. Developmental version of the ICIQ-B 
The above qualitative approaches, encompassing the views of both patients and 
clinical experts, formed the first phase of this study, allowing the formation of 
the first developmental version of the ICIQ-B (Appendix 8)422. Items identified 
for inclusion by the clinical experts, or new items they had recommended, were 
incorporated into the first draft. Themes that had emerged from the qualitative 
interviews and free text analysis were constructed into question items using the 
participants' own descriptions to record the concept most accurately. At this 
stage, care was taken to include all issues to ensure important areas were not 
overlooked, resulting in a lengthy questionnaire. Further studies were 
undertaken, as described below, to refine the developmental ICIQ-B and prepare 
it for quantitative psychometric validation. 
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5.2. Preliminary content validity: Face validity 
The first developmental version of the ICIQ-B was circulated to the clinical 
experts involved in the initial stages of item generation, and refinements or 
modifications invited. 
Face-to-face, structured patient interviews were also undertaken with the draft 
instrument to ascertain whether it was acceptable to potential respondents, and 
whether the items included were applicable and relevant15i, 362. These approaches 
were essential to ensure that the items were clear and interpreted without 
ambiguity, in order to maximise accurate completion of the 
questionnaire90"153,, 424. 
A convenience sample of patients was achieved by approaching individuals 
attending for anorectal physiology testing and/or biofeedback appointments in 
the physiology unit at St. Mark's Hospital, London UK. Male and female patients 
over 18 years of age, referred for anal incontinence of any type, were invited to 
take part during October and November 2005. Participants were asked to 
complete the questionnaire and express their thoughts and opinions regarding 
ease of completion, particularly concerning any difficulties with the items or 
available responses. Patients were advised that this would be followed by an 
interview to enquire about particular elements of the instrument. It was 
explained to potential participants that this process was simply to develop and 
refine the questionnaire, and not a test of them as an individual. This was 
pointed out to avoid social desirability effects where participants may feel it 
easier to commend the instrument in order to not offend90. Written consent was 
obtained prior to participants completing the questionnaire. 
The completion time was recorded for each participant, with the expectation that 
the easier and more relevant the questionnaire was to fill out, the shorter time it 
would take4z. The interviews required a two phase format, firstly involving 
observation during questionnaire completion in order to detect any hesitation 
that could indicate potential difficulties. The investigator discussed any 
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hesitation in completion and invited participants to suggest alternatives for the 
wording of question items and responses in order to improve understanding90. 
The second phase involved structured interviews, based on a prepared interview 
schedule (Appendix 9), to elicit patients' opinions about ease of understanding 
and completion, questionnaire content, length and layout of the instrumentlsl. 
The interview also considered terminology, particularly interpretation of terms 
and how appropriately items were worded from the patients' perspectives. 
Response categories were explored for their suitability and completeness in 
relation to the question items162, and the recall time frame of three months was 
queried. Patients' verbal verification of their symptoms was also sought and 
cross-referenced with their responses to questionnaire items. Verbal responses 
were recorded in written form in each patient's interview schedule. An iterative 
process was employed. These involved cycles of patient interviews and 
subsequent in-depth reviews of the findings, followed by minor amendments 
and further interviews to evaluate the changes. 
A modified developmental ICIQ-B (dICIQ-B) was finalised when this process no 
longer generated new information and the interviews had confirmed that the 
questionnaire was simple and straightforward to complete for the majority of 
respondents90"163. 
5.3. Quantitative psychometric evaluation 
Formal psychometric evaluation of the dICIQ-B required parallel quantitative 
sub-studies of potential respondents, namely individuals with anal incontinence 
of varied origin. Patients due to attend, or having previously attended, an 
outpatient appointment for their incontinence symptoms were identified at St. 
Mark's Hospital, London; Southmead and Frenchay Hospitals, Bristol; and the 
Bristol Royal Infirmary, and consecutively invited to participate between 
February 2006 and August 2007. Ethics approval was granted from Harrow, 
Southmead, and Central and South Bristol local research ethics committees for all 
of the studies. 
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Eligible patients for substudies are detailed in Table 36. Those who had already 
undergone anorectal physiology testing, within the previous month, were 
eligible for recruitment into the criterion validity study group comparing clinical 
test results with individuals' questionnaire responses. Consecutive patients who 
were scheduled for biofeedback treatment (conservative management) and sacral 
nerve stimulator implantation (surgical management) formed two further 
subgroups. These groups were able to complete the dICIQ-B twice, prior to their 
treatment, and once following discharge, from which evaluation of reliability and 
sensitivity to change was possible. In addition, these groups enabled 
comparisons between the different treatment strategies to be undertaken to 
evaluate treatment effects. A number of other studies were also undertaken on 
data provided by patients who completed a baseline questionnaire to evaluate 
the content, construct and convergent validity, and internal consistency of the 
questionnaire. The specific studies and numbers in subgroups are described in 
more detail in Chapter Six (Tables 47 and 48, pp. 175-176). 
Table 36 Subgroups in the quantitative psychometric validation studies 
Clinical group Inclusion criteria Validation study 
Anorectal ARP test within the previous Criterion validity 
physiology (ARP) month 
Biofeedback (BF) Appointment to commence Test-retest reliability 
biofeedback at least 4 weeks Sensitivity to change 
from baseline questionnaire 
completion 
Sacral nerve Appointment for SNS Test-retest reliability 
stimulation (SNS) insertion at least 4 weeks Sensitivity to change 
from baseline questionnaire 
completion 
All clinical groups Included into any of the Content validity 
combined above subgroups and Construct validity 
completed a baseline Convergent validity 
questionnaire Internal consistency 
All studies involved monthly recruitment of new potential participants by postal 
invitation, with a letter outlining the nature of the project (Appendix 10). During 
the first three months of recruitment, participants were asked to return their 
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signed consent form, in order to receive the dICIQ-B for completion. Lower than 
expected response rates led to this method being reviewed and amended for the 
fourth round of recruitment, so that participants received the questionnaire with 
the invitation letter thus removing a potential barrier to taking part. Prepaid 
envelopes were also included to aid recruitment426. 
5.3.1. Further content validity: Missing data 
Following in-depth qualitative studies, content validity was further explored by 
assessing the level of missing data for each question item when administered to 
potential respondents, as described in Chapter Two. Items that were repeatedly 
missed could indicate poorly performing, difficult or irrelevant questions or 
items that required further modification9o"152. Overall response rates would 
indicate the feasibility of the questionnaire for self-completion. 
The percentage of missing data per question item was calculated for the whole 
population with completed baseline questionnaire data (n=261). No strict cut-off 
for acceptable levels of missing data exists, but 3%-5% was accepted as a general 
standard20z427. Response rates were evaluated overall, by clinical subgroup, and 
by geographical area of recruitment, to indicate the general acceptability of the 
questionnaire. 
5.3.2. Construct validity 
Construct validity was investigated in all patients who had completed a baseline 
questionnaire, to establish the questionnaire's ability to detect known theories. In 
order to conduct this evaluation, hypotheses were generated according to 
available published literature. As detailed in Chapter One, sufficient evidence is 
lacking in many areas concerning anal incontinence. Theories were therefore put 
forward for investigation that needed to be interpreted with caution (Table 37). 
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Table 37 Hypotheses for evaluation of construct validity of the dICIQ-B 
Flatus incontinence is more prevalent than liquid stool, solid stool and mucus 
incontinence 
Anal incontinence increases with age 
Frequent anal incontinence will be less prevalent than infrequent incontinence 
for all types of anal incontinence 
Rates of anal incontinence will not differ by gender 
Confidence intervals were compared to investigate these relationships'. This 
method was selected to evaluate the differences between the groups under 
investigation, as more sophisticated tests were not appropriate. Although a chi 
square (X2) analysis for the comparison of proportions within independent 
categorical data would have been appropriate for variables such as age and 
gender, the different types of incontinence that would be reported by 
participants were not expected to be mutually exclusive429. 
5.3.3. Convergent validity 
The St. Mark's Score247 (Appendix 11) was included with the postal 
administration of the dICIQ-B to allow comparisons of responses to similar items 
by all respondents. The encouraging psychometric properties of the St. Mark's 
score were established in small samples only, but as it is widely used in clinical 
practice currently this measure was the most suitable for comparison. However, 
the St. Mark's score was not validated for self-completion and one study 
reported that it was inappropriate for self-completion. In the absence of any 
alternative "gold standard" measures that could better collect data to examine 
convergent validity, the St. Mark's score was used, acknowledging the inherent 
limitations. Table 38 displays the paired items specifically used to evaluate 
convergence of responses. 
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Table 38 St. Mark's score and dICIQ-B items for comparison of convergent 
validity analysis 
St. Mark's score item dICIQ-B item 
1 Incontinence for solid stool 12a Frequency of solid stool 
incontinence 
2 Incontinence for liquid stool 8a Frequency of liquid stool 
incontinence 
3 Incontinence for gas 16a Frequency of flatus incontinence 
4 Alteration in lifestyle 58 Overall interference caused by 
bowels 
5 Need to wear a pad/ plug 52a Taking spare pants/ pads when go 
out 
5 Need to wear a pad/ plug 7a Staining of underwear/need to wear 
pads 
6 Taking constipating medicines 38a Use of antidiarrhoeal medication 
7 Lack of ability to defer defecation for 33a Needing to rush to the toilet to 
15 minutes open bowels 
Response categories for frequency within the dICIQ-B did not match identically 
the response categories within the St. Mark's Score. Recategorisation was 
therefore required, relating to items 1,2 and 3 (St. Mark's score items), and 8a, 
12a and 16a (dICIQ-B items) as detailed in table 39. 
Table 39 Response pairs for comparison in items addressing frequency 
within the St. Mark's score and dICIQ-B 
St. Mark's frequency response dICIQ-B frequency response 
Never Never 
Rarely Less than once a month 
Sometimes Less than once a week 
Weekly Less than once a day 
Daily About once a day/Several times a day 
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For items 5,6 and 7 in the St. Mark's Score, dichotomous variables indicating a 
"yes" or "no" response were used. Recategorisation of the dICIQ-B responses 
were again required to indicate presence or absence, to enable comparisons for 
analysis as detailed in Table 40. 
Table 40 Response recategorisation in the dICIQ-B to enable comparison 
with dichotomous variables in the St. Mark's Score 
St. Mark's response dICIQ-B frequency response 
No Never 
Yes Rarely - always. 
Less than once a month - several times 
a day. 
The item regarding "alteration in lifestyle" within the St. Mark's score matched 
most closely with "overall interference caused by bowels" within the dICIQ-B. 
However, the response categories were a frequency scale for the former (never - 
daily) and a visual analogue scale ranging 0-10 for the latter. A crude comparison 
was undertaken recategorising responses as detailed below (Table 41). 
Table 41 Response pairs for comparison in items regarding lifestyle 
alteration (St. Mark's score) and overall intereference caused by 
bowels (dICIQ-B) 
t. Mark's frequency response dICIQ-B scale response 
Never No interference at all (0) 
Rarely Some interference (1-3) 
Sometimes Moderate interference (4-6) 
Weekly Significant interference (7-9) 
Daily A great deal of interference (10) 
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The associations between the converted responses were evaluated using 
Spearman 's rank correlation coefficient for analysis of ordinal paired data that is 
not expected to be normally distributed429. 
5.3.4. Criterion validity 
Patients who had undergone anorectal physiology (ARP) testing within the 
previous month of completion of the dICIQ-B formed the subgroup to evaluate 
aspects of criterion validity. Hypotheses were generated regarding expected (if 
potentially weak) correlations between ARP test results and responses to the 
questionnaire. These were evaluated using the Spearman's rank correlation 
coefficient. The suggested hypotheses for testing are detailed below (Table 42). 
ARP methods, results and reference ranges differed between the two 
geographical centres. This required the conversion of continuous data into 
categorical variables indicating "below normal range", "within normal range" 
and "above normal range". 
Table 42 Hypotheses for the evaluation of criterion validity of the dICIQ-B 
ARP parameter and outcome Hypothesised dICIQ-B item and 
outcome 
Reduced maximum resting anal Presence of underwear staining (Item 
sphincter pressure 7a) 
Reduced maximum resting anal Presence of reduced ability to wipe 
sphincter pressure clean after bowel opening (Item 40a) 
Reduced peak anal sphincter squeeze Presence of anal incontinence on 
increment Physical exertion (Item 30a) 
Reduced peak anal sphincter squeeze Presence of reduced ability to control 
increment liquid stool incontinence (Item 9a) 
Reduced peak anal sphincter squeeze Presence of reduced ability to control 
increment solid stool incontinence (Item 13a) 
Reduced five second squeeze Presence of urgency (Item 33a) 
increment 
Reduced rectal threshold volume Presence of increased bowel opening 
frequency during the day (Item 3a) 
Reduced rectal threshold volume Presence of increased bowel opening 
freuen per 24 hour period (Item 6a) 
Reduced rectal threshold volume Presence of urgency (Item 33a) 
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5.4. Reliability evaluation 
As indicated in Chapter Two, the reliability of a questionnaire is crucial to 
establishing its robustness. Reliability is particularly important in health 
measurement, where symptoms and their impact may be measured over a 
prolonged period of time. The following studies were designed to provide data 
on the questionnaire's ability to measure: (a) in a stable and reproducible 
manner, and (b) different but related aspects of anal incontinence. 
5.4.1. Test-retest reliability 
A test-retest analysis was conducted of responses provided at different 
timepoints when symptoms were expected to remain stable, as an indication of 
the stability of the questionnaire'94. All respondents who completed a baseline 
questionnaire, and were not due to commence treatment within 3 weeks, were 
invited to complete a further re-test questionnaire. This timeframe was deemed 
sufficient for individuals to be unlikely to recall their original questionnaire 
responses, but not so long that their symptoms may have changed. 
Score differences in paired items between the two administrations were 
presented graphically, to evaluate the spread of difference per question item. The 
items that displayed smaller score differences would indicate more stable items 
within the questionnaire. Those with a larger spread of score differences and 
increased frequency of larger score differences, would indicate reduced stability. 
Agreement between responses was analysed by examining the proportion of 
identical answers between administrations as a further indicator of agreement. 
The weighted Kappa statistic for ordered categorical data was also included to 
evaluate agreement between paired responses beyond the level of agreement 
expected by chance alonel85"430. 
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5.4.2. Internal consistency 
All data from the baseline questionnaire were used to evaluate internal 
consistency - the degree to which the questionnaire examined similar issues from 
different perspectives. This was analysed using Cronbach's alpha coefficient (a), 
with a value larger than 0.7 indicating an acceptable relationship between items, 
and smaller than 0.9 indicating limited redundancy of items181,189,431,432. This 
coefficient was calculated for all of the items within the questionnaire, although 
this was expected to indicate redundancy given the large number of items within 
the developmental version. A more effective use of the Cronbach's alpha 
coefficient was in evaluating the item groupings derived through factor analysis 
described below (section 5.7). Various permutations of items to include in the 
final version of the questionnaire were explored, based on findings from all of 
the validation studies. These will be described below, and in detail in Chapter 
Six. At this stage, the Cronbach's alpha coefficient was able to indicate 
permutations that contained sufficient questions to achieve an adequate 
assessment of symptoms and their impact on quality of life (Cronbach's 
coefficient alpha >0.7), or suggest that items should be removed, reducing the 
overall length of the questionnaire. This information was invaluable in making 
decisions regarding the question items included in the final version. 
5.5. Sensitivity to change evaluation 
The patients who completed questionnaires for the test-retest analysis and 
received treatment went on to complete a third questionnaire following their 
planned treatment. This investigated the ability of the questionnaire to detect 
change in symptoms and associated quality of life. Patients with (a) upcoming 
appointments at the biofeedback clinic, or (b) on planned theatre lists for sacral 
nerve stimulator implantation, formed the two outcome groups. 
Biofeedback is a conservative treatment with published efficacy of improvement 
in over 65% of patients433435. Biofeedback was implemented at St. Mark's 
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Hospital through approximately four visits with a specialist nurse or 
physiotherapist, with treatment individualised to the patient's requirements. 
Advice was given regarding pelvic floor exercises, medication use, behavioural 
and modifiable factors (for example, diet and lifestyle)436. Patients were 
discharged from this care pathway when clinicians believed they had either 
improved or when no further improvement was expected to occur. Patients were 
sent the third dICIQ-B at the point of discharge. 
Those receiving sacral nerve stimulators, (reported success rates in 70% of 
patients or greater, although in small studies437-41) were scheduled for either 
assessment of a temporary stimulator lasting three weeks, or implantation of 
their permanent device. The dICIQ-B was completed two weeks post-insertion, 
when it was expected to show whether or not the treatment had been effective. 
As discussed in Chapter Two (pp. 65-66), it is useful to compare outcomes 
between treatment groups with known efficacy, to evaluate sensitivity to change 
and confirm that the questionnaire detects expected differences. Little is known 
about the expected differences between outcomes from the two treatment groups 
as comparison studies have been flawed by poor outcome evaluation and 
confounded by the severity of symptoms in patients referred for each 
treatment15, "2. Sacral nerve stimulation is also often reserved for those for whom 
all other treatments have failed and, therefore, results are not directly 
comparable between conservative and surgical management. However, it was 
expected that improvements in both treatment groups would be detected. The 
comparison between treatment groups was therefore undertaken to explore the 
similarities and differences in sensitivity to change following these two different 
interventions and, provide further evidence of the applicability of the 
questionnaire. 
Although expected differences were not known between the different treatment 
strategies, it was reasonable to assume that the questionnaire should discriminate 
between those who had improved and those who had not. Evaluation of the 
difference in sensitivity to change between these individuals was therefore 
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undertaken. Discharge summaries were gathered for all patients where available 
to provide a comparative clinical outcome evaluation. In the absence of 
comparisons with any independent verifier, changes detected by the 
questionnaire would be assumed to be related to treatment. The discharge 
summaries were therefore able to provide some further verification of the 
outcome of treatment, albeit not based on robust validated assessment. Discharge 
summaries were reviewed, to identify those individuals who were considered to 
have "improved following treatment", and those who had "not improved 
following treatment", in order to compare dICIQ-B responses between these 
groups. This was a subjective decision made by the researcher, based on the 
summary provided, which described the outcome for patients in these terms. 
The Wilcoxon signed ranks test was used to analyse the difference between 
baseline and outcome responses for the complete intervention group and the 
identified sub-groups. It is a test of the difference between ordinal paired data 
that are not expected to be normally distributed429. 
5.6. Item reduction 
All the data gathered in the above studies provided evidence of how each 
question item performed. This evidence enabled items that were performing 
poorly, repeatedly being omitted, or exhibiting poor reliability or sensitivity to 
change, to be identified. This was essential to reduce the overall length of the 
questionnaire, as the developmental version was likely to be too long to be 
clinically useful. The length was also potentially burdensome to patients. The 
main objective, when reducing the questionnaire, was to produce the most 
comprehensive measure without compromising aspects that were clinically 
important, or important for individuals with symptoms. All the data were 
considered together to permit informed decisions and provide evidence-based 
rationales for the inclusion of items in the final ICIQ-B questionnairel9-443"444. 
The first step to reduce the length of the dICIQ-B was to calculate a correlation 
matrix evaluating the association between all possible paired question items to 
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identify those that overlapped or measured similar concepts. Coefficients above 
0.7 were considered to indicate distinct correlations` 45. Item pairs displaying high 
coefficient values were looked at further with evidence from the validation 
studies, clinical expert opinions and the patients' perspectives from the initial 
exploratory interviews. The item exhibiting the most robust evidence from the 
pair was then retained. 
The baseline questionnaire data were tabulated to identify questions that were 
never reported to be a problem for respondents, those that were a problem for 
the majority of respondents and also issues that, while present, were not 
considered bothersome. This highlighted items that were not contributing 
valuable information to the overall questionnaire findings431.432. The items were 
not removed at this stage, but the results used to inform decisions later in the 
item reduction phase. 
An important step at this stage was to consult once more with the clinical 
experts. "Clinimetrics"446 aimed to ensure that the clinical perspective 
complemented the psychometric perspective and that the final questionnaire did 
not rely too heavily on statistical findings, potentially overlooking clinical 
appropriateness4". Two meetings were arranged, one in London and one in 
Bristol to encourage attendance, with a convenience sample of clinical experts. 
As in the initial stages of item generation, specialist experts were purposively 
selected to include various healthcare professionals responsible for the care of 
individuals with anal incontinence. Attempts were made to include as many of 
the original clinicians as possible, although the group was also increased in size 
to gather wider comments and include new opinions. 
Discussions at the meetings were directed at establishing the importance of items 
to the overall assessment of anal incontinence. A spectrum of importance was 
then established highlighting items that were crucial to evaluation through to 
those that were perhaps only contributing interesting extra information. Where 
attendance at a meeting was not possible, comments were invited by email. This 
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process provided further clinical information to identify essential items for 
inclusion or items for removal. 
5.7. Factor analysis 
As described in Chapter Two, factor analysis was used to identify clusters of 
question items and to show how strongly they related to each other. 
"Eigenvalues" indicated how many individual groups/clusters of items were 
within the dataset, with values greater than 1 identifying distinct factors or 
groups of items. The "factor loading" results then provided information on how 
much each item contributed to the individual factor. Factor loadings range from 
0 (contributing nothing to the factor and not related to the identified group) to 1 
(highest contribution to the factor and relating to the group greatly). There is no 
absolute cut-off but factor loadings of 0.3 or below are generally considered too 
weak to indicate any relation to the identified factor204. 
Factor analysis was carried out on the symptom and quality of life items 
separately. This was a decision made a priori to manage the large number of 
items within the dICIQ-B (56 items). It was also reasonable to assume that the 
symptom items were a distinct group from the quality of life items, and sufficient 
items remained in each group to be able to identify further subgroups/factors. A 
minimum factor loading was set at 0.4 according to the development of similar 
questionnaires for urinary incontinence427k'7. Preference was given to items 
displaying higher factor loadings where possible. 
The factor analysis was a cyclical process with various permutations of question 
items analysed according to evidence from the substudies. Key items identified 
by clinical experts, patients and also items with the most robust psychometric 
findings, were combined in further factor analyses. This balanced the need for 
robust psychometric properties and included items of clinical and patient 
relevance to provide an optimal combination of question items for the final 
questionnaire. Cronbach's alpha coefficient values (a) were analysed for the 
various item combinations to provide evidence of any item redundancy. 
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5.8. Devising a scoring system 
Given the intended use of the ICIQ-B in clinical practice and the research 
environment, a scoring system was explored. The factor analysis was able to 
indicate the presence of distinct groups or domains. However, addition of the 
component items was not necessarily feasible. For example, varying numbers of 
response options could influence the resulting score. If some question items 
contained numerous response options and some contained few, straightforward 
addition could lead to higher value being placed on the items with more 
potential responses205. The contribution to the domain score, however, can be 
equal for the items despite unequal response options. Factor loading results can 
help to identify whether items contribute equally or contribute different 
proportions to an overall score. The factor loadings, by their nature in indicating 
the contribution made by each question item to the overall factor, can indicate 
how a domain score should be calculated. If the factor loadings indicate a fairly 
equivalent contribution from each item within that factor, then a straightforward 
addition of responses to each item should be possible. If, however, there is large 
variability in the factor loadings, it may be that individual responses require 
weighting to account for the greater or smaller contribution they provide. 
The scoring system indicated by the factor analysis for the dICIQ-B was further 
evaluated with the existing data to analyse its ability to perfom in the same 
manner as the individual items. Validity, reliability and sensitivity to change of 
the individual domain scores were looked at to appraise the performance of the 
proposed scores. This score was viewed as preliminary and illustrative because it 
was derived from the same data used in the development of the questionnaire. 
5.9. Analysis strategy 
A number of analyses were included in this study. In summary, systematic 
content analysis of data generated from patients and expert clinicians provided a 
rich source of data on which to base the content of the ICIQ-B. From a more 
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quantitative perspective the content validity of the questionnaire was evaluated 
through levels of missing data and overall response rates. How well the 
questionnaire findings reflected known theories associated with anal 
incontinence (construct validity) were evaluated through confidence intervals 
exhibited in the patient reported data by comparison with the evidence in the 
literature. Spearman 's rank correlation coefficient was used to draw comparisons 
between the findings from the dICIQ-B and both clinical data and patient reports 
from another source. These findings provided approximations of the convergent 
and criterion validity of the developmental questionnaire, respectively. 
Aside from the validity of the dICIQ-B, graphical representation of patients self- 
reports at different time points and the weighted Kappa analysis were used to 
provide evidence of the stability of the questionnaire. Cronbach's alpha 
coefficient was also employed to evaluate the homogeneity of items within the 
dICIQ-B. The Wilcoxon signed ranks test was used to provide evaluation of the 
sensitivity of the questionnaire to detect change in the overall group of 
respondents who had undergone treatment for their symptoms, along with 
various subgroup comparisons. Data from both the qualitative and quantitative 
studies were appraised to derive the final version of the questionnaire to fully 
optimise the balance between clinimetric and psychometric evidence in the ICIQ- 
B. 
5.10. Conclusion 
Qualitative and quantitative studies were designed to provide the evidence 
required to ensure the robustness of the measurement characteristics of the new 
questionnaire: the ICIQ-B. In order to recommend this questionnaire for use in 
clinical practice and research, evidence of its ability to measure the concepts in 
question in a valid, reliable and responsive manner was essential. 
The next chapter will describe in detail the results of these studies and the 
development of the ICIQ-B. 
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CHAPTER SIX: RESULTS 
Introduction 
This chapter will describe the results of the mixed methodology studies 
undertaken to develop and evaluate the psychometric properties of the ICIQ-B. 
Qualitative study findings are outlined, which were employed to generate the 
questionnaire items. Quantitative study findings are also detailed, that evaluated 
the ICIQ-B's psychometric properties: validity, reliability and sensitivity to 
change. Determination of the items for inclusion in the final ICIQ-B is described, 
based on all the data sources, namely psychometric evidence, clinimetric 
evidence and relevance to symptomatic patients. 
6.1. Question item generation 
Qualitative research was used to develop the question items for inclusion in the 
developmental ICIQ-B in three sub-studies and the findings from each are 
described below. Written comments provided by clinical trial patients and 
interview data were used to identify the issues of importance to patients. Clinical 
experts provided comments on the scope of assessment required and the type of 
question items to include within the developmental ICIQ-B. This methodology 
was incorporated to identify relevant and measurable indicators of the 
symptoms of anal incontinence and its impact on quality of life. 
6.1.1. Free text comments made by patients with anal 
incontinence 
A total of 420 patients were screened for entry into a randomised, controlled trial 
comparing biofeedback methods for anal incontinence (359 females - 85 %, 61 
males -15%, median age 
54.0 years, range 15-86)415. In total, 68% of patients 
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(n=284) made comments about the restrictions imposed on their lives as a result 
of poor bowel control, and the impact on quality of life. This subgroup consisted 
of 242 (85%) females and 42 (15%) males (mean age, 54.5 years, range 23-86). 
Content analysis of these comments was conducted whereby each comment was 
coded and therefore information from one individual could appear in more than 
one category, which highlighted the most frequently occurring comments (Figure 
7). The need to always be aware of toilet location and the effect on social life 
emerged as the most restrictive effects of anal incontinence. 















ý, ýý Restrictions imposed by anal incontinence 
This gave a clear indication that quality of life was impaired in several areas and 
helped to indicate that these were important issues to patients. As these 
individuals had been recruited for a study with a different focus, however, not 
specifically for the exploration of associated quality of life issues, the sample 
could not be considered representative. 
6.1.2. Qualitative exploration of patient issues 
Qualitative interviews were undertaken with patients with bowel or related 
problems. This was to ensure the patient's perspective was explored further 
instead of assessing the written comments alone. It was important to fully 
understand the issues that affect patients' 
lives when experiencing anal 
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incontinence and to ensure the questionnaire represented these issues. Thirty- 
one patients (23 females and 8 males) were interviewed over four rounds of 
interviews, with a review of the findings after each round (Table 43). 
Table 43 Characteristics of participants involved in qualitative exploratory 
interviews by interview round 
Interview round Females Males Median age, (age 
range) years 
Round 1 4 3 49, (20-77) 
Round 2 6 0 70, (44-77) 
Round 3 11 1 58, (29-73) 
Round 4 2 4 56, (52-70) 
Twenty-five individuals had presented with anal incontinence, whereas the 
remaining six patients had urinary symptoms (n=3) or inflammatory bowel 
disease (n=3). Of the six patients who had not presented with anal incontinence, 
four had experienced it at some point in their lives, and of these, three patients 
were unable to control flatus on a frequent basis. 
Several issues emerged of particular concern to patients. "Unpredictability" was 
a key issue in these interviews and put forward by twenty five of the 
interviewees. Unpredictability was related to the timing of incontinence as 
described in the comments below, 
Participant no. 3, "... and it it it will come out when you least expect it, 
(flatus), you know we could be walking down that corridor and without any 
notice I would I would, oh whatever you call it, you know it would escape". 
Participant no. 12, "I may have two (incontinence episodes) in one week and 
none the next it's very unpredictable really". 
Unpredictability of type of incontinent episodes was also reported, 
Participant no. 7, "It happened to me when I was in the kitchen one day I was 
cooking the tea, um I passed wind and it (stool) just went all over the kitchen 
floor". 
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The interviews also highlighted a broad spectrum of severity. There were those 
who were effectively housebound due to self imposed restriction: 
Participant no. 9, "... and I just sort of felt dirty um, just wasn't nice you know I mean I couldn't go out". 
Others were unable to leave the house as physical proximity to the toilet was 
fundamental. 
Participant no. 28, "I didn't go out the house, I didn't join in any functions at 
all, I just didn't want to go anywhere, you know. Where I needed to be was be 
close to the loo you know and that was me, me whole life, you know, me whole day 
everyday, seven days a week". 
Coping strategies also emerged as being essential for patients as they described 
ways of minimising the impact of symptoms they were unable to control: 
Participant no. 6, "1 have an emergency bag with me as well, spare pants, 
spare pads and a plastic bag, like your make-up bag". 
Participant no. 12, "If I know I'm going out for the day I've got to take 
extreme, cautions and know where I'm, know where loos are and things, or if I'm 
going on a coach trip somewhere I need to know there's a loo on board. I'm alright 
on a train because there's loos on the trains". 
Participant no. 15, "If I'm going out I don't eat, that's the safest bet 
really.. . you get used to living that way but it's not easy". 
Although only mentioned by a minority of participants (n=5), the importance 
placed on sexual matters by these individuals was considerable: 
Participant no. 6, "1 must admit it does affect your sexual life as well because 
there can be times certainly leaking afterwards, and can be making sort of farts 
because of the trapped air... and I mean our sex life, that's gone, absolutely gone, 
you know, apart from it's just not practical, and it's just painful because I get very 
painful, my bottom gets very painful. " 
Participant no. 25, "My symptoms in the beginning, I found terribly 
embarrassing, more so than average I think, because the first thing I found was I 
had bowel incontinence during sex... 1 was horrified and terrified... it took nearly 
five years I think (to bring it to the attention of a health professional) by which 
time I'd made myself quite ill with like an anxiety problem, which I went to the 
doctor's about, but I knew what was causing the anxiety problem, which I couldn't 
tell the doctor about. " 
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Related to this, strain on relationships was also highlighted as a major impact of 
this condition. 
Flatus incontinence was a problem highlighted by most participants. The 
comments made by the patients below identify the social difficulties associated 
with this aspect of anal incontinence: 
Participant no. 16, "I do get a lot of wind problems and stuff like that. . . and you're sitting there like, and you keep thinking oh God, and then I give myself 
stomach ache because I'm I'm holding in like my stomach all the time". 
Participant no. 19, "1 can get wind coming out [that participant unable to 
control] after meals, so after meals I always tend to visit the toilet, especially if I'm 
out, two or three times ". 
Particpant no. 20, "I also have quite a lot of of wind which I can't always stop. 
I mean the thing is I don't like the wind aspect of it. I have begun to notice recently 
that things have got a bit worse, you know when you're in the office it's not very 
nice to, you know, fart in the office. I think that the wind, the farting, that's the 
worst thing". 
Particiapant no. 22, "The embarrassing situation is when you think you're 
going to be windy. Most people can hold and then can go to a convenient facility. I 
can't hold and you'd be standing and next thing you know you're having a 
conversation, and, Oh my gosh, I've just passed wind. And there is nothing to say 
if it's going to be offensive or if it's not going to be offensive" 
The variability of anal incontinence symptoms were commonly reported with 
patients indicating that they experienced "good days and bad days". An 
interview participant made a suggestion that would enable respondents to reflect 
this variability by providing a response frame that evaluated symptoms as they 
are "usually" and when they are "at their worst". 
Participant no. 6, "Now it would obviously depend on whether I was at my 
worst or just normal. You could make two lines where you could actually put at 
worst and normal. " 
This concept was further explored with other study participants and received 
general support for inclusion in the developmental version of the questionnaire 
168 
These interviews highlighted the most important issues from the patients' point 
of view and provided a framework on which to develop question items in 
patients' own words. 
Terminology 
A major aim in the interviews was to explore the acceptability of ways of talking 
about anal incontinence and related symptoms. Participants' comments 
regarding a terminology prompt list (Appendix 5) were reviewed to establish 
which terms were well understood and interpreted similarly, in order to achieve 
consensus regarding the most appropriate terms for the questionnaire. The 
acceptability of individual terms to potential respondents was also explored. A 
group of core terms that most people found acceptable emerged (Table 44). The 
most unambiguous terms were deemed to be socially unacceptable and not 
appropriate for use in a health questionnaire, for example "fart" (passing flatus) 
and "poo". Reasons given for their inappropriateness were that "fart" was an 
unpleasant word and "poo" was too childlike. 
Table 44 Terminology findings for anal incontinence (n=31) 
Description Term Interviewees 
interpreted 
similarly 










bowels Bowels open 71 opening Liquid stool 82 
Bowel action 63 bowels Motions 75 
Evacuation 44 I'oo lull 
Faeces 94 
Rectum/anus Back passage 100 Mucus 81 
general area Rectum 69 
Anus 63 Incontinence Accident 95 
Bottom 60 Leakage 88 
Staining 86 
Flatus Wind 88 Bo vel seepage 85 
Gas 82 Bowel soiling 59 
Flatus 75 
Fart 100 
The terms selected for use are highlighted and were primarily chosen due to 
increased understanding among the study participants. "Stool", "liquid stool" 
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and "mucus" were all selected, as decriptions for different types of incontinence. 
During this exploration it was discovered that one single term for incontinence 
was not appropriate as different terms were interpreted to indicate different 
types of events. For this reason three terms were incorporated into the 
questionnaire to help clarify the nature of the questions, guided by patients' 
descriptions of their understanding of these terms: "Accident" - uncontrolled 
accidential loss of stool that is more formed, "Leakage" - seepage or loss of 
liquid stool that is a slower or more gradual event than an accident, "Staining" 
actual marking of underwear. Terms that were anticipated to be problematic 
such as "back passage" and "stool" were both understood by 100% of the 
participants due to the context of the questionnaire, and so were used in the 
developmental ICIQ-B. 
6.1.3. Expert clinical opinion 
Clinical expert opinions were sought regarding the question items that were 
clinically relevant, able to characterise the symptoms of interest and guide 
treatment decisions. The sample of purposively selected multi-disciplinary 
clinical experts included one colorectal surgeon, two gastroenterologists, one 
nurse consultant, two nurse specialists and one physiotherapist with particular 
interest in incontinence. Two rounds of information gathering were undertaken 
to include all the clinical experts and to achieve consensus as far as it was 
possible, regarding the question items for inclusion. 
Assessment of wider gastrointestinal symptoms that appeared in some of the 
available instruments was considered by the panel to be unnecessary in a 
questionnaire intended to specifically address anal incontinence. Table 45 
summarises the items deemed by consensus of the clinical experts to be essential 
to symptom evaluation in order to provide a comprehensive assessment, capable 
of indicating functional abnormalities specifically for anal incontinence. 
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Table 45 Essential anal incontinence assessment areas as defined by clinical 
experts 
Assessment areas to be evaluated 
Type, amount and frequency of faecal incontinence episodes (day and night) 
Ability to delay/control passage of flatus and stool 
Straining required to evacuate 
Incomplete evacuation 
Ability to discriminate between flatus and stool 
Passive and urgent episodes of faecal incontinence 
Sensation, if any, experienced during incontinence episodes 
"Normal" bowel pattern for the individual using the Bristol Stool Form Scale 
Antidiarrhoeal/laxative medication use 
Consensus was not achieved over several issues: anal soreness, constipation, 
abdominal pain and ability/ inability to wipe clean following defecation. Further 
clarification of the importance of these issues was sought from the patient 
interviews. "Anal soreness" in particular was suggested by eight of the patients 
interviewed to be an issue that caused significant distress for those affected. 
Further support for the remaining items had not been provided but it was 
decided to retain these items in the developmental version of the questionnaire 
until more robust evidence for their inclusion or exclusion was collected. 
The preliminary version of the questionnaire was then drawn up, based on these 
data, ready for administration and evaluation (Appendix 8). 
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6.2. Validity evaluation 
The formal evaluation of validity required several sub-studies including 
qualitative and quantitative research. The purpose of each sub-study was to 
explore the understanding and acceptability of the questionnaire (content 
validity), its ability to detect known theories evident in the published literature 
(construct validity), its agreement with an existing widely used instrument 
(convergent validity) and agreement with clinical parameters (criterion validity). 
6.2.1. Preliminary content validity: Face Validity 
Content validity was assessed in two sub-studies, firstly involving patient 
interviews to directly explore the acceptability of the questionnaire with 
potential respondents. Patients were observed completing the first 
developmental version of the ICIQ-B (Appendix 8) and interviewed about their 
views. A total of nineteen patients (15 females, 4 males, median age, 59 years, 
range 28-77) participated in three rounds of interviews to produce the final 
"developmental" version of the questionnaire to be psychometrically tested - the 
dICIQ-B. Participants in each round of interviews were similar in terms of age 
and gender (descriptive statistics of the participants involved in each round of 
interviews are provided in Appendix 12). 
The content validity interviews resulted in seven versions of the questionnaire 
being produced to address feedback provided by patients. All refinements were 
re-evaluated in subsequent interviews in an iterative manner. The modifications 
were focussed around clarifying instructions and phrases, and refining response 
categories to make them more intuitive for completion (Appendix 13). 
Considerable discussions were conducted regarding the use of the "usual" and 
"at worst" response categories, which were originally included throughout to 
allow for the variability in symptoms of anal incontinence. The final version 
included these responses in the frequency of incontinence and bowel opening 
frequency items only, as guided by the patient participants. 
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The recall timeframe of three months was explored with patients to assess its 
appropriateness, which was endorsed. One participant commented, 
Participant no. 14, "Three months is good because it's still fresh in your mind but 
long enough because it changes". 
Overall, there were very few comments with regard to suggested changes to the 
quality of life questions, with comments made such as, 
Participant no. 1, "These (quality of life questions indicated) really hit the nail 
on the head" 
Participant no. 18, "These (quality of life questions indicated) were like having 
a conversation with somebody, they really understood the problem". 
In collaboration with individuals experienced in questionnaire design, 
refinements were made to the ordering of questions so as to provide a more 
logical flow for the questionnaire. Similar items were also grouped into sensible 
sections, for example, separating incontinence-specific symptoms from more 
general bowel symptoms. Interviewing continued and minor changes were made 
until the questionnaire was completed easily and only idiosyncratic comments 
arose (Appendix 14). 
6.2.2. The developmental ICIQ-B 
The final developmental version of the questionnaire - the dICIQ-B produced 
from the previous phase remained lengthy - fifty six items organised as detailed 
below (Table 46). 
Table 46 Structure of the developmental ICIQ-B 
Category of items Number of items 
Bowel pattern/ incontinence pattern 30 (including subsections of 4 items for 
each of liquid stool, solid stool, flatus 
and mucus incontinence) 
Other bowel symptoms 9 
Quality of life 17 
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This final developmental version satisfied the aims of being straightforward, 
allowing it to be completed relatively quickly (15 minutes). It covered all 
pertinent issues, without unnecessary repetition, to give a comprehensive 
assessment of anal incontinence and its associated impact on quality of life. All 
instructions and questions in the dICIQ-B also fulfilled the criteria of being clear 
and easy to understand, according to potential respondents. 
Items that were included had been generated from clinical and patient input 
approximately equally (37 items and 35 items respectively - Appendix 15). 
6.3. Quantitative psychometric evaluation 
The second section of this chapter describes the sub-studies undertaken to 
evaluate the measurement properties of the dICIQ-B formally. The data for these 
studies were gathered by postal administration of the questionnaire to 
individuals representing potential respondents attending outpatient clinics in 
both London and Bristol. Large datasets were established in order to conduct 
robust statistical analyses to provide evidence of the questionnaire's ability to 
measure what it claimed to (validity), in a reproducible manner (reliability) and 
its ability to measure change when it occured (sensitivity to change). Ultimately 
these analyses were undertaken to provide evidence on which to base decisions 
regarding the selection of question items for the final version of the 
questionnaire. An optimum set of question items was sought to form the final 
ICIQ-B and decisions regarding this will be detailed throughout the rest of this 
chapter. 
Datasets 
The datasets used in the analyses are detailed overall (Table 47) and by study 
subgroups (Table 48). These tables compare the self-selected sample populations 
with the invited participants to explore the representativeness of the study 
sample. Patients were invited consecutively from their clinical groups 
determined by treatment - patients following anorectal physiology testing, and 
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patients scheduled to commence biofeedback therapy (conservative 
management) or sacral nerve stimulator implantation (surgical management) at 
least four weeks from the date of recruitment. These clinical groups guided the 
sub-study groups for data collection and analysis. 
Table 47 Overall dataset used for the psychometric testing of the dICIQ-B 
n (%) 
Invited Participant London site Bristol site 
population sample 
Total 698 261 202 59 
population 
Females n (%) 63490.8 244 93.5 188 (93.1) 56 94.9 
Males n(%) 649.2 176.5 146.9 35.1 
Mean age 56.7 59.7 59.5 60.3 
(years) I 
Age range 17.4-92.4 24.2-92.1 24.2-92.1 25.0-90.3 
(years) 
As shown in Table 47, participant groups were similar to the total population 
invited to take part, in terms of gender and age distributions. Females 
outnumbered males at both recruitment sites, which were exhibited in the 
sample populations. This would suggest that the sample who took part were 
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The characteristics of the sub-study groups were similar to those of the target 
population and the overall participant sample, according to gender distribution 
and age ranges recorded. The only exception to this was the surgical intervention 
sample evaluated for sensitivity to change. This group included individuals from 
a narrower age range due to the smaller number of participants included. 
A total of 698 individuals were invited to take part in the validation studies of 
the dICIQ-B with an overall response rate of 37.4% (n=261). Response rates in the 
reliability and sensitivity to change sub-studies were higher, 76.0% and 64.6% 
respectively. Differences were also noted between study sites, with an overall 
response rate of 61.5% in the Bristol hospitals, compared to 33.6% in London. 
6.3.1. Missing data 
Further content validity evaluation was provided by analysis of the level of 
missing data in the returned questionnaires when administered by post. The 
percentage of missing data per item within the dICIQ-B was calculated for the 
complete baseline questionnaire data (n=261), displayed separately for symptom 
and quality of life items (Tables 49 and 50 respectively). 
Table 49 Levels of missing data for dICIQ-B symptom items 
Item Missing Item Missing 
data % data 
Bowel pattern/incontinence pattern 
3a Usual bowel opening 7 8a Usual liquid stool leakage 5 
frequency (day) frequency 
3b At worst bowel opening 16 8b At worst liquid stool 23 
frequency (day) leakage fre uencv 
4a Bowel opening frequency 4 9a* Control liquid stool 3 
(night) leakage 
6a Usual bowel opening 5 10a* Liquid stool leakage 3 
frequency (24 hours) (night) 
6b At worst bowel opening 16 ]]a* Amount liquid stool 4 
frequency (24 hours) leakage 
7a Underwear staining 1 12a Usual solid stool leakage 5 
frequency 
`the missing data reported is after exclusion of responses that were omitted due 
to filter questions 
Items that performed very well Items that performed poorly 
177 





Bowel pattern/incontinence pattern 
12b At worst solid stool leakage 
frequency 
29 22a* Mucus leakage (night) 7 
13a* Control solid stool leakage 4 23a* Amount mucus leakage 6 
14a* Solid stool leakage (night) 2 24a Duration of anal 
incontinene 
5 
15a* Amount solid stool leakage 8 25a Incontinence warning 5 
16a Usual flatus leakage 
frequency 
4 26a Unexplained incontinence 6 
16b At worst flatus leakage 
frequency 
23 27a Incontinence awareness 6 
17a* Control flatus leakage 2 28a Incontinence associated 
abdominal pain 
5 
18a* Flatus leakage (night) 17 29a Consiptation associated 
incontinence 
11 
19a* Amount solid stool leakage 5 30a Incontinence with 
exertion 
5 
20a Usual mucus leakage 
frequency 
5 31a Unpredictability 4 
20b At worst mucus leakage 
frequency 
29 32a Incontinence on the mind 5 
21a Control mucus leakage 6 
Other bowel symptoms 
33a Urgency 3 38a Antidiarrhoeal use 6 
34a Flatus discrimination 3 39a Laxative use 3 
: 15a Straining 4 40a Ability to wipe clean 2 
36a Incomplete evacuation 3 41a Anal pain/soreness 2 
37a Abdominal pain (non- 
incontinence associated 
4 
*the missing data reported is after exclusion of responses that were omitted due 
to filter questions 
Items that performed very well Items that performed poorly 
Missing data ranged from 1-29%. The "at worst" response categories displayed 
the highest levels of missed responses (16-29%). Excluding the "at worst" items, 
responses to "flatus incontinence at night" was the next most commonly missed 
at 17%. Comments such as, "How would I know??? ", were frequently added to this 
item on returned questionnaires reporting an unawareness of flatus lost at night. 
The relevance of constipation assessment was questioned with 11 % of 
respondents who 
had not completed this question item. This provided further 
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evidence to be considered alongside the lack of consensus from the clinical 
experts regarding its inclusion. Missing data at an acceptable level of 5% or less 
was observed for twenty eight of the remaining thirty six items. 





42a Worries about smell 2 51a Toilet location awareness 2 
43a Worries about hygiene 2 52a Carry spare pants, pads, 
etc. 
2 
44a Physical activity restriction 2 53a Plan according to bowels 2 
45a Social activity restriction 3 54a Food type alteration 2 
46a Sexual activity restriction 6 55a Food time alteration 2 
47a Embarrassment 3 56a Stay home more 2 
48a Personal relationship 
interference 
5 57a Empty bowels before 
going out 
3 
49a Other relationship 
interference 
3 58a Overall bowel 
interference 
3 
50a Staying near toilets 3 
Items that performed very well Items that performed poorly 
With the exception of the items that addressed personal or sexual relationships, 
responses for the quality of life items were provided in all but 2-3% of cases 
(Table 50). Given the sensitivity of the personal or sexual relationship questions, 
5% and 6% missing responses was considered reasonable. 
6.3.2. Construct validity 
The construct validity of the dICIQ-B was explored in the baseline dataset 
(n=261) by evaluating how well it was able to detect known differences between 
subgroups. As detailed in Chapter One, robust evidence was lacking in a lot of 
areas with regard to the prevalence of anal incontinence. Suggested theories were 
explored, such as differences in the types of anal incontinence experienced (Table 
51), the frequency of different types of incontinence (Table 51) and differences by 
gender (Table 53). 
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Table 51 Prevalence of type of incontinence experienced by study 
respondents 
Incontinence type Respondents reporting 
incontinence type n 
95% confidence interval 
Flatus 230 92.0 88.6-95.4 
Liquid stool 20884.2 79.6-88.8 
Solid stool 157 63.3 57.3-69.3 
Mucus 150 (60.5) 54.4-66.6 
Flatus incontinence was reported by more participants than any of the other 
types of incontinence, followed by liquid stool incontinence. Fewer participants 
reported solid stool and mucus incontinence overall. Minimal overlap between 
the confidence intervals for reports of flatus and liquid stool incontinence 
indicated a difference between the rates of each type. This supported the findings 
in the literature that indicated flatus incontinence affected more individuals than 
any other type of incontinence83-96-9.99 
A clear difference was indicated between reports of solid stool and both liquid 
stool and flatus incontinence. A lower proportion of respondents reported solid 
stool incontinence and there was no evidence of overlap between the related 
confidence intervals. This suggested a distinct difference in the prevalence of this 
symptom. Rates of solid stool and mucus incontinence were similar, and a clear 
overlap between the respective confidence intervals was demonstrated, that 
suggested no detectable difference between the reported levels of these 
symptoms within the sample population. 
Table 52 Frequency of incontinence experienced by study respondents 
Type of Percents e of patients reporting incontinence n% 
incontinence >Daily > Weekly >Monthl < Monthly Never 
Flatus 177 (70.8) 25 (10.0) 15 (6.0) 13 (5.2) 20(8.0) 
Liquid stool 83 (33.6) 37 (15.0) 42 (17.0) 46 (18.6) 39 (15.8) 
Solid stool 42 (16.9) 23 (9.3) 33 (13.3) 59 (23.8) 91(36.7) 
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In this study, patients more commonly reported incontinence that occurred more 
frequently, with the exception of solid stool incontinence (Table 52). For example, 
flatus incontinence was reported to occur "daily" by 70.8% of the sample 
population and "less than monthly" by only 5.2% of respondents. Chapter One 
described studies that indicated incontinence usually occurred less 
frequently83-86,93, %"97,102,114,118,126,136 The studies that reported this level of evidence 
were primarily conducted in community populations which were unlikely to 
reflect the spectrum of severity seen in a clinic population14. This study 
population was selected due to the presence of anal incontinence symptoms 
rather than community-dwelling adults and therefore direct comparisons with 
these findings were not possible. 
Reports of liquid stool incontinence that occurred "at least weekly" to "less than 
monthly" or "never" were fairly equal (15.0%-18.6 0). "Daily" liquid stool 
incontinence was found to be higher (33.6%). Reports of solid stool incontinence 
demonstrated an increased trend towards less frequent events, excluding the 
"daily" frequency results (16.9%). Solid stool incontinence was reported "at least 
weekly" by 9.3% of study respondents, by comparison with 61.4% reporting this 
"less than monthly" or "never". 
Table 53 Prevalence of some degree of incontinence, study sample 
stratified by age 
Age (years) Percentage of patients reporting 
incontinence (n) 
20-29 3.5 (9) 
30-39 7.4 (19) 
40-49 12.5 (32) 
50-59 20.3 (52) 
60-69 29.3 (75) 
70-79 19.1 (49) 
80-89 5.5 (14) 
`0+ 0.82 
The aim to evaluate the dIQQ-B's ability to detect increased incontinence with 
increased age was not possible with the data collected. Patients were recruited 
according to the presence of incontinence symptoms. The distribution of 
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symptoms across age groups, therefore, simply described the demographics of 
the sample population (Table 53). This study may have more accurately reflected 
the characteristics of a population seeking treatment for anal incontinence or 
referral habits, for example, more proactive referral to tertiary centres may be 
reserved for more individuals among their middle ages than older adults. 
Differences in anal incontinence between males and females were evaluated 
according to type of incontinence. Prevalence differences between the genders 
was not feasible as all patients were recruited because they were symptomatic 
patients (Table 54). 
Table 54 Prevalence of some degree of incontinence by gender in study 
participants 
Gender Respondents reporting 
incontinence type n 
95% confidence interval 
Flatus incontinence 
Female 216 (92.3) 88.9-95.7 
Male 14 87.5 69.3-105.7 
Liquid stool incontinence 
_ 
Female 196 84.8 80.2-89.5 
Male 12 75.0 51.1-98.8 
Solid stool incontinence 
Female 14863.8 57.6-70.0 
Male 9 (56.3) 28.9-83.6 
Mucus incontinence 
Female 139 59.9 53.6-66.3 
Male 1168.8 43.2-94.3 
As reported above (Table 54), flatus incontinence was most commonly reported 
by both genders (females 92.3% and males 87.5%). The most infrequent type of 
incontinence reported was that of solid stool, which was reported by 56.3% of the 
male study participants and 63.8% of females. The difference between rates 
reported by females and males for each type of incontinence was 9.8%, at its 
greatest, for liquid stool incontinence. Greater proportions of females reported 
182 
each type of incontinence for all but mucus incontinence. The confidence 
intervals between males and females overlapped for each comparison, which 
suggested little evidence of difference between the genders. 
The published literature was conflicting with regard to the differences between 
genders. Eight studies suggested that incontinence was more prevalent among 
women"', 19.92.10', 10.116.12', as observed here for flatus, liquid and solid stool 
incontinence. Six studies suggested increased prevalence among 
mend, M'109,111,113.126, as reported here for mucus incontinence. Three further 
studies reported equivalence between males and females93,112,114 which was 
evidenced by the overlap in confidence intervals in this study. These findings 
support the general lack of consensus in the evidence regarding differences 
between anal incontinence between genders. It may provide further support, 
however, for the suggestion that flatus incontinence is the most prevalent 
component of this symptom complex83"86-96-98.99. 
The ICIQ-B was therefore able to demonstrate construct validity where the 
comparison was valid and the theory under investigation well-evidenced. 
6.3.3. Convergent validity 
The associations between responses within the dICIQ-B and similar items in the 
St. Mark's score247 were evaluated in the baseline dataset (n=261). The St-Mark's 
score was used as a comparator self-completion questionnaire for this sub-study, 
although it was originally designed for clinician completion, therefore reasonable 
correlations only were expected. The level of convergence of similar variables can 
also be used as a further measure of construct validity. The comparison of item 
pairs is detailed in Table 55. 
183 
Table 55 Correlation between responses to items in the dICIQ-B and the St. 
Mark's score 
St. Mark's score question dICIQ-B item Spearman's r, 
Solid stool incontinence frequency Solid stool incontinence frequency 0.75 
Liquid stool incontinence 
frequency 
Liquid stool incontinence 
frequency 
0.63 
Flatus incontinence frequency Flatus incontinence frequency 0.67 
Lifestyle alteration Overall interference with everyday 
life caused by bowels 
0.61 
Need to wear pad/plug Taking spare pants/pads when 
out 
0.49 
Need to wear pad/ plug Staining of pants/pads 0.38 
Constipating medication use Use of medications to stop the 
bowel opening 
0.51 
Inability to defer defecation for 15 
minutes 
Need to rush to the toilet to open 
bowels 
0.23 
1dICIQ-B2St. Mark's score 
dICIQ-B items that displayed convergence with the St. Mark's score 
The only items that demonstrated strong correlations between the two 
instruments were those measuring the frequency of solid stool incontinence. The 
Spearman's rs correlation coefficient (0.75) was above the widely accepted cut off 
to indicate correlation of 0.7187. The items that measured frequency of liquid stool 
and flatus incontinence suggested reasonable correlations (0.63 and 0.67) but, 
otherwise, correlations were weak. 
The paired items with poor correlations were "best-fit" comparisons with none 
of them measuring identical concepts. Strong correlations would therefore not be 
expected. The low correlation between the items that addressed "having to rush 
when needing to open your bowels" and the "lack of ability to defer defecation 
for 15 minutes" (0.38), may have been expected to demonstrate a stronger 
relationship as they were similar concepts. The time component included within 
the St. Mark's score item, however, may have affected the answers provided by 
respondents. In addition, there were higher levels of missing data for this item 
than any of the other St. Mark's score items, (12%), indicating a potential 
problem with the understanding of the St. Mark's score item. This was likely as 
the question contained a double negative. 
184 
6.3.4. Criterion validity 
Anorectal physiology (ARP) results were used as an objective measure of anal 
incontinence and criterion validity evaluated for a subset of patients who had 
undergone this investigation (n=164: mean age 60.8 years, range 24.2 to 92.1). 
Analyses of correlations between ARP parameters and certain symptoms of anal 
incontinence reported within the dICIQ-B were undertaken. For example, 
reduced anal sphincter pressures may indicate a physiological cause for 
symptoms of incontinence and may, therefore, be expected to correlate with an 
increased occurrence of underwear staining. 
Table 56 Correlation between responses to items in the dICIQ-B and 
anorectal physiology parameters. 
St. Mark's score question dICIQ-B item Spearman's r. 
Reduced maximum resting anal Presence of underwear staining 
sphincter pressure (Item 7a) 
0.05 
Reduced maximum resting anal Presence of reduced ability to 
sphincter pressure wipe clean after bowel opening 
0 
(Item 40a) 
Reduced peak anal sphincter Presence of anal incontinence on 
squeeze increment physical exertion (Item 30a) 
0.03 
Reduced peak anal sphincter Presence of reduced ability to 
squeeze increment control liquid stool incontinence 
0.14 
(Item 9a) 
Reduced peak anal sphincter Presence of reduced ability to 
squeeze increment control solid stool incontinence 
0.14 
(Item 13a) 
Reduced five second squeeze Presence of urgency (Item 33a) 
increment 
0 
Reduced rectal threshold volume Presence of increased bowel 
opening frequency during the day 0.03 
(Item 3a) 
Reduced rectal threshold volume Presence of increased bowel 
opening frequency per 24 hour 
0 
period (Item 6a) 
Reduced rectal threshold volume Presence of urgency (Item 33a) 0.09 
Very low correlations were observed between clinical test results and self- 
reported symptoms within the dICIQ-B: Spearman's r8: 0.03 - 0.14 (Table 56). The 
hypotheses suggested were reasonable assumptions, but the relationship 
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between physiological findings and patients' perception of symptoms is 
notoriously poor, as two different but associated concepts are measured153. 
Furthermore, symptoms of anal incontinence can be due to an array of causes 
and the outcome is rarely linear. Symptoms reported by patients may or may not 
be related to specific clinical parameters as there can be complex causes for the 
resulting incontinence. The absence of correlations would, therefore, be expected 
and provides no evidence of poor criterion validity. 
6.4. Reliability evaluation 
Two components were evaluated to establish the dICIQ-B's reliability. These are 
reported below. Firstly its ability to measure in a stable manner was assessed. 
This is essential for ongoing monitoring of symptom and quality of life status. 
Secondly, its ability to measure similar concepts from different perspectives to 
provide depth of assessment was evaluated. 
6.4.1. Test-retest reliability 
Seventy nine patients (mean age: 58.3 years, range 25.0 to 88.6) completed the 
dICIQ-B twice over a three week time interval to evaluate the stability of the 
questionnaire. This subgroup of patients had scheduled appointments for either 
biofeedback or surgical treatment, and were not undergoing any active 
intervention at the time of both dICIQ-B completions. Their symptoms were not 
expected to alter dramatically and the questionnaire was expected to detect 
similar responses to demonstrate its stability. 
Figures 8 -16 below display the distribution of differences between test and retest 
responses in a selection of the dICIQ-B items. These items were chosen as they 
exhibit minimal variability in terms of the spread of response differences (full 
results Appendix 16). 
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Figures 8- 16 Difference between test and retest responses of selected 
dICIQ-B items (n=79) 
8. Item 4a Bowel opening frequency (night) 9. Item 6a Usual bowel opening frequency 
(24 hours) 
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11. Item 23a Amount mucus leakage 
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Figures 8- 16 continued Difference between test and retest responses of 
selected dICIQ-B items (n=79) 
14. Item 52a Carry spare pants/pads, etc 



















16. Item 58 Overall interference caused by bowels* 
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*11 point visual analogue scale converted to scale containing 5 categories for analysis. 
As displayed in the graphs above, the majority of respondents provided identical 
responses between the test and retest administration of the dICIQ-B in these 
items. Question item 6a that addressed "bowel opening frequency per 24 hour 
period" exhibited excellent stability in terms of the range of difference (Figure 9), 
with all respondents only reporting a maximum of one category difference from 
their original answer. Responses that only differed by one category were also 
provided by all but one respondent 
for the remaining items displayed above. 
Item 58a also displayed minimal variability when grouped into categories, rather 
than comparing identical responses between all eleven points on the visual 
analogue scale. 
The question items deemed to have greater variability between test and retest 
responses were identified 
by larger differences in the retest responses provided. 
Retest responses that differed from the original test responses by at least 5 
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categories were found in the following items (Figures 17-21) which was 
considered when deciding the final items for inclusion in the questionnaire. 
Figures 17 - 21 Difference between test and retest responses of dICIQ-B items 
that exhibited greater variability (n=79) 
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Identical agreement between responses provided at each time point was 
evaluated as an assessment of reliability. The agreement between paired 
responses also underwent analysis using the weighted Kappa statistic, a chance- 
corrected measure of agreement186-188. Table 57 summarises these results and the 
highlighted areas indicate the items that were considered to be the most robust 
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Identical agreement for all respondents was not observed for any of the dICIQ-B 
items displayed. A high proportion of identical agreement (>70.0%) was 
demonstrated in 21 question items. The majority of items (33 question items) 
exhibited a reasonable level of identical agreement, between 60.0% and 69.9%. 
Some variability was expected given the unpredictable nature of anal 
incontinence symptoms and their resultant impact. This level of identical 
agreement was therefore encouraging. Responses to only eight items exhibited 
the lowest level of identical agreement (50.0% and 59.9%). Although these 
questions represented those least likely to elicit identical responses, at least half 
of the responses provided remained the same which was acceptable given the 
variable nature of these symptoms. 
Fifty of the sixty one items evaluated demonstrated "good" or "very good" 
reliability. The five items considered to exhibit "very good" agreement (weighted 
Kappa 0.81-1.0) included question 24a which was expected to remain consistent 
as it enquired about the length of time an individual had experienced symptoms. 
Items 38a and 39a evaluated the use of antidiarrhoeal or laxative medication 
which would be expected to remain stable if symptoms were fairly well 
controlled. The items that assessed "straining" and "always being aware of toilet 
location" also demonstrated their ability to evaluate these concepts in a very 
reliable manner. Most of the items therefore demonstrated "good" agreement 
(weighted Kappa 0.61- 0.80) which is important for long-term monitoring of 
chronic symptoms. The likelihood of agreement was reduced in item 58 that 
assessed "overall interference caused by the bowels" due to the eleven potential 
responses provided by the visual analogue scale, which scored from zero to ten. 
This item was therefore recategorised into five groups to facilitate comparisons 
for agreement (0 "not at all", 1 to 3,4 to 6,7 to 9 and 10 "a great deal"), as was 
undertaken with the evaluation for convergent validity (Table 41, pp. 154). 
"Good" agreement was observed for item 58 when categorised responses were 
analysed. The items considered to offer "very good" or "good" reliability 
193 
included symptom and quality of life assessment variables suggesting that these 
concepts could be measured sufficiently in a stable manner. 
Ten question were identified that provided the least stable assessment over time, 
although moderate agreement was demonstrated (weighted Kappa 0.41- 0.60): 4a 
"bowel opening frequency at night", 6a "usual bowel opening frequency (24 
hours)", 9a and 13a "control of liquid/solid stool leakage", 11a, 19a and 23a 
"amount of liquid/ solid stool/ mucus leakage", 29a "constipation associated 
incontinence", 30a "incontinence with exertion" and 48a "personal relationship 
interference". Items that evaluated the amount of all types of incontinence apart 
from flatus were included among these items. This suggested that perhaps this 
concept may not remain particularly stable or that these items were not able to 
measure this concept in a stable manner. All of the items demonstrated at least 
moderate agreement, which indicated acceptable reliability of the items within 
the dICIQ-B. 
Whilst the "at worst" items were found to exhibit the highest levels of missing 
data overall, as reported earlier in this chapter (Table 49, pp. 177), they 
demonstrated high levels of identical agreement between test and retest 
responses: >80% - 3b "bowel opening frequency (day)", 6b "bowel opening 
frequency (24 hours)" and 16b "flatus leakage frequency"; 64-70% - 8b, 12b and 
20b "frequency of liquid stool/ solid stool/ mucus leakage". In addition, the 
weighted Kappa analysis indicated "good" agreement for all but the frequency of 
mucus leakage (20b) which demonstrated "very good"reliability. It was useful to 
investigate the distribution of the responses provided for these items further 
(Figures 22-27). 
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Figures 22-27 Difference between test and retest responses of "at worst" 
dICIQ-B items (n=79) 
22. Item 3b At worst bowel opening 23. Item 6b At worst bowel opening 
frequency (day) frequency (24 hours) 






2 30 2 30 
















-4-3 -2 -1 01234 
Difference in response 






LO 2 30 
° 20 a 
10 
Z0 










-4 -3 -2 -1 01234 
Difference in response 
27. Item 20b At worst mucus leakage 
frequency 










Question 6b, regarding bowel opening frequency per 24 hours demonstrated the 
most reliable "at worst" 
item in terms of the spread of responses provided. Only 
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three responses differed by more than one category (figure 23). The "at worst" 
items did however exhibit a larger spread of movement among categories 
between the test and retest data overall. Most items displayed movement of up to 
four categories. Higher levels of retest responses were therefore consistent with 
the test responses for these items, indicated by the weighted Kappa and identical 
agreement findings, but where responses varied the difference observed was 
larger for these items. This was considered when selecting the final items for the 
questionnaire. 
6.4.2. Internal consistency 
All data from respondents who completed the baseline questionnaire (n=261) 
were included in the evaluation of internal consistency. Cronbach's alpha 
coefficient (a) for all fifty six items within the dICIQ-B was very high at 0.9394. 
As discussed in Chapter Five, a value greater than 0.9 indicates redundancy 
within the item pool. This was expected, given the exhaustive number of items 
contained in the dICIQ-B. It was also reassuring that the data supported the 
removal of some questions from the developmental instrument. 
Cronbach's alpha values were also calculated for all symptom items and all 
quality of life items separately, to evaluate redundancy within these distinct 
domains. The result of 0.8984 for symptom items was within the accepted range 
(0.7-0.9)191-193. Redundancy could still be indicated, however, as this value was at 
the upper limit of the accepted range. Cronbach's alpha of 0.9235 for the quality 
of life items indicated redundancy in this domain. These levels of redundancy 
were dealt with by factor analysis and clinimetrics (see below pp. 218-222). 
6.5. Sensitivity to change evaluation 
A sub-group of participants who underwent conservative (biofeedback therapy) 
or surgical treatment (sacral nerve stimulator implantation) for their symptoms 
completed the dICIQ-B a third time. This provided data for the overall 
evaluation of the questionnaire's ability to detect change in all respondents 
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undergoing any intervention. Various sub-analyses were also undertaken to 
explore the measurement properties of the dICIQ-B items in different conditions. 
Comparisons between different treatment groups were undertaken and also 
between those who were considered to have "improved following treatment" 
and those who had not. As stated in Chapter Five (pp. 157), a priori expectations 
of difference between the treatment groups were not clear given the lack of 
evidence in this area. The responsiveness of items in the different treatment 
groups was therefore more exploratory in nature. The questionnaire was 
expected to only detect improvement among the individuals who had improved 
however, to ensure the ICIQ-B was measuring reported change and not a result 
of questionnaire design flaws. This hypothesis was tested in the analyses relating 
to those who had "improved with treatment" compared with those who had not. 
Patients reports of "some" level of a symptom or "some" impact on quality of life 
were compared pre- and post-intervention to evaluate the questionnaire's ability 
to detect change following treatment. The significance of the differences detected 
was analysed using Wilcoxon signed ranks test. Throughout this section results 
have been highlighted to demonstrate clearly which items exhibited the most 
robust evidence in order to justify the rationale for item selection during the final 
part of this chapter. 
Resolution of symptoms or impact on quality of life following any treatment was 
investigated in the overall intervention group, (n=51,46 females and 5 males, 
mean age: 60.9 years, range 28.1 to 88.6). Sensitivity to change was evident in 19 
out of the 56 items (P<0.05) as displayed in Table 58. (Full results of the items 
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As indicated above, items 6a (frequency of bowel opening per 24 hours) and 58a 
(overall interference caused by bowels) displayed improvement in symptoms 
following treatment as complete resolution of symptoms or impact was not 
anticipated. For example, increased frequency of bowel opening would be 
expected to reduce following treatment but it would not become absent. 
Improvement was determined by responses that differed by one response 
category or greater. 
Items 7a and 58a that assessed underwear staining and overall interference, also 
retained significance when a Bonferroni correction was applied187. None of the 
other items did. The Bonferroni correction adjusts the level at which a result is 
considered significant, allowing for multiple testing of the data. In effect, it 
reduces the cut-off at which we consider a result to be significant dependent on 
the number of times the test is repeated within a dataset. As this dataset 
contained fifty six items for evaluation the widely accepted significance level of 
0.05 was divided by 56 producing a Bonferroni corrected level of significance of 
0.0008. The Bonferroni correction is, however, extremely conservative and must 
be interpreted carefully to ensure items are not removed unnecessarily187. 
6.5.1. Sensitivity to conservative management 
The subgroup of patients who completed the questionnaire following 
intervention was further subdivided to analyse separately those who had 
undergone conservative treatment and those who had been treated surgically. 
Patients who had undergone conservative treatment formed the majority of this 
subgroup (n=39,36 females and 3 males, mean age: 61.8 years, range 28.1 to 88.6). 
Wilcoxon signed ranks test was used to analyse the differences between 
responses provided before and after conservative intervention. Items that were 
found to have evidence of their ability to detect change are detailed in Table 59 
(results for items that did not demonstrate sensitivity to change in this subgroup 
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Patient reported change following treatment for anal incontinence was found to 
be significant for 13 items within the conservative management subgroup. 
Senstivity to change was demonstrated in both symptom and quality of life items 
indicating the ability to provide responsive assessment for individuals following 
conservative treatment from both perspectives of the intended questionnaire. 
There were fewer responsive items within this subgroup. This may highlight that 
the effects of conservative management were different from the surgical 
outcomes. The other six items may therefore be more sensitive to change 
following surgery: 9a "control of liquid stool leakage", 15a "amount of solid stool 
leakage", 18a "flatus leakage at night", 25a "warning of incontinence", 26a 
"unexplained incontinence" and 39a "laxative medication use". 
Symptom resolution was reported for up to 17.5% of respondents (8a - "Usual 
liquid stool leakage frequency"), who underewent conservative management of 
their symptoms. Resolution of symptoms was more commonly observed in up to 
5% of respondents, however. Larger improvements were also noted in 
"abdominal pain that was not associated with incontinence" (item 37a - 13.6%) 
and "staying at home more often" (item 56a -13.1 %o). 
6.5.2. Sensitivity to surgical treatment 
The difference between responses before and after surgical treatment were also 
analysed using the Wilcoxon signed ranks test (n=12,10 females and 2 males, 
mean age: 57.8 years, range 45.0 to 71.2). Table 60 details items that were found 
to have evidence of their ability to detect change (results for items that did not 
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Patient reported change following treatment for anal incontinence was found to 
be significant for 15 items within the surgical treatment subgroup. The small 
sample size of 12 participants in this analysis must be considered as results found 
to be statistically significant require further evaluation in a larger population in 
order to indicate robust evidence. P-values much closer to the generally accepted 
0.05 cut-off were observed among these items. Stronger evidence of the ability of 
these items to detect patient reported change may be improved within a larger 
dataset. In addition, items that were found to have no evidence of change may 
have been underpowered. Four items were found to be responsive to surgical 
treatment that had not been evident in either the conservative subgroup or the 
overall intervention group: 22a "Mucus leakage at night", 27a "awareness of 
incontinence", 31a "unpredictability", 36a "awareness of incontinence", 38a 
"antidiarrhoeal medication use". 
Symptom resolution was reported for up to 40.0% of respondents (26a - 
"Unexplained incontinence"), who underewent surgical management of their 
symptoms. Resolution of symptoms was more commonly observed in up to 20% 
of respondents, however. These results suggest larger improvements as a result 
of surgical intervention by comparison with conservative management, but the 
small sample size in the surgical subgroup analysis must be considered. 
Five key question items emerged from these analyses that were able to detect 
change overall and following both interventions (Table 61). 
Table 61 dICIQ-B items sensitive to change in all intervention groups 
7a Underwear staining 53a Stay home more 




6.5.3. Sensitivity to change in patients who "improved 
with treatment" 
The following analyses were conducted using individual patients' discharge 
summaries as an independent verifier of their status of "improved with 
treatment". As discussed in Chapter Five, the discharge summaries were based 
on the patients' and the clinicians' interpretation of improvement. They were 
formed through discussion of their symptoms and perceived improvement 
compared to the start of therapy and then noted by the clinician. This was not 
standardised, or a robust measure of improvement, but it did provide an 
alternative perspective with which to compare the dICIQ-B findings in order to 
build on the evidence base for each question item. Discharge summaries were 
available for 40 of the 51 patients (n=40,35 females and 5 males, mean age: 61.2 
years, range 28.1 to 88.6) who underwent any intervention. Summaries that were 
not available were not expected to cause any systematic bias as administrative 
procedures were the cause in most cases. Subgroups were formed of those 
reported to have "improved with treatment" and those who were considered to 
have "not improved with treatment". The questionnaire was expected to detect 
improvement and absence of improvement respectively. 
The difference between dICIQ-B responses provided before and after treatment 
in patients who were reported to have "improved with treatment" were again 
analysed using the Wilcoxon signed ranks test (n=30,28 females and 2 males, 
mean age: 62.4 years, range 28.1 to 88.6). Table 62 details items that were found 
to have evidence of their ability to detect change (results for items that did not 
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Twenty one items demonstrated evidence of their ability to detect change in the 
subgroup of individuals reported to have "improved with treatment". The eight 
items highlighted demonstrated stronger evidence of a difference between pre- 
and post-intervention reports, indicated by smaller P-values. This suggested 
stronger evidence of their ability to detect change in those known to have 
improved. In particular, responses to item 58 evaluating "interference with 
everyday life" demonstrated improvement that retained significance with the 
Bonferroni correction applied. 
It is important to note that while response differences were expected to be 
detected in this group of patients who were considered to have improved, not all 
dICIQ-B items were sensitive to change in this group. The remaining items were, 
therefore, perhaps not conducive to a questionnaire required to detect change in 
symptom or impact status where this had occurred. Similarly, seven items were 
observed to detect change during this analysis that had not been detected in any 
of the previous comparisons: 8b "at worst liquid stool leakage frgeuency", 12a 
and b "usual and at worst solid stool leakage frequency", 20a "usual mucus 
leakage frequency", 23a "amount of mucus leakage", 40a "ability to wipe clean" 
and 57a "emptying bowels before going out". Given the use of subjective opinion 
to define this group and the lack of evidence for these items in the overall 
analysis, the sensitivity of these items may not be certain. 
6.5.4. Sensitivity to change in patients who were "not 
improved with treatment" 
The results described above demonstrated that patients who were considered 
"improved with treatment" reported detectable change in approximately one 
third of the dICIQ-B items. It was then necessary to evaluate if detectable 
changes were reported in any question items among individuals who were 
considered "not improved with treatment" (n=10,7 females and 3 males, mean 
age: 57.4 years, range 47.9 to 67.8), which could have identified measurement 
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errors with the questionnaire. The age range was smaller than in the previous 
subgroup and the sample was also smaller in size. 
There was evidence of a significant patient-reported difference between pre- and 
post-treatment for item 34a that evaluated "ability to discriminate between stool 
and flatus" (P=0.0466). The applicability of this item for the final questionnaire is 
therefore not certain, as it would not be appropriate to include a question that 
reports change where an individual has not improved. This finding may have 
been due to the small numbers involved in the analysis however, and should be 
further evaluated in a larger sample. Alternatively this item may have measured 
actual improvement in this aspect but the subgroups defined as "improved" or 
"not improved" related to incontinence outcome rather than this particular 
aspect. 
All of the responses to the remaining dICIQ-B question items in this subgroup of 
participants demonstrated no change following treatment (Appendix 21). 
Although this small sub-sample was not representative of the overall study 
population in terms of the narrow age range captured, these results were as 
expected and indicated that most dICIQ-B items did not detect change where 
change had not occurred according to patient and clinician reports. 
6.5.5 Sensitivity to change: conclusion 
The results in this section of the chapter indicated that certain items within the 
dICIQ-B were able to detect a change in symptom or quality of life status, as 
reported by potential respondents. The various comparisons identified items that 
were responsive among individuals managed conservatively and surgically, and 
were also able to distinguish between those considered to have improved 
following treatment and those who had not. The items that displayed the 
strongest results for sensitivity to change are detailed in Table 63. All of these 
items exhibited robust evidence of sensitivity to change within one or both of the 
intervention groups considered, and discriminated between those who improved 
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Table 64 provides a summary of dICIQ-B items that were not able to detect a 
change in patients reports in any of the analyses undertaken, which was taken 
into consideration when deciding the items for the final version of the 
questionnaire. 
Table 64 Items with no evidence of sensitivity to change in any of the sub- 
analyses 
dICIQ-B items 
3a Usual bowel opening 28a Incontinence associated 45a Social activity restriction 
frequency (day) abdominal pain 
3b At worst bowel opening 29a Constipation associated 46a Sexual activity 
frequency (day) incontinence restriction 
4a Bowel opening 30a Incontinence with 47a Embarrassment 
frequency (night) exertion 
6b At worst bowel opening 31a Unpredictability 48a Personal relationship 
frequency (24 hours) interference 
10a Liquid stool leakage 35a Straining 49a Other relationship 
(night interference 
11a Amount liquid stool 36a Incomplete evacuation 51a Toilet location 
leakage awareness 
14a Solid stool leakage 38a Antidiarrhoeal use 52a Carry spare pants, pads, 
(night) etc. 
19a Amount solid stool 41a Anal pain/soreness 54a Food type alteration 
leakage 
22a Mucus leakage (night) 42a Worries about smell 55a Food time alteration 
24a Duration of anal 43a Worries about hygiene 
incontinene 
27a Incontinence awareness 44a Physical activity 
restriction 
6.6. Item reduction 
The dICIQ-B contained 56 question items and the Cronbach's alpha results 
indicated redundancy of some items (0.8984 - symptoms items, 0.9235 quality of 
life items). Selection of items for inclusion in the final questionnaire was 
therefore necessary to provide the briefest but most comprehensive evaluation, 
and remove items that were not performing well. Selection of question items and 
subsequent reduction of the overall length of the questionnaire was also expected 
to increase the acceptability of the questionnaire to potential respondents. All the 
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results from the above studies provided evidence on which to base decisions 
regarding inclusion or removal of items. 
Meetings with clinical experts in this specialist area were once again convened to 
discuss the clinical perspective of dICIQ-B items along with the statistical results. 
This clinical input enabled decisions regarding removal of items to be based on 
clinical relevance, as well as the statistical findings, in order to produce a more 
clinically applicable questionnaire. The clinical expert meetings were made up of 
a nurse consultant, colorectal surgeon, colorectal surgical research fellow, 
gastrointestinal physiologist, two continence advisors, three specialist nurses in 
biofeedback and a gastrointestinal research nurse. Extra comments were also 
provided via email by a consultant gastroenterologist, an inflammatory bowel 
disease specialist nurse, two geriatricians with particular interest in bowel 
continence, a nurse consultant and a specialist physiotherapist, who were unable 
to attend the meetings in person. 
Further exploration of the dataset was also undertaken. First, correlations were 
analysed between items to identify areas of obvious overlap and measurement of 
similar concepts. A correlation matrix was produced and values greater than 0.7 
indicated high correlations between item pairs (Table 65). 
Table 65 Overlapping dICIQ-B items identified by correlation matrix 
dICIQ-B item pair Correlation 
coefficient 
3a Usual bowel opening frequency by day 0.7422 
6a Usual bowel opening frequency per 24 hours 
9a Control of liquid stool leakage 0.7067 
13a Control of solid stool leakage 
13a Control of solid stool leakage 0.7215 
21a Control of mucus leakage 
16a Usual flatus leakage frequency 0.7064 
17a Control of flatus leakage 
17a Control of flatus leakage 0.7086 
19a Amount of flatus leakage 
17a Control of flatus leakage 0.7609 
21a Control of mucus leaks e 
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Table 65 continued Overlapping dICIQ-B items identified by correlation 
matrix 
dICIQ-B item pair Correlation 
coefficient 
20a Usual mucus leakage frequency 0.7084 
23a Amount of mucus leakage 
42a Worries about smell 0.7460 
43a Worries about hygiene 
44a Physical activity restriction 0.8043 
45a Social activity restriction 
45a Social activity restriction 0.7158 
53a Plan according to bowels 
45a Social activity restriction 0.8136 
56a Stay home more often than preferred 
46a Sexual activity restriction 0.7679 
48a Interference with personal relationships 
49a Interference with other relationships 0,7286 
56a Sta home more often than preferred 
50a Staying near toilets 0.7917 
51a Awareness of toilet location 
53a Plan according to bowels 0.7368 
56a Stay home more often than preferred 
These pairs were then examined in terms of the existing evidence for each 
question item. The item that exhibited the most robust evidence was retained. 
Some decisions were clearer, for example, several items were identified for 
removal because they lacked evidence of sensitivity to change - 3a "usual bowel 
opening frequency by day", 16a "usual flatus leakage frequency", 19a "amount 
of flatus leakage" and 49a "interference with other relationships". Contrary to 
this, item 51a "awareness of toilet location" was retained in preference to item 
50a "staying near toilets" despite lacking evidence of sensitivity to change. Items 
50a and 51a were intuitively very similar and directly overlapped but 51a 
demonstrated stronger psychometric properties apart from responsiveness (51a - 
2% missing data, 63% identical retest responses provided, "very good" 
agreement; 50a - 3% missing data, 58% identical retest responses provided, 
211 
"good" agreement). More importantly, the issue of always having to be aware of 
toilet location was a major issue identified during the initial patient interviews, 
moreso than actually staying near to toilets necessarily. 
Item 20a "usual mucus leakage frequency" was retained in preference to item 23a 
"amount of mucus leakage". Poorer psychometric properties were demonstrated 
for item 23a and it was considered less clinically important. Participants' 
responses to the items regarding worries about smell (42a) and hygiene (43a) 
correlated highly (0.7460). Item 42a was retained due to its initial increased 
relevance to patients and equivalent psychometric properties (both exhibited 2% 
missing data and "good" agreement). Item 46a "sexual activity restriction" was 
preferred to 48a "interference with personal relationships" based on the patient 
interview data. The necessity for an item regarding affects on sexual activity to 
facilitate discussion in this area had also been identified. 
The items regarding control of liquid stool incontinence, solid stool incontinence 
and mucus leakage (9a, 13a and 21a) were removed at this stage as they all 
closely correlated with each other and the items regarding frequency of 
incontinence (8a and b, 12a and b, 20a and b) were retained. The clinicians had 
reported equivalence of the items that evaluated frequency of incontinence or 
control of incontinence for each different type. Initial explorations were therefore 
undertaken with the frequency items although the problematic "at worst" aspect 
of each question was recognised and the possibility of reintroducing the control 
items in further examinations of different configurations was not ruled out. 
Where the decision was not clear, regarding the items to remove, they were 
retained until more evidence was gathered through further analyses - 44a 
"physical activity restriction', 45a "social activity restriction", 53a "plan 
according to bowels", 56a "stay home more often than preferred". 
Data from completion of the baseline questionnaire was tabulated to identify 
items that were: (a) not reported by many respondents, i. e. rated "never", (b) 
those that were a severe problem for the majority of respondents and rated as the 
most severe response category available, for example, "always", "several times a 
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day" or "never able to control", and (c) those that were not particularly 
bothersome (Table 66). 
Table 66 Items reported to occur infrequently, all of the time or were not 
perceived to be bothersome 
dICIQ-B item Number of respondents n(o/o) 
Infrequently reported issues 
4a Bowel opening frequency by night 71 (28.3) 
38a Antidiarrhoeal medication use 93 37.8 
39a Laxative use 76(29.9) 
Issues re orted "always" by the majority of participants 
3b At worst bowel opening frequency by da 142(64.8) 
7a Underwear staining/ required pad use 14656.4 
16b At worst flatus leakage fr uent 154 76.2 
21a Control of mucus leakage 9553. 
Issues reported "not at all" bothersome by participants 
4a Bowel opening frequency by night 13960.2 
10a Liquid stool leakage by night 8S 44 2 
14a Solid stool leakage by night 99 59.6 
22a Mucus leakage by night 65 41.1 
38a Antidiarrhoeal medication use 100 47.4 
39a Laxative use 108(52.4) 
Few respondents reported bowel opening at night (28.3%), and the use of 
antidiarrhoeal (37.8%) or laxative medications (29.9%). Only flatus leakage that 
happened several times a day "at worst" was reported by the vast majority of 
respondents (76.2%). Items were identified that demonstrated the highest level of 
reports of "not at all bothersome" but these did not indicate a clear majority of 
participants reporting this. No issues were therefore considered "not 
bothersome" for those who had reported at least some level of problem. 
In the first round of item reduction, 26 items were removed that offered little 
value to the final questionnaire on the basis of high intercorrelation coefficients, 
high levels of missing data, no evidence of sensitivity to change, patients unable 
to answer and issues that were rarely reported by patients. The opinions 
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gathered from the clinical experts, and also the information gathered during the 
patient interviews, also guided the removal of items to ensure decisions were not 
made according to the statistical evidence alone. All these forms of evidence 
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"At worst" item retention 
The only "at worst" items removed at this stage were 3b "at worst bowel 
opening frequency daytime" and 16b "at worst flatus incontinence frequency". 
The "usual" part of these question items (3a and 16a) directly overlapped with 
retained items that addressed bowel opening frequency per 24 hours (6a) and 
control of flatus leakage (17a). The remaining "at worst" items were retained at 
this stage despite the high levels of missing data on clinical guidance and 
because patients had suggested they were required to explain symptom 
variability (pp. 168). This was discussed at length and, while the data these items 
provided were not as complete as would be generally accepted in a self-report 
questionnaire (16 - 29% missing data ), the option to offer an "at worst" response 
in some cases was thought to have enabled the more clinically useful "usual" 
response to be completed. 
It was hypothesised that "usual" responses may have been omitted if the 
variability of symptoms could not be accounted for with the "at worst" options. 
This concept was explored further by examination of the completion rates of the 
"usual" and "at worst " responses provided for one of these question items: 
question 6 that assessed "bowel opening frequency per 24 hours". Both the 
"usual" and "at worst" response category was completed by 80.5% of 
respondents. Where a "usual" report was not provided, only 3.8% of respondents 
provided an "at worst" response. Conversely, where an "at worst" response was 
not provided, only 14.2% provided a report of their symptoms "usually". It 
appeared, therefore, that most patients did provide two responses that described 
their symptoms as they were "usually" and "at their worst". It is not possible to 
draw robust conclusions about the reasons for this without comparing the results 
in a substudy, using a version of the questionnaire with an altered response 
frame. It would appear to imply, though, that more respondents were able to 
provide a response for the two considerations as opposed to one or the other 
alone. 
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Thirty six question items therefore remained in the dICIQ-B (considering the 
retained "at worst" items as individual question items) including nineteen bowel 
pattern/ incontinence pattern items, seven for the assessment of other bowel 
symptoms and ten that evaluated quality of life impact. A series of factor 
analyses were then undertaken to identify the optimum set of items for the final 
questionnaire. 
6.7. Factor analysis 
In the initial clinical discussions regarding item inclusion prior to the 
development of the dICIQ-B, the use of the Bristol Stool Form Scales to 
characterise "normal" bowel pattern was strongly recommended. This was again 
upheld in subsequent meetings with the clinical experts. Thus item 5a which 
consisted of the Bristol Stool Form Scale was included as a stand-alone item and 
excluded from the factor analyses. 
6.7.1. Symptom items - Preliminary exploratory analysis 
Factor analysis of the 25 symptom assessment items identified a number of 
factors but only five with eigenvalues greater than one that explained 82.6% of 
the variance in the question items. Exploration of the five factors found factor 
loadings that ranged from 0.40 to 0.76 across three factors with little variability 
explained by the further two factors. Models containing two and three factors 
were therefore examined to identify clusters of items and indicate redundant 
items. In each case a Varimax rotation was applied to clarify interpretation449. 
Thirteen items loaded heavily onto one factor (factor loadings: 0.42 - 0.76) and six 
items loaded onto the second factor (factor loadings: 0.43 - 0.60). Six items did not 
load well onto any factor in these models (loadings <0.38 for all) - bowel opening 
frequency by night, amount of liquid and solid stool leakage, unpredictability, 
incontinence on the individuals' mind and anal pain/ soreness (Appendix 22). 
However, since all of these items except the "amount of stool leakage" items had 
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been identified as essential items for inclusion from the clinical or patients 
perspectives, they were retained at this stage. 
The Cronbach's alpha value for these 25 items was 0.8572. This result was within 
the acceptable range of 0.7 to 0.9 but indicated there may still be some 
redundancy among the items includedl91-193. The evidence from the original 
validation and reliability studies was therefore re-examined more critically. 
Essentially this stage required judgement decisions in order to make the final 
questionnaire as brief as possible without compromising the assessment 
provided, and which demonstrated the strongest psychometric properties. 
Further items identified for removal are detailed in Table 68. 
Table 68 Items identified for removal from the dICIQ-B on secondary 
exploration 
Item removed Rationale 
8a and b Frequency of liquid stool Sensitive to change in the overall intervention group and 
incontinence conservative management subgroup but not evident 
following surgical intervention, 8b high missing data 
(23%), wider variability in retest responses provided, it was 
also hypothesised that item 7a (staining) would capture the 
frequency of incontinence that causes staining (liquid or 
solid stool). 
11a Amount liquid stool leakage Poor factor loading (0.30), not sensitive to change, 
"moderate" reliability, clinically useful but not essential, 
not key issue for patients. 
12a and b Frequency of solid stool Not sensitive to change in the overall or separate 
incontinence intervention groups, 12b high missing data (29%), wider 
variability in retest responses provided, it was also 
hypothesised that item 7a (staining) would capture the 
frequency of incontinence that causes staining (liquid or 
solid stool). 
15a Amount solid stool leakage Poor factor loading (0.38), sensitive to change in the overall 
intervention group and surgical management subgroup but 
not evident following conservative intervention, clinically 
useful but not essential, not key issue for patients. 
20a and b Frequency of mucus Item 21a (control of mucus leakage) evaluated instead as 
leakage frequency of leakage items removed and would maintain 
consistency of format with item 17a (control of flatus 
incontinence), 20b high missing data (29%), not sensitive to 
thane. 
25a Incontinence warning Sensitivite to change in the overall intervention group and 
surgical management subgroup but not evident following 
conservative intervention, clinically useful bot not 
essential. 
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Table 68 continued Items identified for removal from the dICIQ-B on 
secondary exploration 
Item removed Rationale 
30a Incontinence with exertion Poor factor loading (0.43), not sensitive to change, 
"moderate" reliability, not clinically essential, not 
important for patients. 
34a Flatus discrimination Poor factor loading (0.42), not sensitive to change, although 
always asked, clinicians were unsure of its requirement. 
36a Incomplete evacuation Not sensitive to change. 
40a Ability to wipe clean Not sensitive to change, although always asked, clinicians 
were unsure of its r uirement. 
The remaining items were further analysed using a factor analysis. 
6.7.2. Symptom items - Final analysis 
Twelve remaining symptom items could not justifiably be removed according to 
the previous evidence and the rationale for their inclusion is provided (Table 69). 
This group of items reflected clinical and patient requirements while retaining 
items with the most robust psychometric properties. 
Table 69 Rationale for symptom items included in the final factor 
analysis 
dICI B item Rationale 
4a Bowel opening frequency night Clinical requirement, 4% missing data. 
6a Usual bowel opening frequency per 24 
hours 
Clinical requirement, sensitive to change. 
7a Staining underwear/ pad use Clinical requirement, 1% missing data, "Good" 
reliability, sensitive to change. 
17a Control of flatus leakage Patient importance, "Good" reliability, 
sensitive to change. 
21a Control of mucus leakage Clinical requirement, sensitive to change. 
26a Unexplained incontinence Clinical requirement, "Good" reliability, 
sensitive to change. 
31 Un redictabili Patient importance 
32 Incontinence on individuals' mind Patient importance 
33a Urgency Clinical requirement, 3% missing data, "Good" 
reliability, sensitive to change. 
35a strainin Clinical requirement, "Very good" reliability. 
38a Antidiarrhoeal medication use Clinical uirement, "Very good" reliability. 
41a Anal pain/soreness Patient importance, 2% missing data, "Good" 
reliabili 
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These items were entered into a final factor analysis which yielded two factors 
with eigenvalues greater than one (2.64 and 1.20) which explained 95.4% of the 
variance in the question items. All items loaded well onto these factors (factor 
loadings 0.41-0.73) with the exception of item 35a regarding straining (factor 
loadings 0.15 and 0.06). The decision was therefore made to include it as a stand- 
alone item due to its clinical importance. It was recognised that item 6b regarding 
bowel opening frequency per 24 hours "at worst" should not contribute to the 
factor given its high levels of missing data (16%). It was included to merely 
enable respondents to answer the clinically essential question of "usual" bowel 
opening frequency. 
Thus, eleven items loaded onto 2 factors with 6 items on one factor, termed 
"bowel pattern" due to the items contained, (4a, 6a, 32a, 33a, 38a and 41a) and 5 
on the other termed "bowel control" (7a, 17a, 21a, 26a and 31a). This item pool 
achieved a sufficient Cronbach's alpha coefficient value (0.7338) to indicate 
measurement of related concepts with minimal redundancy. 
6.7.3. Quality of life items - Preliminary exploratory 
analysis 
Factor analysis of the ten items that evaluated quality of life identified only one 
factor with an eigenvalue greater than one (5.24). The next factor identified was 
found to have an eigenvalue of 0.72 and therefore was not considered further. In 
addition, the factor identified accounted for 92.6% of the variance in the question 
items. Factor loadings ranged from 0.44 to 0.85 and all items loaded well onto the 
factor. With a Varimax rotation applied the item that evaluated sexual activity 
restriction (46a) no longer loaded well onto the factor (factor loading 0.37) - 
(Appendix 23). As this item was deemed essential for the final version of the 
questionnaire all items were retained at this stage. However, the Cronbach's 
alpha value for this group of items was high (0.8924) and indicated redundancy 
among the ten remaining items. Re-examination of the original substudies was 
undertaken and four further quality of life items were identified for removal as 
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they lacked evidence of sensitivity to change - 42a, "worries about smell", 44a 
"physical activity restriction", 45a "social activity restriction", 55a "food time 
alteration". 
6.7.4. Quality of life items - Final analysis 
The quality of life items retained for exploration in the final factor analysis and 
the rationale for their inclusion are detailed in Table 70. These items included the 
critical issues of importance to patients and demonstrated robust psychometric 
properties. 
Table 70 Rationale for the quality of life items included in the final 
factor analysis 
dICIQ-B item Rationale 
46a Sexual activity restriction Patient importance 
"Good" reliability 
47a Embarrassment Patient importance 
3% missing data 
"Good" reliability 
51a Awareness of toilet location Patient importance 
2% missing data 
"Very good" reliability 
53a Plan according to bowels Patient importance 
2%missing data 
"Good" reliability 
Sensitive to change 
56a Stay home more often Patient importance 
2% missing data 
"Good" reliability 
Sensitive to change 
58 Overall interference caused by Patient importance 
bowels 3% missing data 
Sensitive to change 
The final factor analysis yielded one factor with an eigenvalue greater than one 
(3.01) which explained all of the variance in the question items. All items except 
46a, which evaluated sexual activity restriction (factor loading 0.34), loaded well 
onto the factor (factor loadings 
0.45 - 0.78). This item was retained as a stand- 
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alone item due to its necessity for assessment. The Cronbach's alpha coefficient 
(0.8173) suggested that further items could be removed but this would result in 
the loss of important quality of life issues. 
6.8. Review of the proposed final version of the 
ICIQ-B 
The symptom and quality of life items were combined into one overall 
questionnaire reflecting the identified factors/ domains and circulated for final 
clinical expert opinions. The main criticism raised was that, although question 7a 
assessed the "frequency of underwear staining", there was no overall evaluation 
of the frequency of stool incontinence other than 17a and 21a, which assessed the 
"frequency of ability to control flatus and mucus". Further permutations of items 
were therefore evaluated. 
In order to assess the frequency of stool incontinence, items 8a and 12a ("usual 
liquid/solid stool incontinence frequency") were reviewed that were included in 
the initial factor analysis. The meetings with clinical experts had indicated, 
however, that items 9a and 13a were equivalent: "Frequency of control of 
liquid/ solid stool leakage". The properties of these items and the effect on the 
statistical findings of the addition of both item pairs was therefore evaluated 
(Table 71). 
Table 71 Comparative data for pairs of items to assess frequency of 
incontinence 
Characteristic 8a and 12a item pair 9a and 13a item pair 
Mean missing data % 5 _ 3.5 
Weighted Kappa x 






Inclusion onto factor Bowel control Bowel control 
Items consequently excluded 
from a factor 
32a 32a 
Variance of variables accounted 
for factors % 
90.1 89.3 
Cronbach's alpha coefficient 0.7777 0.7960 
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The pairs of items under evaluation were fairly similar, in terms of psychometric 
properties, although item 12a had not demonstrated evidence of sensitivity to 
change. The inclusion of either pair had little effect on the factor analysis and the 
clinicians' supported the inclusion of either combination. Therefore, items 9a and 
13a were selected for inclusion in further analyses due to the high levels of 
missing data observed with the "at worst" items for the alternate pair (8b-23% 
and 12b-29%). The addition of either of these item pairs did mean that item 32a, 
"incontinence being on the individual's mind", no longer loaded well onto either 
of the symptom domains. Further analyses were conducted to include this item 
within the quality of life domain due to its importance to patients, however 
factor loadings were poor. As the assessment of both of these issues was 
important, the decision was taken to retain item 32a as a stand-alone item. 
The psychometric properties of the final ICIQ-B items (Appendix 24) are detailed 
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6.9. Devising a scoring system 
The proposed final version of the ICIQ-B consisted of three domains identified 
by factor analysis: bowel pattern, bowel control and quality of life (determined 
by the nature of the items included). The three domains contained five, seven 
and five items respectively. The adequate Cronbach's alpha coefficients, 
reasonably consistent factor loadings (Table 73) and standard deviations within 
each of the three factors meant that simple additive scores were indicated and 
weighting of items was not necessary. 
Table 73 Distribution of rotated factor loadings for the ICIQ-B domains 







4a Bowel opening frequency (night) 0.51 
6a Usual bowel opening frequency (24 hours) 0.44 
33a Urgency 0.57 
38a Antidiarrhoeal use 0.49 
41a Anal pain /soreness 0.54 
7a Underwear staining 0.51 
9a Control liquid stool leakage 0.80 
13a Control solid stool leakage 0.80 
17a Control flatus leakage 0.65 
21a Control mucus leakage 0.87 
26a Unexplained incontinence 0.69 
31a Un redictabili 0.57 
47a Embarrassment 0.45 
51a Toilet location awareness 0.62 
53a Plan according to bowels 0.78 
56a Sta home more 0 77 
58 Overall bowel interference . 0.61 
Three simple domain scores were therefore inferred, requiring addition of 
frequency responses largely coded 0 "never" to 4 "always". The three items that 
did not load well onto a factor were included as unscored items along with the 
Bristol Stool Form scale due to their clinical requirement (Bristol Stool Form Scale 
and "needing to strain to open the bowels") or importance to patients ("the 
possibility of incontinence being on the individuals mind" and "sexual activity 
restriction"). The unscored items exhibited "good" or "very good" reliability and 
had reasonable levels of missing data (4-6%0). The item that assessed 
226 
"incontinence being on the individual's mind" was also able to detect patient 
reported improvement. The inclusion of these items was therefore justified in 
terms of their psychometric properties. 
6.9.1. Exploration of the ICIQ-B score 
Descriptive statistics were calculated for the domain scores from the existing 
study data and evaluated for test-retest reliability and sensitivity to change, as 
detailed below. This exploration was not intended to formally evaluate the 
scoring system as a new data set would be required. However, it was useful to 
indicate how the score may perform. Table 74 describes the domain score 
characteristics and data for the existing baseline dataset. 










Bowel pattern (n=220) 1-21 1-19 8.2 (3.5) 8 
Bowel control (n=131) 0-28 2-28 19.7 (6.6) 22 
Quality of life (n=246) 0-26 0-26 16.8 (6.6) 17 
Values of the observed scores largely represented the wide range of possible 
scores within the domain supporting the ability of the ICIQ-B to detect varying 
levels of symptoms and impact. The observed bowel pattern scores were 
normally distributed (mean 8.2 ±3.5, median 8). The bowel control score was 
positively skewed (mean 19.7 ±6.6, median 22), which was expected as the 
population were recruited according to known symptoms of incontinence. The 
quality of life score was also positively skewed as was expected among 
healthcare seeking individuals (mean 16.8 ±6.6, median 17). 
Test-retest reliability of the ICIQ-B score 
Domain scores were generated for the existing test-retest data and evaluated for 
levels of agreement. The majority of scores remained identical, or within one 
point, at retest for the bowel pattern (71.9%) and bowel control (62.5%) domains. 
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The quality of life domain scores were found to be identical, or within one point, 
for over half of the data set (63.5%), which increased to over eighty percent with 
retest scores that differed by two points included (83.8%). 
The agreement between domain scores was further analysed using the weighted 
Kappa statistic. The weighted Kappa statistic indicated "good" agreement for all 
three domain scores. 
Sensitivity to change of the ICIQ-B score 
The sensitivity to change of the ICIQ-B domain scores was evaluated using the 
paired t-test. All three domains exhibited a reduction in mean scores. Larger 
score differences were observed for the bowel control and quality of life domains 
(Table 75), although all were found to have evidence of statistical difference at 
the 0.05 level. 
Table 75 Pre- and post-intervention response difference analysis for the 
ICIQ-B domain scores (paired t-test) 





Bowel pattern 1.0 0.1-2.0 0.0339 
Bowel control 3.8 1.6-6.1 0.0025 
Quality of life 2.4 1.2-3.6 0.0001 
6.10. Conclusion 
This chapter has demonstrated robust evidence of the ICIQ-B's validity, 
reliability and sensitivity to change, to provide a comprehensive assessment of 
anal incontinence and its impact on quality of life. The initial questionnaire was 
generated according to evidence provided by both symptomatic patients and 
clinical experts. The phraseology and specific terms used were guided by 
patients, which was essential for interpretation given the self-completion nature 
of the questionnaire. 
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Content and face validity of the dICIQ-B was explored by gathering further input 
from clinical experts and patients with symptoms, to ensure important issues 
were included from both perspectives. Structured interviews with patients 
provided most of the refinements to the draft questionnaire which resulted in a 
version of the dICIQ-B that was long but straightforward to complete and 
considered to include the issues of relevance. Postal administration of the 
questionnaire enabled collection of a large dataset for each item variable. 
Question items with stronger evidence of their psychometric properties were 
identified through evaluation of further content validity, construct validity, 
convergent validity and criterion validity, in addition to reliability and sensitivity 
to change analyses. Selection of items for inclusion in the final ICIQ-B was 
undertaken according to these sources of evidence and factor analyses enabled 
the identification of domains of assessment. 
The final version of the ICIQ-B contained 21 items arranged over three domains 
that provided assessment of bowel pattern, bowel control and quality of life as 
determined by psychometric, clinimetric and patient reported evidence. A 
scoring system was identified that also showed preliminary evidence of its 
psychometric properties, although this will require reconfirmation in a new 
dataset. 
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CHAPTER SEVEN: DISCUSSION 
AND CONCLUSIONS 
Introduction 
This thesis has detailed the development, psychometric evaluation and 
derivation of the ICIQ-B, a new questionnaire for the assessment of anal 
incontinence symptoms and their impact on quality of life. This chapter will 
provide an overview of the need for the questionnaire, in terms of the size and 
complexity of the problem of anal incontinence and detail how this thesis 
contributes to assessment in this clinical area. Other aspects considered include 
the appropriateness of questionnaire assessment, the strengths and limitations of 
the methodology employed and the potential practical application of the 
questionnaire. It is recognised that this is a starting point for the ICIQ-B and 
recommendations will be made for further evaluation of the questionnaire and 
future research priorities. 
7.1. Summary of the main findings 
The need for a questionnaire to assess anal incontinence was clear from the 
literature review. When the review was undertaken, there were no published 
questionnaires that provided a comprehensive assessment of anal incontinence, 
including flatus incontinence, that had been developed in collaboration with 
clinicians and patients with symptoms, and that had been fully prospectively 
psychometrically validated. The aim of the ICIQ-B was to be as universally 
applicable as possible, rather than reserved for use in specific patient groups. The 
necessity for this questionnaire is supported by the recommendations of the 
National Insititute for Clinical Excellence guideline for the management of faecal 
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incontinence (2007)220, the Third International Consultation on Incontinence 
(2004)153,62 and the National Institute of Health (2008)2 - all had concluded that 
such a questionnaire was lacking. The ICIQ-B formed a module of the ICIQ 
project414, an international project aiming to standardise assessment of lower 
pelvic dysfunction. 
Qualitative studies were undertaken with patients and clinical experts to 
generate the developmental version of the questionnaire, fostering relevance and 
clinical applicability for the population of interest. Clinical experts largely 
influenced the symptom question items for inclusion although appreciation of 
the need to assess impact on quality of life was acknowledged. No new 
symptoms were highlighted for evaluation that did not appear in previously 
available questionnaires, but this process did enable the priorities for symptom 
assessment to be identified and to be evidence-based. Patients' input focussed 
more on the issues of impact on quality of life and the preferred phraseology 
within the questionnaire. Some overlap with existing questionnaires was evident 
for example the issue of "always needing to be aware of toilet location". Novel 
issues highlighted indicators such as "staying at home more often", for example, 
that was found to be more indicative of the severity of anal incontinence than 
previously used generic items such as "physical/social activity restriction". 
Patients also helped to advise on the scope of assessment, indicating the 
importance of flatus incontinence, for example, where evidence was lacking prior 
to this study. 
Extensive quantitative studies were undertaken to evaluate the measurement 
capabilities of the ICIQ-B and to quantify the confidence that could be placed in 
results obtained from its use. The level of this evidence for published 
questionnaires varied. The ICIQ-B is the first questionnaire for use in a non- 
specific population with anal incontinence, to provide robust prospective 
evaluation of all its psychometric properties. The data gathered at this stage 
identified problematic items in terms of missed responses, items that were found 
to elicit less stable responses over time and those that were unlikely to detect any 
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change in symptom or impact status. This evidence also identified the most 
statistically robust question items for inclusion in the final questionnaire. 
Balanced with further opinions from clinical experts and in consultation with 
initial patient-provided information, the final 21-item ICIQ-B was derived. The 
final version consisted of three scored domains: bowel pattern, bowel control and 
quality of life; and four further unscored items that provide evaluation of stool 
type, frequency of straining, incontinence being on the individual's mind and 
sexual activity restriction. 
This thesis has provided evidence of the ICIQ-B's validity, reliability and 
sensitivity to change, while retaining clinical and patient relevance, making it 
suitable for use in clinical practice and research. It is anticipated that the ICIQ-B 
will continue to evolve and will require further evaluation in different patient 
groups. At this point in time it is the best available validated assessment tool for 
use with individuals with anal incontinence. 
7.2. Why was the ICIQ-B required? 
Anal incontinence is a symptomatic complex that can arise due to various 
pathologies29'30'32-34.67-73 (pp. 10-16). Symptoms such as diarrhoea and 
constipation, commonly present in the absence of a clinical diagnosis, are also a 
major cause of incontinence18,30"40. Traumatic injury or obstetric factors can 
compromise the anal sphincter complex and give rise to anal incontinence47.49-51, 
as can treatments for a range of conditions34 62-65. With the range of causes 
attributable, it was not surprising that the literature review revealed that the 
prevalence of these symptoms was higher than generally assumed. The most 
reliable estimates resported that anal incontinence ranged from 11.8% to 19.6%84- 
88 among community men and women. Community-based estimates of faecal 
incontinence, that excluded flatus incontinence, were lower overall, 0.8%-11.2%92- 
95. It is reasonable to assume then, that anal incontinence affects one in six 
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community-dwelling adults, which was reported to rise to one in four in higher 
risk groups, such as patients with urogynaecology symptoms. 
Substantial potential limitations were highlighted with the prevalence studies in 
the literature to date (pp. 36). Unstandardised terminology was common and 
likely to affect the symptoms evaluated between studies, potentially 
systematicially over- or under-estimating symptoms experiencedl, Z82. 
Methodological choices such as direct interviewine, 89.99-l03, l09, llo, iis, in, ia3,129,13a or 
using questionnaires with no evidence of their ability to measure these 
symptoms, also potentially affected the accuracy of reported prevalence 
estimates. Essentially, it is difficult to have much confidence in published 
prevalence estimates, and so further research is required in this area14. 
Guidelines for care in this area stipulate that symptom and quality of life 
evaluation is required for all symptomatic patients13,15,220. However, these 
symptoms are notoriously under-reported, so when a patient finally discloses 
them or a clinician is in a position where it is appropriate to enquire about them, 
accurate evaluation is fundamental14. 
7.2.1. Limitations of the published questionnaires 
Accurate evaluation of this relatively prevalent symptom complex was identified 
as a need, and the variety and wide ranging nature of the causes for these 
symptoms suggested that any evaluation tool needed to be as widely applicable 
as possible. Several existing questionnaires were identified within the published 
literature. They were reviewed to establish their capability for evaluation of 
symptoms of anal incontinence and their impact on quality of life. Two 
questionnaires were considered to most closely reflect the aims of this study: 
Osterberg's questionnaire for fecal incontinence and constipation125 and 
Rockwood's Fecal Incontinence Quality of Life questionnaire4. These 
questionnaires were both applicable for males and females and had undergone 
relatively extensive psychometric evaluation. The former included symptom 
assessment while the latter focussed on quality of life evaluation. However, these 
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questionnaires exhibited a major limitation: they omitted patient involvement at 
the design stage. Furthermore, Osterberg's questionnaire lacked specificity to 
anal incontinence with the inclusion of constipation, urinary symptoms and 
obstetric history assessment (Table 22, pp. 87). 
Lack of patient involvement in questionnaire design 
Considering all of the questionnaires identified, there were four main reasons for 
the decision to develop an entirely new questionnaire. A major limitation of the 
published questionnaires was that all but three had not involved patient 
consultation at the design stage - the Postpartum flatal and fecal incontinence 
questionnaire (PPFI)277, the Colorectal functional outcome questionnaire 
(COREFO)278 and the Expanded prostate cancer index composite(EPIC)274. These 
questionnaires, however, were intended for specific populations and may not 
have reflected the issues for a more general population of individuals with anal 
incontinence. 
Systematic errors may have been introduced in the questionnaires that had not 
involved patient collaboration, as the question items included may not have 
reflected the issues of importance to patientsl%. A number of questionnaires had 
undergone content validation, through interviews or written comments received 
from patients, to review and refine draft versions4,263-M-267,272. This would be 
expected to identify any glaring omissions from the patients' perspective. The 
value of conducting exploratory qualitative research without a draft instrument 
on which to comment, however, had been overlooked in these studies. This 
methodology is now advocated by many authorsl6S, 170,171"196 and even a 
fundamental requirement stipulated in a guidance document released by the 
Food and Drug Administration"3. The guidance suggests that patient 
involvement is imperative in the design of outcome measures and the FDA will 
not support the use of questionnaires that have not used this methodology in 
medication evaluation studies. This provides further recognition of the 
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contribution of this involvement to resulting instruments in terms of robustness, 
applicability and relevance to the population. 
Qualitative exploration of the appropriateness and completeness of the content of 
the published questionnaires with potential respondents would have been 
required, in order to consider using any of the available instruments. Evaluation 
of their relevance to both sexes, inclusion of those with flatus incontinence and, 
individuals who were not from specific population groups required examination. 
In doing so it was anticipated that such changes would indicate an entirely new 
questionnaire. This was supported by the findings from the qualitative studies 
undertaken for development of the ICIQ-B. 
Psychometric evaluation 
The validation undertaken with the published questionnaires was incomplete or 
lacked rigour in many cases (Chapter three, pp. 72-109). Sensitivity to change had 
not been evaluated for most of the available questionnaires which was 
particularly important for the provision of an outcome measure4.9,263-269.271-278. 
While it might have been possible to conduct further evaluation of the 
psychometric properties of these questionnaires, this would only have been 
possible relying on the existing items, for which there was little robust 
justification. With the ICIQ-B, the intention was to start with qualitative research 
to derive an extensive number of assessment items and gather data on which to 
make evidence-based decisions regarding the final items to include in the 
questionnaire, for all its psychometric properties. 
Quality of life evaluation 
Some of the instruments had not incorporated quality of life evaluation which 
was a main aim of this study and primarily patients report it is important. This 
was not necessarily a limitation of the questionnaire as not all instruments 
identified intended to provide assessment of impact of these symptoms. It did 
preclude them from further consideration as a universal assessment instrument 
however. The bowel function questionnaire266, fecal incontinence questionnaire267 
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and FICA271 were the only symptom assessment instruments to incorporate 
evaluation of quality of life impact. The FIQL4, MHQ272 and PFIQ2.269 were 
specifically focussed on impact on quality of life and were commonly used 
alongside existing symptom evaluations. These questionnaires could, therefore, 
have been considered for further modification or further validation. But, none of 
this was relevant because of their lack of patient input at the design stage. 
Relevance to anal incontinence 
Finally, looking more broadly at the scope of assessment available within the 
published questionnaires, a number were developed for a purpose that lacked 
specificity to anal incontinence, for example, gastrointestinal symptoms, wider 
bowel diseases or more widely associated pelvic floor disorders9.263. The wide- 
ranging nature of the intended patient populations meant that incontinence 
represented only one aspect of interest for these assessments. This excluded them 
from further consideration as a universal assessment of anal incontinence and its 
impact on quality of life. Even the incontinence-specific questionnaires identified 
dedicated less than one third of question items in each instrument to 
incontinence12,2 269"m, 280. Furthermore, only three of the incontinence-specific 
questionnaires included assessment of flatus incontinencel25,2ft-269 which was 
identified as an area of essential assessment by both clinicians and patients in this 
study. It is recognised that the ICIQ-B is focussed on incontinence specifically 
and that these broader questionnaires would be more applicable for assessment 
where incontinence is not the only clinical aspect of interest. The applicability of 
the ICIQ-B is discussed in more detail later in this Chapter (pp. 269-272). 
If lack of psychometric validation data had been the only limiting factor in the 
existing questionnaires, it may have been more appropriate to consider 
modification of an existing measure. However, as the instruments were found to 
lack evidence of the reasons for item inclusion, not contain quality of life issues 
or were relevant to a broader evaluation, it was considered fundamental to take 
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the process back to the beginning and develop a new tool to provide a robust 
questionnaire to assess anal incontinence. This became the study's aim. 
7.3. Differences between the ICIQ-B and 
published questionnaires 
As indicatd above, Osterberg's questionnaire for faecal incontinence and 
constipation and the FIQL were the questionnaires that came closest to achieving 
the aims of this study in terms of scope of assessment and level of validation. As 
expected, therefore, a degree of overlap was observed with these instruments 
and the ICIQ-B. This is most evident among the symptom items. It was 
recognised that the items of relevance for clinical assessment in this area remain 
the same and as the majority of available questionnaires were developed by 
clinicians, they were well represented. The greatest differences exhibited by the 
ICIQ-B in question item content were, therefore, evident among the quality of life 
items. 
Considering the similarities and differences in quality of life evaluation it is 
necessary to compare the ICIQ-B directly with the FIQL as Osterberg's 
questionnaire only contained two impact questions regarding physical and social 
activity restriction. The FIQL did provide assessment of activity avoidance, 
awareness of toilet location and planning according to bowel activity, which 
were issues that were emphasised by patients in the qualitative studies 
undertaken for the ICIQ-B. The FIQL did not provide assessment of 
unpredictability, embarrassment and practical coping strategies, which were 
major issues identified for inclusion in the ICIQ-B by patients. Flatus 
incontinence was also identified as a problem for individuals in this study, but it 
was excluded from the FIQL, as well as eight other questionnaires out of the 
eighteen reviewed (Byrne's direct questioning of objectives method is excluded 
as the issues are identified by each patient individually)4.9 " 267" . 274.280. 
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One item within the FIQL enquired about feelings of "such sadness and 
discouragement that led the individual to wonder whether anything was 
worthwhile". A number of participants in the ICIQ-B study expressed frustration 
and demoralisation with their symptoms. None of the study participants 
however described the desperate scenario in the FIQL item and, in fact, a number 
of participants were determined to "not let their symptoms beat them". The 
overall bother item that was included in the ICIQ-B to address "interference 
caused by the bowels", enabled patients to reflect the general impact of anal 
incontinence. Individuals were able to provide an answer on a continuum 
between "no bother at all" to "a great deal of bother". This was felt to be more 
appropriate than asking how often the most extreme form of desperation was 
experienced. Patient comments supported this suggestion and the excellent 
psychometric data for this item further reinforced its inclusion. This further 
highlights the value of patient input to ensure that the most relevant indicators 
were measured. It was recognised that validated anxiety and depression 
evaluations are available that could be used in combination with either the ICIQ- 
B or the FIQL, for example the Hospital Anxiety and Depression scales or the 
Beck Depression Inventory451. These tools were designed to evaluate 
psychological aspects of life and would provide more sensitive indicators and, 
therefore, thorough evaluation of these psychological issues, by comparison with 
one or two superficial items within a symptom-specific questionnaire, if 
necessary. 
A major strength of the ICIQ-B is that the level of psychometric evaluation 
undertaken was more systematic and rigorous than with the majority of the 
published questionnaires. The extensive psychometric evaluation undertaken 
with the ICIQ-B enabled the inclusion of items specifically relevant to individuals 
with anal incontinence. For example, two items were included in the analysis 
that were widely used generic quality of life items and appeared in a number of 
questionnaires: "restriction of physical and social activities". Evidence of their 
sensitivity to change was not observed in this study, however, robust evidence of 
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this property was reported for the more specific question of "staying at home 
more often". It is suggested that this item perhaps provided a more accurate way 
of describing the real issue for these individuals, and the description may have 
resonated better with potential respondents. Considering restrictions in terms of 
physical or social activities was not how patients described their situations in the 
qualitative interviews. 
The validation studies also enabled the identification and removal of repetitive 
and uninformative items. The item, "staying at home more often" was found to 
encompass various manifestations of life restriction which meant that repetitive 
enquiry of several issues was not required. In comparison, the FIQL contains 
several similar items: fear of going out, avoidance of visiting friends, difficulty 
going to the movies or church, travelling, and separately, avoidance of travelling 
by plane or train. These individual items probably offer more specific assessment 
of quality of life impact caused by faecal incontinence, but evidence from the 
ICIQ-B suggests that there is a significant degree of overlap that may be 
unnecessary and may increase respondent burden. 
It was inevitable that some of the same issues would appear in the ICIQ-B that 
had already appeared in published questionnaires, albeit spread across the 
different instruments. Although clinicians developed the majority of the existing 
tools, the items they included would have been based on clinical experience and 
numerous interactions with patients reporting similar issues to those identified 
in the qualitative studies undertaken here. The ICIQ-B does however offer 
assessment of novel issues which are directly attributable to patient input and 
provides an evidence base for the inclusion of items that had previously 
appeared in the published literature. The ICIQ-B also minimises the degree to 
which assessment is overlapping while still providing a reliable assessment of 
related concepts, supported by the data relating to internal consistency (pp. 196). 
In essence, the ICIQ-B captured the issues that patients described as the most 
bothersome for those living with these symptoms everyday and the important 
clinical components of assessment. Thus, it provided a comprehensive self- 
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contained assessment instrument for anal incontinence that was not available in 
the published literature. Some aspects of the ICIQ-B are evident in a number of 
the previous questionnaires but none of these questionnaires comprise the 
resultant combination of items with a robust evidence base for their inclusion. 
Furthermore, the ICIQ-B provides a relatively brief tool that will make it feasible 
for use in both the clinical and research settings. 
7.4. Is questionnaire assessment appropriate for 
patients with anal incontinence? 
Previous questionnaires had been developed for assessment in this area and the 
ICIQ-B provides a new instrument that addresses the limitations of these 
measures. This relies on an a priori assumption that questionnaire assessment is 
appropriate in this patient group. The review undertaken for this thesis 
identified two main types of assessment for anal incontinence: physiological 
testing and symptomatic evaluation. Physiological tests largely encompass 
identification of anatomical deficiencies or poor physiological function211-213. 
Inherent problems have been identified with these methods, namely that they 
lack standardisation and validated normal ranges, and exhibit poor 
reproducibility and intra- and inter-observer variability214-219. From an individual 
perspective however, it could be argued that physiological assessment is most 
appropriate as physiological changes are often the intended outcome of 
treatment. The aim of surgical intervention in particular is the repair of 
anatomical defects; strengthening of the anal sphincter musculature is the aim of 
pelvic floor muscle training. 
But, it is symptoms that influence help-seeking behaviour, not the patient's 
awareness of the presence of anatomical defects. In a non-life threatening 
condition, symptoms are more important to patients than physiology452. 
Evidence has suggested that physiological findings are not linearly associated 
with symptoms. It can, therefore, be suggested that symptomatic evaluation will 
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provide the most accurate appraisal of the status and severity of anal 
incontinence from the patient's perspective "241. It is also evident that 
physiological testing cannot capture the impact of anal incontinence on everyday 
life153. This has led to the recommendation that physiological assessment be 
reserved for use when considering more complex treatment such as surgery 
rather than form part of the standard baseline assessments=7-2. Physiological 
evaluation most certainly has its place in the array of assessments available. But, 
questionnaires can provide an objective measure of subjective phenomena, such 
as symptoms and quality of life, and have an important, perhaps essential, place 
in the evaluation of chronic, non-life threatening conditionsl53. Assessment tools 
should not be considered to be mutually exclusive but as providing key 
information regarding different perspectives of the same picture. 
It is apparent that in order to evaluate a symptom complex, a symptom 
evaluation is required. This most often takes the form of a clinical history, bowel 
diary or questionnaire assessment, or a combination of these. The reason 
questionnaires lend themselves so well to this form of assessment is that they 
enable the individual to report their own experience privately4. Clinical 
histories are a traditional form of assessment in practice but their clinician- 
centred nature has been reported to underestimate the impact caused by 
symptoms°261. In addition, patients may not volunteer what is not asked 
about401. This process is also not standardised. The severity scores identified in 
Chapter Three have attempted to standardise clinical assessment, but only with 
limited evaluation of their measurement capabilities3,247,248. The difficulty still 
remains that the patient's interpretation of their circumstances may be very 
different from that of a clinician. This was evidenced in Rockwood's study where 
patient and clinician ratings of severity of anal incontinence differed, with 
patients rating potentially embarrassing incontinence as more severe than 
clinicians, who rated severity according to underlying sphincter integrity248. 
It could be suggested that questionnaires measure subjective parameters that 
may not always be changeable. For example, the issue of "incontinence being on 
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the individual's mind", that arose as an important consideration within this 
study could have been considered attributable to personal characteristics or to 
the subjective experience of anal incontinence. It could be argued that treatment 
aimed at reducing the occurrence of incontinence episodes might not alter this 
perception, and anything further may be attributed to individual coping or 
personal perception as suggested by the disability paradox370. However, the 
ability of this question item to detect change following treatment in this study, 
among others measuring subjective issues as shown in the outcome studies, 
reinforces the value of evaluating these important patient indicators. Only 
patients can report on their experience accurately, for which well designed 
questionnaires are considered a useful, perhaps the only suitable, tool 153,362,453. 
Questionnaires have also been reported to increase disclosure among patients 
where symptoms of a taboo nature are concerned. One direct comparison study 
among individuals with faecal incontinence found that asking people face-to-face 
about symptoms underestimated the level of symptoms in comparison to 
disclosure through the use of a questionnaire'17. Questionnaires can also provide 
a vehicle to initiate discussion without having to verbalise these symptoms, 
which can be difficult for both individuals and the health professional 
involved6,103,119,126,249,357,3e0,400-4o3. Questionnaire assessment can, therefore, be 
considered a powerful tool by which to evaluate subjective experiences and they 
are now widely used in many aspects of healthcare362. Descriptive data are lost in 
terms of each individual but this is balanced with standardised assessment that, 
if developed from a qualitative perspective, can provide evaluation of important 
subjective elements. 
It is perhaps necessary to consider the relevance of all of these assessment tools 
more simply. Why can we not just ask patients if they are better after treatment? 
This indeed provides a global evaluation, enables comparisons of different 
treatment strategies, captures the patient's perspective, reduces respondent 
burden and avoids all the difficulties associated with misinterpretation. The 
problem with this approach is that in practice it is commonly unstandardised in 
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both its phraseing and recording. Responses would be largely descriptive and 
not comparable between patients or treatments unless taken at the most basic 
level of improved or not. Standardisation in approach and particularly 
categorisation of responses could be achieved but then the richness of the 
descriptive account would be lost. 
The global approach also lacks specificity to the particular nuances of anal 
incontinence. The ICIQ-B provides a tool to identify areas which have improved 
and also those that may have stayed the same or deteriorated, which a global 
evaluation cannot reflect. What the ICIQ-B offers above global assessment tools 
in particular is the evaluation of specific quality of life aspects that enables 
subjective improvements to be detected. It has been suggested that the 
therapeutic relationship and subsequent increased understanding of anal 
incontinence can vastly improve outcomes from a psychological perspective 
regardless of the treatment intervention or symptomatic outcome415'454. Both 
global ratings of improvement and condition-specific questionnaires would 
detect improvement, psychological or otherwise, but the ICIQ-B, for example, 
also provides more detailed information regarding the nature and degree of any 
improvement. 
Global evaluations and condition-specific questionnaires have inherent 
contrasting advantages and disadvantages and these must be considered when 
selecting an evaluation tool. The main objective is to select robust assessment 
instruments that are fit for their particular purpose and this may require a 
combination of tools. Both approaches rely on the patient's perspective of their 
situation. The psychometric evidence provided in this study also supports the 
feasibility of questionnaire assessment in this clinical area. However, not all 
individuals with anal incontinence will be able to write or comprehend all 
aspects of the ICIQ-B or questionnaires in general. Limitations of the 
applicability of the ICIQ-B are discussed further below (pp. 269-272). 
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7.5. What contribution did patient input make to 
the final ICIQ-B? 
The psychometric properties of a questionnaire are important. The process 
undertaken to derive the developmental versions of questionnaires for 
evaluation, however, are often overlooked. This fundamental stage can affect the 
resultant psychometric properties as an inadequately designed questionnaire can 
omit the issues of importance for the subject area in question and risk the 
occurrence of systematic errorsl66.190"196. For example, in the case of the ICIQ-B, it 
was imperative that the question items generated for inclusion reflected the 
issues of importance for the key component areas: symptoms and quality of life. 
Thus, it seemed intuitive to gather clinical and personal input from those with 
expertise in this area and individuals who lived with these symptoms151,167- 
170,424,455_ 
Only a small number of qualitative studies had been published to explore the 
issues associated with anal or faecal incontinence in symptomatic individuals. 
The literature in this area was reviewed to investigate the issues already 
identified when considering the personal impact of these symptoms. Themes that 
emerged from these studies included emotive concepts such as fear, shame, 
embarrassment and low self-esteemlO3,276.374,37. Restriction of activities was also 
identified, typified by societal norms such as interference with praying or limited 
ability to go shopping103.276,374,377. Coping strategies were also identified which 
facilitated "normalisation" in society by minimising the occurrence of 
incontinence. These strategies were found to be instrumental in adaptation to life 
with incontinence which in turn had positive effects on mood and quality of life 
impact as individuals described "mastering their symptoms"374.376,385. 
Subsequently, the issues identified in the ICIQ-B study were found to be similar 
to the findings of this small number of exploratory studies and it may, therefore, 
have been possible to use these findings for the basis of the ICIQ-B 
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development'. Unfortunately, these studies lacked generalisability as they were 
largely conducted in females and consisted of specific study aims such as 
evaluation of a psycho-educational support group377. The similarity between 
findings could not be assumed prior to the exploratory interviews undertaken 
here and indeed further issues were identified from the qualitative interviews. 
However, this literature did provide further evidence for the inclusion of the 
identified issues. 
The inclusion of patients in the development of the ICIQ-B was considered to be 
one of this study's major strengths as highlighted throughout this thesis. 
Previous efforts to develop questionnaires for this patient group had been 
derived according to clinical assumptions in all but three questionnaires for 
specific patient groups274"277,278. This may have contributed to the problematic 
phraseing of several questionnaires and uncertainty of the relevance of the items 
included. Cockell et al's study had already highlighted that modifications were 
required to the FIQL when patients were consulted on the bothersome issues 
related to living with anal incontinence277. These refinements included the 
content of question items in addition to altered phraseing to be suitable for 
individuals with anal incontinence. 
A number of issues were highlighted for inclusion in the ICIQ-B that were 
specifically attributable to patient contributions, most notably the issues of 
"unpredictability", "incontinence being on the individual's mind", "anal 
soreness", "sexual activity restriction" and an array of coping strategies. The 
necessity to include flatus incontinence was also highlighted as individuals 
reported this to be embarrassing as it was difficult to conceal and considered 
highly inappropriate in a social setting. This had been overlooked in some of the 
existing instruments4. u "w7"2r3"274,2w and was not initially predetermined for 
inclusion here. The evidence suggested this symptom was most prevalent, of the 
anal incontinence symptoms, in the community estimates83,85.88-%"98.99 and 
similar findings were observed in this study(Table 51, pp. 180). Patients 
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themselves also reported it to be an issue (pp. 168) and it was, therefore, 
considered a crucial aspect of assessment. 
All of the published instruments failed to capture the most crucial aspect of 
"unpredictability", which was reported by all of the participants with symptoms 
of anal incontinence in this study. One item within the FIQL addressed "lack of 
control" but lack of control and unpredictability are distinct concepts. The former 
reflects awareness of the pattern of occurrence of incontinence with an inability 
to impose a sense of adult control, while the latter reflects the inconsistent and 
random nature of anal incontinence. Perhaps more interestingly, patients 
repeatedly described "unpredictability" as the major factor affecting their quality 
of life, while comments on lack of control predominantly reflected their ability to 
delay incontinence long enough to access a toilet. Nevertheless, it seems intuitive 
that intrinsic links exist between these concepts and as Cummins et alp 
reported, "perceived control is central to life quality". The ICIQ-B was, therefore, 
required at the exploratory outset at least, to capture and explore the effects of 
both unpredictability and loss of control as key indicators for these individuals. 
The issue of sexual activity restriction was also important to the patients 
interviewed and only three studies had previously investigated the impact of 
incontinence on sexual activities103,374,397. While this was not a primary focus of 
this study it emerged that it was a key question item for some participants and 
thus, inclusion in the questionnaire as discussed in Chapter Six, (pp. 167). 
Although those affected did not represent the majority of participants, for those 
who experienced restriction of their sex life the impact was sizeable. The 
likelihood of spontaneous disclosure and discussion of those symptoms was 
minimal, given the literature regarding the reluctance to disclose anal 
incontinencel03,249,374,377,400"401, in combination with the inherently taboo nature of 
discussing sexual matters. Of the eighteen published self-completion 
questionnaire, nine enquired about sexual matters4,2 65 2n, 272,274,275,277,2 8 This 
area was, therefore, fairly well represented in the scope of available assessment, 
in particular, two of the three quality of life specific-questionnaires4.272 included 
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this component. This provided further evidence of the requirement for the ICIQ- 
B to include such a question item in order to promote and facilitate discussions 
between clinicians and patients117.153. 
A further major contribution made by patients to this study was their input 
regarding terminology. While it was methodologically the simplest aspect of the 
study, the use of appropriate terms that would encourage correct interpretation 
and understanding of the questionnaire was critically important. This was 
particularly relevant as the ICIQ-B was intended for self-completion. 
Misinterpretation was a problem identified in the literature3,247,271. Bartlett's 
study, comparing clinician- and patient-completed questionnaires, identified that 
participants misinterpreted the term "soiling" and did not fully understand this 
term. This led to inaccurate information being captured when completed by the 
patient rather than by the clinician407. Bharucha likewise implied that flatus 
incontinence was included in their questionnaire study and yet may have 
excluded many individuals with flatus incontinence by the use of a filter 
question that did not clearly include this symptom, "... problems with leakage of 
stool (accidents or soiling)"271. It was vitally important, therefore, that the words 
used in the ICIQ-B were based on patients' opinions and re-confirmed in the 
content validity interviews. Errors due to systematic misinterpretation would 
have flawed the whole questionnaire. 
As the bowels are not often talked about socially it was imperative to ascertain 
the most acceptable words within the general population. It was interesting that 
the terms of choice were either fairly medical, such as "stool" and "bowel 
movement", or relatively colloquial in the case of "back passage", providing they 
were not deemed vulgar such as "fart". From the findings of this aspect of the 
study it was clear that the most effective way to minimise ambiguity would have 
been to use the words deemed vulgar as all participants agreed that there was 
complete understanding of these words. Most people did not think they were 
appropriate, however, for a questionnaire that they might receive from a hospital 
or as part of a health research study. Methodologically, therefore, although 
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understanding would have been maximised the completion rate of the 
questionnaire would most likely have suffered. This provided a good example of 
where the findings had to be interpreted in context as complete understanding of 
these terms did not mean that they were the right terms for inclusion in the ICIQ- 
B. The ability to draw on patient's own descriptions also helped enormously in 
phrasing the quality of life questions and aided interpretation. This was 
demonstrated by patients' comments within the content validity interviews, 
"These questions are like having a conversation with somebody". 
The specificity of this terminology to the UK English language must be 
recognised. Terms like "back passage" to indicate the rectum and anus, are 
particularly colloquial and will perhaps lack relevance in any other language 
version of the questionnaire. Due to the international nature of the ICIQ project 
and in an effort to standardise assessment in this area, translation of the ICIQ-B 
will be encouraged according to standard linguistic validation and cultural 
adaptation methodology4. Establishing the most appropriate language and 
culturally acceptable terms in new language versions will be of utmost 
importance, to ensure the ICIQ-B retains its robustness. 
7.6. Methodological issues in the ICIQ-B study 
The use of mixed methodology in the development of the ICIQ-B was effective in 
producing a data-rich evidence base from the qualitative studies, reinforced by 
rigorous quantitative studies. The information generated from the qualitative 
studies provided a strong foundation, entrenched in sound clinical knowledge, 
that reflected the experience of anal incontinence which only individuals with 
these symptoms could know. Proof of the ICIQ-B's psychometric properties was 
essential to provide confidence in the results obtained, as described in Chapter 
Two, in order to encourage acceptance by clinicians and researchersl54. 
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7.6.1. Developmental study findings 
The in-depth exploratory interviews with patients highlighted important issues 
associated with living with anal incontinence. It was hypothesised that these 
issues may serve to mask the true severity of incontinence measured by 
frequency of events alone. Assessment of the items included in the ICIQ-B is 
likely to provide more sensitive indication of improvement, or indeed 
deterioration, of symptoms because these issues are what cause most "bother" to 
patients. It was possible, however, that these issues may not be easily addressed 
with available treatments. For individuals who have experienced anal 
incontinence, learning to trust that their symptoms are improved or, relaxing the 
coping mechanisms that have been built into their everyday lives, may have 
roots in personal behaviour bearing little relation to objective improvement or 
deterioration457. 
Four of the quality of life items were found to be sensitive to change despite the 
fact that these items may have reflected habits that were slower to respond, such 
as "always being aware of the toilet location". Hence, measurement of these 
indicators was achievable and likely to provide a more sensitive evaluation of the 
experience for individuals with anal incontinence. Larger effects may have been 
observed, however, if the follow-up period had been extended. Participants in 
this study only completed the third questionnaire on discharge which may have 
excluded items that were slower to respond. 
Input was also sought from a multidisciplinary group of clinical experts to 
ensure the ICIQ-B reflected issues of clinical relevancel51,167. This more closely 
reflected the developmental process of the published questionnaires as all but 
two had involved clinicians in their development266"276. Clinicians in this study 
were invited to comment on the question items for inclusion in the ICIQ-B to 
provide a comprehensive assessment of anal incontinence. Consensus was 
achieved with regard to most question items although this was in a small group 
of multidisciplinary experts, seven participants of whom three were nurses. 
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There are no guidelines in the literature regarding an acceptable number of 
participants for this stage but it is supposed that a larger group of individuals 
would have provided more strength in the consensus opinion achieved and 
clarified issues where consensus was initially lackingln. Alternatively more 
participants could have introduced more disagreement. The study was designed 
to include as many question items as possible and only exclude items when there 
was robust evidence to do so, in an attempt to ensure required items were not 
overlooked. It is recognised though that it cannot be assumed that all possible 
question items for all clinical specialities were included. 
7.6.2. Evaluation of psychometric properties 
Representativeness of the study sample 
The second stage of development was more quantitative in nature and involved 
studies that gathered data in greater numbers by way of postal administration of 
the questionnaire to potential respondents attending outpatient clinics. The 
methodology employed involved recruitment of consecutive patients thereby 
aiming to achieve representativeness in a wide range of individuals with these 
symptoms. Females were recruited disproportionately to males (93%: 7%) 
because this reflected the population seeking healthcare for these symptoms. The 
proportions of those consecutively invited to participate were not dissimilar 
(91 %: 9%). This suggests that the recruited sample reflected the population 
targeted, but the potential bias of recruiting predominantly women must be 
acknowledged. 
The overall response rate for the ICIQ-B achieved through postal administration 
was 37.4%. A general cut-off of 70-80% is considered to indicate acceptability of 
an instrument as it implies more widespread acceptance by the population of 
interest90. Given the length of the developmental questionnaire, and the sensitive 
nature of the subject, it was anticipated as likely that the optimum levels of 
response indicated above would not be achievedl83. This was evident in previous 
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validation studies, with a response rate of only 16% achieved with the FIQL via 
postal administration only4. Higher response rates in questionnaire design 
studies have been achieved when directly approaching patients in clinic (61 %4 
and 93%2«), or follow-up of existing patient groups (70%278) and previous patient 
populations (72%272). The postal administration method was selected in order to 
reflect the intended practical application of the questionnaire. Increased response 
rates were exhibited in the retest and sensitivity to change study subgroups in 
the ICIQ-B study (76.0% and 64.6% respectively) where patients had already 
been recruited into the study. This was similar to the findings of previous 
studies, in which an existing relationship with respondents appeared to 
encourage increased participation. 
The involvement of only two study sites was also a possible limitation. Inclusion 
of two study sites rather than one, however, enabled comparisons between study 
sites to be undertaken to evaluate differences in response rates. Increased 
response rates in Bristol in comparison to London were found (61.5% vs. 33.6%). 
This was encouraging as it could suggest an explanation for non-response other 
than the ICIQ-B simply not being appropriate or acceptable to potential 
respondents. 
In terms of age and gender, the respondents who participated in the study were 
similar to the non-responders, and the sub-study groups were also similar, 
suggesting the data were representative of the adult population with anal 
incontinence. The ages of patients involved in the study ranged from 24 years to 
92 years. This suggested that age-related issues in the population of interest were 
covered by the broad age range sampled. In addition, the youngest participant in 
the qualitative interviews was aged 20 years to ensure the issues of relevance to a 
younger population were included. The self-selective nature of the participants 
may have introduced bias, but there is no reason to think it was systematic or 
that it affected the purpose of the study. 
There is no definitive standard regarding the sample size for questionnaire 
development studies. Larger sample sizes are expected to increase the 
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applicability and generalisability of the resulting instrument as more potential 
respondents would have been included458. The number of patients recruited for 
the ICIQ-B study was the largest study to date for the development of a 
questionnaire that included males and females in this area (n=261). The sample 
size was considered large enough to encompass most aetiologies for anal 
incontinence, although the cause for each participants' symptoms was not 
determined. It was assumed that over the 19 months of consecutive recruitment 
varied causes of symptoms would have been sampled. This is supported by the 
data on causes of incontinence that were collected within the qualitative 
interviews. Among the relatively small sample of 31 participants included in the 
developmental phase, which used similar consecutive recruitment methodology, 
causes for their symptoms were described as: obstetric factors, traumatic injury 
to the anorectal region, spinal injury, neurological conditions, functional bowel 
disorders, inflammatory bowel conditions and sequelae from treatment 
intervention. Patients with various disorders or neurodegeneration that would 
have prevented self-completion however, were not specifically targeted and it is 
likely that these individuals were not represented within the study. Due to the 
nature of referral to the recruitment clinics it is also recognised that non- 
independent individuals living in residential care were not recruited into this 
study, perhaps potentially limiting the applicability of the ICIQ-B in this context. 
Applicability of the ICIQ-B to a wide population is indicated, in terms of gender, 
age and some causes of symptoms, but universal applicability to all cannot be 
confirmed at this stage. 
Validity 
As described earlier, the evaluation of validity was crucial to ensure the 
questionnaire was capable of measuring anal incontinence and its impact and 
that it did not detect chance findings as the result of systematic errorsl54,174,175. 
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Content validity 
Structured patient interviews were conducted with 19 patients to evaluate the 
understanding and appropriateness of the questionnaire. Several iterations of the 
ICIQ-B were produced during this and the final developmental ICIQ-B was 
considered applicable, well understood, straightforward to complete (although 
lengthy) and relevant to the population of adult females and males, with 
symptoms of varied cause. Unresolved issues remained following the content 
validity interviews, (Appendix 14), however these were not raised again during 
the quantitative data gathering phase and so were considered to be idiosyncratic. 
Low levels of missing data were exhibited for the quality of life items (2-6%) and 
during interviews participants had commented that they felt these questions 
"really understood the symptoms". These items received most input from 
patients. The majority of symptom evaluation items exhibited acceptable levels of 
missing data (less than 5%). Problematic items were identified that exhibited up 
to 29% missed responses which were largely the "at worst" items. The inclusion 
of "at worst" response frame was suggested through patient input, and 
reinforced for use in certain question items during subsequent patient 
interviews. The provision of this alternative response option was considered a 
reasonable format, in order to reflect the inherent variability of these symptoms 
and enable individuals to describe their symptoms accurately. High levels of 
missing data for these responses were, therefore, not expected but suggested that 
perhaps some patients did not need to distinguish their symptoms. 
In the final version of the questionnaire one question retained a "usual" and "at 
worst" response frame which was related to "bowel opening frequency per 24 
hours". This enabled patients for whom variability was a problem to provide an 
answer, where ordinarily they may have been unable to provide a response, 
preventing complete assessment. Where this distinction was not required, 
completion of the "usual" category would be considered sufficient, as advised by 
the clinicians, because the "usual" response would most often be the aspect of 
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clinical relevance. In this context 16% missing data evident in the validation 
studies was acceptable. 
Construct validity 
The ability of the ICIQ-B to detect known theories was evaluated according to the 
published literature for type of incontinence, frequency of incontinence and 
gender of those affected, for all study participants. Robust evidence with which 
to compare the questionnaire findings was lacking, however, as described in 
Chapter One. The ICIQ-B was able to detect theories with some evidence, such as 
flatus incontinence that was reported by more respondents than liquid or solid 
stool incontinencelo, 83,85,8<', 88,9('-100.10.3.118-120,136,137. 
Current literature is limited and conflicting with regard to the prevalence of type 
of incontinence and gender83,88,89,92,93.107,109-114,116,126,127. It was, therefore, 
expected that the ICIQ-B would not detect a significant difference in levels of 
symptoms exhibited between females and males. The absence of a significant 
difference between genders is considered to provide further evidence of the 
construct validity of the ICIQ-B. 
In contrast to the literature, incontinence of greater frequency was reported 
among the study participants, compared with incontinence of lower 
frequency'3x"93-%"97, loz, 114,118"lw"136. The ICIQ-B study population was a clinical 
population, however, selected for the study purposes because of their known 
symptoms. The studies that demonstrated incontinence of lesser frequency were 
largely community-based studies and so did not provide a direct comparison for 
the evaluation of this theory. The studies with evidence of more frequent 
incontinence were conducted in populations of adults attending an associated 
clinic10.127 or women over 40 years of agelol. These studies included individuals 
with increased risk factors for anal incontinence and, therefore, may more 
accurately demonstrate the construct validity of the ICIQ-B. 
On reflection, comparison with a control group may have enabled further 
evaluation of the construct validity of the ICIQ-B. This would have assumed that 
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the questionnaire was appropriate for use in a non-incontinent population, 
which has not been established at this stage. 
Convergent validity 
Convergent validity of the ICIQ-B with the St. Mark's Score247 was demonstrated 
where similar concepts were evaluated, and these relationships were not as 
evident where the items under scrutiny were dissimilar. Items found to have 
evidence of convergence measured more directly comparable issues, such as 
frequency of different types of incontinence (correlation coefficient 0.67-0.75). 
Associations reduced as the relevance of the comparison diminished, for example 
"need to wear pad or plug" and "staining of underwear" (0.38). 
A further factor that could have reduced the correlations detected was that the St. 
Mark's score was used for self-completion in this study, despite not being 
developed for this mode of use. In the developmental study of the COREFO, in 
which a modified version of the St. Mark's score for self-completion was used, 
15% of respondents reported misunderstanding the structure of the questions 
and found them confusing278. Phrases such as, "taking constipating medicines" 
and "lack of ability to defer defecation" were used. It could be argued that not all 
participants would be aware that their medications were constipating in nature. 
Considered together with responses that potentially require a negative response 
to a negative question, for example "lack of ability", misinterpretation could 
arise. In the absence of a suitable gold standard, this widely used tool was used 
as the comparator, but perhaps provides further evidence of the need for a tool 
that is designed for purpose and measures appropriate indicators. 
Criterion validity 
The relationship between self-reported symptoms in the ICIQ-B and findings 
from anorectal physiology testing were evaluated for 164 patients for whom 
these data were available. A number of hypotheses were suggested such as a 
reduced maximum resting anal sphincter pressure, which was expected to result 
in increased frequency of underwear staining given the aetiology of passive 
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incontinence47. Poor correlations were reported for all suggested hypotheses 
(0.03-0.14). This has been reported within the literature regarding urinary 
incontinence and, as commented at the Third International Consultation on 
Incontinence, "it is perhaps not surprising that what is demonstrated clinically is 
distinct and different from what is perceived by patients in their everyday lives 
to be troublesome"153. In particular with anal incontinence, physiological 
parameters and symptomatic reports are often poorly correlated, as described 
earlier in Chapter Three (pp. 70-72)153,234,237,238. The main problem with these 
associations is that they assume a causal effect between one physiological finding 
and one symptomatic outcome and, while some of these relationships appear 
sensible, it must be appreciated that the relationship is not necessarily linear220, 
as concluded by Deutekom et alp, 
"the hypothesised associations between urge and passive incontinence and 
functional and anatomical impairment of the anorectum are less clear-cut than 
previously assumed". 
Anal continence requires coordination of varied aspects of the nervous and 
gastrointestinal system. Further influences such as health status, and 
environmental, practical and psychological factors, can affect an individual's 
ability to remain continent. Interplay of the fine balance between all these 
components is responsible for the presence or absence of symptoms, thus a 
reduced maximum resting anal sphincter pressure, as detected by anorectal 
physiology tests, will not always result in increased underwear staining, as 
detected by the ICIQ-B. Nor will its importance be measurable, except by asking 
patients. The lack of associations between the ICIQ-B responses and anorectal 
physiology results were, therefore, not considered to damage criterion validity. 
Reliability 
The stability of the ICIQ-B was established using a test-retest analysis for 79 
patients. This was particularly important for one of the intended uses of the 
ICIQ-B, monitoring of symptom and impact status over time. Graphical 
representation of the differences between administrations showed minimal 
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variance in the majority of the question items. The weighted Kappa statistic 
provided evidence of "good" or "very good" agreement in 46 of the 56 items 
analysed, indicating their acceptability for measurement in a healthcare setting. It 
must be considered that most patients also reported unpredictability of 
symptoms. Thus, it was highly likely that individuals would report less than 
100% agreement in symptoms, or the impact caused by them, at different time 
points. 
The reliability of the ICIQ-B in terms of the relationship between question items 
(internal consistency) was evaluated. Initial results indicated the ability of the 
ICIQ-B to measure different aspects of anal incontinence and its impact on 
quality of life, as the Cronbach's alpha coefficients for both groups of question 
items were greater than 0.7 (symptom items a=0.8984, quality of life items 
a=0.9235). These results also indicated redundancy of some question items, as 
the Cronbach's alpha coefficient for the quality of life items was greater than 0.9 
and very close to this value for the symptom items. This was expected, due to the 
exhaustive nature of the developmental questionnaire, and refinement of this 
version was intended. 
Sensitivity to change 
The main psychometric limitation of the previous questionnaires was the absence 
of sensitivity to change data. However, this is only important when considering 
outcome evaluation and not all of the questionnaires had been designed for this 
purpose. The ICIQ-B aimed to provide outcome evaluation, thus sensitivity to 
change evaluation was imperative. It was also important to collect these data 
prospectively in order to form the final version of the questionnaire based on this 
evidence in addition to the data regarding the other psychometric properties of 
validity and reliability. 
The FIQL has published evidence of sensitivity to change which was evaluated 
retrospectively through intervention trials and the repeated finding of this 
property has indicated the responsiveness of this too1287-289. The difficulty with 
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this methodology is that retrospective evaluation of sensitivity to change can 
only evaluate the items that were already included in the final version of the 
questionnaire. Prospective evaluation of this characteristic may have resulted in 
a very different final version of the questionnaire being published. For example, 
the final ICIQ-B items were selected according to the evidence for all 
psychometric properties. Selection of items based on validity and reliability data 
alone would have produced a very different version of the questionnaire. 
Retrospective analysis of that version may have provided evidence that the ICIQ- 
B was not responsive to changes in symptom or impact status. The FIQL 
demonstrates evidence of its responsiveness but it must be considered that a 
prospective analysis may have meant that more sensitive or more appropriate 
question items would have been included. 
The ability of the ICIQ-B to detect change was explored in a sub-group of 
patients who had already completed a retest questionnaire. Fifty one patients 
completed questionnaires before and after conservative or surgical treatment., 
which represented two thirds of participants involved in the reliability sub-study 
(65%). The small sample size was therefore not considered to be related to study 
design. The vast majority of individuals who completed a baseline questionnaire 
did not undertake scheduled clinical intervention in the terms described: a 
course of biofeedback therapy or sacral nerve stimulator implantation. One 
hundred and fifty eight patients (61 %o) who had completed a baseline 
questionnaire attended for only one appointment and were given advice and 
education information that was not pursued through further appointments. In 
addition, funding issues associated with sacral nerve stimulator implantation at 
the time of the study meant that low numbers were approved for this treatment 
and recruitment could only be targeted at a small population. 
Sensitivity to change was examined for complete resolution of symptoms or 
impact which was demonstrated in 19 out of the 56 question items. Two question 
items retained significance when a Bonferroni correction was applied during the 
analysis: "underwear staining" and "overall interference caused by bowels". The 
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Bonferroni correction adjusted the level at which significance was determined 
from the widely accepted 0.05 level to 0.0008, allowing for multiple tests of 
significance within the same dataset. This was undertaken to reduce the chance 
of a Type I error (incorrect conclusion of a significant result) although there are 
criticisms that this correction is too restrictive187. The correction was used in the 
analyses undertaken here for completeness and provided compelling evidence 
for the inclusion of the items that assessed "staining of underwear" and "overall 
interference caused by bowels". The remaining items that were found to be 
sensitive to change without the Bonferroni correction were also considered for 
inclusion. Although their sensitivity to change without the correction may 
suggest their significance was questionable it must also be considered that only 
complete resolution of symptoms was evaluated. Resolution of symptoms was 
analysed to provide the most robust evaluation of sensitivity to change, but it 
was likely that more subtle improvements that may have been considered 
worthwhile by patients, could also have been detected. 
The ICIQ-B was able to distinguish between those who improved and those who 
did not when independently verified. This meant that the questionnaire was not 
detecting reported improvement where this had not occurred. The independent 
verifier was the subjective clinical discharge report determined through 
discussion between the clinician and patient. As discussed in Chapter Five, this 
did not represent a robust indicator of improvement. The aim of this study was 
to provide a robust, standardised assessment for these symptoms and yet clinical 
discharge summaries were inherently subjective, unstandardised and essentially 
represented personal opinion. This comparison was only included as a crude 
further evaluation of the questionnaire's measurement capabilities and it 
provided evidence of exactly what was expected. 
Fewer of the ICIQ-B quality of life items were found to be responsive. It was 
acknowledged that these items reflected habits that may require longer to 
respond to an improvement in symptoms, such as no longer needing to "locate 
toilets on every outing" or not feeling "embarrassed". Three of the five quality of 
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life items included in the final version were individually able to detect change in 
quality of life status and the overall domain score was also able to respond to 
such changes. Thus, the findings supported use of the ICIQ-B for the evaluation 
of outcomes from clinical or research interventions. 
The more generic quality of life items regarding restriction of "physical" and 
"social activities" that appeared within numerous published questionnaires were 
also included in the developmental ICIQ-B for evaluation. These items were not 
found to be sensitive to change following intervention within any of the analyses. 
This was interesting as one might assume that these broader question items 
would address facets of restriction experienced by individuals with anal 
incontinence. More specific items that addressed "staying near to toilets", 
"staying home more often" and "planning according to the bowels", however, 
were more informative in the evaluation of the impact of symptoms for an 
individual. This brings up two points for consideration. Firstly, the lack of 
prospective validation undertaken with the published questionnaires that did 
not identify reduced measurement capability due to the use of non-specific 
question items. Secondly, these results further support the importance of the 
qualitative studies in enabling measurement of indicators of relevance. 
The appropriateness of the sensitivity to change analysis in this study must be 
considered further. It is feasible that certain question items may be more 
appropriate for an evaluation of surgical treatment compared to conservative 
management. This was evident in the analyses undertaken. Thirteen items were 
found to be responsive to reported resolution of issues following conservative 
management and fifteen responded to patients' reports of improvement 
following surgery (Tables 59 and 60, pp. 200-202). The indicators of improvement 
may, therefore, have varied between the treatments. To be completely purist a 
version of the questionnaire to evaluate outcome from conservative management 
could have been produced in addition to a surgical outcome tool. However, as 
the questionnaire was intended to be a widely applicable standardised 
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assessment and overlap existed in the responsive items for both groups, an 
overall treatment evaluation was produced. 
The prospective evidence of the ICIQ-B's sensitivity to change is a novel 
contribution in this area and supports use of the ICIQ-B in evaluating outcomes 
from clinical or research interventions. It would be further enhanced by 
repeating this study on a larger scale, particularly in a randomised controlled 
trial. Evaluation of the responsiveness of the ICIQ-B in a larger sample 
population with longer follow up periods, for other surgical and conservative 
treatment options, would also provide more information or its applicability. 
Item reduction 
In an effort to reduce the burden of the lengthy questionnaire, specific items were 
selected for inclusion in the final ICIQ-B, according to the available evidence 
gathered in the various substudies. The evidence included the psychometric data 
in addition to further clinical input and the orginal patient interview comments. 
This also enabled poorly performing items to be identified and excluded. This 
compromise between the statistical findings and qualitative evidence was 
considered essential to ensure the clinimetric properties of the questionnaire 
were retained, as well as the psychometric evidence base444'459. 
The tension that arose during the discussions with clinical experts was a 
perceived need to include all areas of assessment within the draft questionnaire, 
alongside comments that noted the excessive length of the questionnaire and its 
consequent impracticality for clinical use. Thus, it was necessary to revisit the 
earlier findings from the group and explore fully the reason for inclusion of 
assessment items, challenging habitual practice where necessary. This was 
conducted to ascertain items that would truly contribute valuable information to 
such an assessment. The group of clinical experts at this stage was larger than the 
earlier stage, including sixteen individuals from a multidisciplinary background. 
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Factor analysis 
Factor analysis was conducted to identify domains containing items that related 
to each other within the ICIQ-B, to explain the underlying structure of the final 
questionnaire. Various analyses of item combinations were undertaken to 
identify those that provided the most comprehensive assessment, displayed 
evidence of the strongest psychometric properties, and reflected the 
requirements of clinical assessment and issues of importance for patients. Factor 
analysis can be criticised as it is a relatively subjective process and different 
outcomes can be produced from the same data"9. This is an important aspect of 
analysis in terms of the ICIQ-B as it was necessary to interpret the findings in a 
subjective manner. Essentially the factor analysis provided one element of 
quantitative data to complement the other qualitative and statistical findings on 
which to base the composition of the final ICIQ-B. 
The final 21-item questionnaire contained domains to assess bowel pattern, 
bowel control and quality of life. The final ICIQ-B includes assessment of flatus 
incontinence, liquid and solid stool incontinence and mucus loss, providing a 
comprehensive assessment of all facets of anal incontinence. The bowel pattern 
domain provides characterisation of the symptoms of interest, namely bowel 
opening frequency, urgency, the use of antidiarrhoeals and anal soreness. The 
bowel control domain summarises the ability to control each type of 
incontinence, in addition to staining of underwear or required pad use, 
unexplained incontinence and unpredictability. The quality of life domain 
assesses the key indicators reported to determine impact caused by incontinence: 
embarrassment, awareness of toilet location, planning according to bowels, 
staying at home more often and overall interference. 
Four unscored items were included to provide evaluation of stool type, the need 
to strain on bowel opening, incontinence being on the individual's mind and 
restriction of sexual activities. Although these items assessed issues consistent 
with the suggested domains, they did not load strongly onto any of the factors 
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identified. This identified the need for single dimension items that did not 
statistically relate to others, but were essential for assessment that provided a 
more complete clinical picture of symptom status and interference with daily 
life175,189. In addition, the item for the assessment of sexual matters may have 
been problematic with regard to the related score if it had been included in a 
domain. The sexual activity restriction question demonstrated 6% missing data 
and also included a "not applicable" option and may have been difficult to 
account for when missed, or altered the interpretation of an additive score. 
The individual domain scores were analysed using Cronbach's alpha coefficient 
to evaluate the relationship between items and it was evident that the value for 
the bowel pattern domain (0.61) was lower than the usually accepted cut off of 
0.790.151-153. This was acceptable in accordance with a previously published widely 
used questionnaire in the field of urinary incontinence43l. Further exploration of 
alternative arrangements of question items, or additional question items for this 
domain, found that the removal of items within the domain did not improve the 
Cronbach's alpha coefficient. This suggested that the items included were 
required for the thorough assessment of bowel pattern. The addition of extra 
items moved assessment further away from those clinically relevant, in order to 
improve the statistical findings. This was felt to be inappropriate as the statistics 
were one source of evidence to be used to complement the other sources, such as 
clinimetrics-459. Also, in the interests of keeping the ICIQ-B as brief as possible, 
the selection of items for inclusion was required to be evidence-based. 
Conversely, the bowel control domain exhibited a higher Cronbach's alpha value 
(0.83), potentially indicating redundancy. Further items were required to be 
added, following the first clinical review, to make the assessment complete with 
regard to the frequency of incontinence. Thus, this was expected in order to 
ensure the ICIQ-B did not overlook a clinically important factor. The Cronbach's 
alpha value for the quality of life domain also suggested some redundancy (0.82). 
Again, removal of items would have omitted important assessment items with 
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regard to patient issues. Although some redundancy may be indicated, the 
values are within the acceptable range for this property181,189. 
Scoring the ICIQ-B 
Data from the factor analysis indicated that a simple scoring system was 
achievable, due to the fairly equal number of items in the domains and the 
contribution made by items within the domains. It is anticipated that the quality 
of life domain score, in combination with the bowel pattern and bowel control 
scores, will provide a detailed evaluation of individuals with anal incontinence. 
Use of the domain scores in combination will enable further interpretation of 
each domain, compared with evaluation of any one aspect in isolation. The three 
domain scores underwent preliminary exploration and were found to 
demonstrate validity, "good" reliability and sensitivity to change. These findings 
were expected as the score data were derived from the original dataset used to 
evaluate the questionnaire properties. This is problematic because the score data 
will reinforce the results in the original sample. This was only intended to 
provide a preliminary descriptive evaluation of the score. Further exploration of 
the ICIQ-B score is recommended in a new dataset to test the score among 
individuals reporting different findings and without the same biases. A 
randomised-controlled trial would provide more robust evidence of the domain 
scores' psychometric properties, as undertaken in similar questionnaire design 
studies203. 
7.7. Why were the final items included in the 
ICIQ-B? 
The reduction of the length of the developmental questionnaire was vital to 
increase its clinical applicability while achieving the aim of providing a 
comprehensive measurei90"0. The final items for inclusion in the ICIQ-B were 
decided according to all of the available evidence for validity, reliability, 
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sensitivity to change, correlations between similar items, and factor analyses, and 
to achieve the aims of clinical and patient relevance. Throughout this study 
tension always existed between achieveing clinimetric and psychometric 
robustness, and ideally an acceptable balance between both. The inclusion of 
items required to achieve clinimetric relevance exclusively may have 
compromised the psychometric robustness of the ICIQ-B. More emphasis placed 
on the psychometric evidence may have led to the removal of items that did not 
exhibit the strongest statistical findings but were clinically important. The 
degrees of sacrifice to achieve both aspects may be considered by some to 
constitute a weakness in the overall robustness of the questionnaire, but it was 
considered an essential requirement459. This was a primary objective of the study 
and a measure that strived for either clinical or psychometric perfection 
according to the available data, would have exhibited inherent flaws for the 
intended use of the ICIQ-B. 
Several items emerged as definite questions for inclusion according to their 
excellent psychometric properties and clinical or patient relevance. These items 
were "underwear staining", "control of flatus leakage", "urgency", "staying at 
home more often" and "overall interference caused by bowels". A number of 
items were also clearly identified for exclusion (Table 67, pp. 215-216), for 
example "flatus incontinence at night", which was found to be nearly impossible 
to report accurately for the majority of respondents. This left a cohort of question 
items to include or exclude from the final ICIQ-B which exhibited varying levels 
of positive or negative findings. Detailed exploration of all of the evidence 
regarding these items was undertaken to ensure the decision was evidence- 
based. 
An example of one of the items that required detailed consideration was that 
regarding abdominal pain associated with incontinence. Missing data for this 
item was found to be 5%, "good" reliability was observed but no evidence of its 
responsiveness was detected. Psychometrically this item did not perform badly 
but would not be useful in an outcome evaluation due to its lack of sensitivity to 
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change. The clinical importance of this item was reviewed. Consensus had not 
been achieved from the initial clinical expert opinions and clinically it was 
deemed less useful due to the number of varied causes of abdominal pain and 
the potential lack of relationship with incontinence. It was consequently 
excluded. Consultation with the original interviews undertaken with patients 
helped to clarify this exclusion, as abdominal pain was only a significant issue 
for individuals with inflammatory bowel conditions. Individuals with anal 
incontinence of varied origin had not reported major issues with pain and so the 
rationale to exclude this item was clear. 
Similarly, the item that addressed worsening incontinence associated with 
constipation was also identified for removal. Psychometrically the findings were 
poor. "Moderate" agreement and 11% missing data were observed and evidence 
of sensitivity to change was lacking. This again was an item that the clinical 
experts were not in agreement about from the outset and in the final clinical 
discussions it was suggested that incontinence was just as likely to improve with 
constipation as it was to worsen in terms of overflow incontinence. Thus, the 
question item did not offer diagnostic value and was excluded. 
Further examples of the importance of consultation with clinicians were the 
eventual retention of the items that assessed "bowel opening frequency at night", 
"use of medications to stop the bowel opening" and "straining". Although the 
level of missing data for the nocturnal bowel opening item was acceptable at 4%, 
it was reported by very few participants within the study, which was taken to 
indicate its lack of relevance. It was highlighted by clinicians that, while 
infrequent, this was an important clinical issue that indicated other causes for 
symptoms and was required in the final questionnaire. Similarly, the use of 
medications to stop the bowel opening was considered clinically important 
information when interpreting the frequency of incontinence despite the 
observed higher level of missing data at 6%. Use of antidiarrhoeal medications 
could significantly affect the resulting number of incontinence episodes and was 
reportedly valuable in the ongoing monitoring of patients. The item regarding 
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straining exhibited acceptable psychometric properties with 4% missing data, 
"very good" reliability but no evidence of sensitivity to change. Its relevance was 
questioned as it appeared to evaluate a different concept to incontinence, which 
was further reinforced by its poor loading onto the identified domains in terms 
of factor analysis data. Again the relevance of this symptom clinically, due to its 
association with subsequent pelvic floor damage and resulting incontinence47, 
ensured that it was retained despite the potential untidiness of including 
unscored items within the questionnaire. 
The issue of urge incontinence assessment was also raised by the clinical experts 
as this was not included as a separate question item as is the case in some of the 
published questionnaires. Typically question items included for the assessment 
of this symptom generally addressed the ability to reach a toilet before 
experiencing incontinence, for example "does stool leak before you can get to the 
toilet"° or "lack of ability to defer defaecation for 15 minutes"247. This issue was 
discussed and given much consideration as it was essential that the ICIQ-B 
offered clinically relevant assessment. Urge incontinence assessment can be 
argued to provide evaluation of toilet proximity in comparison to indicating 
anything clinically useful. For example, an individual who reports that they 
experience urgency "most of the time" but "rarely" experience actual 
incontinence may reflect the ability of their external anal sphincter to prevent 
that event, a clinically useful indicator. Alternatively, it may represent an 
individual who stays so close to the toilet that incontinence is infrequent because 
they know they would be unable prevent incontinence for any length of time. 
The complex interplay between physiological status, coping mechanisms and the 
resultant outcome were highlighted and the inherent difficulty of assessing the 
aspect of interest. The item regarding urgency was further reinforced for 
inclusion aside from its excellent psychometric properties as it provided the 
more clinically useful information regarding the necessity to rush to a toilet in 
order to avoid incontinence. This symptom of urgency was felt to reflect the issue 
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of interest as it was more indicative of the mechanism of incontinence regardless 
of proximity to a toilet, than actual urge incontinence episodes. 
The value of the original patient interview data was also highlighted at this stage, 
reflected by the retention of items that assessed "incontinence being on the 
individuals mind" and "sexual activity restriction". These items did not load 
well in terms of statistical factor loadings and exclusion would have provided a 
neater score than retaining stand-alone items. Their necessity in terms of 
providing a complete assessment from the patients' perspective however meant 
that they should be included if, as was evident, acceptable psychometric 
properties were observed. 
After identifying the importance of issues regarding coping strategies within the 
qualitative stages of this study, only the question items regarding "planning 
according to the bowels", "awareness of toilet location" and "staying home more 
often' were retained. Question items that assessed "staying near toilets", 
"carrying spare pants/pads", "altering the time/ type of food eaten" and 
"emptying the bowels before going out" were removed from the final version of 
the questionnaire. These items exhibited low levels of missing data (2-3%) and 
"good" reliability, but only the item that addressed "staying near toilets" was 
found to be sensitive to change and so they could not be considered for inclusion 
for accurate outcome evaluation. 
The exclusion of these items could be a criticism of the ICIQ-B as over a longer 
period of time these issues may have demonstrated a change in the reports 
provided. In addition, these items provided more detailed evaluation of specific 
aspects of the impact on quality of life caused by anal incontinence. If one of the 
main objectives of the study had not been to provide an outcome evaluation, 
these items would have been considered for inclusion according to the available 
evidence. As the questionnaire was required to provide a responsive assessment 
for evaluation following intervention the items that exhibited sensitivity to 
change were, therefore, considered further. 
268 
The retained item that evaluated "awareness of toilet location" was found to 
overlap with the item for "staying near toilets" (0.7917). It was, therefore, 
considered to cover the same issue as "staying near toilets". The item "planning 
according to the bowels" was considered a proxy for all of the coping strategies 
although correlation coefficients did not reinforce this suggestion from a 
statistical perspective. Intuitively, however, it would make sense that taking 
spare clothes wherever one goes or altering the timing or type of food eaten 
would constitute planning according to the bowels. This approach may have 
perhaps also captured other coping strategies that were not identified through 
the qualitative studies. 
The compromise required to provide a psychometrically robust questionnaire 
that also provided assessment of clinical and patient relevance is evident 
throughout the descriptions above. The ICIQ-B in its final format represents the 
optimum combination of items to achieve the study objectives but this does not 
indicate its applicability to all assessment situations and all potential individuals. 
7.8. Practical applications of the ICIQ-B 
The ICIQ-B is indicated for use in routine clinical practice and the research 
setting. The robust psychometric evidence of its measurement capabilities 
support the recommendation for its clinical use where symptom monitoring, 
treatment decisions and evaluation rely on the provision of accurate and reliabile 
assessment data. In the research setting, clinical trials evaluating new treatments 
require robust measures of the effects of an intervention in order to provide 
evidence-based conclusions on which to make future recommendations. 
Screening patients for inclusion into clinical trials requires accurate 
characterisation of individuals, for which the ICIQ-B would be well suited. 
Standardised assessment in both the clinical and research setting would also 
facilitate more widespread communication and comparisons between different 
treatment strategies and different groups of individuals with altered bowel 
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symptoms. This standardised approach will help to improve the general 
evidence base regarding effective treatment in this clinical area. 
The nature of the bowel pattern, bowel control and quality of life scores included 
in the ICIQ-B provide complementary data enabling a broad clinical picture to be 
established. Consideration of the domain scores, in combination with each other, 
will enable interpretation of the clinical picture. For example, a mid range bowel 
control score may be more accurately interpreted with a high (indicating 
increased impairment) quality of life score, indicating the level of adaptation 
required to minimise incontinence episodes. The scores provide information on 
each of the individual assessment areas, which may be of particular interest, and 
consideration of the domain scores together provides a balanced assessment of 
all important aspects. The individual questions within the ICIQ-B also enable 
issues of primary importance for a given patient to be identified. The bother 
scales of each question item in particular will enable individuals to identify the 
issues of most concern for them, which will be inherently subjective, facilitating 
targeted treatment and ongoing individualised evaluation. 
The nature of the sample of health-seeking, independent participants recruited 
for these evaluations studies means that the applicability of the ICIQ-B in 
different patient groups needs to be further explored. Further qualitative studies 
should target specific patient groups who may have been more poorly 
represented in this study such as older adults, those with spinal cord injuries and 
those living in residential care. Individuals for whom questionnaire completion 
is not a practical possibility also require further consideration and the 
exploration of proxy completion of the ICIQ-B is recommended. 
Evaluation of the acceptability of the ICIQ-B in a non-incontinent population 
would also be of great value. If the ICIQ-B, or a modified version, was found to 
be suitable within a community population this would support its use in future 
prevalence studies. These much needed data are required to establish more 
robust information regarding the level, type and impact of symptoms 
experienced through studies employing a consensus definition of anal 
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incontinence and an accurate measurement instrument14. Accurate data in this 
area would provide valuable information on which to base estimates regarding 
healthcare requirement and the degree to which individuals actually are 
"suffering in silence". The size of the study required to establish these findings is 
the most limiting factor, given the relatively low prevalence of these symptoms 
within the community 
The focus of the ICIQ-B on incontinence, although a main objective of this study, 
may be considered a limitation when considering broader assessment of 
inviduals with anal incontinence. For example, individuals with general bowel 
disorders could complete this questionnaire with regard to incontinence 
symptoms but the ICIQ-B would not provide further assessment of the other 
symptoms of interest, or impact on quality of life caused by them. This was a 
prospective decision given the availability of assessment tools validated to 
varying degrees for other gastrointestinal symptoms, and the lack of a robust 
incontinence-specific tool. The ICIQ-B cannot provide detailed assessment of 
other bowel symptoms as the intention was to provide a detailed assessment of 
one bowel symptom that can have varied origins. The ICIQ-B can be used 
alongside other forms of assessment to provide a more comprehensive 
evaluation tailored to the necessary requirements. The utility of the ICIQ-B will 
also be complemented by existing questionnaires within the ICI, providing a 
suite of questionnaires for global pelvic floor assessment. Pelvic floor disorders, 
such as anal incontinence, often occur in combination with disorders of similar 
aetiology such as urinary incontinence and pelvic organ prolapse461"462, for which 
the ICIQ provides questionnaire assessment2O3"414,463. 
The recently published NICE guideline suggests that healthcare professionals 
should enquire sensitively about the presence of symptoms with patients at risk 
of faecal incontinence to promote identification and disclosure of symptoms. 
The applicability of the ICIQ-B to aid this sensitive enquiry and provide a tool for 
case-finding is examined. It is possible to determine a "hierarchy of disclosure" 
from the published literature, according to the methods used. Individual 
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characteristics and personality undoubtedly influence the relevance of these 
findings. Voluntary disclosure of symptoms by patients', however, is suggested 
to be the least likely form of disclosure. This is considered to be due to the taboo 
nature of incontinence symptoms. Whitehead summed this up in an editorial 
comment, "If you don't ask them, they won't tell"401, supported by Hawes et al, 
Brooks and Norton° "406. Direct questioning of individuals has been criticised, 
as it relies on the individual describing socially undesirable symptoms, verbally 
and most commonly, face-to-face with a healthcare professional117. There is 
evidence to suggest that patients did not mind discussing their symptoms, 
providing they were not required to initiate the discussion and they felt well 
supported377.407. Thus, it is suggested that the method deemed most likely to elicit 
disclosure of symptoms may be a self-report questionnaire. This format provides 
a platform for the individual to communicate their experiences non-verbally, 
with a basis from which the healthcare professional can sensitively enquire 
during the ensuing discussions. The ICIQ-B may, therefore, provide a vehicle to 
implement this aspect of the NICE guideline and would be an exciting 
innovation for this research220. Further evaluation of the appropriateness of this 
approach is required in a comparative study, in addition to establishing the 
ICIQ-B's applicability in a non-incontinent population as already discussed. 
7.9. Strengths and limitations 
The strengths and limitations of this study have been illustrated in detail 
throughout this chapter. In summary, the qualitative studies undertaken with 
patients to derive the items for inclusion in the ICIQ-B were considered a major 
strength of this study. This input enabled the identification of relevant question 
items and the most appropriate terminology for this patient group. The nature of 
these studies must be considered in order to evaluate the relevance of the ICIQ-B 
to patients. In the initial exploratory studies, only thirty one patients were 
interviewed which may be considered to threaten the generalisability of the 
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findings. This is a common criticism and often contentious issue in qualitative 
research as patient samples are selected to be representative but not in the same 
manner as more quantitative approaches, such as stratified sampling or a 
predetermined sample size419.4". Individuals were recruited to this study to 
represent those with the symptoms of interest and an iterative methodology was 
employed to achieve saturation of emerging themes. Further interviews were 
not providing new information which would suggest that the predominant 
themes for this patient group had been identified. It cannot be assumed however, 
that all issues for all symptomatic patients were included. 
The large sample size recruited in this study was considered a major asset by 
comparison with previous questionnaire design studies. This large sample meant 
that a large dataset could be established regarding all items within the 
developmental version of the questionnaire, although smaller populations within 
the sub-studies are acknonwledged. The extensive analysis of this dataset 
provided robust prospective evidence of the psychometric properties for the 
ICIQ-B. It is acknowledged that the majority of recruitment was undertaken in a 
tertiary referral centre, which may have introduced bias. This bias may have 
affected the resulting population in two ways. The patients recruited potentially 
represented those with particularly severe symptoms and also those who were 
most motivated to access treatment for their symptoms, namely females. No 
interviews were undertaken among patients not seeking treatment for their 
symptoms who may have represented either end of the severity spectrum. 
Further targeted qualitative studies would be beneficial to provide more 
evidence of the applicability of the ICIQ-B among individuals with varying levels 
of symptoms and, its potential use for epidemiology purposes. The wider 
applicability of the questionnaire to those individuals who were not well 
represented within this study also requires evaluation, for example, individuals 
living in residential care. 
The low response rate of the baseline questionnaire (37%) was an initial cause for 
concern. Differences were exhibited between the study sites and also among the 
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patients followed up in subsequent sub-studies that indicated higher return rates 
(62-76%). The length of the developmental questionnaire and the fact that it 
enquired about sensitive issues were considered to contribute to the initial 
findings. It was also recognised that a number of patients who were invited to 
take part in the study did not ultimately attend their clinic appointments. 
Personal reasons to those particular individuals, unknown to the investigator, 
were also considered attributable for the lower return rate of the questionnaire. 
While it cannot be assured, it is suggested that these return rates support the 
appropriateness of the ICIQ-B for the patient group, and its feasibility for postal 
administration. 
7.10. Recommendations from this research 
There is an element of overlap when making recommendations for the clinical 
application and further evaluation of the ICIQ-B. Further research is required in 
some cases to increase knowledge of the clinical applicability and uptake of the 
questionnaire. As expected, the recommendations for research are intrinsically 
linked with the clinical application of the ICIQ-B but suggestions for these two 
areas are included below. 
7.10.1. Recommendations for clinical practice 
The ICIQ-B can be incorporated into clinical practice to provide a robust 
self-completion assessment for individuals with anal incontinence at 
baseline, ongoing monitoring and treatment evaluation. 
. Active dissemination of the ICIQ-B for use in clinical practice is 
encouraged, to achieve standardisation of assessment in this clinical area. 
"A consensus definition for anal and/or faecal incontinence is required to 
enable multidisciplinary and multinational agreement of symptom 
parameters. 
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" Accurate prevalence and incidence data are required in this area, using 
uniform definitions and robust measurement tools, to establish healthcare 
requirements. 
7.10.2. Recommendations for future research. 
" Sensitivity to change of the ICIQ-B should be further evaluated in a larger 
population of symptomatic individuals, undergoing different treatment 
modalities (for example, alternative surgical options or injectable bulking 
agents), and include a longer period of follow-up. 
9 The clinical scoring system requires appraisal in a new dataset to 
determine the psychometric properties of the domain scores. 
. Evaluation of differences between treatment types is suggested through a 
randomised controlled trial using the ICIQ-B. 
The applicability of the ICIQ-B should be evaluated in individuals not 
represented well in this study, for example, older adults, individuals with 
spinal cord injuries and dependent individuals living in residential care. 
This may also require evaluation of completion by a proxy. 
" Evaluation of the meaning of score differences to patients to establish 
minimal clinically important differences and aid score interpretation. 
. The applicability of the ICIQ-B for use as a case-finding tool requires 
exploration in a non-incontinent population. 
. Similarly to clinical practice recommendations, dissemination and 
facilitation of access to the ICIQ-B is encouraged, to standardise outcome 
evaluation in the research setting. Accurate reporting and widespread 
communication of research outcomes using the ICIQ-B will establish a 
more robust evidence-base for treatment outcomes in this field. 
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7.11. Conclusion 
Anal incontinence is a difficult area in which to establish robust evidence as, 
consensus is lacking at the basic level of its definition. The literature review of 
this thesis has established that it affects a small proportion of the community, but 
in greater numbers than was previously thought. The literature also showed 
increased risks of anal incontinence for women following childbirth, those with 
neurological conditions, and those experiencing complications following 
numerous treatments and surgeries. It also showed that, although anal 
incontinence only affects a minority, the effect on them can be substantial and 
socially debilitating. This is not only due to the direct effects of incontinence, but 
also from the considerable effort taken to conceal the existence of these 
symp 
Historically, assessment had taken the form of clinical severity scales which were 
useful for quantifying incontinence clinically, but failed to capture the impact of 
these events on patients and largely lacked evaluation of their measurement 
capabilities. Physiological measures were also used for assessment and, while 
these have their place in identifying anatomical defects, they fail to capture the 
lived experience of symptoms. The importance of the patients' perspective has 
been recognised with the increased evaluation of quality of life. The symptomatic 
experience and subsequent impact for patients is likely to be the motivating 
factor when considering treatment options and assessing success or failure. 
Before the research for this thesis, there had been no psychometrically robust 
measurement of anal incontinence and its impact on quality of life that had been 
developed in collaboration with clinicians and patients. The importance of this 
was twofold: firstly, vital indicators of impact for patients had been overlooked - 
issues more likely to signal improvement or deterioration as they are pertinent 
for individuals with these symptoms. Secondly, exclusion or inadvertent 
omission of flatus incontinence ignored an important facet of this symptom 
276 
complex, which may be more prevalent than any of the other types of faecal 
leakage, as observed in this study. 
This study, to develop the ICIQ-B, incorporated clinicians' and patients' 
perspectives to determine the content of the questionnaire, and prospectively 
evaluated its measurement properties. This means that users of the ICIQ-B are 
able to judge the confidence that can be placed in the results obtained. This study 
provides evidence that the questionnaire is a valid, reliable and sensitive self- 
report questionnaire for anal incontinence and its impact on quality of life. The 
ICIQ-B is suitable for use in individuals with anal incontinence of varying cause 
although further evaluation studies will continue to provide evidence of the 
ICIQ-B's applicability. It comprises a scientifically justified scoring system which 
will be valuable in clinical practice and research. The ICIQ-B provides a robust 
tool to standardise assessment of anal incontinence and reflect the patient's 
perspective of the severity of their symptoms and impact on quality of life. Thus, 
the ICIQ-B will provide improved assessment capability in this important and 
relatively neglected area of clinical practice. 
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Free text analysis coding frame APPENDIX 1 
Coding frame devised to code free text comments made by patients in a 
randomised controlled trial of biofeedback in response to question: 'If your 
bowel control does restrict your life, please briefly describe in what way(s)? ' 
Anal pain/ soreness Travel/holidays 
Clothing Toilet location 
Working life Social life 
Food restriction Anxiety/ nervousness 
Fear of incontinence/ going 
out 
Medication 
Stress type leakage General worry 
Coping strategies Wind 
Incontinent episodes Physical activities 
Bowel unpredictability Tiredness 
Hygiene/ odour issues Bowel control 
Dietary timing Personal relationships 
Urgency Reduced confidence 
Sex life Overall life 
Frequency Body exposure 
Pain/ discomfort abdo Depression 
Isolation Incomplete emptying 
Stress Noise of bowels 
Diarrhoea/constipation Embarrassment 
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Patient interviews - patient information sheet APPENDIX 2 
ICIQ Study 
Development of the ICIQ questionnaire 
Introduction 
We would like to invite you to help us develop a new questionnaire to assess bowel symptoms. 
The questionnaire aims to measure patients' bowel symptoms and the impact of these symptoms 
on patients' quality of life. The questionnaire will then be available for use by patients to measure 
the effectiveness of treatments for bowel symptoms. 
The questionnaire is called the ICIQ (International Consultation on Incontinence questionnaire). 
At the moment, the questionnaire is being developed, and we are asking for patients to help us by 
giving us their opinion on the content of the questionnaire with the aim of developing some new 
questions. This will help us to develop the questionnaire and make it a more useful tool in 
assessing bowel symptoms. 
What will I have to do if I take part? 
The study will involve 50 patients. We are interested in the views of all patients, including those 
who do not have bowel symptoms. If you would like to participate in the study, all that you would 
be required to do is discuss your symptoms with a member from our research team - Miss Nikki 
Gardener (Research Associate/Nurse). 
The discussion will take a maximum of 60 minutes and will be held in a private room. Once you 
have left the discussion, the study is finished. 
Are there any possible benefits? 
The information that we get from this study will help us to develop a better questionnaire schedule 
for measuring patients' bowel symptoms and the impact of these symptoms on patients' quality of 
fife. The questionnaire will then be used to measure the effectiveness of treatments for bowel 
symptoms. 
Do I have to take part? 
No, taking part is voluntary. If you prefer not to take part you do not have to give a reason. Your 
doctor will not be upset and your future treatment will not be affected. If you take part, but later 
change your mind, you can withdraw at any time without affecting your health care. 
What do I do now? 
You will be asked by the researcher named above to participate in a discussion about your 
symptoms. Once the discussion is completed, the study is finished. 
please note that the discussion is strictly confidential and anonymous. Information gathered will 
only be used for the purposes of the research mentioned above and the results presented such 
that the information from a single individual cannot be Identified. Access to the Information you 
provide will be limited to members of the research team and will not be seen by the doctors or 
nurses in the clinic or by your GP. 
Thank you very much for considering taking part in our research. 
Professor Paul Abrams (Professor of Urology) 
Miss Nikki Gardener (Research Associate/Nurse) 
Bristol Urological Institute, Southmead Hospital, Westbury-on"Trym 
Bristol, BS10 SNB. (0117) 950 5050 x2228 
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Patient consent form APPENDIX 3 
Centre Number: 
Study Number: 
Patient Information Number for this trial: 
CONSENT FORM 
Title of Project: 
Name of Researcher: 
[Name and number of independent person] 
Please initial box 
1. I confirm that I have received enough information about this study. 
ED 
2. I understand that my participation is voluntary and that I am free to 
L1 
withdraw at any time without my medical care or legal rights being 
affected. 
3. I am willing to allow access to my medical records but understand that 
strict confidentiality will be maintained. The purpose of this is to check 
that the study is being carried out correctly. 
4.1 agree to take part in the above study. ED 
Name of patient Date 
Name of person taking consent Date 






Qualitative interview schedule APPENDIX 4 
ICIQ study Interview schedule pre- 
Main aim to explore pertinent issues for people with anal incontinence. Prompt 
list only. 
" How would you describe your symptoms? 
" What type of incontinence? 
" How long suffered with it? 
" What brought them to the doctor? 
" How manage symptoms? 
" Does type/frequency of incontinence vary? 
" Does anything cause the incontinence? 
" What is the biggest/main problem for you with regard to these 
symptoms? 
" What bothers you most about these symptoms? 
" How does it bother them? 
" How does this condition affect your life? 
" Does it stop them doing anything? 
" Do you do anything differently because of this condition? 
" How do they refer to it eg. accident, leakage, etc? 
" List of bowel terms for their opinions regarding acceptability. 
" What would you like to be asked regarding this problem? 
" What are the important aspects that we need to ask about? 
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Terminology exploration list APPENDIX 5 
List of terms used to describe bowel associated concepts for use in patient 
interviews to explore acceptability and understanding. 
" Bowel movement " Poo 
" Rectum " Mucus 
" Gas " Faeces 
" Motions " Flatus 
" Bowel action " Accident 
" Liquid stool " Bottom 
" Bowel soiling " Fart 
" Evacuation " Leakage 
" Bowels open " Anus 
" Stool " Staining 
" Bowel seepage " Back passage 
" Wind 
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Qualitative interview analysis coding frame APPENDIX 6 
Coding frame devised to code qualitative patient interview transcripts. 
Bowel symptoms 
Diarrhoea Rectal bleeding 
Improvement with medication Frequency 
Abdo pain Constipation 
Bloating Mucus 
Anal soreness Soft stool (not inco) 
Prolapse Piles 
Bladder worsens bowel Wind 
Anal incontinence 
Dramatic leakage Seepage leaks e 
Varied frequency Time of incontinence 
Type of incontinence Improvement with treatment 
- Varied awareness of incontinence UrjenZy- 
Varied control Varied amount 
Inability to discriminate between flatus 
and stool 
Incomplete emptying 
Unpredictabili! y/no pattern 
Lifestyle 
Dietary restrictions Stress 
Use of pads Need for emergency pads /pants 
Relationshis Main bother 
Importancef toilet location Social life 
Sex life Exercise 
Incontinence being on the mind Hygiene 
Fear of going out Travel issues 
Embarrassment Social acceptability 
A related condition Not letting it stop activities 
Coin strategies Negative feelings 
Plan activities around bowels Clod-tin decisions 
Other symptoms 
Irritabili Urinary incontinence 
Other issues 
poor information give Weight issues 
Test results Associated "unwellness" 
Difficulty with pelvic floor exercises 
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Symptom item list for clinical expert comments APPENDIX 7 
Symptom items circulated to the sample of clinical experts for comments 
regarding inclusion in the new questionnaire. 
Upper abdominal symptoms 
Eating affected Nausea 
Swallowing affected Burping/ belching 
Heartburn Bloating 
Chest pain Upper abdominal fullness 
Regurgitation Abdominal distension/swelling 
Lower bowel symptoms - storage 
Ability to delay bowel movements Longest bowel movement free period 
Urgency of bowel movement Need to return to toilet less than an hour since 
bowels last open 
Frequency of bowel movement Rectal fullness sensed before incontinence 
Number of bowel movements Flatus and stool discrimination 
Lower bowel symptoms - evacuation 
Use of antidiarrhoeals Rectal in anal soreness 
Use of laxatives, enemas, suppositories Pain on bowel movements 
Straining Average length of time for bowel movement 
Severity of straining Timespent on commode 
Length of time straining (duration in years) Altered positioning required to enable bowel 
movement 
Di Tation for bowel opening Bowel pattern 
Vaginal di Tation for bowel opening Abdominal pressure required for defaecation 
inability to open bowels when have the 
urge/constipation 
Stool consistency 
Constipation duration Stool loose or watery (not incontinent) 
Use of constipation medication Stool hard (not incontinent 
Incomplete evacuation Mucus (not incontinent) 
Obstructive symptoms Diarrhoea 
Abdominal pain Blood in stool 
Lower bowel symptoms - incontinence 
Stool leakage Frequency of liquid stool incontinence, day and 
night 
Stool leakage for no reason and not associated 
with no need for the toilet 
Frequency of solid stool incontinence, day and 
night 
Uncontrolled stools Frequency of mucus incontinence 
Duration of incontinence Amount of leakage 
incontinence waking/ sleeping Protection used 
Rectal sensation during incontinence Protection used waking/sleeping 
Ur t stool leaks e Underwear staining, day and night 
Frequency of flatus incontinence Difficulty wiping clean following bowel 
movement 
322 
Developmental ICIQ-B (1) APPENDIX 8 
QQ QQ QQ 
CONFIDENTIAL DAY MONTH YEAR 
Today's date 
Many people experience bowel accidents or bowel leakages. We are trying to And out how 
many people experience these symptoms and how much this bothers them. We would be 
grateful It you could answer the Mowing queslons, thinking about how you have been over the 
PAST THREE MONTHS. There are 3 answers for most questions that we would like you to 
consider how you are "usually'. how you are at your ~ and then how much it bothers you. 
I Please write in your date of birth: 0[0EE 
DAY MONTH YEAR 
2 Are you (tick one): Female [] Male [] 
Bowel pattern 
3a. How often do you open your bowels during the day? (Tick one box in each co/wnn) 
Usual At 
worst 
several limes a day D. [] 
once a day QQ 
every other day QQ 
Inas than twice a week QQ 
less than once a week 
3b. Now much does this bolt er you? 
PlMse'Mp a number befMeen 0 (W at arg and 10 (a great deal) 
0123456789 10 
not at al a great deal 
44L How often do you ogel Yost bowlt dwii 1110 Rlhl from OWN to bed to sleep 
uFM you Od uP In the momma? (Tkk one box in Dach c dumm) 








4ä How much does this bother you? 
four or mom + 
P! eaae my a number betwow 0 (not at ato and 10 (a great 4050 
0123456789 10 
not at a0 a great deal 
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5a. Using the pictures, please indicate how your bowel movements are most of the 
time? (7eck ati boxes that apply; 
separate hard lumps 
° 
like nuts (hard to pass) 
sausage-shaped but lumoy 
El 
like a sausage but with cracks on it's surface 
+ý ß 
like a sausage or snake - smooth and soft 
soft blobs with clear cut edges (easy to pass) AD 
flufifi pieces with ragged edges, a mushy stool 
i l eces watery. no so id p 
5b. How much does this bother you? 
Pease nng a number between G (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
6a. How many times do you open your bowels per day? (Tick one bo)) 
less than one 
one to three 
three to ten Q 
ten or more F-] 
6b. How much does this bother you? 
Please nng a number between C (. not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
7a. Do you experience any staining of your underwear or need to wear pads because 
of your bowel problem? ( Tick one box in each column) 
Usual At 
worst 
never 71 [] 
less than once a month D EJ 
about once a month [] 0 
about once a week 0Q 
every day [] 
7b. How much does this bother you? 
Piease ring a number between 0 (not at ail) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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Liquid stool 
8a. Now often do you experience liquid stool leaking from your back Raasape, on 
average? (Tick one box In eea, coWw) 
üsuel At 
worst 
never E] [:: I less than once a month 1-I [J 
about once a month QQ 
about once a week ý] Q 
about once a day] 
so 8b. Hort much does this bather you? several Imes a 
day 
Please rmp a number between 0 (not at all) and 10 (a great deal) 
0123455789 10 
Tat all a great deal 
9a. Are you able to control liquid stool leaking from your back passage? (Tirak one 




Hast of the time QQ 
some of the eQQ 
QQ 
sb. How much does this bower you? 
MW E] C_-.! 
Please rsp a rnanber between 0 (not at aV and 10 (a great dealt 
0123456789 10 
not at all a great deal 
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10a. How often do you experience liquid stool leaking from your back passage at 




Im man once a minim QQ 
abaßt once a month EJ Q 
about once a wow Elj [] 
about once a night E: ] Q Q Q1 10b. How much doe: this bother you? 
3everai # mesa night 
Please ring a number bet~ 0 Mat at aQ and 10 (a Hower deal} 
0123456789 10 
not at all a great deal 
11a. How much liquid stool do you think leeks from your back paasape? (Tick one box 




a small amount D 
a moderate amount [J Q 
a la ge amount 
11b. Now much does this bother you? 
Please ft a nun*er between 0 (not at ae and 10 (a great mal) 
0123456789 10 
not at all a great deal 
Solid bowel movement 
12a. How often do you experience accidental loss of solid bowel movement from your 
beck gesso'. on average? (Tirck wie box irr each colunm) 
Usual At 
worst 
never El f-I 
Ism than once a month DD 
about Once a month D [] 
about once a week DD 
about onceadirL] D 
several Inas a day DD 12b. How much does this bosh r you? 
P1®aae r* a number between 0 (not at al and t0 (a great dew) 
0123456789 10 
not at all a great deal 
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13a. Are you able to delay accidental loss of solid bowel movement from your back 




most of the time nQ 
some of the *ne F-1 F-1 
QQ DD now 130. How much does this battier you? 
Please Im a n&nber between 0 (not at alo and 10 (a great dread 
0123456789 10 
not at all a great deal 
14a. How ollen do You experience Vital loss of solid bowel move t from your 
back PessqP at night, on average? (Tick one box in each column) 
Usual At 
worst 
now na kess ihan once a Month 7F1 
about once a month D 
about once a week ý] U 
about once a right QQ 
several Imes a night D [D 
14b. How much does this bother You? 
Please MV a number between 0 (not at aiQ and 10 (a mat deW) 
0123456789 10 
not at al a great deal 
15e. Haw much soUd bowel movement do You think you eccitbnn ly loss from yaw 
back pessape? (liar one box i, each column) 
u At wow 
none DL 
a small amount QQ 
a moderato amount 0D 
entire bowel movement D 71 
15b. How much does this bother you? 
pease nyp a number between 0 (rat at &V and f0 (a great deal) 
0123456789 10 
not at all a great deal 
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Wind 
16a. Now o11en do you experience wind accidentdly escapi g from your beck 




less than once a month QQ 
about once a month QQ 
about once a week QQ 
about once a day t] Q 
several times a day nQ 
16b. How much does this b~ you? 
Pease na rwmber between 0 (not at aN) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
1 78. Are you able to control wind ascapi ig from your beck passage? (Tick one box in 
eadº CO OM) 
Usual At 
wont 
always [] D 
most of the time [D C] 
some of the time JJ [j 
rarely 71 F-I 
17b. How nnarh does this bother you? 
"DD 
Please ring a number between 0 (not at aH) and 10 (a great deep 
0123456789 10 
not at all a at deal 
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1es. How often do you eperlsace wind accidentally escaping from your beck 




has than once a math E] El 
about once a month Da 
abonce oweek ut a about once a night nQ 
semw ti at 1ý C7 18b. How much does this boQMx yyou? 
Please mw a number between 0 (net at al) and 10 (a great deal) 
0123456789 10 
not at al a great deal 
19a. Now much wind do you think escapes fron year back passage? (Tick one box in 
each _- -) tbwl At 
"we 
now D0 
a small amount D El 
a moderate amount D] Q 
19b. How much does this bother you? 
a large amount J C] 
Please Hing a number between 0 (not at al) and 10 (a g, eat deal) 
0123456789 10 
not at me a mat duet 
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Mucus 
206. Now often do You expe[ienoe mucus les" from your back Passage, on 




Bess than once a month D 
about once a month [] 
about once a weeks DQ 
about once a day E] [ý 
several times a day UU 20a. How much does this bot er you? 
Please hrp a minter between 0 (nat at airy and 10 (a great deal! 
0123456789 10 
not at a4 a great deal 
21a. Are you able to contrd mucus looking from your back passage? (Tick aura box in 




most of the lime Q 
Same of the IRS DD +D D 
now D Cl 21b. How ouch does Ulis bother y ou? 
Please rrtp a number between 0 (not at MR and 10 (a peat deal) 
0123456789 10 
not at all a groat deal 
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22a How often do you mucus lea q from your back passage at night, on 
aMarape? (Tk* one box in each cc*mw ) 
Usual At 
Mraorst 
never DD less than once a mo 1h QQ 
about once a month F-1 71 
about once aweek DD 
about once a not D E1 
2M Fiorr much does this bother you? 
several Imes a night DQ 
Please ring a nwanber between 0 (not at M) and 10 (a great deal') 
0123456789 10 
not at al awat deal 





a small amount F-1 
a modenift amount 
a law amount D Ca 23b. How nah doss this botlnr you? 
Pfeaae rU a ntai er beMewº 0 (not at alp and tO (a at deal) 
0123456789 10 
notatal aOno dear 





nx* of the *no D0 
na 24b. How much dop this bot you? 
Please tw a nea7 er 6 es 0 (net st aNj and 10 (a pmt dean 
0123456789 10 
net at a1 a gle t del 
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most of the +Dn 
sorm of the +i DD DD now DD 
. Hcw much don this boffw you? Flenne rüg a number between 0 (not at aH) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
26a. Do you have bowel accidents when you have no need to open your bowels? (Tick 
am box in each column) 
Usual At 
worst 
never ED 0 
some of the nie 0 [I 
most of the äme [] Q 
26b. Now much does this bother you? aa 
Please rbc a nranber be(weaº 0 (not at aI) and 10 (a mat deal) 
0123456789 10 
not at al a great deal 





nvM of the *m nQ 
some of the lkne QQ 
row QQ 
never QQ 27b. Haw much does this b~ you? 
P%M ring a nu nV. er bei+seen 0 rust at MY) and 10 (a Weeat deal) 
0123456789 10 
not at as a great deal 
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291. How long hm you experienced bowel leakages or accidents? (Tkk one box 
IBS than one year 
one to Ave years El 
five to ten years F] 
Inas than ten years [] 
28b. How much does this bother you? 
Please *a number bmv en 0 (not at airy and 10 (a great deal) 
0123456789 10 
not at all a great deal 
29a. Are you able to lei On c ilWel between needing to pass wind and needing to 




most of tim *m D0 
of the D0 
ran* 00 
now D Cl 
29b. How much dons this bother yyou? 
Plleaas ring a ncanber be%Keen 0 (not at at) and 10 (a great deal) 
0123456789 10 
not at all a gait deaf 
30a. Do you need to Wain to open your bowels? (Tick one box In each cakann) 
WWI At 
worst 
QQ Mesa than once a month QQ 
about once a month D [] 
about once a week C] 
about once a day [] Q 
several times a day QQ 
30b. How much floes this bother you? 
Please ring 8 nLMer between 0 (not at aN) and 10 (a at deal) 
0123450789 10 
not at all a great deal 
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most at the ume DQ 
some of the em El [l 
ra+Q Q 
nevQ Q 
310. How much does thk bother YOU? 
Please g* a minter befivwn 0 (not at a i) and 10 (a eat deal) 
0123456789 10 
not at all a great deal 





less than once a moth LJ 
D 
about once a month 
about once a week El 
about once a day nQ 
several times a day ý] D 
32b. How, much does this bbother you? 
Please ring a nurr)er between 0 (rat at el and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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no less than once a mauem D El 
about once a nmx th Ej 
about once a wee* DQ 
about once a day j_] 0 
ý---_I l-1 33b. How much does this boom you? 
several times a day 
Please n, a number between 0 (not at aA) and 10 (a great deal) 
0123458789 10 
not at all a great dead 
34a. Do you experience pain in year etomacb with any bowel socidents? (Tikk one box 






some of the hme L] E 
most of the *ne nQ 
DQ 
34b. How much dome, this bogw you Pleaas MV it hunter betvaen 0 (not at a0) and 10 (a met deal) 
0123456789 10 
meaty agrog deal 




now EJ D 
scow of the *m [] [l 
most of the time r-] [7 
35b. How much does this bot you? 
0M 
PYses 1mg a number be[~ 0 (rod at af) and 10 (a great deal) 
0123456789 10 
not at al a dOM 
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MOOS and knpact 




of to time M most a, thne Q Q 36b. How much don this bcow you? P! esse is a member between 0 (not at WO and ,0 (a great dWQ 
0123456789 10 
not at al ag deal 
37a. Are your bowel accidents or kwk@ s unpredictable? (7 ck one box) 
never (J 
ra* 
o sorm of #W *m 
37b. How much does this bother you? 
Pfease rNI9 a mater bel eaen 0 (not at a) and 10 (a great deal) 
0123456789 10 
data agrog deal 




some d the lime C1 
most of the lime 0 
38b. Now much does this bother you? 
Pbose me a nwt r between 0 (rot at aE) and 10 (a Dreat d 
0123456789 10 
not at 4a great deal 
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39a. Do you restrict your physical activities (e% sport, shopping) due to your bowel 
problem? (Tick one box) 
never a 
rarely some of the time 
most of the time Q 
*ways a 39b. How much does this bother you? 
Please rung a number between 0 (not at all) and 10 (a great deaf) 
0123456789 10 
not at all a great deal 
40a. Do you restrict your social activities (eg. visiting friends, travelling) due to your 
bowel problem? (7,: k one box) 
never 
rarey Q 
some of the time F--j 
most at the time F-] 
always Q 
40b. How much does this bother you? 
Please ring a number between 0 (not at alQ and 10 (a great deaf) 
0123456789 10 
not at all a great deal 
41a. Do you restrict you sexual activities clue to your bowel problem? (Tick one box) 
never 
" NCI 
some of the time Q 
most of the time [J 
allays fl 
41 a. How much does this bother you? 
Please ring a number between 0 (not at aA) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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42a. Does your bowel problem cause you to feel embarrassed? (Tick one box) 
never 
rarely C] 
some of the time 
most of the time 
a 42b. How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 




some of the time Q 
most of the time a 
wa Y5 El 
43b. Now much does this bother you? 
Please ring a number between 0 (not at a! Q and f0 (a great deal) 
0123456789 10 
not at all a great deal 
44a. Does your bowel condition cause you to stay near a toilet? (Tick one box) 
never [J 
rarely Q 
same of the time [1 
most Of the Ome [--j 
a 44b. How much does this bother you? 
Please ring a number between 0 (not at alp and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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some of the time (l 
most of the time [l 
alW2ys Q 
45b. How much does this bother you? 
Please ring a number between 0 (not at all) and f0 (a great dea ) 
0123456789 10 
not at all a great deal 
46a. Does your bowel condition cause you to take spare pants, pads and/or clothes 
with you when going out? (Tick one box) 
never Q 
rarely F-I some of the 6me [J 
most of the time 
always 46b. How much does this bother you? 
Please ring a number between 0 (not at atj and f0 (a great deal) 
0123456789 10 
not at all a great deal 
47a. Does your bowel condition cause you to make plans according to your bowels? 




Some c( the time 
most of the time 
always [--I 47b. How much does this bother you? 
Please ring a number between 0 (not at NO and 10 (a great deaf) 
0123456789 10 
not at all a great deal 
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some of the time 
most of the time 
amays a 48b. Flow much does this bother you? Please ring a number between 0 (not at NO and 10 (a great deal) 
0123456789 10 
not at all a great deal 
49e. Does your bowel condition cause you to not eat before going out? (Tick one box) 
never a 
rarely a 
some of the time [J 
most of the time 
atways 0 
49b. How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great dea) 
0123456789 10 
not at all a great deal 
50a. Does your bowel condition cause you to stay home more often than you would 
like? (Tick one box) 
never 
rarely Q 
some of the time Q 
most of the time [] 
50b. How much does this bother you? 
Pleaae ring a number between 0 (not at all) and 10 (a great deal) 
0123456799 10 
not at all a great deal 
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51a. Does your bowel condition cause you to make sure your bowel is completely 
empty before going out? (Tick one box) 
never 
rwety a 
some of the time M 
most of the time F: j 
always Q 
51b. Now much does this bother you? 
Please ring a number between 0 (not at WO and 10 (a great deal) 
0123456789 10 
not at all a great deal 
52a. Do you notice any of the following? (Tick one box) 
walking causes you to leak Q 
leakage is worse when constipated Q 
Inability to wipe clean alter having bowels open Q 
52b. Now much does this bother you? 
Please ring a number between 0 (not at a11} and f0 (a great deal) 
0123456789 10 
not at all a great deal 
53. Overall, how much do bowel leakape5Iaccidents Interfere with your everyday life? 
Please ring a number between 0 (not at at) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
Please use the space below to describe any worries you have about bowel 
accidents or leakages , or anything else you think we should know. 
Thank you very moth for answering these questions. 
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Patient content validity interview schedule APPENDIX 9 
ICIQ study Interview schedule 
SPECIFIC ISSUES 
" What do you think of when you answer questions regarding liquid stool? 
What do you think of when you answer questions regarding solid stool? 
What are your thoughts on the use of the "Usual" and "At worst" columns? 
Is the term back passage necessary in questions regarding leakage from...? 
What are your thoughts on the use of the words delay and control? 
" Do delay and control mean different things? 
" What do you think of when you answer questions regarding wind? 
Are all of the wind questions appropriate? 
Is question 6 different to 3? 
What are your thoughts on the use of the terms "bowel problem" and "bowel condition"? 
Is question 31 clear regarding incomplete emptying? 
" "Does your bowel problem cause you to... " is this understandable wording? 
What do you feel about the timeframe of three months? 
GENERAL ISSUES 
" How easy or difficult did you find the questionnaire to complete? 
" Were there any words, phrases or terms that were unfamiliar, ambiguous or difficult to 
understand? If so, which and why? 
" Were the items clear? If not, which ones and why? 
" Were the instructions clear? If not, which ones and why? 
" Does the questionnaire cover all issues related to bowel accidents or leakages that you 
consider to be important? If not, why? 
" Do you feel that further items should be added to the questionnaire to assess additional 
issues or to assess those already covered in more depth? If so, what issues? 
" Are there any items that cover issues that you feel are irrelevant or unimportant? If so, 
which ones and why? 
Did you object to answering any items? If so, which ones and why? 
" Were any of the response categories unclear, inappropriate or inadequate to allow you to 
express what you felt? If so, which ones and why? 
" Do you feel that additional response categories should be added to any of the items? If 
so, which ones and why? 
" What do you feel about the length of the questionnaire? 
Was the layout and overall appearance of the questionnaire clear and attractive? 
" Are there any further comments you would like to make or items you would like to ask 
about. 
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Postal administration - patient information sheet APPENDIX 10 
ICIQ Study 
Development of the ICIQ questionnaire 
Introduction 
We would like to invite you to help us develop a new questionnaire to assess bowel symptoms. 
The questionnaire aims to measure patients' bowel symptoms and the impact of these symptoms 
on patients' quality of life. The questionnaire will then be available for use by patients to measure 
the effectiveness of treatments for bowel symptoms. 
The questionnaire is called the ICIQ (International Consultation on Incontinence questionnaire), 
which is being developed in Southmead Hospital, Bristol and at St. Mark's Hospital, London. At 
the moment, the questionnaire is at an early stage of development, and we wish to try it out with 
the help of some patients. This will help us to improve the questionnaire and make it a more 
useful tool in assessing bowel symptoms. 
What will I have to do if I take part? 
We are interested in the views of all patients. If you would like to take part in the study, all you 
need to do is complete the enclosed questionnaire and return it to us in the freepost envelope 
provided. Once you have completed the questionnaire you have finished the study. 
Are there any possible benefits? 
The information that we get from this study will help us to develop a better questionnaire schedule 
for measuring patients' bowel symptoms and the impact of these symptoms on patients' quality of 
life. The questionnaire will then be used to measure the effectiveness of treatments for bowel 
symptoms. 
Do I have to take part? 
No, taking part is voluntary. If you prefer not to take part you do not have to give a reason. Your 
doctor will not be upset and any future treatment will not be affected. If you take part, but later 
change your mind, you can withdraw at any time. 
What do I do now? 
Please complete the enclosed questionnaire and return it to us in the envelope provided. Once 
you have returned this questionnaire, the study is completed. It is important that the questionnaire 
is completed and returned to us as quickly as possible when You receive it. If you have any 
difficulties with the questionnaires, or any questions about the study, you can contact Nikki 
Gardener at Southmead Hospital (details below). She will be happy to answer any questions you 
may have. 
Please note that the contents of the questionnaires are strictly confidential. Information gathered 
will only be used for the purposes of the research mentioned above and the results presented 
such that the information from a single individual cannot be identified. Access to the information 
you provide will be limited to members of the research team and will not be seen by the doctors 
or nurses in the Clinic or by your GP. 
Thank you very much for considering taking part in our research. 
Professor Christine Norton (Professor of Gastrointestinal Nursing) 
Professor Paul Abrams (Professor of Urology) 
Miss Nikki Gardener (Research Associate/Nurse) 
Bristol Urological Institute 
Southmead Hospital, Westbury-on-Trym, Bristol, BS10 5NB 
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St. Mark's Score APPENDIX 11 
The St. Mark's score administered alongside the dICIQ-B. 
Please answer the following questions, where: 
Never = no episodes in the past four weeks 
Rarely =1 episode in the past four weeks 
Sometimes = more than 1 episode in the past four weeks but less than 1 
episode a week 
Weekly =1 or more episodes a week but less than1 a day 
Daily =1 or more episodes a day 
Please ring one number on each line 
Never Rarely Sometimes Weekly Daily 
a. Incontinence for solid 012 3 4 
stool 
b. Incontinence for liquid 012 3 4 
stool 
c. Incontinence for gas 012 3 4 
d. Alteration in lifestyle 012 3 4 
No Yes 
e. Need to wear a pad or plug 0 2 
IF. Taking constipating medicines 0 2 
g. Lack of ability to defer defecation for 15 minutes 0 4 
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Sample characteristics - content validity interviews APPENDIX 12 
Descriptive statistics of participants in content validity interview rounds. 
First round 5 females, 1 male (median age, 66 years, range 28-74) 
Second round 6 females, 1 male (median age, 54 years, range 39-72) 
Third round 4 females, 2 males (median age, 55 years, range 40-77) 
345 
Modifications to dICIQ-B - content validity APPENDIX 13 
Alterations to dICIQ-B and rationale following first round of interviews 
Change made Reason for change 
Removal of "usual" and "at worst" Out of 6 participants, 4 found it 
response categories from all symptom confusing and unnecessary, while 1 
items. person reportedly found it helpful but 
had not used it throughout. 
Response items for frequency questions The "about" categories were perceived 
altered to "less than" time categories to impose a definite time period 
instead of "about". instead of an estimation in 2 of the 
participants and 1 would have 
preferred a simple Yes or No. 
"Bowel problem" altered to "bowel 2 participants preferred to avoid the 
condition" throughout. word 'problem' and the remaining 4 
reported that either term was 
acceptable. 
"Delay" replaced with "control" Delay was reported to be a result of the 
throughout. ability to control in 4 participants and 
this ability was the key element to 
prevention of incontinence. 
Underlined terms in certain areas to Throughout, certain questions were 
draw attention to descriptors eg. "on answered differently when particular 
average how often", "medication to words were drawn attention to in the 
stop, '. interviews. Participants reported that 
had these points been more obvious 
they would have answered differently. 
Alternative terms added for types of Many people were interpreting solid 
incontinence to improve understanding stool as very hard stool and liquid stool 
of the question e. g. solid or ormed stool. as diarrhoea only. 
Hygiene and odour question split into 1 participant suggested this change as 
two separate items. they were reportedly different 
concepts. 
Affect on relationships question split 1 participant suggested this change, as 
into 'family and friends' and 'personal there are reportedly different concerns 
relationships' items. within different relationships. 
Opening instruction removed This instruction was reported to be 
regarding, "There are 3 answers for confusing by 2 participants as there 
most questions that we would like you were 5 response options for most 
to consider". questions and until they were looking 
at individual questions containing 3 
parts it did not make sense. 
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Modifications to dICIQ-B - content validity APPENDIX 13 
Alterations to dICIQ-B and rationale following second round of interviews 
Change made Reason for change 
"Usual" and "at worst" responses were 5 participants found difficulty 
reintroduced to items addressing answering these items and reported it 
frequency of opening bowels and was due to the variability of their 
frequency of incontinence. symptoms. When offered the "usual" 
and "at worst "options their response 
selection was much simpler. 
Filter questions added to incontinence 6 participants suggested and were able 
type sections. to use filter questions in order to omit 
irrelevant items if they did not 
experience a certain type of 
incontinence. 
Medication types expanded to include 'Medication' perceived to indicate 
liquids. tablets only and this excluded enemas 
and liquid suspensions. 
Extra instruction added in relevant Due to the reintroduction of the 'usual' 
questions, "Tick one box for 'usual' and and 'at worst' responses in only some 
tick one box for'at worst'. " questions, it was necessary to provide 
clear instructions regarding 
completion. 
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Issues that remained unresolved following completion of the content validity 
interviews. 
Unresolved issues I Reason for leaving 
Two participants overall reported that the 
potential of incontinence is more bothersome 
than the actual frequency which is difficult to 
reflect with the bother scales attached to each 
Item 32, "Is the possibility of having a bowel 
accident on your mind? " was felt to attempt to 
address this. 
Three participants in the third round of 
interviews reported the 'less than' frequency 
responses difficult to interpret, not liked or 
participants would have preferred 'about' or 
'more than' instead. 
Two participants overall stated that the 
bothersomeness of individual aspects of faecal 
incontinence depend on their circumstances at 
the time, for example in public or at home. 
Two participants overall recommended that 
concerns for the future should be added. 
Two participants overall commented on item 
52 regarding the necessity to carry spare 
underwear, pads and clothes, stating that it did 
not capture their situation as one had to 
destroy all her underwear and one managed 
the condition by not wearing any underwear. 
Two participants recommended the inclusion 
of an item addressing their perception of the 
cause of their incontinence. 
Appropriate terming of frequency was deemed 
to always be problematic. The use of 'about' 
was strongly disliked within the first round of 
interviews. It was considered that consistency 
throughout the instrument would be preferable 
and therefore mixing responses should be 
avoided. 
This is true of any bother scale and the 
intention is that the scale will capture all 
aspects of the bothersomeness as one overall 
combined interpretation of the impact. The 
alternative of including two scales to address 
alternative situations was felt to lengthen the 
questionnaire unnecessarily as the majority of 
interviewees did not report a problem. 
This was felt to form an aspect of overall bother 
(item 58) when considered by the individual. It 
was deemed unnecessary to be added to the 
instrument as the item would not add anything 
further to the evaluation that clinicians or 
researchers would be aiming to address. 
However, an open ended final question was 
provided to allow respondents to raise any 
individual concerns for discussion. 
The item was thought to capture the situation 
reported by the participant who required new 
underwear but perhaps not address the more 
important issue for the patient, regarding the 
expense involved with constantly replacing 
underwear. As the remaining comment was a 
separate solitary issue, it was not felt necessary 
to make an amendment of this nature. 
While it was discussed that this would be 
captured within the history taken by clinicians 
or researchers, it was felt to be an interesting 
addition, particularly focussing on the 
individual's perception of cause. This was 
therefore added within the free text item at the 
end of the questionnaire. 
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dICIQ-B item sources 
Source of of items included within the final developmental ICIQ-B. 
APPENDIX 15 
Question item Source of item 




Nocturnal frequency BO  
Stool type  
BO frequency in 24 hours  
Staining due to bowels   
Liquid leakage frequency   
Ability to control liquid 
leakage_ 
  
Nocturnal liquid leakage 
frequency 
  
Liquid leakage amount  
Solid leakage frequency   
Ability to control solid 
leakage 
  
Nocturnal solid leakage 
frequency 
  
Solid leakage amount  
Wind leakage frequency   
Ability to control wind 
leakage 
  
Nocturnal wind leakage 
frequency 
 
Wind leakage amount  
Mucus leakage frequency 
Ability to control mucus 
leakage 
 
Nocturnal mucus leakage 
fre uenc 
 
Mucus leakage amount  
Duration of incontinence  
Warning of incontinence  













dICIQ-B item sources APPENDIX 15 
Question item Source of item 
Clinical expert opinion Patient input 










Incomplete evacuation  






Laxative medication use  
Inability to wipe clean . 
Anal pain/soreness '  
Smell worries t 




Restrict social activities t 








Always stay near toilet  
Aware of toilet location t 
S are ants/ ads carried t 
Make plans according to 
bowels 
t 
Alter food type t 
Alter food time t 
Restricted to house t 
Attempt to open bowels 
before going out 
t 
overall contribution 37 items 35 items 
areas wnere consensus not achieved 
tissues identified in both free text comments and patient interviews 
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Test-retest reliability results - distribution of responses APPENDIX 16 
Paired differences between test and retest responses for all items within the 
dICIQ-B. 
Question Difference N % Question Difference N % 
item between item between 
responses responses 
3a -3 1 1.4 8b -4 1 1.8 
-2 1 1.4 -2 1 1.8 
-1 6 8.1 -1 6 10.7 
0 51 68.9 0 38 67.9 
1 14 18.9 1 6 10.7 
3 1 1.4 2 3 5.4 
4 1 1.8 
3b -3 2 3.3 9a -2 3 4.6 
-2 2 3.3 -1 15 22.7 
-1 2 3.3 0 37 56.1 
0 49 80.3 1 8 12.1 
1 3 4.9 2 2 3.0 
2 3 4.9 3 1 1.5 
4a -2 1 1.4 10a -3 3 4.5 
-1 7 10.0 -2 2 3.0 
0 53 75.7 -1 3 4.5 
1 9 12.9 0 44 65.7 
1 14 20.9 
2 1 1.5 
6a -1 16 21.3 lla -1 10 15.9 
0 56 74.7 0 42 66.7 
1 3 4.0 1 9 14.3 
2 2 3.2 
6b -2 2 3.3 12a -5 1 1.3 
-1 7 11.7 -4 1 1.3 
0 48 80.0 -3 1 1.3 
1 2 3.3 -2 4 5.3 
2 1 1.7 -1 12 16.0 
0 46 61.3 
1 8 10.7 
2 1 1.3 
3 1 1.3 
7a -2 2 2.6 12b -4 1 2.0 
-1 7 9.1 -2 2 4.0 
0 56 72.7 -1 6 12.0 
1 10 13.0 0 32 64.0 
2 2 2.6 1 5 10.0 
2 1 2.0 
3 1 2.0 
4 2 4.0 
Sa -3 1 1.4 13a -3 4 6.7 
-2 1 1.4 -1 13 21.7 
-1 10 13.5 0 34 56.7 
0 45 60.8 1 5 8.3 
1 10 13.5 2 4 6.7 
2 4 5.4 
3 2 2.7 
5 1 1.4 
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Question Difference N % Question Difference N % 
item between item between 
responses responses 
14a -3 1 1.7 20a -3 2 2.6 
-2 1 1.7 -2 3 4.0 
-1 4 6.8 -1 7 9.2 
0 47 79.7 0 52 68.4 
1 5 8.5 1 6 7.9 
4 1 1.7 2 4 5.3 
3 2 2.6 
15a -1 8 14.6 20b -2 2 3.6 
0 42 76.4 -1 5 8.9 
1 4 7.3 0 39 69.6 
2 1 1.8 1 6 10.7 
2 3 5.4 
4 1 1.8 
16a -2 4 5.3 21a -2 1 2.4 
-1 11 14.5 -1 3 7.3 
0 47 61.8 0 30 73.2 
1 8 10.5 1 6 14.6 
2 3 4.0 3 1 2.4 
3 1 1.3 
4 2 2.6 
16b -4 1 1.6 22a -3 1 2.4 
-2 2 3.1 -2 1 2.4 
-1 2 3.1 -1 4 9.8 
0 52 81.3 0 29 70.7 
1 3 4.7 1 3 7.3 
2 2 3.1 2 3 7.3 
3 2 3.1 
17a -2 1 1.4 23a -2 1 2.4 
-1 10 13.7 -1 2 4.8 
0 52 71.2 0 32 76.2 
1 7 9.6 1 7 16.7 
2 2 2.7 
3 1 1.4 
18a -4 1 1.8 24a -2 1 1.4 
-2 5 8.8 -1 6 8.1 
-1 1 1.8 0 62 83.8 
0 39 68.4 1 5 6.8 
1 4 7.0 
2 3 5.3 
3 2 3.5 
4 2 3.5 
19a -1 7 10.0 25a -2 2 2.7 
0 46 65.7 -1 15 20.3 
1 15 21.4 0 45 60.8 
2 2 2.9 1 7 9.5 
2 5 6.8 
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Question Difference N % Question Difference N % 
item between item between 
responses responses 
26a -2 6 8.5 35a -2 1 1.3 
-1 11 15.5 -1 5 6.6 
0 41 57.8 0 64 84.2 
1 13 18.3 1 5 6.6 
2 1 1.3 
27a -4 1 1.4 36a -2 5 6.5 
-2 1 1.4 -1 9 11.7 
-1 12 16.4 0 53 68.8 
0 49 67.1 1 8 10.4 
1 10 13.7 2 2 2.6 
28a -2 2 2.7 37a -1 8 10.8 
-1 12 16.2 0 45 60.8 
0 46 62.2 1 19 25.7 
1 12 16.2 2 2 2.7 
2 2 2.7 
29a -3 1 1.5 38a -4 1 1.3 
-2 3 4.5 -3 1 1.3 
-1 11 16.4 -2 1 1.3 
0 40 59.7 -1 6 7.9 
1 8 11.9 0 60 79.0 
2 1 1.5 1 6 7.9 
3 3 4.5 4 1 1.3 
30a -2 4 5.6 39a -5 1 1.3 
-1 12 16.7 -1 4 5.2 
0 39 54.2 0 68 88.3 
1 13 18.1 1 3 3.9 
2 3 4.2 2 1 1.3 
4 1 1.4 
31a -2 2 2.7 40a -3 1 1.3 
-1 11 14.9 -2 2 2.6 
0 51 68.9 -1 13 16.9 
1 10 13.5 0 48 62.3 
1 13 16.9 
32a -2 2 2.7 41a -3 1 1.3 
-1 15 20.6 -2 1 1.3 
0 48 65.8 -1 9 11.7 
1 7 9.6 0 49 63.6 
2 1 1.4 1 16 20.8 
2 1 1.3 
33a -2 1 1.3 42a -2 2 2.6 
-1 7 9.1 -1 13 16.9 
0 58 75.3 0 52 67.5 
1 8 10.4 1 8 10.4 
2 2 2.6 2 2 2.6 
3 1 1.3 
34a -3 1 1.3 43a -2 4 5.3 
-1 14 18.2 -1 7 9.2 
0 51 66.2 0 50 65.8 
1 9 11.7 1 12 15.8 
2 2 2.6 2 3 4.0 
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Question Difference N % Question Difference N % 
item between item between 
responses responses 
44a -2 1 1.3 51a -3 1 1.3 
-1 9 11.7 -2 1 1.3 
0 52 67.5 -1 4 5.1 
1 14 18.2 0 63 80.8 
2 1 1.3 1 9 11.5 
45a -3 1 1.3 52a -2 1 1.3 
-2 5 6.6 -1 14 18.0 
-1 13 17.1 0 53 68.0 
0 50 65.8 1 10 12.8 
1 7 9.2 
46a -5 3 4.2 53a -1 15 19.2 
-4 1 1.4 0 43 55.1 
-2 1 1.4 1 17 21.8 
-1 5 6.9 2 3 3.9 
0 51 70.8 
1 9 12.5 
2 1 1.4 
5 1 1.4 
47a -2 3 4.0 54a -1 14 18.0 
-1 8 10.5 0 44 56.4 
0 57 75.0 1 17 21.8 
1 6 7.9 2 3 3.9 
2 2 2.6 
48a -5 2 2.8 55a -2 3 3.9 
-3 3 4.2 -1 12 15.6 
-2 4 5.6 0 49 63.6 
-1 7 9.7 1 8 10.4 
0 43 59.7 2 3 3.9 
1 8 11.1 3 2 2.6 
2 2 2.8 
3 1 1.4 
4 1 1.4 
5 1 1.4 
49a -2 3 4.0 56a -2 1 1.3 
-1 10 13.3 -1 8 10.3 
0 49 65.3 0 47 60.3 
1 9 12.0 1 22 28.2 
2 4 5.3 
50a -1 10 13.2 57a -3 1 1.3 
0 58 76.3 -2 4 5.3 
1 7 9.2 -1 7 9.2 
2 1 1.3 0 47 61.8 
1 17 22.4 
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Wilcoxon signed rank test results for all items within the dlCIQ-B - overall 














3a 33 (70.2) 26 (55.3) -7 (14.9) 0.1449= 
3b 29 (78.4) 25 (67.6) -4 (10.8) 0.2322; 
4a 14 (28.0) 10 (20.0) -4 (-8.0) 0.0583 
6a 42 (93.3) 30 (66.7) -12 (-26.6) 0.0201; 
6h 32 (86.5) 22 (59.5) -10 (-27.0) 0.22911 s 
7a 46 (92.0) 44 (86.3) -2 (-5.7) 0.0006t 
8a 42 (84.0) 34 (66.6) -8 (-17.4) 0.0031 
8b 40 (88.9) 33 (78.6) -7 (-10.3) 0.0261 
9a 44 (97.8) 38 (95.0) -6 (-2.8) 0.0185 
10a 21 (44.7) 15 (35.7) -6 (-9.0) 0.1 146 
11a 44 (95.7) 37 (90.2) -7 (-5.5) 0.3834 
12a 32 (65.3) 26 (51.0) -6 (-14.3) 0.0957 
12b 28 (73.7) 26 (66.7) -2 (-7.0) 0.0379 
13a 34 (94.4) 34 (89.5) 0 (-4.9) 0.0011 
_i 4a 8(21.6) 9(23.1) +1 (+ 1.5) 0.8033 
153 31 (88.6) 28 (71.8) -3 (-16.8) 0.0454 
163 45 (90.0) 42 (85.7) -3 (-4.3) 0.3027 
16b 41 (93.2) 36 (92.3) -5 (-0.9) 0.0833 
17a 46 (100.0) 45 (95.7) -1 (-4.3) 0.0023 
183 29 (70.7) 25 (64.1) -4 (-6.6) 0.0246 
193 45 (97.8) 45 (95.7) 0 (-2.1) 0.1031 
203 23 (47.9) 18 (36.0) -5 (-11.9) 0.1989 
20b 23 (57.5) 18 (47.4) -5 (-10.1) 0.2133 
213 26 (96.3) 19 (86.4) -7 (-9.9) 0.0051 
223 14 (51.9) 10 (43.5) -4 (-8.4) 0.1905 
233 25 (92.6) 17 (73.9) -8 (-18.7) 0.0535 
243 48 (100.0) 48 (100.0) - - 
25a 44 (91.7) 41 (89.1) -3 (-2.6) 0.0274 
263 37 (77.1) 34 (72.3) -3 (-4.8) 0.0310 
273 38 (79.2) 31 (67.4) -7(-11.8) 0.1312 
283 26 (54.2) 26 (56.5) 0 (+2.3) 0.6551 
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29a 20 (45.5) 17 (40.5) -3 (-5.0) 0.2229 
30a 37 (77.1) 30 (63.8) -7 (-13.3) 0.2598 
31a 47 (97.9) 42 (93.3) -5 (-4.6) 0.3669 
32a 46 (95.8) 42 (91.3) -4 (-4.5) 0.0146 
33a 50 (100.0) 49 (96.1) -1 (-3.9) 0.0010 
34a 39 (78.0) 38 (74.5) -1 (-3.5) 0.3166 
35a 41 (82.0) 44 (86.3) +3 (+4.3) 0.9498 
36a 44 (88.0) 47 (92.2) +3(+4.2) 0.0906 
37a 34 (70.8) 31 (60.8) -3 (-10.0) 0.0119 
38a 26 (53.1) 28 (56.0) +2(+2.1-)) 0.6396 
39a 16 (31.3) 12 (24.0) -4 (-7.3) 0.0341 
40a 43 (84.3) 39 (78.0) -4 (-6.3) 0.1100 
41a 43 (84.3) 40 (80.0) -3 (-4.3) 0.2383 
42a 43 (84.3) 43 (86.0) 0 (+1.7) 0.7336 
43a 45 (88.2) 41 (82.0) -4 (-6.2) 0.1889 
44a 46 (90.2) 40 (80.0) -6 (-10.2) 0.1157 
45a 39 (78.0) 38 (74.5) -1 (-3.5) 0.2027 
46a 24 (77.4) 19 (63.3) -5 (-14.1) 0.3842 
47a 47 (94.0) 47 (92.2) 0 (-1.8) 0.1122 
48a 25 (67.6) 23 (67.6) -2 (0) 0.6987 
49a 38 (76.0) 36 (70.6) -2 (-5.4) 0.6289 
50a 47 (94.0) 44 (86.3) -3 (-7.7) 0.0236 
51a 47 (94.0) 47 (94.0) 0 (0) 0.7232 
52a 44 (88.0) 45 (90.0) +1 (+2.0) 0.3844 
53a 42 (84.0) 41 (82.0) -1 (-2.0) 0.0083 
54a 44 (88.0) 47 (94.0) +3 (+6.0) 0.7211 
55a 31 (63.3) 31 (62.0) 0(-1.3) 0.1017 
56a 40 (80.0) 33 (66.0) -7 (-14.0) 0.0130 
57a 45 (90.0) 43 (86.0) -2 (-4.0) 0.2962 
58 45 (90.0) 19 (38.0) -26 (-52.0) 0.0001 tt 
Shaded items represent those sensitive to change. 
, alteration in response category evaluated as absence not expected 
tretains significance with Bonferroni correction 
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Conservative management sub-group 
APPENDIX 18 
Wilcoxon signed rank test results for all items within the dICIQ-B - conservative 














3a 24 (68.6) 19 (54.3) -5 (-14.3) 0.1040$ 
3b 21 (80.8) 18 (69.2) -3 (-11.6) 0.4622$ 
4a 11 (28.9) 9 (23.7) -2 (-5.2) 0.1450 
6a 31 (93.9) 22 (66.7) -9 (-27.2) 0.0348$ 
6b 24 (85.7) 18 (64.3) -6 (-21.4) 0.5819$ 
7a 35 (92.1) 35 (89.7) -1 (-2.4) 0.0056 
8a 32 (84.2) 26(66.7) -6 (-17.5) 0.0055 
8b 32 (94.1) 26 (83.9) (-10.2) 0.1183 
9a 35 (97.2) 31 (93.9) -4 (-3.3) 0.1004 
l0a 15 (39.5) 13 (38.2) -2 (-1.3) 0.3517 
11a 35 (94.6) 30 (90.9) -5 (-3.7) 0.4795 
12a 22 (59.5) 19 (48.7) -3 (-10.8) 0.4014 
12b 21 (70.0) 18 (64.3) -3 (-5.7) 0.1622 
13a 24 (92.3) 26 (89.7) +2 (-2.6) 0.0046 
14a 4 (14.8) 7(23.3) +3 (+8.5) 0.1671 
15a 21 (84.0) 22 (73.3) -4 (-10.7) 0.4795 
16a 35 (92.1) 33 (86.8) -2 (-5.3) 0.1015 
16b 32 (97.0) 27 (96.4) -5 (-0.6) 0.0747 
17a 36 (100.0) 35 (94.6) -1 (-5.4) 0.0463 
18a 21 (67.7) 18 (62.1) -3 (-5.6) 0.0557 
19a 35 (97.2) 35 (94.6) 0 (-2.6) 0.2059 
20a 15 (41.7) 12 (31.6) -3 (-10.1) 0.1570 
20b 17 (58.6) 13 (46.4) -4 (-12.2) 0.5054 
21a 19 (95.0) 14 (93.3) -5 (-1.7) 0.0464 
22a 9 (45.0) 7(43.8) -2 (-1.2) 0.8881 
23a 18 (90.0) 13 (81.3) -5 (-8.7) 0.2.568 
24a 37 (100.0) 36 (100.0) - 0.4003 
25a 33 (89.1) 33 (91.7) 9 (+2.6) 0.2997 
26a 26 (70.2) 28 (75.7) +2 (+5.5) 0.3820 
27a 27 (73.0) 24 (66.7) -3 (-6.3) 0.7985 
28a 19 (51.3) 19 (52.8) (1 (+1.5) 0.2887 
29a 13 (38.2) 13 (38.2) 0 (0.0) 0.7488 
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30a 27 (73.0) 23 (62.2) -4 (-10.8) 0.3277 
31a 36 (97.3) 34 (94.4) -2 (-2.9) 0.9480 
32a 35 (94.6) 33 (89.2) -2 (-5.4) 0.0211 
33a 39 (100.0) 37 (94.9) -2 (-5.1) 0.0104 
34a 30 (76.9) 28 (71.8) -2 (-5.1) 0.5350 
35a 32 (82.1) 35 (89.7) +3 (+7.6) 0.5763 
36a 34 (87.2) 36 (92.3) +2 (+5.1) 0.3461 
37a 24 (64.9) 20 (51.3) 4(-13.6) 0.0134 
38a 17 (44.7) 20 (52.6) +3 (+7.9) 0.5774 
39a 11 (28.2) 9 (23.7) -2 (-4.5) 0.2173 
40a 32 (82.1) 29 (76.3) -3 (-5.8) 0.4747 
41a 31 (79.5) 30 (78.9) -1 (-0.6) 0.5854 
42a 31 (82.1) 33 (86.8) +2 (+4.7) 0.3617 
43a 34 (87.2) 31 (81.6) -3 (-5.6) 0.4009 
44a 34 (87.2) 29 (76.3) -5 (-10.9) 0.0932 
45a 29 (76.3) 28 (71.8) -1 (-4.5) 0.3947 
46a 33 (86.8) 30 (78.9) -3 (-7.9) 0.7286 
47a 36 (94.7) 37 (94.9) +1 (+0.2) 0.2898 
48a 28 (73.7) 30 (76.9) +2 (+3.2) 0.6328 
49a 26 (68.4) 27 (69.2) +1 (+0.8) 0.8446 
50a 36 (94.7) 35 (89.7) -1 (-5.0) 0.0302 
51a 36 (94.7) 36 (94.7) ogo) 0.5663 
52a 33 (86.8) 34 (89.5) +1 (+2.7) 0.7002 
53a 31 (81.6) 31 (81.6) 0(0.0)6 0.0480 
54a 33 (86.8) 35 (92.1) +2 (+5.3) 0.1148(, 
55a 22 (59.5) 22 (57.9) 0 (-1.6) 0.1489 
56a 29 (76.3) 24 (63.2) -5 (-13.1) 0.0273 
57a 33 (86.8) 33 (84.6) 0(-2.2) 0.3488 
58 33 (86.8) 11 (28.9) (-57.9) 0.0004$t 
Shaded items represent those sensitive to change. 
$alteration in response category evaluated as absence not expected 
tretains significance with Bonferroni correction 
Sno change is indicated as proportions relate to complete resolution of symptoms. Wilcoxon- 
signed ranks test evaluated significance of any improvement. 
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Surgical management sub-group 
APPENDIX 19 
Wilcoxon signed rank test results for all items within the dICIQ-B - surgical 














3a 9(75.0) 7(58.3) -2(-16.7) 0.8591 
3b 8 (72.7) 7 (63.6) -1 (-9.1) 0.29454 
4a 3 (25.0) 1 (8.3) -2 (-16.7) 0.1573 
6a 11 (91.7) 8 (66.7) -3(-25.0) 0.3173$ 
6b 8 (88.9) 4 (44.4) -4 (-44.5) 0.1797$ 
7a 11 (91.7) 9 (75.0) -2 (-16.7) 0.0441 
Sa 10 (83.3) 8 (66.7) -2(-16.6) 0.2893 
8b 8 (72.7) 7 (63.6) -1 (-9.1) 0.0808 
9a 9 (100.0) 7 (100.0) -2 (0.0)3 0.0496 
10a 6(66.7) 2(25.0) -4 (-41.7) 0.1447 
Ila 9 (100.0) 7 (87.5) -2 (-12.5) 0.5564 
12a 10 (83.3) 7 (58.3) -3 (-25.0) 0.0755 
12b 7(87.5) 8 (72.7) +1 (-14.8) 0.0848 
13a 10 (100.0) 8 (88.9) -2 (-11.1) 0.0919 
14a 4 (40.0) 2 (22.2) -2 (-17.8) 0.2348 
15a 10 (100.0) 6 (66.7) -4 (-33.3) 0.0276 
16a 10 (83.3) 9 (81.8) -1 (-1.5) 0.3464 
16b 9(81.8) 9(8-1.8) 0 (0.0) 0.6547 
17a 10 (100.0) 10 (100.0) 0 (0.0)3 0.0167 
18a 8 (80.0) 7 (70.0) -I (-10.0) 0.2018 
19a 10 (100.0) 10 (100.0) 0 (0.0) 0.2893 
20a 8 (66.7) 6 (50.0) -2 (-16.7) 0.7987 
20b 6 (54.5) 5 (50.0) -1 (-4.5) 0.2430 
21 a 7 (100.0) 5 (71.4) -2 (-28.6) 0.0516 
22a 5 (71.4) 3 (42.9) -2(-28.5) 0.0495 
23a 7 (100.0) 4 (57.1) -3 (-42.9) 0.1)863 
24a 11 (100.0 10 (100.0) -1 (0.0) 0.1573 
25a 11 (100.0) 8 (80.0) -3 (-20.0) 0.0165 
26a 11 (100.0) 6 (60.0) -5 (-40.0) 0.0165 
27a 11 (100.0) 7 (70.0) -4 (-30.0) 0.0099 
28a 7 (63.6) 7 (70.0) 0 (+6.4) 0.3173 
29a 7 (70.0) 6 (50.0) -2 (-20.0) 0.0833 
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30a 10 (90.9) 7 (70.0) -3 (-20.9) 0,5791 
31a 11 (100.0) 8 (88.9) -3 (-11.1) 0.0477 
32a 11 (100.0) 9 (100.0) -2 (0.0) 0.3173 
33a 11 (100.0) 12 (100.0) 0 (0.0)6 0.0267 
34a 9(81.8) 10 (83.3) +1 (+1.5) 0.2945 
35a 9 (81.8) 9 (75.0) 0 (-6.8) 0.3656 
36a 10 (90.9) 11 (91.7) +1 (+0.8) 0.0464 
37a 10 (90.9) 11 (91.7) +1 (+0.8) 0.5637 
38a 9(81.8) 8 (66.7) -1 (-15.1) 0.0469 
39a 5(41.7) 3 (25.0) -2 (-16.7) 0.0466 
40a 11 (91.7) 10 (83.3) -1 (-8.4) 0.0556 
41a 12 (100.0) 10 (83.3) -2 (-16.7) 0.0839 
42a 11 (91.7) 10 (83.3) -1 (-8.4) 0.2965 
43a 11 (91.7) 10 (83.3) -1 (-8.4) 0.2661 
44a 12 (100.0) 11 (91.7) -1 (-8.3) 0.8981 
45a 10 (83.3) 10 (83.3) 0 (0.0) 0.2886 
46a 10 (83.3) 9 (75.0) -1 (-8.3) 0.2314 
47a 11 (91.7) 10 (83.3) -1 (-8.4) 0.1677 
48a 10 (83.3) 10 (83.3) 0 (0.0) 0.9244 
49a 12 (100.0) 9 (75.0) -3 (-25.0) 0.5345 
50a 10 (83.3) 9 (75.0) -1 (-8.3) 0.4959 
51a 11 (91.7) 11 (91.7) 0 (0.0) 0.0839 
52a 11 (91.7) 11 (91.7) 0 (0.0) 0.2965 
53a 11 (91.7) 10 (83.3) -1 (-8.4) 0.0466 
54a 11 (91.7) 12 (100.0) +1 (ý8.3) 0.5221 
55a 9 (75.0) 9 (75.0) 0 (0.0) 0.3173 
56a 11 (91.7) 9(75.0) -2 (-16.7) 0.2568 
57a 11 (91.7) 10 (90.9) -1 (-0.8) 0.6042 
58 12 (100.0) 8 (66.7) -4 (-33.3) 0.0467$ 
Shaded items represent those sensitive to change. 
talteration in response category evaluated as absence not expected 
tretains significance with Bonferroni correction 
Sno change is indicated as proportions relate to complete resolution of symptoms. Wilcoxon- 
signed ranks test evaluated significance of any improvement. 
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"Improved with treatment" sub-group 
Wilcoxon signed rank test results for all items within the dICIQ-B - individuals 














3a 19 (65.5) 14 (48.3) -5 (-17.2) 0.2374$ 
3b 13 (72.2) 12 (66.7) -1 (-5.5) 0.1288$ 
4a 9 (31.0) 7 (23.3) -2 (-7.7) 0.0578 
6a 26 (96.3) 17 (62.3) -9 (-34.0) 0.0114$ 
6b 17 (85.0) 10 (50.0) -7 (-35.0) 0.20,59t 
7a 27 (93.1) 26 (86.7) -1 (-6.4) 0.0033 
8a 25 (83.3) 18 (60.0) -7 (-23.3) 0.0012 
8b 22 (88.0) 18 (75.0) -4 (-13.0) 0.0413 
9a 26 (96.3) 21 (95.5) -5 (-0.8) 0.2977 
1a 11 (40.7) 8 (34.8) -3 (-5.9) 0.2406 
]]a 26 (96.3) 19 (82.6) -7 (-13.7) 0.3915 
12a 20 (69.0) 12 (40.0) -8 (-29.0) 0.0196 
12b 17 (77.3) 14 (63.6) -3 (-13.7) 0.0169 
13a 20 (95.2) 19 (86.4) -1 (-8.8) 0.0045 
14a 5 (23.8) 4 (18.2) -1 (-5.6) 0.5724 
15a 17 (89.5) 15 (68.2) -2 (-21.3) 0.0780 
16a 28 (93.3) 25 (86.2) -3 (-7.1) 0.4529 
16b 23 (92.0) 20 (95.2) -3(+3.2) 0.4321 
17a 27 (100.0) 27 (93.1) 0 (-6.9) 0.0372 
18a 16 (61.5) 15 (60.0) -1 (-1.5) 0.0187 
19a 26 (96.3) 27 (93.1) +1 (-3.2) 0.4515 
20a 13 (44.8) 10 (33.3) -3 (-11.5) 0.0414 
20b 10 (47.6) 8 (38.1) -2 (-9.5) 0.5605 
21a 13 (92.9) 9 (81.8) -4 (-11.1) 0.0281 
22a 6 (42.9) 4 (33.3) -2 (-9.6) 0.13t n 
23a 12 (92.3) 9 (75.0) -3 (-17.3) 0.0253 
24a 29 (100.0) 28 (100.0) -1(0.0) 0.3082 
25a 25 (86.2) 23 (82.1) -2 (-4.1) 0.1102 
26a 20 (69.0) 20 (69.0) 0(0.0)6 0.1623 
27a 24 (82.8) 19 (67.9) -5 (-14.9) 0.2366 
28a 13 (44.8) 13 (46.4) 0 (+1.6) 0.3942 
29a 13 (50.0) 15 (60.0) +2 (+10.0) 0.2498 
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30a 24 (82.8) 19 (65.5) -5 (-17.3) 0.0737 
31a 28 (96.6) 24 (88.9) -4 (-7.7) 0.4724 
32a 28 (96.6) 25 (89.3) -3 (-7.3) 0.0286 
33a 28 (96.6) 28 (93.3) 0 (-3.3) 0.0012 
34a 22 (75.9) 20(667) -2 (-9.2) 0.0687 
35a 21 (72.4) 25 (83.3) +4 (+10.9) 0.7544 
36a 24 (82.8) 27 (90.0) +3 (+7.2) 0.1767 
37a 18 (64.3) 15 (50.0) -3 (-14.3) 0.0251 
38a 16 (57.1) 17 (56.7) +1 (-0.4) 0.5481 
39a S(26.7) 7 (24.1) -1 (-2.6) 0.3583 
40a 27 (90.0) 24 (82.8) -3 (-7.2) 0.0114 
41a 24 (80.0) 21 (72.4) -3 (-7.6) 0.1958 
42a 25 (83.3) 23 (79.3) -2 (-4.0) 0.9625 
43a 28 (93.3) 25 (86.2) -3 (-7.1) 0.3281 
44a 27 (90.0) 24 (82.8) -3 (-7.2) 0.1411 
45a 22 (75.9) 22 (73.3) 0 (-2.6) 0.1237 
46a 25 (86.2) 24 (80.0) -2 (-6.2) 0.8675 
47a 27 (93.1) 27 (90.0) 0 (-3.1) 0.1984 
48a 21 (72.4) 21 (70.0) 0 (-2.4) 0.4310 
49a 21 (72.4) 20 (66.7) -1 (-5.7) 0.7852 
50a 28 (96.6) 25 (83.3) -3 (-13.3) 0.0084 
51a 28 (96.6) 28 (96.6) 0 (0.0) i 0.6577 
52a 25 (86.2) 26 (89.7) +1 (+3.5) 0.3040 
53a 25 (86.2) 24 (82.8) -1 (-3.4) 0.0179 
54a 27 (93.1) 28 (96.6) +1 (+3.5) 0.5439 
55a 18 (64.3) 18 (62.1 ) 0 (-2.2) 0.1541 
56a 23 (79.3) 18 (62.1) -5 (-17.2) 0.0037 
57a 27 (93.1) 23 (79.3) -4 (-13.8) 0.0098 
58 26 (89.7) 8 (27.6) -18 (-62.1) 0.0004$t 
Shaded items represent those sensitive to change. 
$alteration in response category evaluated as absence not expected 
tretains significance with Bonferroni correction 
no change is indicated as proportions relate to complete resolution of symptoms. Wilcoxon- 
signed ranks test evaluated significance of any improvement. 
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"Not improved with treatment" sub-group 
Wilcoxon signed rank test results for all items within the dICIQ-B - individuals 














3a 5 (71.4) 4 (57.1) -1 (-14.3) 0.5637 
3b 6 (66.7) 5 (55.6) -1 (-11.1) 0.2893 
4a 2 (20.0) 2 (22.2) 0 (+2.2) 0.6148 
6a 6 (85.7) 6 (85.7) 0 (0.0) 0.3173 
6b 6 (85.7) 4 (57.1) -2 (-28.6) 0.7023 
7a 9 (90.0) 9 (90.0) 0 (0.0) 0.0842 
8a 9 (90.0) 9 (90.0) 0 (0.0) 0.9498 
8b 8 (88.9) 8 (88.9) 0 (0.0) 0.7130 
9a 9 (100.0) 8 (88.9) -1 (-11.1) 0.2618 
10a 6 (66.7) 5 (55.6) -1 (-11.1) 0.5637 
lia 9 (100.0) 9 (100.0) 0 (0.0) 1.0000 
12a 5 (55.6) 7 (70.0) +2 (+14.4) 0.8018 
12b 5 (71.4) 7 (87.5) +2 (+16.1) 1.0000 
13a 7 (100.0) 8 (100.0) +1(0.0)8 0.0861 
14a 2 (28.6) 4 (50.0) +2 (+21.4) 0.1585 
15a 7 (100.0) 7 (87.5) 0 (12.5) 0.1573 
16a 7(77.8) 7(77.8) 0 (0.0) 0.3173 
16b 7 (87.5) 8 (88.9) +1 (+1.4) 0.9251 
17a 8 (100.0) 8 (100.0) 0 (0.0) 0.3173 
18a 5 (83.3) 4 (66.7) -1 (-16.6) 0.3173 
19a 8 (100.0) 8 (100.0) 0 (0.0) 0.3173 
20a 5 (62.5) 4 (44.4) -1 (-18.1) 0.5564 
20b 7 (77.8) 5 (55.6) -2 (-22.2) 0.3903 
21a 7 (100.0) 5 (83.3) -2 (-16.7) 0.3173 
22a 5 (71.4) 5 (83.3) 0 (+11.9) 0.4773 
23a 7 (100.0) 5 (83.3) -2 (-16.7) 0.1573 
24a 9 (100.0) 9 (100.0) 0 (0.0) 1.0000 
25a 9 (100.0) 9 (100.0) 0 (0.0) 0.1573 
26a 8 (88.9) 6 (66.7) -2 (-22.2) 0.1580 
27a 7 (77.8) 8 (88.9) +1 (+11.1) 0.4142 
28a 5 (55.6) 6 (66.7) +1 (+11.1) 0.5637 
29a 2 (25.0) 3 (33.3) +1 (+8.3) 0.3173 
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30a 6 (66.7) 5 (55.6) -1 (-11.1) 0.6662 
31a 9 (100.0) 9 (100.0) 0 (0.0) 0.3173 
32a 8 (88.9) 8 (88.9) 0 (0.0) 1.0000 
33a 10 (100.0) 10 (100. ()) 0 (0.0) 0.6089 
34a 6 (60.0) 8 (80.0) +2 (+20.0) 0.0466 
35a 1O (100.0) 10 (100.0) 0 (0.0) 0.5225 
36a 9 (90.0) 9(90.0) 0 (0.0) 0.3173 
37a 7 (77.8) 7 (70.0) 0 (-7.8) 0.5637 
38a 7 (70.0) 7 (70.0) 0 (0.0) 0.6544 
39a 3 (30.0) 2 (20.0) -1 (-10.0) 0.1579 
40a 6 (60.0) 7(70.0) +1 (+10.0) 0.2212 
41a 8 (80.0) 9 (90.0) +1 (+10.0) 0.5225 
42a 9 (90.0) 9 (90.0) 0 (0.0) - 
43a 8 (80.0) 7 (70.0) -1 (-10.0) 1.0000 
44a 9 (90.0) 9 (90.0) 0 (0.0) 0.5637 
45a 9(90-0) 8(80.0) -1 (-10.0) 0.6547 
46a 8 (80.0) 7 (70.0) -1 (-10.0) 0.1508 
47a 9 (90.0) 9 (90.0) 0 (0.0) 0.1573 
48a 8 (80.0) 8 (80.0) 0 (0.0) 0.6547 
49a 9 (90.0) 8 (80.0) -1 (-10.0) 0.5225 
50a 8 (80.0) 9 (90.0) +1 (+10.0) 0.1579 
51a 9 (90.0) 9 (90.0) 0 (0.0) - 
52a 9 (90.0) 9 (90.0) 0 (0.0) 1.0000 
53a 9(90.0) 8 (80.0) -1 (-10.0) 0.3173 
54a 8 (80.0) 9 (90.0) +1 (+10.0) 0.5791 
55a 7 (70.0) 7 (70.0) 0 (0.0) - 
56a 7(70.0) 8 (80.0) +1 (+10.0) 0.3173 
57a 9 (90.0) 9 (90.0) 0 (0.0) 0.6544 
58 9 (90.0) 7 (70.0) -2 (-20.0) 0.5225 
Shaded items represent those sensitive to change. 
$alteration in response category evaluated as absence not expected 
Eno change is indicated as proportions relate to complete resolution of symptoms. Wilcoxon- 
signed ranks test evaluated significance of any improvement. 
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Factor loadings for the twenty five symptom items includedin the preliminary 
factor analysis. 
Question item Factor Ioadin s 
Factor 1 Factor 2 
4a Bowel opening frequency (night) 0.38 
6a Usual bowel opening frequency (24 hours) 0.45 
6b At worst bowel opening frequency (24 hours) 0.51 
7a Underwear staining 0.55 
8a Usual liquid stool leakage 0.76 
8b At worst liquid stool leakage 0.70 
Ila Amount liquid stool leakage 0.30 
12a Usual solid stool leakage 0.67 
12b At worst solid stool leakage 0.65 
15a Amount solid stool leakage 0.38 
17a Control flatus leakage 0.61 
20a Usual mucus leakage 0.63 
20b At worst mucus leakage 0.63 
25a Incontinence warning 0.56 
26a Unexplained incontinence 0.63 
30a Incontinence with exertion 0.43 
31a Unpredictability 0.28 
32a Incontinence on the mind 0.32 
33a Urgency 0.60 
34a Flatus discrimination 0.42 
35a Straining 0.43 
36a Incomplete evacuation 0.49 
38a Antidiarrhoeal use 0.56 
40a Ability to wipe clean 0.50 
41a Anal pain /soreness 0.24 
Shaded items indicate those that did not load well onto a factor. 
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Factor loadings for the ten quality of life items includedin the preliminary factor 
analysis. 
Question item Factor loadings 
Factor 1 
42a Worries about smell 0.52 
44a Physical activity restriction 0.84 
45a Social activity restriction 0.84 
46a Sexual activity restriction 0.37 
47a Embarrassment 0.65 
51a Toilet location awareness 0.70 
53a Plan according to bowels 0.81 
55a Food time alteration 0.68 
56a Stay home more 0.85 
58 Overall bowel interference 0.77 
Shaded items indicate those that did not load well onto a factor. 
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diCl" 
QQ QQ QQ 
CONFIDENTIAL DAY MONTH YEAR 
Today's date 
Many people experience bowel accidents or bowel leakages. We are trying to find out how 
many people experience these symptoms and how much this bothers them. We would be 
grateful if you could answer the blowing questions, thinking about how you have been over the 
PAST THREE MONTHS. 
I Please write in your date of birth: 
2 Are you (leck are): 
Bowel pattern 
QQQQQQ DAY MONTH YEAR 
Female [] Male E: ] 
3 On average how many times do you open your bowels in 24 hours? 
(Tick one box for 'usual' and tick one box for 'at Worst9 
(a) (b) 
Usual At worst 
less than once EI ' 0, 
one to three times _ D, 
three to ten times El, 
ten or more times 
11'4 
(c) How much does this bother you? 
444 ýýý11 
Please ring a number between 0 (not at al! ) and t0 (a great deal) 
0123456789 10 
not at all a great deal 
4 How often do you open your bowels during the night from going to bed to sleep 
until you get up in the morning? (lick one box) 
(a) 




four or more times [J 
(b) How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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5 Do you have to rush to the toilet when you need to open your bowels? 




some of the time Q= 
most or the time Q, 
always Q 
(b) How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
6 Do you use medications (tablets or liquids) to stop you opening your bowels? 
(Tick one box) 
a 
never 
less than once a month D 
less than once a week : 
less than once a day Q 
about once a day [--I 
several times a day Q 
(b) How much does this bother you? 
Please ring a number between 0 (not at alp and 10 (a great deal) 
0123456789 10 
not at all a great deal 
7 Do you experience pain/soreneas around your back passage? (Tx one box) 
(a) 
never E: 1 
rarely Q 
some of the dme Q 
most of the time Q 
always 
(b) How much does this bother you? 
Please ring a number between 0 (not at a! Q and 10 (a great deal) 
0123456789 10 
not at all 2 great deal 






8 Do you experience any staining of your underwear or need to wear pads because 
of your bowels? (Tick one box) 
(a) 
never Qa 
less than once a month [7 
less than once a week 
less than once a day 
everyday Q 
(b) How much does this bottler you? 
Please Rng a number betwreen 0 (not at alI and t0 (a great deal) 
0123456789 10 
not at all a great deal 
9 Are you able to control watery or loose stool leaking from your back passage? 
(Tick one box) 
(a) 
atwaysa most of the time j 
some of the time [- 
rarery 0 
never 
(b) How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
10 Are you able to control accidental loss of formed or solid stool from your back 
passage? (Tick one box) 
always 
most of the time 0, 
some of the time F -I 
rarelly a never [] 
(b) How much does this bother you? 
Please ring a number between 0 (not at al0 and 10 (a great deal) 
0123456789 10 
not at at! a great deal 
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11 Are you able to control wind (flatus) escaping from your back passage? 
(Tick one box) 
(a) 
Q, always 
most of the time Q 
some of the time Q= 
rarely 
(b) How much does this bother you? 
never 
Please ring a number between 0 (not at alQ and 10 (a great deal) 
0123456789 10 
not at all a great deal 
12 Are you able to control mucus (disdwge) leaking from your back passage? 
(Tick one box) 
a 
always F-I 
most of the time [] , 
some of the time Q 
rarely 0, 
never 0 
(b) How much does this bother you? 
Please nng a number between 0 (not at NO and 10 (a great deal) 
0123456789 10 
not at all a great deal 
13 Do you have bowel accidents when you have no need to open your bowels? 
(Tick one box) 
(a) 
never E] " 
rarely 
some of the time 
most of the lime 0 
A ways 
(b) How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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some of the time Q 
most of the time 
always 
(b) How much does this bother you? 
Please nng a number bet een 6 i'ot at all) and t0 {a great deaf) 
0123456789 10 
not at all a great dea! 
Bowel control score: sum scores 8a - 14a F-I 1: 1 
Other bowel symptoms 
15 Using the pictures please indicate how your bowel movements are most of the 
time? (Tick all boxes that apply? 
la) 
separate hard lumps like nuts (hard to pass) 
sausage-shaped but lumpy 
like a sausage but with cracks on its surface 
like a sausage or snake - smooth and soft 
F 
soft blobs with clear cut edges (easy to pass) F1 
flufry nieces with ragged edges, a mushy stool ue 
watery. no solid pieces 
(b l How much does this bother you? 
Please ri rg a number between 0 (. not at all) and 110 (a great deal) 
0123456789 10 
not at all a great deal 
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some of the time 
most of the time C] 
] 
(b) How much does this bother you? ys[ 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 




some of the time Q: 
most of the time Q 
always 4 
(b) How much does this bother you? 
always 
L1 
Please ring a number between 0 (not at a!! ) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
Sexual impact 
18 Do you restrict your sexual activities because of your bowels? (Tick one box) 
a 
never F-I 
rarely [: j 
some of the time [] 2 
most of the time Q 
always F-1 - 
not apßhcable [] + 
(b) How much does this bother you? 
Please ring a number between 0 (not at ail) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
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19 Do your bowels cause you to feel embarrassed? (Tick one box) 
(a) 
never C] - 
rareiy 0 
some of the time Q= 
most of the time Q 
aWaysED 
(b) How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
20 Do your bowels cause you to make sure you know where toilets are? 




some of the time [J J 
most of the time D 
always 
(b) How much does this bother you? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0123456789 10 
not at aN a great deal 
21 Do your bowels cause you to make plans according to your bowels? 
(Tick one box) 
a 
never F-I Q 
rarely 0 
some of the time [J : 
most of the timeE] 
always Q 
(b) How much does this bother you? Please ring a number between 0 (not at alq and 10 (a great deal) 
0123456789 10 
not at a0 a great deal 
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22 Do your bowels cause you to stay home more often than you would like? 




some of the time Q 
most of the time Q 
(b) Now much does this bother you? 
always El 
Please ring a number between 0 (not at alf) and 10 (a great deal) 
0123456789 10 
not at all a great deal 
23. Overall, how much do your bowels interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
01234567B9 10 
not at all a great deal 
Quality of life score: sum scores 19a -23 
R 
24 Please use the space below to describe any worries you have about bowel 
accidents or leakages, what you think may have caused your bowel accidents or 
leakages, or anything else you think we should know. 
Thank you very much for answering these questions. 
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